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Traditional Chinese medicine (TCM) plays an important role in health care 
systems in many parts of the world. Most people in the Asiatic countries are 
firm believers in traditional herbal medicines for cure and for body-
strengthening purposes. A general perception that TCM lacks systematic 
pharmacological, toxicological, and clinical studies. The deficiency In 
efficacy and safety has been a major hindrance to the progress of TCM, 
despite the success of herbal medicine in treatment of diseases for which the 
orthodox drugs in western medicine are ineffective. Although there is a huge 
amount of data available documenting the pharmacologically active 
ingredients of many herbal medicine, cases of severe toxicity resulting from 
use of herbal medicine were documented occasionally. This brief review 
aims to serve as an introduction and a reference guide to TCM toxicology. 
The reason of herbal toxicity occurs not only because of a lack of 
pharmaceutics quality control in harvesting and because the increased 
awareness among physicians and allied professionals of the toxic potential of 
some of these substances. In order to clarify the adverse reaction caused by 
III 
herbal medicine, a systematic research is necessary. With the information 
from my studies show that problems may arise when toxic herbs are used in 
excessive doses，with improper preparation, or when they are substituted 
erroneously. Future TCM research, new drug development, and safety 
evaluation require adequate toxicity testing and mechanistic toxicology studies. 
Considering the extent of use of Chinese herbal medicine, a large scaled 
continued surveillance program is necessary to detect, evaluate, and develop 
mechanisms to prevent the adverse effects of Chinese herbal medicine. (299 
words) 
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中 藥 不 良 反 應 
論 文 摘 要 
傳 統 的 中 藥 在 全 球 各 地 醫 療 領 域 中 均 佔 一 重 要 席 位 ， 尤 
其 亞 洲 地 區 的 居 民 更 深 信 傳 統 的 中 藥 除 可 治 病 外 更 有 強 身 
保 健 的 效 果 ’ 但 一 般 民 眾 對 傳 統 中 藥 的 理 解 所 知 不 多 ’ 普 
遍 認 爲 傳 統 中 藥 雖 然 對 某 類 西 藥 未 能 治 療 的 頑 疾 有 效 ， 但 
其 真 正 的 療 效 及 安 全 性 等 均 缺 乏 科 學 化 理 據 的 支 持 ’ 而 且 
更 缺 乏 公 認 的 臨 床 藥 理 及 毒 理 方 面 的 試 驗 引 證 ， 所 以 亦 造 
成 發 展 傳 統 中 醫 藥 的 一 大 障 礙 。 雖 然 近 年 科 學 界 公 佈 大 量 
有 關 各 種 草 藥 之 有 效 藥 理 成 份 數 據 結 果 ， 但 同 時 亦 有 不 少 
的 中 藥 不 良 反 應 個 案 公 開 ， 這 種 情 況 不 但 是 由 於 草 藥 製 品 
於 生 產 過 程 中 存 在 質 量 控 制 的 問 題 ， 更 由 於 醫 療 人 員 及 民 
眾 對 此 提 高 警 覺 及 加 深 認 識 所 致 。 爲 對 中 藥 的 不 良 反 應 加 
深 了 解 ， 是 有 必 要 對 此 作 出 深 入 的 硏 究 ； 而 從 今 次 的 研 究 
中 發 現 大 多 數 中 毒 個 案 是 由 於 過 量 使 用 有 毒 中 藥 及 其 配 製 
方 面 出 錯 或 錯 誤 運 用 其 他 有 毒 中 藥 所 致 ° 爲 日 後 能 全 面 發 
展 中 醫 藥 ， 對 中 藥 的 安 全 性 是 需 要 有 足 夠 之 毒 理 分 析 及 硏 
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Chapter 1 - Introduction 
Modem medicine developed very quickly and made major contributions to disease 
control in the past century. Interestingly, despite a rapid growth in knowledge and 
techniques in modem medicine, the later decade of the last century also saw a 
dramatically increased interest in traditional medicine. The increasing public demand 
for its use has led to considerable interest among policy—makers, health administrators, 
and medical doctors on the possibilities of bringing traditional and modem medicine 
together. This increasing use of traditional medicine is also raising the interest of 
governments. Several countries and areas in the region are seriously considering 
integrating traditional medicine into their conventional health care system. However, 
such government involvement needs government policy on traditional medicine, which 
clearly states the level and the direction of its involvement. 
Based on the accumulation of experience over many thousands years, traditional 
Chinese medicine (TCM) draws on materials that are widely available in nature, 
including plants, animals and mmerals.(Tai YT, But PH et al, 1993) The great majority 
of Chinese herbal preparations are safe，and some useM Western drugs have been 
derived from these herbs. This system of medicine presupposes an elaborate mechanism 
of homeostasis within the body, disturbance of which results in disease. Treatment 
depends on not only correction or repletion of the disrupted elements but strengthening 
of “related parts". The use of traditional Chinese medicine (TCM) is universal in 
Chinese populations throughout the world and is becoming increasingly frequent in the 
West. It is used as first line treatment for many minor ailments and some chronic diseases 
in Chinese populations. A major attraction of this type of therapy is the apparent lack of 
1 
side effects compared with the drug therapies used in allopathic medicine. However the 
increased use of herbal medicines has resulted in mounting concern about both the 
efficacy and safety of these products. 
Chinese herbal medicines (CHM) and Chinese proprietary medicines (CPM) are 
widely used by people of Chinese origin throughout the world. Generally speaking, 
uncontaminated herbal medicines in recommended doses are safe. Although the use of 
these medicinal materials rarely causes significant toxic effects, cases of severe and even 
fatal poisoning have occurred after medication with herbs containing aconitine, 
podophyllin, and anticholinergic substances. Furthermore, CHM and CPM are often 
adulterated with substituted herbs, heavy metals, and western medicines; such 
contamination can have important clinical consequences. However, standards for 
evaluating the safety and quality of herbal medicine and herbal medicine products have 
not been well established. 
In TCM, ingredients are commonly used in combinations, allowing the use of 
smaller doses of herbs with synergistic beneficial effects, and it is thought that some 
materials may counteract the potential toxicity of others. Most popular herbal medicines 
are relatively harmless at usual doses, with adverse effects consisting primarily of mild 
and infrequent gastrointestinal or dermatological reactions. However, such kind of 
poisonings by Chinese herbal medicines is difficult to assess. It was because the existing 
knowledge of the pharmacological effects of Chinese herbal medicines is limited and 
each prescription typically consists of 10-15 herbs, which in turn contain many 
ingredients. The diagnosis can be easily missed if patients are not questioned about the 
use these preparations. Futhermore the herbalists are often reluctant to disclose the 
contents of their prescriptions. 
2 
In order to evaluate the extent of herbal poisoning worldwide, an extensive research 
and systemic review is necessary. This review focuses on examples from experience of 
adverse effects of Chinese herbal medicine and some other herbal medicines used 
worldwide. The information generated through this review may be expected to facilitate 
future management of such cases, to offer concrete data for policy-making in the control 
of herbal medicines, and to upgrade the scientific contents of Chinese and other herbal 
medicines by defining their safety limits. 
3 
Chapter 2 一 Chinese herbal medicines used in Hong 
Kong 
2.1 Overview 
TCM has been practiced in China for over 2000 years. Both Western medicine and 
TCM are widely available in Hong Kong. Despite the dominance of Western medicine in 
Hong Kong, a result of the favored position enjoyed by Western medicine during the 
British rule, both Western people and the local population have used Chinese medicines 
concurrently. Before 1997, the British Hong Kong Government adopted a non-
interventionist approach towards the practice of Chinese medicine in Hong Kong. Any 
adults of Chinese descent were allowed to practice any form of use of Chinese 
medicines but its development otherwise received very little government attention, and 
certainly no support‘ On the other hand. Western medicine was the only form of 
medicine receiving formal government recognition and support. Hong Kong Medical 
College，which subsequently amalgamated with the University of Hong Kong，was 
established to provide Western medical training in Hong Kong over 100 years ago. 
Throughout the past century, the Western medical health care system developed and 
flourished in Hong Kong. However, the majority of the population probably explains 
and understands their illnesses in Chinese medical concepts rather than Western medical 
principles. These two types of professional services are coexisting in the pluralistic 
health context of Hong Kong. By 1999，there were over 9000 doctors registered in 
Hong Kong serving a population of almost 7 million. Most of the hospital care is 
provided in the public hospital system On the other hand, 3000 private general 
practitioners provide over 80% of the primary care. The Government's general outpatient 
4 
clinics and other registered practitioners, including practitioners of TCM, provide the 
other 20% of primary care in Hong Kong. TCM practitioners are widely available in 
Hong Kong, but they only need to acquire a business registration without any 
assessment of their qualifications or standard of training and，hence, their standard varies. 
Some of them are often attached to an herbal medicinal shop and their charges are often 
no more than HK$20-30. Depending on the herbs prescribed, the total costs are often 
less than HK$50-60 per consultation.(Lam TP, 2001) 
2.2 The Policy In Hong Kong - Past And Present 
The lack of legal control over herbal practice in Hong Kong dated back to the 
Nanking Treaty of 1842, in which Chinese medicine was protected from control as part 
of "Chinese customs and usages". In the past, all the Chinese patent medicine sold in 
Hong Kong was only under the regulation of Undesirable Medical Advertisements 
Ordinance, which provided that it was illegal to advertise in respect of diseases specified 
in the Ordinance. The Hong Kong Government used to adopt a policy of nonintervention 
in the use of traditional Chinese Medicine. The Pharmacy and Poisons Ordinance 
(Chapter 138), which stipulates the need of registration of pharmacists and related 
matters, also provides that "nothing in this Ordinance shall apply to the sale, 
manufacturing, dispensing or compounding of traditional Chinese medicines as listed in 
the Chinese Herbal Materia Medica (Bencao Gangmu) or which are made from herbs 
customarily used by the Chinese people" (But PPH and Kan WK, 1995) This laissez-
faire practice left much room for erroneous identification, careless dispensing, improper 
processing, unscrupulous substitution, or even intentional adulteration of herbs and 
herbal products, and also for quacks and unqualified or ill-trained practitioners. (But PPH, 
Tai YT et al, 1995) The local herbal industry，relying only on experience and 
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organoleptic inspection, was allowed to handle its trade. Proprietary Chinese medicines 
are fiirther subject to import licensing control and post-marketing surveillance for adul-
teration with western medicine and contamination by heavy metals. 
The policy for the future development of Chinese medicine was enshrined in the 
Basic Law of the Hong Kong Special Administrative Region. Article 138 of the Basic 
Law provides that "the Government of the Hong Kong Special Administrative Region 
shall, on its own, formulate policies to develop western and traditional Chinese medicme 
and to improve medical and health services. Community organizations and individuals 
may provide various medical and health services in accordance with law." The Chief 
Executive, in his 1998 Policy Address, declared the vision to establish Hong Kong as a 
world center for the development of health foods and pharmaceuticals based on Chinese 
medicines. Hong Kong is aiming to establish itself as the global center for the scientific 
study and commercial exploitation of traditional Chinese medicines.(Cyranoski D，2001) 
Before 2002，The Hong Kong丨s Innovation and Technology Commission, the main 
applied research funding body in the territory, has already spent more than HKSlOO 
million over the past few years on research into traditional medicine, involving many of 
Hong Kong's leading biomedical researchers. Given its historical and business 
connections to the West and its close cultural connections to China, Hong Kong could 
very well become the center for internationalization of Chinese medicine. The 
Government has also recently launched a new initiative on the development of 
regulatory standards for Chinese medicinal herbs. Alongside the regulatory and 
infrastmctural development, the Government, with the pledged donation of HK$500 
rnimon (or US$64 million) from the Hong Kong Jockey Club Charities Trust Limited, 
has set up the Hong Kong Jockey Club Institute of Chinese Medicme Limited 
6 
(HKJCICM) to steer, co-ordinate and strengthen the modernisation and further 
development of Chinese medicines in Hong Kong. 
Although adverse reactions caused by traditional Chinese medicine are infrequent 
and low, it is important for the government to be aware of these. In a prospective study 
of hospital admissions during an 8-month period in Hong Kong, adverse events due to 
CHM accounted for 0.2% of admissions (3 patients in 1701 admissions), and those due 
to Western pharmaceuticals accounted for 4.4%.(Chan TY, Chan JC et al, 1993) This 
study only measured severe adverse event, and the lack of data on the relative use of 
CHM and Western medicine makes this comparison difficult to interpret. 
2.3 The Preparatory Committee on Chinese Medicine (PCCM) 
In August 1989, the Secretary for Health and Welfare of the Hong Kong Government 
set up the Working Party on Chinese medicine to review the use and practice of Chinese 
medicine in Hong Kong and to advise on measures that should be taken to promote the 
proper use and good practice of Chinese medicine. The working party has made 
recommendations on: (I) Registration of Chinese medicine practitioners; (II) Restricted 
use of proprietary Chinese medicines; (III) Processing, manufacturing and trading of 
Chinese medicine; (IV) Training and research in traditional Chinese Medicine; (V) 
Training of dispensers and public education. Following the Working Party's 
recommendation, the Preparatory Committee on Chinese Medicine (PCCM) was 
appointed in 1995. The Preparatory Committee on Chinese medicine and its two sub-
committees, consisting mainly of members of the traditional Chinese medicine 
profession and supported by health officials and academics, were formed in April 1995 
to manage the implementation of these recommendations. During its four years of 
appointment, the Preparatory Committee conducted a census on Chinese medicine 
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practitioners in Hong Kong. Based on the submission of PCCM's first report in 1997, 
which recommended the creation of a regulatory framework and a statutory body for 
regulation and control, and based on second report in 1999 recommending further 
regulation and development, the Chinese Medicine Ordinance was passed by the 
Legislative Council in 14 July 1999. The government policy included the following 
main topics: development of a statutory framework, development of education, and 
scientific research in TCM. (WHO, 1999) 
2.4 The Chinese Medicine Council of Hong Kong 
The Chinese Medicine Ordinance provides for the setting up of the Chinese 
Medicine Council of Hong Kong ("The Council”). This statutory regulatory body 
con^rises practicing Chinese medicine practitioners, members of the trade of Chinese 
medicines, academics, laypersons and government officials. The contents of the Chinese 
Medicine Ordinance include the composition and functions of the Chinese Medicine 
Council, Chinese Medicine Practitioners Board, Chinese Medicines Board and the six 
committees established under the Chinese Medicine Council; the regulatory system for 
Chinese medicine practitioners, which includes registration, examination and discipline 
of Chinese medicine practitioners; and the regulatory system for Chinese medicines, 
which includes licensing and regulation of Chinese medicines traders and registration of 
proprietary Chinese medicines. In addition, the Ordinance contains Schedule 1 of 31 
types of potent/toxic Chinese herbal medicines and Schedule 2 of 574 types of Chinese 
herbal medicines. Proprietary preparations containing a combination of herbal 
ingredients and conventional drugs are regulated in the same manner as other 
conventional drugs. 
8 
The Council was established in September 1999 and is responsible for 
implementing the regulatory measures for Chinese medicine. A licensing system and a 
registration system to regulate manu&cture and trade were established in the year 2000. 
Under the new licensing system for Chinese medicine practitioners, Chinese medicine 
doctors in Hong Kong must prove they have practiced continuously for at least 15 years, 
as of January 3 2000, to avoid taking licensing examination and registration 
assessment.(Chak M, 2001) Totally 8,000 applications were collected by the Chinese 
Medicine Council of Hong Kong but twenty-eight Chinese medicine practitioners were 
investigated by the police because of allegedly faking documentation. (Chak M, 2001) 
Totally 7,707 eligible applicants were placed on the List of Listed Chinese Medicine 
Practitioners and were listed in the Government of the Hong Kong Special 
Administrative Region Gazette, which was published on 21 December 2001. Only these 
Listed Chinese Medicine Practitioners (CMPs) wm be allowed to practice Chinese 
medicine in the Hong Kong Special Administrative Region on March 1 (2002) when the 
relevant legislation comes into effect. Their practice could continue when the Listed 
CMPs become Registered CMPs or until the end of the transitional period on such date 
as specified by the Secretary for Health and Welfare. 
For Chinese medicines, upon completion of relevant subsidiary legislations, the 
Council will implement the licensing system of Chinese medicine traders and the 
registration system of proprietary Chinese medicines by phases. Products already in the 
market on 1 March 1999 when a new legislation was set into force are “grand fathered’， 
and will be reviewed particularly on quality aspects. New products require assessment of 
safety, quality and efficacy by the Chinese Medicine Board. The dispensation, storage 
and labeling of Chinese herbal medicines will also be regulated. A government survey 
9 
of patent Chinese medicines on the market revealed over 3,000 patent Chinese 
medicines. The majority of these patent Chinese medicines are imported from Mainland 
China. 
In order to safeguard public health, besides regulating the practice of Chinese 
medicine, the Chinese Medicine Council regulates the manufacture, sale and use of 
Chinese medicines. The regulatory measures for Chinese medicines include a licensing 
system for Chinese medicine traders and a registration system for proprietary Chinese 
medicines. For the former, retailers and wholesale dealers of Chinese herbal medicines 
and wholesale dealers and manufacturers of proprietary Chinese medicines are required 
to obtain the appropriate licenses from the Chinese Medicines Board of the Chinese 
Medicine Council for their businesses. In addition, all proprietary Chinese medicines 
will be assessed and registered by the Chinese Medicines Board before they are allowed 
to be sold or roanufacturecL As with conventional synthetic drugs, safety and toxicity 
data that are collected on herbal medicines should be distributed to health professionals, 
both in Hong Kong and abroad�Moreover, the Chinese Medicine Council also set up a 
toxic herbs name list for herbalists to use as in China and Taiwan. (See Table 2a and 2b) 
2 5 Development of Standards 
The establishment of a statutory framework laid the solid foundation for the future 
development of Chinese medicine in Hong Kong.(Leiing TH and Fung YK, 2001) Other 
strategies include the development of health-related and industry-related standards. Lo-
cally, the Chinese medicine Council of Hong Kong sets standards for the regulation and 
registration of Chinese medicine. To fecilitate the development of international standards 
relevant to Chinese medicine concerted efforts from the World Health Organization 
(WHO) and experts worldwide are required. A WHO meeting on Methodologies for 
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Research and Evaluation of Traditional Medicine was held in April 2000 in Hong Kong. 
An internationally accepted guideline was published and disseminated to member states 
for reference in early 2001. 
2.6 Development of Centers of Good Clinical Practice 
It is proposed in the "Consultation Document on Health Care Reform，，(Health and 
Welfare Bureau. Government Secretariat. Government of the Hong Kong Special 
Administrative RegioiL The People's Republic of C, 2000) released at the end of 2000 
that the provision of Chinese medicine in the public health care system would be 
introduced. As the first step, the mode of delivery of outpatient Chinese medicine 
services will be examined. Primary care is one of the strengths of Chinese medicine. 
This proposal will enable this strength to be maximized for the benefits of the patients. 
It is also proposed to pilot the practice of Chinese medicine in selected public hospitals 
supporting clinical research for the evaluation of health benefits derived from Chinese 
medicine-based products and facilitating the development of standards and models of 
interface between western and Chinese medicine. In the long term, Chinese medicine 
will be integrated into the public health care system providing treatments to patients in 
collaboration with western medicine. 
2J Establishment of a Good System of Education and Training 
Before 1998, there were no full time training courses in Chinese 
medicine.(Leung TH and Fung YK，2001) At present, fUU-time degree courses on 
Chinese medicine are provided by three universities. In the long run, an adequate pool 
of high calibre professionals can be produced locally to support Hong Kong's 
development to become an international center for Chinese medicine. Furthermore, it is 
important to create a network of research institutions of high standing to support new 
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drug development and enhance competitiveness of industry. Locally an institute of 
Chinese medicine ha been set up with donations from the Hong Kong Jockey Club to 
support research on Chinese medicine. Moreover, it is planned to introduce Chinese 
medicine into the public healthcare system. This includes providing out-patient Chinese 
medicine services in the public sector，piloting the practice of Chinese medicine in 
selected public hospitals, supporting clinical research, and facilitating the development 
of standards and models of interface between western and Chinese medicines. 
2.8 Investigation of Suspected Herbal Toxicity Cases 
In order to investigate the particular situation of Chinese medicine in Hong Kong, 
several surveys were performed. A survey done in 1980 showed that (I) the majority 
(over one half) of respondents resorted to western doctors and 10% consulted traditional 
Chinese medicine practitioners, mostly herbalists, (n) In addition, Chinese medicine was 
generally perceived to be better than or as good as Western, scientific medicine in some 
ways, such as for tonic care, for fewer side effects，for curing the cause (not symptoms) 
of diseases, and for treating certain diseases. Therefore, to ordinary Chinese people, 
Chinese and Western medicine may perform either equivalent or complementaiy 
functions. (EI) As regards the process of seeking medical care, most people seem to 
follow the pattern of moving from self-medication, using Chinese and/or western home 
remedies, to western-style doctors, to Chinese-style practitioners, and finally to a 
western medical hospital Another two surveys done in 1993 and 1995 regarding the 
role of traditional Chinese medicine in health care produced similar results.(Wai WT, 
LanWSeta l , 1995; Lau J and Yu A, 2000) 
In contrast to the situation for conventional drugs, there was no government scheme 
for monitoring or reporting adverse reactions to herbal medicines before 1999. The 
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Chinese Medicinal Material Research Center (CMMRC) (Now changed into The 
Institute of Chinese Medicine) of the Chinese University of Hong Kong and Drug and 
Poisons Information Bureau (DPIB) within the Clinical Pharmacology Department 
(Now changed into Department of Medicine & Therapeutics) at the Prince of Wales 
Hospital were established in 1979 and 1988 respectively to collect adverse reaction data 
on herbal medicine and perform multidisciplinary research on various aspects of Chinese 
medicine. These two units also provide consultation and assistance in response to both 
local and overseas requests. 
2.8.1 Herbal Safety Surveillance 
This two-year project is partially supported by the University and Polytechnic 
Grants Committee (UPGC). The principal investigators in this project are Professor Paul 
But from the Chinese Medicinal Material Research Center (now changed to the Institute 
of Chinese Medicine) at the Chinese University of Hong Kong and Professor Brian 
Tomlinson from Department of Clinical Pharmology, Prince of Wales Hospital, the 
Chinese University of Hong Kong. 
The aim of the project is to actively collect cases of suspected herbal poisoning and 
try to determine the actual or potential causes of the adverse reactions. The information 
generated through this project is expected to facilitate future management of such cases, 
to offer concrete data for policy-making in the control of herbal medicines, and to 
upgrade the scientific contents of Chinese and other herbal medicines by defining their 
safety limits. Both prospective and retrospective cases are the concerns in this project. 
Totally 96 cases of suspected herbal poisoning were collected within 2 year. Several 
case were reported and published by the pharmaceutical journal However, most of the 
cases are lack of enough information or evidences to follow. When a case of adverse 
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reaction to Chinese herbal medicine is suspected, the difficulty in establishing the 
diagnosis is well recognized. Each preparation (herbs or compound medicines) typically 
is made up of a number of ingredients that in turn consist of many different chemicals. 
Very often, the chemical nature and pharmacological actions of these ingredients and 
their constituents are largely unknown. If the actual prescription cannot be traced, 
chemical analysis of each ingredient is not possible. On the other hand, the success in 
making the diagnosis to some extent will also depend on the clinician's suspicion and an 
awareness of particular patterns of clinical features which may suggest CHM toxicity 
rather than being features of the underlying disease or being related to toxic effects of 
pharmaceutical drugs. 
In the absence of the residues of the preparations taken on, comments can only be 
made based on the remaining sample of preparations and the prescriptions given by the 
patient's familier and the TCM practitioner are reluctant to cooperate to disclose the 
prescription because of economic consideration. Furthermore, they would like to use an 
alias or secret signal to replace the common name of some herbal medicine and make 
confusion. So investigation is very difficult. Methods for grading herb toxicity (in 
therapeutic use or overdose) were developed based on a combination of the quality of 
reports, severity of adverse reaction, supporting animal studies, extrapolation from 
pharmacology and empirical evidence. 
2.9 Conclusion 
In the 21st Century, there remain other issues that need to be addressed to realize 
the fiill role and function of Chinese medicine in the health care systenL These，among 
others，include the use of modem scientific knowledge to explain Chine medicine so that 
Chinese medicine can be understood and accepted by the international community and 
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the determination of the strategic positioning Chinese medicine in the health care systenL 
The development of models of interface of Chinese medicine practitioners and 
practitioners of western medicine and the promotion of the integration Chinese and 
western medicine. 
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Chapter 3 -Herbal medicines used in other countries 
3.1 Overview 
It is difficult to use traditional medicme effectively to support primary health care 
without the commitment of governments. In turn the government's involvement needs a 
national policy that provides a clear statement on the role of traditional medicine and the 
government's position with regard to the relationship between traditional medicme and 
the official health service systenx The adoption of such a policy will be particularly 
helpful in establishing appropriate standards for traditional medicine. 
The WHO is supporting Member States to improve the quality of herbal medicines. 
Since 1992, several workshops and training courses on the quality of herbal medicines 
and control of heavy metals in herbal medicme have been conducted in China. A 
collaborative research project on pesticide residue in medicinal plants was also 
conducted in China. The WHO has worked with interested countries to apply good 
manufacturing practices (GMP) to the manufacture of herbal medicine products. 
3.2 China 
China has a vast amount of land, with a population of 1.2 billion people. Over 
thousands of years, traditional Chinese medicme has developed a theoretical and 
practical approach to the treatment and prevention of disease. The first documented 
source of Chinese medical theory, the Huangdi Nei Jing ("Inner Classic of the Yellow 
Emperor") was written between 300 BC and 100 BC. It describes the diagnosis and 
treatment of a huge range of disorders and gives advice about healthy lifestyles, exercise, 
and diet which conforms remarkably well to current recommendations for the 
prevention of chronic disease.(Hesketh T and Zhu WX, 1997) 
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China is the only country in the world where Western medicine and the traditional 
medicine work alongside each other at every level of the healthcare system. Every city 
has a hospital practicing traditional Chinese medicine, and there is a plan for every 
county to have one. Based on State Administration of Traditional Chinese Medicine 
(SATCM) information, in 1998, there were 2,629 hospitals for TCM in China, including 
hospitals for TCM integrated with Western medicine (WM) and hospitals of national 
minority medicine with 260,000 beds in these hospitals. In addition, there were 288 
clinics for TCM. TCM has made great contributions to the medical care. According to 
statistics, in 1998, 150 million outpatients and 2.87 million inpatients had treatment in 
hospitals for TCM. All the general or special hospitals of Western medicine (WM) in 
China have departments of TCM with outpatients amounting to 22% of the total in 
hospitals of WM and beds at the departments of TCM accounting for 5-10% of the total 
beds in hospitals of WM. TCM serves one third of outpatients and a quarter of 
inpatients in rural areas of China.(see Table 3a) More than 170,000 TCM workers are 
employed in over 50,000 clinics. The majority of the 970,000 rural physicians use both 
TCM and WM in treatment and prevention of diseases. At present, TCM has greatly 
expanded its coverage and it is playing an important and irreplaceable role in the 
medical and healthcare systems in China. 
In general, although hospitals of TCM are generally smaller than those of WM in 
scale, each physician in hospitals of TCM treats more outpatients than those in hospitals 
of WM at the same level. If the two systems are to be truly complementary, more 
research in this area is essential to Militate a more rational approach. 
Traditional Chinese rr^dicine has become a source of great interest to the 
international research community. It is acknowledged that many of the treatments have 
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enormous potential and could be utilized more widely. In China, the licensing and 
official regulation of traditional Chinese medicine and the Chinese Proprietary medicine 
was by the State Administration of Traditional Chinese Medicine (SATCM). It has its 
own medical schools, hospitals, and research institutes. The licensing of drugs and 
official regulation of their sale is equally stringent for Western and Chinese medicines. 
At each different level of administration particular administrative institutions were 
formed�Thus, an administrative system exists from top to bottom.(WHO, 1999) There 
are five different levels of legislation on traditional TCM from the state constitution 
(where the legal status of TCM is stipulated) to local laws in provinces and 
municipalities. New drugs have to be examined and approved according to the Drug 
Administration Law. New drug approvals require documentation of identification, 
cultivation, physical and chemical characteristics, pharmacology, standards of clinical 
use, stability, and preparation methods along with three reference samples. After 
approval, a New Drug certificate is granted an approval number. The factory is then 
permitted to put the product on the market. To date over 1000 new drug applications 
have been approved.(WHO, 2000) Further development of TCM in the fiitiire would 
include creation of new laws and revision of the existing ones, and enlargement of 
international exchange and cooperation programmes. 
In China, the use of TCM is supported by central government, and it is practiced 
alongside ‘Western, medicine at every level of healthcare, so that treatments with 
western and herbal medicine are often prescribed simultaneously. However, the largest 
expansion of traditional and herbal medicines is occurring in the industrialized cities, as 
patients look for alternative and less invasive approaches to healthcare. Furthermore, 
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patients often use herbal and traditional medicines without informing their 'Western' 
medicine healthcare practitioner. 
Training in traditional Chinese medicine varies from family apprenticeships to 
three to five year university training at a college of traditional Chinese medicine, though 
the educational standard of these undergraduates is generally lower than their 
counterparts at the Western medical schools. All Western medical schools devote 
around 10-15% of curriculum time to traditional Chinese medicine, so all doctors have 
some traditional training.(Hesketh T and Zhu WX, 1997) 
The introduction of a market based economy into the health care system in China 
since the early 1980s have meant that health professionals and hospitals have to generate 
most of their income, including the salaries of staff in many cases. Drugs can be 
charged at a mark up of 15%. . Furthermore, staff in pharmacies is often untrained and 
unregulated medicines are widely sold and many products are available over the counter. 
It is estimated that only 20% of China's hospitals buy medicines from licensed state 
wholesalers, because the black market products are much cheaper. This complicated 
situation contributes to the numbers of adverse reaction to TCM reported in the Chinese 
literature every year. In China alone, there were over 600 reported cases in the past 30 
years.(Wu YB, 1988) 
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Table 3a: Numbers of Hospitals of TCM，Beds and Physicians in China. 
Hospitals of TCM 
… Hospitals of & 广 � f ~ O t h e r 
Total T o S a b o v e a � ‘a t e d 0 TCM hospitals of  
_ t y 丨 e v e丨？S f s o f TCM 
Hospitals  
""“1980 678 647 - _ 31 
1986 2050 — 1576 31 12 39 
1995 2522 2371 41 ^ 70 
一1998 2629 2444 | 43 | 53 | 89 
Beds  
一1980 49977 49151 - - 826 
1 9 ^ 1 2 8 7 8 4 1 1 3 0 0 8 10931 一 3627 ""“ 1218 
—~1995 236060 206812 17603 8875 2770 
""“1998 260386 229000 17695 10863 2828 “ 
Physicians  
1980 73458 72097 丨 _ | _ 1361 
1986 198158 ~ 169591 21263 ^ 1433 
^ 3 7 3 309401 27503 13556 2913 
一1998 397235 349261 27908 17054 3012 “ 
(Information from State Administration of Traditional Chinese Medicine, People's 
Republic of China) 
Note: 
1. According to statistics issued by the Health Ministry in 1996 (every 5 years), there 
were 71838 beds at the departments of TCM in hospital of WM (general, special and 
affiliated hospitals) in China in 1996. 
2. in the table indicates no available data. 
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Table 3b. Toxic Herbs Controlled in China and Taiwan. (Richard KJ, 1999) 
Toxic Herbs Controlled in China- 
1. Unprocessed main root of Aconitum carmichaeli 
2. Unprocessed tuber of Aconitum kusnezoffii 
3. Unprocessed lateral root of Aconitum carmichaeli 
4. Unprocessed tuber of Typhonium giganteum 
5. Unprocessed tuber ofPinellia temata 
6. Unprocessed root of Euphorbia ebracteolata and E. fischeriana 
7. Unprocessed tuber of Euphorbia kansui 
8. Tuber of Arisaema erubescens, A. heterophyllum and A. amurense 
9. Root-tuber of Aconitum brachypodum 
10. Unprocessed resin of Garcinia morella 
11. Flower of Datura metel 
12. Fbwer of Rhododendron mo lie 
13. Unprocessed seed of Strychnos pierriana and S. mix-vomica 
14. Unprocessed seed of Euphorbia lathyris 
15. Unprocessed seed of Hyoscyamus niger 
16. Unprocessed fruit of Croton tiglium 
17. Body of Lytta caraganae 
18. Body ofHuechys sanguinea and H. philaemata 
19. Body ofMylabris phalerata and M. cichorii 




24. Mercuric oxide Realgar 
25. Processed mixture of mercury, niter, and alunite 
26. Crystals formed with mercurous chloride and mercuric chloride 
Toxic Herbs Controlled in Taiwan.  
1. Root of Euphorbia fischeriana and E. ebracteolata 
2. Root of Knoxia valerianoides 
3. Seed of Hyoscyamus niger 
4. Seed of Strychnos mix-vomica 
5. Body ofMylabris phalerata and M. cichorii 





11 ’ Root of Aconitum carmichaeli 
12. Tuber of Arisaema erubescens, A. heterophyllum and A. amurense 
13. Root of Euphorbia kansui 
14. Root of Aconitum coreanum  
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15. Tuber of Aconitum kusnezoffii 
16. Root ofPhtolacca acinosa and P. americana 
17. Stem bark and root bark ofMelia azedarach and M‘ toosendan 
18. Resin of Rhus vemiciflua 
19. Flower bud of Daphne genkwa 
20. Flower of Datura metel 
21. Seeds ofPharbitis nil and P. purpurea 
22. Seed of Impatiens balsamina 
23. Seed of Ricinus communis 
24. Fruit of Croton tiglium 
25. Seed of Euphorbia lathyris 
26. Body ofHimdo nipponica, Whitmania pigra, and W. acranulata 
27. Body of Tabanus bivittatus 
28. Skin slough ofElaphe carinata, E. taeniura, and Zaocys dhumnades 
29. Secretion ofBufo bufo gargarizans and B. melano- stictus 
30. Body ofScolopendra subspinipes mutilans 
31. Sal-ammoniac  
3.3 Macau 
Traditional Chinese medicine (TCM) is a popular form of health care in Macau. 
Many of the people still consult doctors and practitioners of TCM. In addition, a very 
high percentage of the population regularly uses TCM in preparing soups, herbal teas or 
herbal tonics as supplementary food. In view of this situation, the Health Authority 
realized several years ago that it was crucial to establish laws and other regulations to 
improve the quality, efficacy and safety of these medicines, and to define the professional 
backgrounds and technical skills for trading in and dispensing pharmaceutical products， 
the most important aspects. 
The first Chinese traditional pharmacy was registered in the Health Department in 
1936, and by 1990, there were already 102 licensed traditional Chinese pharmacies. Since 
the law regulating licensing was very old, it could not deal with updated technological 
requirements developed in the last two decades. The new law, Decreta-Lei n 53/94/M, was 
enacted in November 1994 and aimed at better public health through adequate licensing of 
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medicines, import, export and wholesalers companies, dispensing pharmacies, and 
pharmacists and other technicians of traditional pharmacies. Based on this law, a list that 
includes 456 types of traditional medicinal material, which may only be sold in Chinese 
pharmacies of Macau, was prepared. The list consists of two sub-lists: Part 1. - toxic 
traditional Chinese materials; and Part 2. 一 common therapeutic traditional Chinese 
materials. Under this law, a simple but effective registration system for imported 
traditional medicines, the so-called "alternative registration system" started to be 
implemented. Only traditional medicines that have been registered in a country can be 
imported into the Macau market; but for those from Hong Kong, Singapore and other 
countries without a registration system at the moment, the importer must provide 
analytical certificates issued by the manufacturer or recognized laboratories. Throughout 
Macau, there are two hospitals but the government hospital is not providing TCM 
therapy but one of the health centers provides outpatient TCM clinic services. 
3.4 Taiwan 
Healthcare delivery in Taiwan has inherited the culture of TCM practices since 
early immigration in the late seventeenth century.(Huang WF, Wen KC et al, 1997) 
Taiwan's health care system has also been much affected by Japanese colonization 
(1895-1947) before the Nationalist Government fled to Taiwan from China in 1949. 
Contrary to western medical professionals who are educated through established medical 
school programs, TCM practitioners in Taiwan are produced from diversified 
backgrounds, mainly through apprenticeship, and a small percentage through an 
institutional education process. The two medical practice systems have been in 
coexistence for more than half a century. In Taiwan, 60% of the public uses multiple 
healing systems, including modem Western medicine, Chinese medicine, and religious 
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healing.(Bodeker G, 2001) The medicines used in each type of medical practice 
generally remain within individual domains of modem medicines and TCM, respectively. 
In Taiwan, the government has put great efforts into promoting the modernization of 
Chinese medicine. As a result, there are now people trained in both traditional Chinese 
and modem Western medicine who have made commendable contributions to the 
treatment of hepatitis, high blood pressure, cancer, and other diseases that are so far 
difficult to treat. In the area of pharmacology, researchers have evaluated effectiveness, 
analyzed, tested, and formulated concentrated dosages of Chinese pharmaceutical 
products for commercial sale. The prescriptions for these drugs are easier to fill, and are 
much more convenient for the patient than the old boiling method. In the area of basic 
science, modem research is being conducted in the field of pulse diagnosis. The three 
fingers used in the past to determine illness through the feeling of the pulse are now 
being replaced by pressure reactors. The pressure reactor converts variances in pulse 
pressure into electromagnetic waves, and registers them on a screen. These data are then 
analyzed by a computer. Many important new discoveries have been made through 
unique combinations of traditional and modem science. 
Contrary to western medical professionals who are educated through established 
medical school programs, traditional Chinese medicine practitioners in Taiwan are 
produced from diversified backgrounds, mainly through apprentice-ship, and a small 
percentage through an institutional education process. The two medical practice systems 
have been in coexistence for more than half a century. The medicines used in each type 
of medical practice generally remain within individual domains of modem medicines 
and traditional Chinese medicines, respectively. The current practice of traditional 
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medicine is prevalent among the licensed traditional medicine doctors, herb shops, street 
vendors, snake shops, temples, etc. 
Pharmaceutical products, both in western and in traditional Chinese medicine dose 
forms are required to have premarketing approvals by the Department of Health in 
accordance with Taiwan's Pharmaceutical Affairs Law. Addition of unlabeled 
therapeutic substances other than the approved formula is strictly prohibited by law. The 
National Laboratories of Foods and Drugs (NLFD) functions as the technical gatekeeper 
for the Department of Health in food and drug analysis in Taiwan. It has been regularly 
monitoring the commercial packages of traditional Chinese medicines since the 1970s, 
as such prohibited adulterations of traditional medicines from Asian sources were 
reported occasionally in other countries. Samples are collected from Chinese medicine 
practitioners and drugstores periodically for inspection and to establish systematic 
analytical methods. Since 1975, the Food and Drug laboratory Bureau (FDB) of the 
Department of Health, Executive Yuan, has had an ongoing program of Traditional 
Medicine Analysis Survey�The purpose of this program is to identify unlicensed 
traditional medicine and the possible mixtures with western medicine. Between 1975 
and 1981, among the 249 cases of unlicensed traditional medicine tested, 214 (86%) 
were found to contain "western medicines".(Deng JF, 1994) 
Traditional Chinese medicines produced in China, however, usually receive no 
premarket approval by the Department of Health according to current regulatory 
practices in Taiwan, and the commercial distribution of these products is not legal. The 
existing channels to pursue drug safety control of traditional medicine in Taiwan include: 
(1) Consumer Protection Service Center at County Health Departments; (2) Consumer 
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Protection Association (CPA); (3) Medical Centers; (4) Department of Justice; (5) the 
Food and Drug Laboratory Bureau (FDB).(Deng JP, 1994) 
The distribution of prescribed medicines or bulk materials has not been effectively 
controlled in accordance with the existing medical and pharmaceutical laws, mainly 
because the dispensing practices of physicians, inherited from the Japanese colonization, 
continue to prevail and because of a lack of commitment by the health authorities to a 
policy to change such practices. Therefore, the National Laboratories of Foods and 
Drugs initiated the program to monitor traditional Chinese medicines in 1992. This was 
the first time an island-wide approach was adopted to monitor, through hospital 
pharmacies, the prohibited adulteration of traditional Chinese medicines. The objective 
of this program was to screen samples of traditional Chinese medicines, suspected of 
adulteration that were used by the patients in several major hospitals. It was purported to 
serve as a basic model of incorporating hospitals into a safety-monitoring system for 
traditional Chinese medicines. 
In Taiwan, herbs can be obtained from temples, night markets, street venders，herb 
stores, traditional medicine doctors, and neighborhoods or relatives. People like to 
recommend the medicine they used to their relatives and friends without safety 
considerations. The general public and many of the traditional medicine practitioners 
also believe that the herbs are non-toxic and can be used in managing many health 
problems. 
Younger people appeared to consider the value of TCM and were more likely to 
favor its use. Those with higher education levels were more likely to be familiar with 
TCM, but were also more likely to present a negative attitude towards its effectiveness. 
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3.5 Japan 
Traditional medicines have been used effectively in Japanese society for more than a 
thousand years. Japanese traditional medicine may be divided into folk medicine and 
Chinese medicine from ancient China, the so-called Kampo medicine. Kampo Medicine 
is extremely popular in Japan, where the per capita consumption of herbal medicine seems 
to be the highest in the world. The drugs used are known as Kampo drugs. Each Kampo 
drug is a formula usually consisting of 5-10 different herbs. New features have been 
introduced into the practice of Kampo. Most of the modem ready-to-use forms of the 
original formulae are produced in industrialized granular, powdered or other forms based 
on the classical decoction. Introduced in 1957, it is now estimated that more than 95% of 
Kampo drugs used in Japan are taken in such a ready-to-use form as ethical drugs. Since 
1961, the National Health Insurance (NHI) has covered almost 100% of the Japanese 
population. 43 Kampo drugs for ethical use were included in the NHI Drug Price Tariff in 
1976, joining a few predecessors. More Kampo drugs were included later, and now 147 
Kampo drugs (as formulae) are available as ethical drugs. As the Ministry of Health and 
Welfare (MHW) already registered these as drugs, their inclusion might be assumed to 
have been a matter of course. Their acceptance took place without clinical validation 
studies. In Japan, 80% of practicing physicians have experience using herbal formulas. 
Japan now produces 210 Kampo herbal formulas according to strict quality controls, 147 
of which are covered by health insurance.(Yamada Y, 1991) 
Along with the expanding consumption of the Kampo medicines in the clinical 
treatments, several side effects of the Kampo medicines has recently been reported by 
the collection of adverse reaction data of MHW, these side effects are important signals 
for believing the safety of natural drugs.(Satake M, 1998) Safety and efficacy have been 
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estimated based on general methods employed by modem medical science. In 1972, the 
MHW designated 210 formulas as over-the-counter drugs. This selection was based 
mainly on the experience of doctors actually practicing Chinese galenical medicine. In 
1976, the Ministry specified 146 prescriptions as Nlfl applicable prescription drugs. In 
the case of an application for approval of a prescription other than those mentioned, 
specified data on safety, stability, comparison with other drugs, clinical test results, etc. are 
required to be submitted. 
Plant materials have been characterized and classified into five categories, by the 
Ministry of Health and Welfare (MHW), Japanese Government, in 1971, which include 
three medicine divisions and two food divisions.(Satake M, 1998) New Kampo drugs 
are regulated in essentially the same way as Western drugs in Japan. They are regarded as 
a form of combined drug, and the same data required for new Western drugs are required 
for new Kampo drugs in the NBA. The time-consuming and expensive chronic toxicity 
tests and special toxicity tests such as for mutagenicity, carcinogenicity and teratogenicity 
depend on the possible length of treatment and indications that apply to them. Data for 
three-phase clinical trials are also required. For generic Kampo drugs, bioequivalence data 
are required, which may discourage development, because pharmacokinetic studies of 
Kampo drugs are difficult to conduct and bioassay methods are quite limited. 
There was an improvement in the quality control of Kampo drugs in the mid-1980s. 
(Yamada Y, 1991) After a report on the situation of quality control, the Advisory 
Committee for Kampo Drugs was established in 1982 in close association with the 
Pharmaceutical Affairs Bureau of the MHW. The Pharmaceutical Affairs Bureau setting 
standards for the manufacture of Kampo drugs and quality control of Kampo drugs 
established a Working Group on the Quality of Kampo Drugs. This ensures that the 
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quality of herbs used in each original formula meets precise standards. The regulations 
also call for quality monitoring of specific ingredients, using at least two different 
chemical or physical methods to test them. Since October 1986, Good Manufacturing 
Practice (GMP), a standard required of pharmaceutical drugs issued by MHW in 1976, 
applies also to Kampo drugs. In addition, in 1988, the Japan Kampo Medicine 
Manufacturers' Association drew up self-imposed guidelines that take into consideration 
the unique nature of Kampo drugs.(Yamada Y，1991) In 1985, guidelines for ethical 
extract products in oriental medicine formulations were developed, according to which the 
data from a comparative study of the extract and a standard decoction have to be provided 
by the manufacturer of an ethical extract product. Besides data on the crude drug and on 
the standard decoction prepared in accordance with the Chinese traditional medicine 
prescription, a comparative study has to describe the content of an indicator ingredient in 
the finished product, which is required to be more than 70% of the content of the indicator 
ingredient in the standard decoction 
The Ministry of Health and Welfare (MHW) has three major systems for the 
collection of domestic adverse reaction data. The first is the Adverse Drug Reaction 
Monitoring System under which 2,915 monitoring hospitals have been designated and 
requested to report cases of adverse reactions to the MHW, (Yamada Y, 1991) This is a 
"voluntary" monitoring system, and 1,158 cases of adverse reaction were reported in 
1990, of which 15 cases pertained to Kampo drugs. 
The second data collection system is the Pharmacy Monitoring System formed by 
2,733 pharmacies. This system mainly collects data on cases of adverse reactions to over-
the-counter drugs. In recent years, about 400 cases have been reported annually. Among 
these, reactions caused by Kampo drugs are the most common, though most of these 
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adverse reactions are minor, involving symptoms such as gastric discomfort and skin 
problems. Fifty cases were reported in 1989. (Yamada Y, 1991) 
The third system is Adverse Reaction Reporting from Manufacturers. Several severe 
cases caused by "Shosikoto", including drug-induced hepatitis and pneumonitis, were 
documented at medical conferences and in journals and were reported to the MHW by the 
responsible company in 1990. In addition, since 1988, the newly drafted Good Post-
Marketing Surveillance Practice (GPMSP) has been used on a pilot scale for Western 
drugs dispensed in Japan. When new Kampo drugs are approved and appear on the market, 
this guideline will also apply to thenx 
3.6 Singapore 
Singapore's healthcare services are based on Western medical science. There is a 
role for TCM to play as a con^lementary form of medical care in S i n g a p o r e � I n 
Singapore about 45% of the population has consulted traditional Chinese medical 
practitioners.(Singapore MOH, 1995) Only those properly trained in TCM should be 
allowed to practice TCM. The local TCM training schools have made valuable 
contributions to the training of TCM practitioners in the past. However, the training 
they provide and the quality of trainees are not up to the standard of the TCM colleges in 
some other countries. Government and community efforts to upgrade the training of 
TCM practitioners and the standard of TCM practice in Singapore should be supported. 
Apart from the control of poisons, the Ministry of Health has in the past not been 
actively involved in TCM practices in Singapore. This is largely due to the lack of 
expertise in this area and the relatively low usage of TCM by the population. However, 
with the development of TCM particularly in China over the past 2 to 3 decades, and 
increasing interest in complementary medicine the world over, public interest in TCM 
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has also risen. It is therefore timely to review the standards of training and practice of 
TCM in Singapore. In July 1994, the Minister of Health appointed a Committee to 
review the practice of TCM and recommend measures to safeguard patient interest and 
safety, and to enhance the standard of training of TCM practitioners. The Committee 
recommends that the two main local schools upgrade their part-time courses to a 3-year 
full-time diploma course or a 6-year part-time equivalent. Moreover, as the dispensers 
play an important role in the delivery of traditional Chinese medicines to customers and 
patients, the local TCM organizations are planning to provide refresher-training courses 
for existing dispensers. In future, dispensers may also be required to receive formal 
training and be registered.(Singapore MOH, 1995) 
At present, the Government imposes minimal control on Chinese Proprietary 
M e d i c i n e � T h e nforcement activities currently carried out are targeted more towards 
safeguarding the public from toxic substances, prevention of adulteration and 
exaggerated claims. As most raw herbs have low toxicity and herbs containing toxic 
substances are already controlled under the Poisons Act, the control of raw CMM (in 
terms of the import, export, sale and distribution) can be maintained at the present level. 
The Singapore Trade Development Board has reported that Singapore imported US$ 79 
million worth of herbs and ginseng in 1993 and re-exported $ 13 million worth of these 
products during the same year. (WHO, 2000) 
3.7 Australia 
Traditional Chinese medicine, best known for the practices of acupuncture and 
Chinese herbal medicine (CHM), has been practiced in Australia for many years and is 
being used now more than ever before.(Bensoussan A, Myers SP et al, 2000) In order to 
elevate the usage of TCM in Australia, the Victorian Department of Human Services 
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(DHS) (formerly known as Health & Community Services) sought tenders for research 
into the practice of Traditional Chinese Medicine (TCM) in that State at 1995. The first 
stage involved a major research project to collect information on the risks and benefits 
of TCM and the nature of the TCM work force; and to consider the need, if any, for 
registration of TCM practitioners and regulation of Chinese herbal medicines. The 
outcome was that the researchers recommended to the Australian Health Ministers 
Advisory Council (AHMAC) and to all State governments that occupational regulation 
of the profession of TCM proceed as a matter of urgency. 
In Australia in 1996-97, the Commonwealth Health Insurance Commission paid over 
$17.7 million in Medicare rebates for 960,000 acupuncture treatments by registered 
medical practitioners�There has been a similar increase in the practice of other aspects 
of Traditional Chinese medicine, including herbal medicine, therapeutic massage, 
manipulation, dietary therapy and exercise therapy.(Bensoussan A, Myers SP et al, 2000) 
Moreover, complementary medicine services in Australia have grown to the extent that 
consumers now spend approximately twice as much on complementary medicines as 
their out-of-pocket contributions to pharmaceuticals. The resulting research report. 
Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia, was 
launched in November 1996. The researchers found that the risks in the practice of 
TCM relate primarily to the practice of acupuncture and Chinese herbal medicine, which 
have resulted in at least five documented deaths in Australia, 
With the growing use of TCM, regulatory authorities, health professionals, and the 
public need to understand the risks involved in TCM.Consumercomplaints are dealt with 
by the Department's Therapeutic Goods Unit concerning herbal preparations, some of 
which had been adulterated with potent western medicines, along with the difficulties 
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experienced by the Commonwealth Therapeutic Goods Administration in controlling 
this area. 
In Australia, products for human medicinal use must be placed on the Register of 
Therapeutic Goods [Therapeutic Goods Act 1989 (Cwlth)] in one of two categories -
”listed" or registered. Formulations can be listed for a small fee if they contain 
substances regarded by the Therapeutic Goods Administration (TGA) as being of low 
public health concern and comply with the Therapeutic Goods Advertising Code.(Drew 
AK and Myers SP, 1997) This restricts wording of claims to "assist" rather than "treat" 
and limits indications to minor self-limiting conditions. The products have to be 
manufactured by a TGA-licensed manufacturer following a recognized code of Good 
Manufecturing Practice. Labeling requirements are the same as those for registered 
products. Efficacy data have to be held by the manufacturer/distributor of such products 
and can be called on at any time by the TGA or the Australian. 
Competition and Consumer (formerly, the Trade Practices) Commission. About 
4500 plant-based products are listed; these are given an "AUST L" number, indicating 
their listing on the register and that they can be sold legally in Australia. 
Registered products, which bear an "AUST R" number, contain herbs that are either 
restricted by the federal Standards for the Uniform Scheduling of Drugs and Poisons, 
those for which efficacy claims are more substantial, or those which are specified by the 
TGA as being of some health concern. For registration, which is more costly, 
appropriate documentation outlining clinical trial work must be submitted to the 
Traditional Medicines Evaluation Committee (established in 1991 - soon to be replaced 
by the Complementary Medicines Evaluation Committee) which advises the TGA. 
Fewer than five CAM products have been evaluated in this way. Although Australia has 
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more regulatory controls than many other countries for CAM preparations, including 
herbals, most of these preparations are not exposed to the premarketing evaluation 
process that prescription and scheduled proprietary medicines undergo. Few CAM 
preparations can be patented, so they are not subject to the financial incentive that drives 
the pharmaceutical market.(Drew AK and Myers SP, 1997) 
There is significant black market activity in the importation of unlisted and/or 
unregistered patent medicines. Deficiencies exist in the ability of the Federal 
Therapeutic Goods Administration to address both this problem and that of the 
importation of raw herbs. In order to control such a situation, a tighter regulation of 
importation of raw herbs and patent medicines are needed to protect the public 
adequately. 
In Australia, reporting of adverse effects of any medication, whether alternative or 
conventional, is usually undertaken by a medical practitioner, pharmacist or dentist, who 
completes and forwards a ”blue card" to ADRAC. Although the person reporting needs 
not assess the association between the medication and the adverse effect, this process 
enables trends to be spotted. ADRAC has received 154 reports relating to 
complementary and alternative medicine (CAM) in 25 years.(Drew AK and Myers SP, 
1997) 
A study performed in Australia in 1996 collected data on adverse events that 
occurred in clinical practice and have been self-reported by practitioners of TCM, 
including those who practiced only TCM and those whose primary specialty was not 
TCM. Totally four hundred fifty-eight (30%) of 1517 medical practitioners responded 
and the adverse reaction rate caused by TCM was 0.16%.(Bensoussan A, Myers SP et al, 
2000) 
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3.8 Others Asian countries 
In the Philippines, eight public hospitals provide acupuncture clinics and treatment. 
Several doctors at these hospitals have been trained in acupuncture with WHO 
support.(WHO, 2000) In Vietnam, 45 traditional medicine hospitals at national and 
provincial levels and 265 general hospitals provide traditional medicine services. In the 
Republic of Korea, a national medical law was passed in 1952 and traditional medicine 
was introduced into the health service as a parallel system alongside modern medical 
science. In the Republic of Korea, there are 11 colleges providing formal education on 
traditional medicine and there are about 9210 licensed traditional medicine doctors. 
In Malaysia the market for traditional medicine is estimated at about RM 1 billion 
annually and more than 16,000 traditional medicine products have been submitted to the 
National Pharmaceutical Control Bureau, Ministry of Health, for registration. (WHO, 
1998) 
3.9 USA 
The commercialized herbal industry is now blossoming in the United States, More 
than 500 different herbs are currently marketed in the United States, and Americans 
spent more than US$12 billion on natural supplements in 1997, nearly double the 
amount spent in 1994, while sales still continue to grow by more than 10% a year. 
Increasingly, alternative therapies such as herbal products are being used in the 
United States. Approximately 25 % of Americans who consult their physician about a 
serious health problem are employing unconventional therapy, but only 70 % of these 
patients inform their physician of such use.(Eisenberg DM, Kessler RC et al, 1993) 
Another national survey of alternative medicine performed in 1997 demonstrated that 
42% of Americans used alternative medicine in the past year.(Eisenberg DM, Davis RB 
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et al，1998) The result of the studies showed that female gender, age 35-49 years, 
college education, annual income greater than $50,000 and residence in the western 
quarter of the United States best characterizes users of alternative medicine. More than 
this, an investigative survey in 1997 showed that nearly 30% of Americans aged 65 and 
older were using alternative medicine.(Forster PJG, Calverley M et al, 1979) Almost 
three million people aged 65 and older took herbal therapies, with two million taking 
both herbal therapies and prescription medications. Those who use both prescription 
medications and herbal therapies are at potential risk for unintended adverse interactions. 
In 1962, thalidomide was found teratogenic and Congress passed an amendment to 
the Food and Drug Act to increase assurance of drug safety and efficacy. While 
successful in general, the amendment initiated a regulatory dilemma regarding herbal 
therapies in the United States.(OTIara M, Kiefer D et al, 1998) Before 1994, dietary 
supplements were regulated under the Food, Drug, and Cosmetic Act as either foods or 
drugs, depending on the intended application.(Rotblatt MD, 1999) For new foods or 
food additives, safety had to be demonstrated before marketing. A product was 
considered a drug if the manufacturer, including structure or function claims, made any 
therapeutic claims or if other evidence existed that the intended use was as a drug. 
In 1994 the Dietary Supplement Health and Education Act (DSHEA) was passed 
by Congress and created a new category for dietary supplements. Under the act, 
supplements can claim to affect structure and function, but they cannot be intended to 
treat, prevent, mitigate, cure, or diagnose disease. Under DSHEA, herbs can be labeled 
and advertised as having certain healthful or nutritional properties as long as no 
therapeutic claims are made. Labeling can include suggested doses, despite the fact that 
few dose-response studies of herbal medicines have been conducted. Nonspecific 
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labeling statements such as these both confuse consumers and promote skepticism 
among healthcare professionals. Basically, manufacturers can allude to a therapeutic use 
of an herb, whether it is effective or not. Herbal medicines and other dietary 
supplements were not subject to approval by the FDA before marketing.(U.S. Public 
Law S, 1994) Theoretically, manufacturers should be able to substantiate their 
"structure and function" claims, but they are not required to share this information with 
the FDA or make it publicly available. In fact, manufacturers are not required to notify 
the FDA of label claims until 30 days after their products are marketed. The FDA can 
take action only once a supplement is on the market and found to be a significant or 
unreasonable risk to consumers. New dietary supplement labeling regulations, 
implemented in March 1999, ensure that labels should include complete ingredient 
listings in a format that is easy to understand, but manufacturers are not required to 
furnish information such as side effects, contraindications, or warnings. According to 
DSHEA, dietary supplements must include the following statements in the product 
labeling: "This statement has not been evaluated by the FDA. This product is not 
intended to diagnose, treat, cure, or prevent any disease�” (Klepser TB and Klepser ME, 
1999) 
Quality control and manufacturing standardization are not required of herbal 
medicines in the United States.(Rotblatt MD, 1999) With guidance from the 
Commission on Dietary Supplement Labels (appointed by President Clinton and 
established by the Congress in the DSHEA), the FDA is considering other regulations, 
such as working to improve post market surveillance of dietary supplements, requiring 
pertinent warning statements in product information, and taking action to protect 
consumers and withdraw unsafe products from the market or take other protective 
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action.(FDA, 1998) Partly due to the lack of GMPs, some dietary supplements contain 
impurities and adulterants. Unlike pharmaceutical companies, supplement manufacturers 
often lack personnel to obtain information on overdoses or adverse events. 
Although the FDA regulates labeling，advertising of dietary supplements fall under 
the purview of the Federal Trade Commission. The FDA has suggested that 
manufacturers not make any claims with respect to their products and use in pregnancy. 
(O'Neil C and Fetrow C, 2001) 
Numerous big pharmaceutical companies in United States and Europe were doing 
research on Chinese medicine.(Cyranoski D, 2001) The Center for Food Safety and 
Applied Nutrition of the FDA recently published a document entitled, "Dietary 
Supplement Strategy: Ten Year Plan.”(FDA US，2000) It outlines the strategy to reach 
its goal to have a "science-based regulatory program" that provides consumers with a 
"high level of confidence in the safety, composition, and labeling" of the products. The 
FDA developed six strategy teams that are organized into categories of safety, labeling, 
boundaries, enforcement, research, and outreach. The plan is to fully implement the 
DSHEA. The FDA's 10-year plan is an ambitious undertaking and will help solve many 
of the unresolved issues. 
Furthermore, western medical professionals have also changed their perspective. 
The American Medical Association (AMA) resolved in 1995 that alternative / 
complimentary / herbal medicine should be included in the medical curriculum. Now, 
over 50% of the medical schools in the U.S. have a course on this subject. 
Base on the fact that herbal remedies are considered food products under the 
DSHEA and hence they are not subject to rigorous clinical testing, as are pharmaceutical 
products. No manufacturing standards regulate the quality and production of herbal 
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remedies. All these factors have led to increase adverse reactions in patients choosing 
alternative therapies. 
Adverse reactions associated with dietary supplements in USA, especially herbal 
remedies, can be caused by inherently toxic herbs, by herb overdoses, or by drug-herb 
interactions, especially with pharmaceuticals that have a narrow therapeutic index. They 
can also represent idiosyncratic reactions to herbs, such as allergic responses or 
anaphylaxis. Other adverse reactions can be due to adulteration caused by manufacturing 
and quality problems, misidentification, substitution of one herb for another, variability 
in the amount of active ingredients, inaccurate or incomplete label identification, 
� improper processing and preparation, or contamination. Physicians who are treating 
patients suspected of herb-related adverse reactions are encouraged to contact the US 
Food and Drug Administration's MEDWATCH program or the local poison control 
center, so that data can be collected and analyzed. 
3.10 United Kingdom 
The use of Chinese herbal medicines is increasing rapidly in Britain, and relatively 
few patients are now Chinese.(David AJ, 1994) This has led to problems, as most of 
those who now seek treatment are unable to distinguish between adequately and 
inadequately trained practitioners. Practitioners fall into three broad categories: those 
who have had a full training in the discipline (available only in China), those who have 
received limited training in Britain or China, and those who have no training. No data 
exist on how many practitioners now offer Chinese herbal treatment in Britain, and only 
some of them belong to a professional body. The main body is the Register of Chinese 
Herbal Medicine, which maintains minimum standards of training and practice. This 
body's main shortcoming is that virtually none of the fiilly qualified Chinese 
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practitioners currently belong to it. 
In Great Britain and the Republic of Ireland there is no direct regulation of non-
medically qualified practitioners: they can practice freely, subject to minor limitations 
imposed by various laws.(Fisher P and Ward A, 1994) For instance, they may not treat 
venereal disease or claim to be members of state registered health professions. A survey 
in the United Kingdom in 1980-1 suggested that there were 12.1 non-medically qualified 
practitioners per 100000 popLilation--27% of the number of general practitioners. The 
number of non-medically qualified practitioners was estimated to be growing by about 
10% a year. More recent evidence suggests growing interest in complementary therapies 
among general practitioners - surveys have shown 31-38% of general practitioners had 
received training in complementary therapies，with 15-42% wanting further 
traiiimg.(Fisher P and Ward A, 1994) 
The herbs prescribed by practitioners of traditional Chinese medicine in Britain are 
generally purchased from wholesale companies that specialize in this trade. These 
companies import herbs from the People's Republic of China either directly or through 
dealers in Hong Kong. The quality of imported herbs varies considerably, and great skill 
is needed to ensure that the correct herbs are provided to the practitioner. Some 
substitution of herbs is acceptable in China but can lead to problems if the wholesaler or 
practitioner is unaware of the substitution. Confusion may arise over the precise identity 
of the herb being ordered: no standardized nomenclature exists for herbs. Fortunately, 
the best wholesalers and properly trained practitioners are able to make fairly reliable 
checks, at least visually. 
The acceptance and regulation of complementary medicine, including herbal 
medicines, varies considerably between Western coimtries.(De Smet PAGM, Hansel R 
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et al, 1993) Since 1991, the UK National Poisons Unit, based at Guy's Hospital， 
London, has taken a special interest in toxicological problems resulting from exposure to 
herbal medicine. They have recently published summary statistics from their database of 
adverse effects (Chan TY, 1997) The data were collected retrospectively from enquiries 
to the National Poisons Information Service from January 1983 to March 1989, and 
prospectively in 1991. It is unclear what degree of follow-up was undertaken to identify 
the products involved. There were 5,536 enquiries relating to vitamins, minerals, amino 
acids，fish oils, evening primrose oil, kelp, yeast, herbal preparations, royal jelly and 
slimming preparations. Of these, 656 (12%) were symptomatic at the time of the call A 
total of 1,070 enquiries related to herb extracts, royal jelly, pollen, enzyme preparations 
and hormonal and glandular products, of which 270 (25%) were symptomatic, 
suggesting that this body of products is more likely to generate symptomatic adverse 
effects than the overall family of traditional medicines. The paper reports one adverse 
effect with a Chinese herbal product used for eczema that resulted in acute fatal liver 
failure. 
3.11 Europe 
Complementary or unconventional treatments are used by many doctors and other 
therapists throughout Europe. The major forms are acupuncture, homeopathy, manual 
therapy or manipulation, and phytotherapy or herbal medicine. The relative popularity of 
therapies differs between countries, but public demand is strong and growing. Over the 
last 10 years, Europe has witnessed a rapid growth in Traditional Chinese Herbal 
Medicine (TCM). Practitioners number around 11,400, while the annual market is 
estimated to total S$60 million. The European market for phytopharmaceuticals in 1995 
was reported to be US $ 1,098 million and it was estimated that this would increase to 
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u s $ 1,375 million by the year 2001.(Fisher P and Ward A, 1994) The European 
Community has developed a comprehensive legislative network to facilitate the free 
movement of goods, capital, services and persons in the Community. According to 
Directives 65/65/EEC and 75/318/EEC, pharmaceutical products require pre-marketing 
approval before gaining access to the market. Requirements for the documentation of 
quality, safety, and efficacy, the dossier and expert reports are laid down in Directive 
91/507/EEC. 
Direct comparisons of numbers and types of practitioners between countries, even 
within the European Union, are impossible because of varying legal situations. In most 
member states of the European Union, including Belgium, France, Spain, Italy, and 
Greece, the practice of medicine, except by statutorily recognised health professionals, is 
illegal. This is also technically the situation in the Netherlands, but the Dutch 
government has stated that it will not prosecute non-medically qualified practitioners 
unless there has been malpractice. In Denmark nonmedically qualified practitioners 
may practice but the scope of their activities is restricted by law� 
On 1 January 1994 two European Council directives-on homeopathic medicinal 
products and on homeopathic veterinary medicinal products - came into force.(Fisher P 
and Ward A, 1994) The directives are intended to ensure a single European market for 
these products. The provisions cover manufacture and inspection, marketing, and 
labeling. The most important provision is the establishment of a simplified registration 
procedure applying to medicines containing less than one part per 10000 of the undiluted 
tincture or less than "1/100th of the smallest dose used in allopathy." 
EC directive 65/65 on proprietary medicinal products has considerably constrained 
product licenses for herbal medicines. Concern at the possible carcinogenic effects of 
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pyrolizidine alkaloids, which occur in a number of medicinal herbs, most importantly 
comfrey (Symphytum officinale), has recently prompted both the German and British 
governments to restrict the availability of these herbs. The case of comfrey highlights a 
regulatory problem—the plant is common in many European countries and is sometimes 
taken as a tea or vegetable. This problem remains unresolved; the European Court of 
Justice has had to adjudicate on whether vitamins and herbal medicines are foods or 
medicines.(Fisher P and Ward A, 1994) 
3.12 Germany 
In Germany, the Ministry of Health established the Commission E, a committee of 
doctors，pharmacists, scientists and herbalists to evaluate the safety, quality and efficacy 
of herbs.(Valli G and Giardina EGV, 2002) Commission E approves new remedies and 
publishes monographs with recommendations on dose, indications, contraindications, 
interactions and mechanisms. Physician prescriptions for herbs account for more than 
one-half of sales in Germany and nearly one-quarter are for cardiovascular 
conditions.(Flemmg T and Montvale NJ, 2000) The German equivalent of the FDA 
requires absolute safety and has high standards for quality control. Because good 
clinical studies were generally not available until recently, however, approvals for herbal 
drugs were based on "reasonable certainty" of efficacy.(Rotblatt MD, 1999) 
Germany has the unique Heilpraktiker (health practitioner) system. Originally 
introduced in 1939, it licenses practitioners who are not members of recognised health 
professions to practice provided they have passed an examination in basic medical 
knowledge and are registered.(Fisher P and Ward A, 1994) The system is administered 
by the Lander (provincial governments), and standards vary considerably between 
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regions. Heilpraktikers are specifically prohibited from practicing obstetrics, dentistry, 
and venereology. Nonmedical psychotherapists are regulated by the same system. 
German has allowed some 600-700 herbal products to be marketed in that country. 
Approximately 70% of German physicians now prescribe phytopharmaceuticals to their 
patients，which serves to maintain one of the worlds' largest markets for herbal drugs. In 
1978, the German government established an expert committee, the Commission E, to 
evaluate the safety and efficacy of over 300 herbs and herb combinations sold in 
Germany. For the past 3 decades, the German Health Authority has systematically 
reviewed the evidence on about 300 herbs and formulated clinical guidelines. An 
English translation of the resulting German Commission E Monographs was due for 
release in 1998.(0'Hara M, Kiefer D et al, 1998) 
A positive trend towards the use of natural medicines in Germany could be 
shown in a study conducted by the Institute for Demoscopic Research Allensbach in 
1997. According to this study, the group of users of natural medicines comprised two 
thirds of the German population (65%). In 1970, only 52% of the population were 
included in this group. The users estimated the risk attached to natural medicines was 
lower than the ones attached to chemical pharmaceutical products. 80% of the 
population believed that the risk of natural medicines is low, whereas 47% and 37%, 
respectively, of the population estimated the risk of chemical medicines as intermediate 
and great, respectively.(WHO, 1999) Although acceptance of traditional medicine has 
grown during the last few years, traditional medicine is not officially recognized in most 
countries. Even when a government has formally announced its support for the proper 
use of traditional medicine, this is not always accompanied by strong political, legal or 
material support. Doubts about the appropriate role for traditional medicine may remain, 
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and scientifically - based evidence on traditional medicme is being produced only slowly. 
There is also slow progress in developing quality standards and regulations on herbal 
medicines, in part because few resources are devoted to assessing traditional herbal 
remedies. 
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Chapter 4 - Herbal Adverse reaction 一 General Aspect 
4.1 Overview 
In many developing countries, traditional medicines are still the only available 
health services that can be afforded by the majority of the population. Traditional 
therapies are applied in public hospitals in China, Japan, the Lao People's Republic, 
Mongolia, Papua New Guinea, the Philippines, the Republic of Korea, Singapore and 
Viet Nam. About 25% of modem pharmaceutical drugs have botanical origins, such as 
digoxin from foxglove, morphine from poppies, aspirin from willow bark, and 
tamoxifen from the Pacific yew tree.(Tyler VE, 1994) 
Examination of today's allopathic medications reveals that approximately 25-33% 
of currently available modern medicines in the United States have their origin in plants, 
animal, or mineral systems. Traditional medicine provided a first line and basic health 
service for people living in these areas. In industrialized countries, this picture is quite 
different because the services provided by modem medicine are readily available. For 
many people, conventional therapies may not be available or ineffective or may carry 
significant risk that the user may not be willing to accept. People begin to appreciate the 
application of natural products in preventing disease and improving quality of life. The 
use of traditional medicine has increased in popularity in recent years and is becoming a 
significant healthcare option for many people. In addition to herbal and homeopathic 
products, traditional therapy includes acupuncture, chiropractic therapy, yoga, 
meditation, and nutritional therapy. People nowadays are more health conscious than 
before as their standard of living has improved. 
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4.2 Traditional Chinese medicine 
Traditional Chinese medicine (TCM) has a histoiy of several thousand years and is 
one of a few forms of 'alternative' (as opposed to conventional) medicine that are 
endorsed by the World Health Organization.(Tang JL and Wong TW, 1998) TCM is a 
highly developed system, well documented and with its own body of theory. 
Traditional Chinese medicine was exported to neighboring countries such as Japan, 
Taiwan, Republic of Korea and Viet Nam, which then developed their own variants, 
TCM makes a significant contribution to the health of the peoples of the Region. Its 
influence is growing as more people are prepared to look for alternative approaches to 
maintain their health. Western medicine is often regarded as more effective in acute 
situations or where the etiology is known, traditional Chinese medicine is more effective 
for immune conditions, chronic illness, or where the etiology is iinknowiL 
Chinese herbal medicines (CHM) and Chinese proprietary medicines (CPM) 
continue to be widely used by people of Chinese origin throughout the world. The main 
reasons for their popularity appear to be: (1) a belief that CHM and CPM are more 
effective than Western medicines for common ailments such as excessive 'endogenous 
beat' (a concept in traditional Chinese medicine), cough, phlegm and indigestion; (2) a 
belief that most CHM, having been used for centuries in China and being of natural 
origin, are fairly harmless; or (3) an intention to save money and the bother of visiting a 
medical practitioner. 
Recently, there has been a reported increase in adverse reactions due to herbs. The 
higher incidence is probably due to increase physician awareness and a better 
surveillance system. From 1915 to 1990, there were 2788 cases of adverse reactions 
associated with 460 different herbs reported in 408 Chinese medical journals. Prior to 
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1950, there were only 26 cases of adverse reactions reported, from 1950-1969, 147 
cases, 398 cases in 1970-1979, and in the 1980s, 2217 cases.(Du S, Cao F et al.’ 1992) 
Of the total adverse reaction reports in the Chinese literature, herbs constituted 
approximately 40% of all products (herbs and pharmaceuticals). The most common 
herb-related adverse reactions were with aconite roots (576 cases), followed by 
Tripterygium wilfordii Hook f . (90 cases), and Isatis tinctoria L (38 cases). In 1990, 
there were 46 cases due to aconite root related adverse reactions and 16 cases due to 
Isatis tinctoria L. 
The recognition of toxic potentials of medicinal materials could be traced to the 
very early phase of the development of TCM. A prevailing view in the ancient times 
simply regarded all medicines as poisons or poisonous, for their ability to influence or 
modify the fiinctions of the body. The Book of Rites (1100-50 B.C.) recorded that 
"physicians handled medical matters, and stocked poisons (poisonous herbs) for 
therapeutic uses." Another much quoted statement concerning the legendary Divine 
Plowman or Heavenly Husbandman is that he "tasted hundreds of herbs and found 70 
poisons (poisonous herbs) in a day". A more explicit comment was presented in Ban 
Cao Hui Bian (15% A.D.) by Wang Ji who wrote that "medicines, in form of such kinds 
as plants, fishes, insects, fowls and beasts, with the ability to combat diseases, are all 
regarded as poisons".(But PPH. and Kan WK, 1995) 
Information on the toxic potentials and other properties of Chinese medicines has 
been systematically recorded in some 330 editions of bencaos (Chinese herbals) issued 
in the last two thousand years. In the oldest herbal, the Divine Plowman's Herbal (Shen 
Nong Ben Cao Jing) which was compiled between 200 B.C.-200 A.D., herbs were 
classified into three categories:(But PPH, Hu SY et al., 1980) 
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(a) Superior category — herbs of the superior category are non-toxic and are used for 
longevity and maintenance of health; they can be consumed 
regularly; 
(b) Medium category— herbs of the medium category are toxic or non-toxic and are to be 
used with discretion in convalescence and debility; and 
(c) Inferior category ~ herbs of the inferior category are toxic and should be used only 
when necessary in the treatment of diseases, but never for 
prolonged consumption. 
Information on toxic potentials of Chinese medicines continues to appear in 
modern publications. Even the P.R.C. Pharmacopoeia (1990 edition) includes such 
information under each entry of herbs. For example, in the entry on the aconite 
Chuanwu {Aconitum cannichaeli root stock), the herb is noted to be "very toxic", and 
cautioned that "normally the cured (processed) form is used and care must be taken if 
used for oral consumption." 
The potent toxic herbs were using for thousands of years. The Yellow Emperor's 
Classic of Internal Medicine (Huangdi Neifmg, 1000-200 B.C.) noted that "in the use of 
very poisonous herbs for treating diseases, discontinue when the disease is cleared by 
six-tenths. In the use of poisonous herbs for treating diseases, discontinue when the 
disease is cleared by seven-tenths. In the use of slightly poisonous herbs for treating 
diseases, discontinue when the disease is cleared by eight-tenths. In the use of poisonless 
herbs for treating diseases, discontinue when the disease is cleared by nine-tenths. Then 
use foods such as the five grains, five fruits, and five vegetables for nourishment, to 
allow gradual recovery of the positive essence and eliminadon of evil factors." 
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4.2.1 Compound Prescriptions to Reduce Toxicity 
In order to use such kind of toxic herbs to treat disease，some processing procedure 
was invented to control toxicity. Another approach of TCM to control toxicity is to 
apply herbs in compound prescriptions. Guiding principles have been established for 
strategic combination of several herbs in a compound prescription, for the simultaneous 
actions on various target organs or systems, and for the restoration of the whole body to 
the normal or “balanced,，state. Toxicity of potent herbs may be eliminated or reduced 
by other herbs included in a prescription. For example, in many classical prescriptions 
using aconites issued by masters in Chinese medicine, honey or licorice are often 
included and considered helpful in reducing adverse reactions. Experience also led to the 
notion that certain herbs should not be used simultaneously, such as licorice in the 
presence of euphorbia {Euphorbia pekinensis root) as it has been noted that the two 
herbs together would induce adverse reactions.(Hsu HY，Chen YP et al, 1986) 
Properties of individual herbs, including their reputed functions, nature, and effects 
on organs and channels, are to be taken into consideration. Such combinations of herbs, 
each in small amounts, aim to maximize the beneficial actions of each herb and to 
minimize the adverse effects of the potent items. 
4,2.2 Processing Of Chinese Herbs 
Accepting that some herbs can be toxic or can cause adverse reactions, TCM deals 
with toxicity by curing (processing) the potent herbs. Various curing methods have been 
developed, including boiling, steaming, frying，soaking in water, defetting, fermenting, 
and denaturing with wine, vinegar, licorice, bile or urine. One of the important 
objectives in curing herbs is to reduce the toxicity of herbs.(Hsu HY, Chen YP et al’ 
1986) 
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Traditional Chinese medicine is a science founded on the accumulated experiences 
of the ancestral Chinese. Chinese herbal drugs come from natural products. As they 
instructed, most medicinal herbs should be processed before use. Traditional Chinese 
medicine places great importance on the processing of herbal drugs. The term for the 
processing in Chinese is "Pao Zhi (Pao Chih, ：!：包製)”. 
As early as the book Huang Di Nei Jin (Huang Ti Nei Ching,黃帝內經，The 
Yellow Emperor's Classic of Internal Medicine, 6274 B.C.), a processing method for 
Pinellia was recorded. Later, other books such as Shang Han Lun (傷寒論，Treatise on 
Febrile Diseases) and Ben Cao Gang Mu (Pen Ts'ao Kang Mu,本草綱目，General 
Catalog of Herbs) followed suit. For example, Shang Han Lun records processing 
methods for various herbal components of 113 formulas. Today, different methods of 
herbal processing are still used in accordance with the therapeutic, dispensing and 
pharmaceutical requirements of the herbal drugs. In China, the pharmacopoeia has 
standardized the processing methods for different Chinese herbs. In Taiwan, traditional 
herbal pharmacies generally follow methods of processing mentioned in Lei Gong Pao 
Zhi Lun (Lei Kung Pao Chin Lun,雷公炮炙論)• In &ct, despite the lack of scientific 
verification, today is processing methods for Chinese herbal drugs are mainly based on 
the ancestral experiences. 
4,2,2,1 The Aims of Herbal Drug Processing 
(1) Cleaning and increasing in purity is necessary to remove impurities and 
unwanted parts. For example, the skin of apricot kernel and peach kernel is removed 
before the kernels are used medically. (2) Reduction of toxicity and adverse effects is 
important for the toxic herbs such as aconite (烏頭 ) .The raw pinellia causes throat 
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irritation, processing reduces or eliminates this adverse effect. (3) Promotion of 
therapeutic effects of some particular herbs. Processing with liquid adjuvants such as 
wine, vinegar and ginger juice can obtain designed quality and action of herbal drugs. 
For example, after wine processing. Dang Guei (當歸）can be easily extracted. The 
alkaloids of corydalis are hardly soluble in water, but after vinegar processing they 
become readily soluble, thus enhancing the therapeutic effect. (4) Alteration of drug 
properties also needed for some herbs and it often augments or alters drug properties 
after processing. For example, raw He Shou Wu (何首烏） is cathartic, but after 
steaming it nourishes yin and invigorates liver. Moreover, processing could (5) improve 
flavor and have odor removing. Crude drugs are inevitably subject to contaminants and 
some have unpleasant odor. Processing cleans the drugs; prevents mould growth, rotting, 
and degeneration; removes the unpleasant odor and renders them palatable. 
4.2.2.2 The Methods of Herbal Drug Processing 
Certain herbal preparations require specific methods of preparation to reduce their 
toxicity. Herbal drugs usually undergo screening, cutting, and one or more of the 
following five basic types of processing. These techniques facilitate the storage of drugs, 
rendering drugs more suitable for therapeutic use. Processing methods have developed 
over a period of several thousand years. 
4.2.23 External processing (simple treatment by trimming) 
By this method the parts to be used are retained while the non-usable parts, 
contaminants, or impurities are removed by hand, by cutting, or by simple implements. 
This method entails various activities: 
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a) picking or selecting (杉K選）to separates usable from non-usable parts; i.e. separating 
lonicera leaves from the flowers. 
b) sifting or sieving (篩）to remove soil, sand, gravel and contaminants from the herbal 
drugs. 
c) winnowing or joggling (颠飯)，because of the difference in density between the drugs 
and the contaminants. Thus they can be separated with a fan or winnower� 
d) scraping (刮）off unwanted parts; i.e. removing the coarse outer cork layer of 
magnolia bark orcinnamon bark‘ 
e) brushing (刷）off the attached hairs or contaminants; i.e. the hair on loquat leaves or 
the hairy roots of cyperus. 
f) mashing or pounding (搗）and cutting (切）larger herb into smaller pieces. 
4.2.2.4 Water processing 
This method removes impurities from drugs by means of water, or renders drugs 
soft and easy to cut, or reduces the toxicity of drugs. 
a) washing (洗)，soil and impurities are washed away from drugs with water. Close 
attention must be paid to the length of washing time to prevent loss of the active 
ingredients of the herbs. 
b) immersing (、浸）or moistening (潤）herb in water, softens them and facilitates cutting. 
Sometimes adjuvants are added to water to remove the toxicity; Le. alum is added 
in water for processing pinellia. 
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c) soaking (泡 t h i s process requires less time than immersion. Herbal drugs that can be 
readily cut by being subjected to brief water soaking, or the active ingredients in 
herb are not stable by immersion are processed in this way. 
d) leaching (漂)，herb may be stirred and leached in large amounts of water, water 
should be changed from time to time to leach toxic constituents or salt. This process 
applies especially to seaweeds and kelp. 
4.2.2.5 Fire processing 
According to the heating temperature, heating time, and methods of heating, this 
process has the following methods: 
a) Frying (火少)，drugs are stir-fried until the desired extent of heating is reached, i.e. 
frying till the herb cracks, to a yellow colour, charred or carbonized. 
b) Frying with solid adjuvants (力口輔料炒、）to reduce toxicity, remove oil，moderates 
drug potency and improves taste; Le. processing with bran, rice, shell powder, 
talcum powder and sand. The heating temperature is higher than that of stir-frying 
and more evenly heated with sand, and sand-heating is usually used for processing 
the drugs which are difficult to be heated, such as caparax (Gui Ban 龜板，Bie Jia 
驚甲). 
c) Calcining (锻)，drugs are calcined with fire. This method involves open and anaerobic 
calcining; Le. pyritum. 
d) Wrap-up roasting 考)，drugs are wrapped up in moist paper or wheat flour and 
roasted in a bed of red-hot ashes or in powdered talc that has been heated. Paper 
wrap-up roasting removes the oil content of the drugs; i.e. myristica is processed 
in this way. 
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e) Baking with liquid adjuvants (炙）in order to impregnate the drugs with adjuvants, 
such as honey, ginger juice, wine, vinegar, and salt. Processing with honey 
imparts a sweet taste, a mollifying action, and an aridity-moistening effect; with 
ginger imparts a warming and dispersive character for expectorants; with wine 
causes ascending and counteract chills; with salt leads drugs downward and 
entering kidney. 
4.2.2.6 Water-fire processing 
a) Steaming (蒸)，drugs are steamed above boiling water; i.e. steaming raw rehmannia 
cures it; steaming aconite roots (Chuan Wu 烏，Chao Wu 草烏，Fu Zi 附子） 
reduces their toxicity. 
b) Boiling (煮)，drugs are cooked by boiling alone or together with adjuvants; i.e. scute 
is boiled with wine to reduce the degradation of active components. 
c) Boil-scalding (輝)，drugs are dropped into boiling water, stirred a while, then taken 
out and their out skin removed; Le. apricot. 
4.2.2.7 Other methods 
a) Defetting or ashing, drugs (often seeds) are compressed and strained to remove their 
oil content. The remaining portion is used medically; i.e. croton seeds. 
b) Fermenting, some drugs, such as Liu Shen Qu (Liu Shen Chu 六神麴)，are fermented 
c) Blending, drugs are blended with another drug or adjuvants; i.e. poly gala is blended 
with liquorice, and He Shou Wu (何首烏）with black beans. 
4.3 Practical Problem in Traditional Chinese Medicine 
Extensive work of varying quality, clinical relevance and accessibility have 
suggested that, in vitro at least, individual chemicals derived from a variety of plants 
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may have antibacterial, antioxidant, anticytokine, antispasmodic, cytotoxic and 
neuromodulatory actions. Chemistry and bioavailability of herbal medicines remedies 
derived from herbs contain a huge range of compounds, some common to many plants 
(for example pyrrolizidine alkaloids) and others specific to individual plants. It is 
clearly difficult to extrapolate from a knowledge of the chemical composition of a given 
plant extract to its possible efficacy (or safety) in vivo. This will depend on a variety of 
factors including amounts of individual constituents in the extract (which may vary with 
the plant origin and method of preparation of the extract), interactions between 
individual constituents, and their pharmacokinetics, itself largely unstudied. 
Conventionally TCM decoctions are prepared at home by the patient or the family. 
Therefore quantitative and qualitative control become a probleriL Decoction is prepared 
in an unscientific way, e.g. various amounts of water used, different temperatures and 
duration of boiling, the "age of the plant,”（for plants and herbs, there is no expiry date). 
The patients invariably end up receiving different dosages of medicine each time, 
seriously affecting the therapeutic effect� 
In TCM, herbal medicines are prepared by boiling, and re-boiling to produce a 
decoction. Through boiling for many hours, some of the active ingredients might have 
dissolved in the water to produce a therapeutic effect. Some preparations require mixing 
with alcohol; presumably some ingredients dissolve better in alcohol. It was found that 
many standardized herb extracts failed to deliver full potential. The therapeutic effect 
might have been different had the whole plant been used. Therefore it was postulated 
that in TCM many active ingredients work together, rather than one single ingredient. It 
is not known whether the ingredients have complementary, synergistic, antagonistic 
effect. 
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If a drug containing a single chemical extracted from herb is produced for use, it 
can no longer be considered as TCM practice. In TCM, it is the whole herb that is 
prescribed as formulation. Would the product still be considered as “herbal”？ It is more 
akin to a novel and unlicensed drug! It is in fact a modem formulation with a 
pharmaceutical approach. The drug might have an unknown direct toxic effect! Another 
difficulty encountered in the study of herbal medicines is that the actions of herbs are 
multiple. One single herb has anti-microbial, hypotensive, cholerectic, diuretic，and 
sedative actions. Some effects are beneficial but others are undesirable, or even harmful. 
Some herbs have an opposing effect when given in different dosages. For example, Da-
huang {rhubarb or Rheum officinale), when prescribed in a larger dose (1-5 gm of 
sennoside A) causes catharsis; but in a smaller dose (0.05 to 0.3 gm) causes constipation. 
In TCM, one plant product is considered a single item in the prescription. But one plant 
product contains multiple pharmacological agents or chemical compounds. These 
chemical compounds may act on non-target organs the therapeutic effects of which may 
be considered undesirable. Furthermore, pharmacokinetic study of various components 
is extremely difficult. 
4.4 Evaluation of herbal adverse reactions 
To have a better understanding of the types of adverse effects and hence preventive 
measures associated with taking herbal medicines, a classification system has been 
proposed. 
4.4.1 Type A reactions 
Some agents in the Chinese materia medica have direct toxicity and predictable 
adverse effects, with a number considered sufficiently toxic to be included. 
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4.4.2 Type B reactions 
These reactions are not related to the principal pharmacological properties of a drug 
and they do not improve when the dose is reduced 一 the drug has to be withdrawn 
completely. They are idiosyncratic reactions that occur in only a minorky of patients. 
Although type B reactions occur in only a minority of the users, they can be so severe 
that withdrawal of the responsible agent from general drug use is warranted. An 
example of a herbal medicine, which has been repeatedly associated with type B 
reactions, is the Japanese Kampo medicine Sho-saiko-to. (De Smet PAGM and D'Arcy 
PF, 1996) 
4.4.3 Type C reactions 
When reactions develop during chronic therapy in a pharmaco logically predictable 
way, they are called type C reactions. A herbal example is the occurrence of muscuJar 
weakness due to hypokalemia in long-term users of herbal anthranoid laxatives.(De 
Smet PAGM and D'Arcy PF, 1996) 
4.4.4 Type D reactions 
This category consists of certain delayed effects，such as teratogenic yand 
carcinogenicity.(Ellenhom MJ, Schonwald S et al, 1997; O'Hara M, Kiefer D et al, 1998] 
4.5 Chinese Proprietary medicine 
Many traditional Chinese medicinal prescriptions are now being formulated into 
tablets, pills，and liquids.(Richard KJ, 1999) These new formulations are known as 
Chinese patent medicines (CPM), herbal pills or liquids, or other terms to distinguish 
them from unprocessed medicinal plants, minerals, and dried animal parts. CPMs have 
gained wide acceptance by the Asian community in the past 20 years and have increased 
in popularity among non-Asian consumers who seek alternative therapy. They are sold 
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as over-the-counter medicines labeled with indications and instructions, and patients no 
longer rely on the technical knowledge of a traditional Chinese medical doctor. 
Unfortunately, many patent medicines manufactured in foreign countries contain toxic 
ingredients such as mercury, lead, arsenic, or prescription and unapproved active 
ingredients that may or may not be declared on the label. 
4.6 Potential Risks for Herbal Adverse Reaction 
When a case of herbal adverse reaction was suspected, the difficulty in establishing 
the diagnosis was well recognized. Each preparation (herbs or compound medicines) 
typically is made up of a number of ingredients that in turn consist of many different 
chemicals. Very often, the nature and actions of these ingredients and their constituents 
is large unknown. If the actual prescription cannot be traced, chemical analysis of each 
ingredient is not possible. On the other hand, the success in making the diagnosis to 
some extent will also depend on the clinician's suspicion.(Chan TY, Chan AY et al, 
1992) 
The follow mainpoint were the potential risks for herbal adverse reaction: 
4.6.1 Misidentification 
Misidentification can result in erroneous associations being made, with potential 
clinical implications. It is difficult to track and identify adverse effects of herbal 
ingredients, as the plants can be named in four different ways — the common English 
name，the transliterated name, the latinised pharmaceutical name, and the scientific 
name. It is essential that plants are referred to by their binomial Latin names for genus 
and species; misidentification can occur when other names are used. Furthermore, plant 
material can be misidentified at the time of the manufacturer's bulk purchase or when 
wild plants are picked. The most notorious trouble is the toxic herb Guijiu (鬼臼）which 
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is derived from the root and rhizome of Podophylium hexandrum (P. emodi). 
4.6.2 Lack of standardisation 
Poor quality of herbs that require proper curing and of proprietary medicines is also 
found to be a major cause of herbal poisoning. The therapeutic / toxic components of 
plants vary depending on the part of the plant used, stage of ripeness, geographic area 
where the plant is grown, and storage conditions. Therefore, batch-to-batch 
reproducibility of plant material should be assessed in the production of marketed 
products, but, in practice, product variation in herbal medicines can be significant. 
4.6.3 Contamination 
During growth and storage, pesticide residues, microorganisms, aflatoxins, 
radioactive substances, western medicine and heavy metals can contaminate crude plant 
material. 
4.6.4 Incorrect preparation / dosage 
The processing of crude plant material carried out by a manufacturer, TCM 
practitioner or the patient is a major determinant of the pharmacological activity of the 
finished product. Certain herbal preparations require specific methods of preparation to 
reduce their toxicity such as Aconitum carmichaelia. Failure to specify these 
requirements clearly can result in severe toxic reactions including cardiovascular 
collapse and cardiac arrhythmias. 
Another point to consider is that the activity of crude plant material may differ from 
that of the purified constituents, as some constituents may modify the toxicity of others. 
4.6.5 Excessive dosage 
Some of the cases of herbal poisoning are due to excessive doses. The beetles 
Mylabis phaletaia and M. cichoni are known as Bamnao ( S S ) in Chinese medicine. 
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The recommended dose of this herb in the PRC Pharmacopoeia is 0.03-0.06 g.(But PP, 
1994) A young immarried pregnant woman tried to induce abortion by consuming a 
decoction prepared by boiling in water over 200 pieces ofBanmao, The dose amounted 
to over 50 g. The woman went into shock and later died with acute renal failure, 
hematuria and bleeding.(Cheng KC, Lee HM et al, 1990) 
4.6.6 Individual errors 
Errors committed by individual patients can lead to herbal poisoning. A patient 
made a mistake to drink a spoonful of the orthopedic tincture Tonbigy (痛>必治).This 
preparation contains extracts of aconites and other potentially arrhythmogenic 
glycosides and is intended for only topical application. The patient thus suffered serious 
arrhythmia. 
4.6.7 Individual response 
Each individual may have idiosyncratic responses to Chinese medicines that are 
generally regarded as safe to the average pa t i en t s�A girl without any history of allergy 
presented with urticaria, pufiy eyelids and difficulty in breathing, two hours after taking 
a soup made from Dazao, the fruit of Ziziphus jujuha.(CYmn TY’ Chan AY et al，1992) 
4.6.8 Unqualified herbal practitioner with wrong prescriptions. 
Adverse events associated with TCM are usually associated with poor training 
and/or unethical conduct. Potential harm is likely to be minimized if the patient's 
response to treatment is adequately monitored by an appropriately trained practitioner, 
who will make appropriate referrals when necessary. Practitioners should have sufficient 
knowledge of western medicine to know when to refer a patient to a medical practitioner. 
In a fatal case of aconite poisoning, aconites were prescribed together with Chuanbeimu 
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from the bulb of Fritillaha cirrhosa.(fi\xi PPH，1994) This two herbs should not be used 
in the same prescription, according to principles and experience of traditional Chinese 
medicine, as they would have adverse interaction resulting in higher toxicity.(Hsu HY, 
Chen YPeta l , 1986) 
4.6.9 Interaction with Western medicine 
Also very little knowledge is available concerning the potential adverse reactions 
due to interaction of Chinese and Western medicines. We analyzed the herbs used by a 
patient suffering from multiple organ failure and coagulopathy in Australia,(Gorey JD, 
Wahlqvist ML et al, 1992) and found that the patient took both Western medication 
containing aspirin and herbs including Danshen (Salvia miltiorrhea) and Tianqi (Futus 
Panax potoginseng) which have anticoagulatory effects. 
4.6.10 Prolonged usage 
Very little knowledge is known about the chronic toxicity of most Chinese herbs. In 
Belgium, a health clinic prescribed capsules containing a combination of herbs and 
pharmaceuticals as a slimming regimen. After enrolling in the program and taking the 
capsules for 6 months to three years, 70 women suffered progressive renal fibrosis; 30 of 
them had terminal renal failure. The case was identified to the presence of the herb 
Cuangfangji (廣防己）derived from the root of Aristolochia fangchi，which Lontains the 
nephrotoxic aristoiochic acid.(But PPH, 1993; Vanherweghem JL，Depierreux M et al, 
1993) 
4.6.11. Coexisting disease 
Coexisting disease is another important problem since diseases can alter the 
metabolism of the herbs and affect their pharmacology. Many herbs are found to have 
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special reaction when coexist with other disease. Coptis chinensis/japonicum and 
Artemisia scoparia are highly effective in displacing bilirubin from its serum protein 
binding site and should not be used for patients with hyperbilirubinemia or in infants 
who are deficient in glucose-6-phosphate dehydrogenase. As in previous chapter 
mention, Kernicterus in preterm infants with neonatal jaundice caused by huang-lian 
{Coptis chinensis) is probably due at least in part, if not all, to its major and active 
ingredient, berberine, which acts as both a potent bilirubin displacer and an inhibitor of 
bilirubin metabolism. Immunoallergic reactions can occur that may not be apparent. 
Germander has been associated with hepatitis and it has been suggested that the 
mechanism of the adverse reaction is consistent with an allergic reaction. Vasculitis has 
been associated with an herbal preparation containing Passiflora extract reflecting an 
idiosyncratic hypersensitivity reaction to Passion flower extract. Other allergic reactions 
associated with herbs ranged from rash to anaphylaxis. Individuals with genetic diseases 
may be at higher risk for toxic effects. Glucose-6-phosphate dehydrogenase deficient 
patients who ingest herbs containing Acalypha indica or Salix caprea have an increased 
risk of acute intravascular hemolysis. 
4.7 Conclusion 
Although some pharmacy publications included articles that encourage the sale of 
herbal medicines, editorials and commentaries in a number of journals and consumer 
publications preached caution, physicians and pharmacists have begun to recognize the 
relative safety and efficacy of at least some of the more well researched herbs on the 
market, many have concerns about contraindications, potential adverse reactions, and 
possible herb-drug interactions. 
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Chapter 5 - Substitution, Adulteration or Misusing with 
Toxic Herbs. 
5.1 Overview 
The term "adulteration" refers to traditional Chinese medicines that are tested and 
found to contain chemical substances not prescribed or labeled as part of the intended 
use. In traditional Chinese medicines (TCM), herbal raw materials are commonly used in 
combinations, which may allow the use of smaller doses of herbs with synergistic 
beneficial effects, and some materials may counteract the potential toxicity of others. 
Some herbal combinations that may potentiate toxicity have been recognized and can 
usually be avoided but interactions between herbal materials and standard drug treatments 
have not been widely studied and represent a potential area of conceriL 
Herbal poisoning has occurred in self-styled and weekend botanists who 
unwittingly picked the wrong herb. Besides this, it also conceivable that the careless 
gathering, storage, or distribution of medicinal plant material results in accidental 
substitution or contamination with another botanical Inexpert or negligent herbal drug 
dealers may fail to recognize such a problem in time.(De Smet PAGM, Hansel R et al, 
1997) Serious poisoning by herbal medicine can occur when an importer or retailer 
mistakes one herb for another, owing to similarity in appearance or confusion about the 
nomenclature. 
The use of common names to label or to order plant materials often with 
devastating consequences. Croom pointed out in 1983 that Cimicifuga racemosa had 22 
different common names offering ample scope for confusion and that it is important to 
record common names of plants because the scientific name is itself easily subject to 
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error particularly when recording traditional plant usage. He also pointed out that just as 
a single species may have a number of common names so one common name may refer 
to several different plants and he gave the example of Black Snake Root which could 
apply not only to Cimicifuga racemosa, family Ranunculaceae but also to Asarum 
canadense family Aristolociaceae and to two Sanicula species of the family Apiaceae�It 
is similarities in common names that are most likely to result in confusion e.g the name 
Jia-pi for Periploca and as part of the Chinese name for Eleutherococcus. 
The most tragic example of this confusion is the Fang Ji case. In the early I990’s, a 
weight loss clinic in Belgium was dispensing a weight loss regimen that contained 
numerous drugs and two Chinese herbs. The herbs used were Stephania tetrandra (han 
fang ji) and Magnolia officinalis (hou po). However, instead of using Stephania 
tetrandra (han fang ji), the incorrect herb Aristolochia westlandi (guang fang ji) was 
used. After ingesting this combination of drugs and herbs over a long period of time, 
several illnesses were reported, (for detail please see Chapter 12) 
5.2 Adulteration by Guijiu 
Adulteration of traditional Chinese medicme by a cheaper, and often more toxic, 
substitute is also common. Herbal drug dealers may deviate from pharmacopoeia or 
other authoritative specifications of botanical identity for various reasons: 
Inadvertent dispensing of this type has led to two patients being given Guijiu (the 
roots of Podophyllum emodi wall), which contains podophyllin, instead of the intended 
longdancao {Gentiana species).(Ng TH, Chan YW et al, 1991) Both patients developed 
podophyllin intoxication with severe gastrointestinal, renal, hepatic, and haematological 
signs and permanent neurological damage. In China, there have been many warnings 
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about the use of Guijiu as an adulterant of longdancao.(Liii HR and Chen SJ，1988; Chan 
TY，ChanJCetal, 1993) 
In Hong Kong, in 1995 and 1996 respectively, three and nine cases of neuropathy 
have been reported after consumption of the adulterant mixed with Wai-Ling-Sin in 55 
importers.(But PPH, Kwok I et al, 1996) Health searched for Wai-Ling-Sin in 55 
importers and 867 retail outlets and found podophyllum in 22 of the 234 samples 
analyzed. The adulterated samples were imported by five importers and distributed to 
the retailers by 14 distributors. The poisoning is caused by ingestion of the herb known 
in Cantonese as Gwai-Kou, which is derived from the roots and rhizomes of 
Podophyllum hexandrum (also known as P emodi; podophyllum). The herb Guijiu, 
called ‘Taoerqi’ in northwestern China, is derived from the roots of Podophyllum emodi 
Wall., also known under the synonyms R emodi Wall var. chinensis Sprague and 
Sinopodophyllum emodi (Wall). 
The patients with podophyllum poisoning first developed serious vomiting and 
diarrhea. Patients complained of numbness of the arms and legs and difficulty in walking, 
and clinical findings included an absence of jerks, reduced plantar responses, lack of 
coordination of the fingers, ataxic and unsteady gait, poor standing balance, and 
impaired proprioception and vibration sense. Sensory responses and motor coordination 
returned partially over months. In the two cases that occurred in 1989, after ingestion of 
a high dose of podophyllum (probably greater than 20 g), encephelopathy was still 
present five months after the incident. 
The Chinese Medicinal Material Research Center (the former of Institute of 
Chinese Medicine) in The Chinese University of Hong Kong developed two instant 
methods for spot-checking the contamination of the toxic herb Podophyllum hexandrum 
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in herb samples of Clematis chinensis (威靈{山）and this method was published in the 
journal Veterinary and Human Toxicology.(But PPH, Cheng L et al., 1997; Kwok IMY, 
Cheng L et a l 1998) 
Two young persons developed gastrointestinal symptoms with vomiting and 
diarrhoea after taking a decoction supposedly prepared from the rootstock of Gentiana 
rigescens Longdancao (Gentianaceae).(Ng TH, Chan YW et al, 1991) On admission, 
they were lethargic and mute and became comatose 12 h later. They were treated in the 
intensive care unit with ventilatory assistance and haemoperflision, but the condition 
was remained unchanged for the next 10 days. Both patients developed severe 
encephelopathy with extensive and permanent neurological damage - cognitive 
dysfunction, cortical atrophy, optic neuropathy, axonal peripheral and autonomic 
neuropathy. One was left with severe disability, and the other recovered with mild to 
moderate impairment of higher mental functions. 
The decoction consumed by the 2 patients was intended to have been prepared from 
the herb longdancao.(Ng TH, Chan YW et al, 1991) According to the Pharmacopoeia of 
the People's Republic of China, the officially accepted plant origin of this herb is the 
root of Gentiana manschurica Kitag., G. scabra Bunge, G. triflora Pall and G. 
rigescens Franchet. Commodities from the last species, generally regarded as a lower 
grade, are more specifically called "guizhou longdancao，，(桂洲龍膽草）in the local 
herbal industry. Because of the apparent similarity in morphology, both the importer 
and retailer mistook guizhou for longdancao. 
The herb Guijiu, called 'Taoerqi' in northwestern China, is derived from the roots 
of Podophyllum emodi Wall； also known under the synonyms F. emodi Wall var. 
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chinensis Sprague and Sinopodophyllum emodi (Wall). Podophyl lo toxin, 
demethylpodophyllotoxin, sikkimotoxin, diphyllin, demethyldeoxypodophyllotoxin, 
deoxypodophyllotoxin, kaempferol and quercetin can be found in this herb. 
Longdancao has been in use through the centuries without report of major side 
effects, apart from mild diarrhea when given in excess. Pharmacognostic evaluation of 
the herb samples revealed that the samples were adulterated by the root of Podophyllum 
emodi Guijiu (Berberidaceae), which contain the neurotoxin podophyllotoxin. 
Chromatographic analysis of the herb samples, decoctions and corresponding gastric 
lavage contents confirmed the presence of podophyllin toxin in high concentrations. 
Neurotoxicity of podophyllin manifests in a variety of ways. Cerebral involvement 
results in acute alteration of sensorium ranging from mild confusion to frank coma, as 
well as permanent impairment of higher mental functioiis.(Filley CM, Graff-Radford NR 
et al, 1982) In this 2 cases，the patients were suffered severe encephelopathy in the acute 
stage, followed by irreversible cognitive dysfunction. Pathological sequela could found 
in the first case, probably due to greater absorption of the toxin because gastric lavage 
was not performed. Cerebral atrophy could see in CT and MRI as a result of the toxic 
insult. Moreover, symmetrical sensorimotor polyneuropathy, autonomic neuropathy, 
dorsal radiculopathy and optic atrophy could found also. Electrodiagnostic studies in 
these 2 patients indicated axonal degeneratioiL 
Subsequent investigation revealed that the supplier in China was responsible for the 
substitution and the herbal trade missed the error. Guijiu was reported to have been 
exported also as an adulterant or substitute of Weilingxin from China to Malaysia and 
Taiwan. Furthermore, the presence of podophyllum in some herbal preparations for use 
as laxatives or slimming preparations can lead to accidental poisoning.(CuUis JE, 1962) 
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5.3 Anticholinergic reactions Caused by Yangjinhua 
"Yangjinhua" refers to the flower of Datura metel and D. innoxia (Solanaceae). 
In the herbal industry in Hong Kong, it is called ''Naoyanghua".(Chan JC, Chan TY et al, 
1994) It is noted for its antasthmatic, antirheumatic, anesthetic, and analgesic effects. It 
is employed in asthma, convulsion or epilepsy, and in rheumatism. It is also used as an 
anesthetic in surgery. The bio active components in “Yangjinhua” are scopolamine, 
hyoscyamine and atropine. The typical features include confosion or cx)ma, fever, 
tachycardia, flushed dry skin, dilated pupils, dry mouth and urinary retention. The herbs 
contain scopolamine, hyoscy amine and atropine. They are often used for upper respiratory 
problems such as chronic bronchitis or asthma or various painful conditions. 
Four women in Hong Kong suffered drowsiness or confusion after the consumption 
of herbal decoctions. These cases improved after conservative management and were 
discharged after a few days. The four patients consulted the same TCM practitioner and 
had their prescriptions dispensed at the same herbshop. Examination of the herb samples 
revealed that the problem arose from "Lingxiaohua", a herbal ingredient in the 
compound prescription. According to the Pharmacopoeia of the People's Republic of 
China, "Lingxiaohua" should be the flower of Campsis grandiflora and C. radicans 
(Bignoniaceae). In Hong Kong and other parts of southern China, this herb is frequently 
substituted by 'paotunghua' (the flower of Paulownia fortunei and P. tomentosa). It is 
indicated for upper respiratory tract infections, mumps, enteritis, dysentery and 
conjunctivitis. However, in these four cases, the actual flower found in the herb samples 
was "Yangjinhua". The amounts of "Yangjinhua" range from 6 g in the drowsiness 
cases to 11 g in those of confusion. Thin-layer-chromatographic analysis confirmed the 
presence of atropine and scopolamine. A subsequent search by the police concluded that 
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the retailer at the herbshop made the mistake. 
But et al. described a pediatric case of anticholinergic poisoning after the ingestion 
of'naoyanghua'.(But BWM, Chan WH et al., 1999) Like her mother, this 7-year-old girl 
was found confused. Initial physical examination showed that the child was delirious. 
Her blood pressure was 160/110 mmHg and pulse was 90 beats/minute. Her body 
temperature was 35.2^C. She had facial flushing and both pupils were dilated. The 
urinary bladder was palpable. Gastric lavage was performed. Activated charcoal was 
given and supportive care was provided. It was subsequently noted that the child had 
drunk a decoction intended to be 'Lingxiaohua' on the night of admission. The child 
became fully conscious 12 hours after admission and blurred vision initially present 
subsided a day later. 
The great majority of patients with (herb-induced) anticholinergic poisoning made 
a complete recovery. However, heat stroke, which carries a high morbidity and mortality, 
may occur in high environment temperatures and during intensive physical activity. 
With severe poisoning, intravenous physiostigmine can be used to reverse the 
anticholinergic features.(Ramirez M, Rivera E et al., 1999) 
Datura metel L. is widely distributed in south Asia and south China. Its flowers, 
leaves and seeds all contain atropine and other anticholinergic substances and are 
therefore poisonous. Ingestion of its flowers and/or seeds, either accidentally or as 
herbal remedies for some common ailments，can cause severe poisoning.(Yuan H and 
Tan D, 1991; Zhu T and Jiang PC, 1992) The clinical presentations may include dry 
mouth, dilated pupils, agitation, tachycardia, tachypnea, unsteady gait, hallucination, 
coma and even deaths. Moreover, four other Datura species, D. innoxia Mill., D. 
stramonium L., D. tabula L and D. fastuosa, are known to contain anticholinergic 
70 
substances and have been used as Chinese herbal medicmes.(He LY, 1982; Kang TG, Ji 
JY et al, 1987) In Chinese materia medica, 'yangjinhua' (the dried flowers of D. metel L.) 
is used for treating bronchial asthma and chronic bronchitis. Other indications include 
epigastric pain, rheumatic pain, pain from injury, toothache, surgical anesthesia, 
convulsion and psychosis. It has been given by the oral or intravenous routes or as 
cigarette smoke. The recommended oral dose is 0.3-0.6 g. 'Yan^inhua' contains 0.3-
0.43% alkaloids, mainly scopolamine (85%) and hyoscyamine/atropine (15%). The 
alkaloid components and amounts vary greatly with the place of origin and season of 
harvest. The dried seeds of H. Niger L. contain 0.2% alkaloids, mainly hyoscyamine, 
scopolamine and atropine. The seeds of H. bohemicus F.W. contain hyoscyamine 0.04% 
and scopolamine 0.01%. 
In addition, an outbreak of cholinergic poisoning were occurred in New York City 
in 1994.(Carl HK, Paul L et al, 1995) Seven individuals from three families of South 
American origin were affected. Signs and symptoms of illness included dry skin, 
hyperthermia, tachycardia, dilated pupils, agitation, and hallucinations within 3 days. 
Onset of illness in all cases was temporally associated with consumption of a tea that 
was labeled "Paraguay Tea" and was purchased from a grocery store specializing in 
South American foods. Paraguay tea, made from the leaves of the hoUy, Ilex 
paraguariensis, contains caffeine and theophylline and is a popular beverage in South 
America. Samples of the tea analyzed with gas chromatography contained belladonna 
alkaloids but neither caffeine nor theophylline. The tea is nontoxic with normal use, and 
the leaves do not contain belladonna alkaloids. The only reported toxic effects of 
Paraguay tea is a single case of hepatic veno-occlusive disease in Great Britain in a 
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patient who consumed large amounts of Paraguay tea over a period of years.(McGee JD， 
Patrick RS et al, 1976) 
After analysis, the suspected herbal Paraguay tea has some unusual brown steins and 
branchlike appearance rather than the familiar leafy reddish mixture, and those who 
drank it stated that it did not have the taste of Paraguay tea. A number of plants are 
known to contain belladonna alkaloids. These plants are toxic to humans by ingestion 
and inhalation if smoked. Jimsonweed {Datura stramonium) may be the cause of such 
poisoning and this herb has a worldwide distribution. Ingestion of the leaves produces 
rapid onset of anticholinergic symptoms, with tachycardia, hypotension, hyperthermia, 
confusion, hallucinations, mydriasis, dry mucous membranes and skin, diminished 
bowel sounds, and urinary retention. In severe poisonings, seizures and coma can occur. 
Cases of human poisoning with plants containing belladonna alkaloids are reported with 
regularity. 
For instance, it has become difficult to obtain real golden rod (Solidago virgaurea), 
but this species can be justifiably substituted with the related S. gigan tea or S. 
canadensis. It is obvious that such changes are only acceptable when the replacing herb 
is properly labeled with its correct identity. 
A less honorable practice is the deliberate, undeclared substitution of medicinal 
herbs by inferior and/or cheaper species. Some years ago, a Belgian consumer 
organization reported that the majority of locally purchased peppermint herbs and 
capsules did not contain Menthapiperila at alL but the much cheaper species M. crispa. 
Likewise, most samples of lime-tree flower did not originate from Tilia cor data or T. 
platyphyllos, but from the inferior species T. argentea. Another eloquent example is the 
recent widespread availability of roots marketed as Echinacea but in reality coming from 
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the less expensive composite Parthenium inlegrifolium. 
In many cases of botanical adulteration, direct toxicological implications for the 
user are unlikely or remain unknown. As the following examples show, however, every 
now and then a report appears in the literature about increased health hazards of a herbal 
medicine due to substitution or contamination with a toxic botanical (De Smet PAGM, 
Hansel Re ta l , 1997) 
Cases of suspected anticholinergic poisoning after ingestion of a broth of ginseng 
{Panax ginseng) bought in China were reported. The chemical content of ginseng varies 
greatly in different brands of the preparation. Ginseng preparations on the US market 
were reported to be adultered with Mandragora officinarum (scopolamine), Raicwolfia 
serpentia (reserpine), and Cola s p e c i e R K , 1977) These contaminants yield the 
well-known toxic compounds reserpine and belladonna alkaloids, respectively. 
Seeds of the poison hemlock {Coniurn maculaturn) have occasionally been found 
in anise seed, and roots of Veratrurn album are sometimes mislabeled as Primula 
roots.(De Smet PAGM, Hansel R et al, 1997) Coniurn seeds have well-known nicotine-
like toxicity due to the presence of conime and related-alkaloids, and Veratrurn alkaloids 
can produce severe toxic symptoms, such as bradycardia and hypotension.(Lampe KF 
and McCarm MA, 1985) 
Fruits of the star anise tree {Rlicium verum) may be adulterated with those of the 
related shikimi tree (Z anisaturn). The latter are more dangerous than the former due to 
the presence of the toxic sesquiterpene dilactones anisatin and neoanisatiiL(Zanglein A, 
Schultze Weta l , 1989) 
Belladonna root {Atropa belladonna) has been identified as a substitute for 
marshmallow root，an admixture to elfdock root，and as an adulterant of burdock 
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root.(De Smet PAGM, Hansel R et al, 1997) Burdock root tea preparations and other 
commercial herbal products that normally do not contain atropine-like substances have 
been regularly associated over the past years with delirium and the vegetative symptoms 
of anticholinergic poisoning. 
5.4 Overdosage 
The problem has often been related to use of excessive doses of these herbs. Herbs 
used commonly as food flavorings and apparently innocuous in small amounts can be 
toxic in large amounts. 
5.4.1 Overdose of Aconitine 
Aconite poisoning is one of the most serious adverse effects of CHM. The 
common species used in Chinese medicme are the root stocks of Aconitum carmichaeli 
Chuanwu, A. kusnezof/ji Caowu, and A. brachypodum Xueshang Yizhihao, and the 
lateral root of A carmichaeli Fii2i.(But PPH and Kan WK, 1995) They contain the C,9-
diterpenoid ester alkaloids (including aconitine, mesaconitine, and hypaconitine) and 
other biologically active substances. 'Chuanwu' and 'caowu' are regarded as 'interior-
warming, chill-repelling herbs', which may increase general or local blood flow, 
improve energy metabolism and increase the digestive and absorptive activities of the 
gastrointestinal tract. For these reasons, they have been used to treat conditions such as 
rheumatism, arthritis, bruises, post-traumatic pain, fractures, hemiplegia, diarrhoea and 
acute abdominal pain due to 'pathogenic cold' (a concept in traditional Chinese 
medicine). In China, aconitine poisoning may be due to Tuzi' (the lateral root of A. 
carmichaeli) or five other less commonly used aconite roots as well as the more common 
'Caowu' and 'Chuanwu'.(Ng YB, 1988) In Japan, 'Bushi' prepared from Aconitine 
species of Chinese and Japanese origin is the most important cause of aconitine 
74 
poisoning. Asians living in Australia and other Western countries may have surprisingly 
easy access to CHM containing aconite roots.(Kelly SP, 1990) In western countries, 
aconitine poisoning usually occurs after ingesting aconite roots as medicines or the wild 
Aconitum plant. 
Raw aconite tubers are extremely toxic. For this reason, they are always 'processed' 
or 'cured' before use, with the aim of reducing the content of toxic ingredients. Aconites 
are processed by prolonged steaming or boiling in water, which leads to hydrolysis of 
the aconitine alkaloids into the less toxic derivatives benzoylaconitines and 
aconites.(Kosuge T and Yokota M, 1976) Soaking and boiling in water with or without 
the addition of chemicals may reduce the original alkaloid content by as much as 90%. 
Recommended dosages for processed aconites in the Pharmacopoeia of the People's 
Republic (1990 edition) are as follows; Fuzi 3-15 g，Caowu 1.5-3 g, and Chuanwu 1.5-3 
g-
Several factors may be of importance in deciding whether poisoning will occur 
following the ingestion of 'chuanwu' and 'caowu'. The alkaloid contents and amounts in 
these herbs，which vary with the factors described above, will determine the severity and 
clinical presentations. The use of inadequately processed samples will increase the 
likelihood of poisoning�Some patient with tetraplegia could have taken a preparation 
with hypaconitine as the predominant constituent. Poisoning may occur if patients do 
not prepare the decoction as instructed. These different J^ctors may explain why some 
of our patients were apparently well with their first dose. Perhaps, they hurried the 
preparation procedures for later doses or obtained the preparations from another shop. 
Severe poisoning has been reported after the consumption of a decoction made from 6 g 
of processed" aconite root. A dose of 7-11 g each had been prescribed for our patients, 
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although the recommended dose has been lowered progressively to 1.5-3 g after reports 
of toxicity. 
In the past five years, more than 35 cases of accidental herb-induced aconite 
poisoning have been managed in six public hospitals in Hong Kong. (But PPH and Kan 
WK, 1995) The decoctions or tinctures were used mainly for the treatment of 
musculoskeletal disorders including rheumatism, arthritis and post-trauma pain. Based 
on the analytical result performed by Chan TY(Chan JC, Chan TY et al, 1994) stated 
that all patients became unwell after taking the first dose of aconite roots (mostly 
'chuanwu' and 'caowu') together with approximately 10 other herbs. Among patients in 
whom the prescription could be traced, a dose of 7-11 g each of 'chuanwu' and ^caowu' 
had been prescribed. The latent period between ingestion of decoction and the 
occurrence of symptoms ranged from 0.3 to 1.5 hours (mean 0.9 hour). 
The great majority of patients presented with neurological features starting with 
burning sensation and paraesthesia in the mouth and tongue and progressing to 
paraesthesia in the extremities and generalised muscle weakness, cardiovascular features 
(hypotension, bradycardia or ventricular ectopics) and gastrointestional features (nausea 
and vomiting). Moreover, the clinical presentation of poisoning due to “Chuanwu” and 
"Caowu" can be explained by the actions of aconitine and related alkaloids in various 
parts of the body. Aconitine is a known neurotoxin and cardiotoxin and acts on the 
voltage-sensitive sodium channels of the excitable membrances. It produces a state of 
persistent activation of sodium channels resulting in increased permeability to sodium 
and prolonged depolarization preventing repolarisation of the excitable membranes. 
Through its action on the sodium channels in the axons, aconitine can produce 
conduction block and muscle paralysis. Hypaconitine activates the sodium channels in 
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the axons more selectively and is more potent in producing the neuromuscular block 
than aconitine and mesaconitine. Through its action on the fast sodium channels in the 
heart, aconitine has digitalis-like cardiotoxic effects. It has a positive inotropic effect on 
the heart by prolonging the sodium influx during the action potential. The associated 
increase in intracellular calcium concentration via NaVCa^^ exchange induces and 
enhances automaticity, which, together with the increased vagal activity and slowed 
atrioventricular conduction, leads to arrhythmias. The slowed atrio-ventricular 
conduction may progress to complete heart block. The negative inotropic and 
cardiodepressant effects appear to be vagal as they can be blocked with atropine, and this 
is appropriate treatment when these features are present. 
Aconitine also acts on the central nervous system. The stimulation of the medullary 
centre results in slowing of heart rate and reduction in blood pressure. A central action 
may be the explanation for the presence of hyperventilation in some patients. The 
numbness or paresthesia first starts in the mouth and tongue and then progresses to the 
extremities. Generalised convulsions have been reported. Other features include 
hypokalemia, metabolic acidosisis, respiratory acidosisis, respiratory alkalosis，renal 
impairment, hepatic impairment, and aspiration pneumonia.(Tai YT, But PH et al, 1993) 
The diagnosis of herb-induced aconitine poisoning is based on the history and clinical 
features. The management of aconitine is essentially supportive, as there is no specific 
antidote other than atropine for the features of cholinergic excess. All patients should be 
observed in the hospital because of the risk of ventricular arrhythmias, which are most 
likely to occur in the first 24 hours. Toxic symptoms occur after an average of 0.9 hour, 
suggesting of rapid absorption of the alkaloids by the upper gastrointestinal tract. Hence, 
measures to reduce absorption, e.g. the use of activated charcoal, might only be of use if 
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patients are seen soon after ingestion. Hypokalaemia and dehydration as a result of 
vomiting and diarrhoea should be corrected. Patients should be closely monitored for 
blood pressure and cardiac rhythm disturbances for at least 24 hours. It is not clear 
which of the anti arrhythmic drugs would be most effective. 
After analyzes, the following problems have been identified in the 30-35 cases of 
aconite poisoning: (1) prescription of excess amounts of the aconites, (2) inconsistent 
quality control with suboptimal curing of the aconites, (3) inappropriate combination of 
herbs in the prescriptions, (4) nonadherance to recommended methods for preparation of 
the herbal decoction on the part of the patient, resulting in inadequate detoxication, and 
(5) individual differences in the ability to tolerate the potent components.(Tai YT, But 
PPH et al, 1993) 
5.4.2 Overdose of Liquorice ('gancao') 
Liquorice {Glycyrrihzia glabra) and its extracts are commonly used in traditional 
Chinese medicine and in confectionery. Licorice root, widely used to flavor confections, 
has caused sodium and water retention, severe hypokalemia, hypertension, heart failure, 
and cardiac arrest. They contain glycyrrhizic and glycyrrhetinic acids, which may cause 
the syndrome of mineralocorticoid excess by inhibiting 11-p-hydroxysteroid 
dehydrogenase and hence conversion of Cortisol to cortisone.(Stewart PM et al, 1987) 
Licorice is present in clinically significant amounts in Lydia Pinkham's Compound, an 
over-the-counter preparation used to treat "women's problems", and at least one case of 
hypokalemic myopathy related to long-term ingestion of this compound has been 
reported.(Lai F, Venna N et al, 1980) Patients have presented with symptoms of 
hyperaldosteronism after regularly consuming licorice in the form of candy. 
Glycyrrhetic acid, a metabolite of glycyrrhizin produced by human microbial flora, 
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has a chemical structure closely resembling that of aldosterone. Most reports of adverse 
reactions have been associated mainly with its excessive use, and clinical presentations 
include hypertension, edema due to sodium and water retention, and hypokalemia. This 
herb may precipitate hypokalemic periodic paralysis attacks in patients with 
thyrotoxicosis.(Chan TY, Chan AY et al, 1992) 
In traditional Chinese medicine, ’gancao’ is used to treat pharyngolaryngitis, cough, 
palpitations, stomachache, peptic ulceration, pyogenic infections and skin ulcers. 
Liquorice intoxication is a well-known exogenous cause of hypokalemia. Liquorice 
abuse can thus lead to enhance Cortisol action on the mineralocorticoid receptor in the 
distal tubuli of the kidneys. This will promote potassium excretion and sodium and 
water retention, leading to hypokalemia and hypertension, respectively.(Walker B and 
Edwards CRW, 1994) Peripheral edema in this patient may occur and the hypokalemia 
may lead to muscle pain and weakness, tetany，parasthesias, headaches and cardiac 
dysrhythmias. An example of a 44-year-old woman, attended the hospital because of 
irregular heart rhythm and she displayed repeated episodes of life-threatening torsades 
de pointes ventricular tachycardia after ingested moderately large amounts of liquorices 
every day for 4 months.(Eriksson JW, Carlberg B et al, 1999) The patient recovers after 
cessation of liquorice and receives symptomatic treatment. Another case is a young 
woman who had an acute embolic episode that affected her right upper limb after long 
time consumption of liquorice.(Lozano P, Flores D et al, 2000) The patient had a long 
lasting history, longer than ten years, of continuous licorice ingestion. Blood samples 
showed severe hypokalemia that caused EKG changes. Transesophageal 
echocardiogram discovered mild mitral valve prolapse. An axillo-brachial 
thromboembolectomy was performed after which distal pulses were recovered. The 
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combination of surgery and potassium supplements was successful in treating this rare 
and potentially life-threatening disease. 
5.4.3 Overdose of Chansu 
Chansu refers to toad venum from Bufo hufo gargarizan and B. melanostictus 
(Bufonidae). It contains the cardiotonic bufotoxins and used its anti-inflammatory 
analgesic and anaesthetic properties.(Tomlinson B and But PPH, 8-11 November 1994) 
The recommended dosage is 0.015-0.03 g. In Hong Kong, a herbal practitioner reported 
a fetal case due to over-prescription of 5 g of this herb, and the patient was finally died. 
It is also found in the proprietary Chinese medicine ‘Lushenwan,, which is a famous and 
popular remedy for upper respiratory symptoms or used as a topical preparation for skin 
infections. Overdosage of these tiny pills can cause cardiac glycoside toxicity in children 
and topical applications may cause local skin inflammation. 
5.5 Misusing — Personal abuse 
5.5.1 Banmao 
The risk that a poisonous plant is used instead of the required medicinal herb might 
become particularly high when people without botanical expertise start to collect their 
own plant material. Every now and then, a case report in the literature makes it 
abundantly clear that the erroneous identification of self-selected plant material can 
result in serious or even lethal poisoning. In Hong Kong, a 23-year-old unmarried 
pregnant woman tried to induce abortion by consuming a decoction prepared by boiling 
in water over 200 pieces of Banmao.(But PPH and Kan WK, 1995) The dose of the herb 
amounted to over 50 g. A few hours after consuming the decoction, she presented to 
hospital with pain in the mouth and throat, nausea, vomiting, diarrhea, and abdominal 
pain. Physical examination showed swelling and multiple erosions of the mucous 
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membranes of the mouth, the tongue and the pharynx. Blisters were found in the lower 
limbs. Gastric lavage and intensive treatment were not useful, and her conditions 
continued to deteriorate. Sixteen hours after admission, the fetal heart sounds became 
undetectable and spontaneous abortion occurred nine hours later. She later went into 
shock with acute renal failure, hematuria and bleeding. She remained in deep coma and 
died two days after admission. Autopsy of the body found congested and bleeding 
patches in visceral organs. The amounts of cantharidin found in ante-mortem blood， 
ante-mortem urine, postmortem blood，and liver were 0.27 p-g/ml, 4.45 |ag/ml, 0.11 
jig/ml, and 1.24 )ig/g，respectively. 
Banmao refers to the beetles Mylabris phalerata and M. cichoni (Meloidae). It has 
antivirulent, antulcerative, anticoagulant, and discutient actions. It is mainly used to treat 
malignant sores, abdominal mass, lymph node tuberculosis, thyroid tumor and rabies. It 
has also been used to induce abortion. The Pharmacopoeia of the People's Republic of 
China (1990 edition) (Pharmacopoeia C, 1990) noted that Banmao is very toxic and 
should be used with care for oral consumption and avoided during pregnancy. The 
recommended dosage of this herb is 0.03-0.06 g and the major bioactive component is 
cantharidin. Cantharidin was formerly used as a counter irritant and vesicant, in hair 
lotions for their rubefacient action, and in flexible collodion for the removal of warts. 
The lethal dose of cantharidin has been reported to be in the range of 10-60 mg, which is 
equivalent to about 4-24 pieces of the dried beetles. 
5.6 Discussion 
A botanist of appropriate training and experience should examine herbs. A 
qualified botanist to identify herbs may be difficult to find and other professionals 
81 
should be consulted. Schools for pharmacognosists, acupuncturists, naturopathic 
practitioners, and herbalists can serve as invaluable sources. Other experts in herbs 
include trade professionals like importers and herbal product manufacturers. Traditional 
identification methods may include organoleptic as well as visual. Two independent 
qualified experts should be utilized to confirm the identity of the herbs. Consistent 
terminology (Latin or scientific names) should be used in the identification process since 
familiar toxic agents may be hidden behind unfamiliar names. 
After the suspected herbs have been visually identified, it is essential to confirm the 
identity of the herbs by laboratory analysis since misidentification, substitution, 
improper preparation, and contamination are all possible causes of adverse reactions. 
Confirmation can be done by pharmacognostical study of the morphology and anatomy 
of the herbs, chemical analysis, or bioassay. If an adverse reaction does not correspond 
to the known pharmacological actions of the identified herb，improper preparation and 
contamination should be considered and detailed chemical analysis should be pursued to 
determine possible adulterant(s). 
Chemically defined constituents of medicinal plants can play an important role in 
the quality control of herbal products. Some constituents may serve a qualitative 
purpose; their presence in a herbal product assures that the product has been prepared 
from the correct botanical ingredient. If possible, one should monitor the constituents 
which are held responsible for the pharmacological activity of a herbal drug. When the 
active constituents are uncertain or unknown, however, quality control may be based on 
so-called chemical markers, Le., constituents which are considered characteristic for the 
herbal ingredient. The Committee for Proprietary Medicinal Products of the EC has 
explicitly recognized the usefulness of markers in the quality assurance of herbal 
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remedies. This Committee specifies in its recent "Note for Guidance on the Quality of 
Herbal Remedies" that a marker may serve to calculate the quantity of vegetable drug or 
preparation in a finished product if that marker has been quantitatively determined in the 
vegetable drug or preparation when the starting materials were tested.(De Smet PAGM, 
Hansel R et al, 1997) 
Traditional methods for analyzing natural products include thin-layer 
chromatography (TLC) and gas and liquid chromatography (GC and LC) linked to mass 
spectrometry. For example, a TLC check on the presence of menthoflirane in a 
peppermint drug may verify that it comes from Menthapiperila and not from M. arvensis 
var. piperascens. Other constituents are used in a more quantitative way, that is to say，a 
certain level in a herbal remedy is taken as a measure of the amount of the herbal 
ingredient in that product. All three methods offer the advantage of screening for a wide 
range of polar and nonpolar compounds especially when the ingredients are unknown. 
However, the extraction process can be complicated and time consuming. In recent 
years，researchers have shown that supercritical fluid extraction is an alternative for 
many of these matrices and analyte. 
For instance, in an evaluation of commercial ginseng products on the US market, 
ginsenosides (- panaxosides) were determined to assess the amount of Panax root in each 
product. Capsules containing powdered root or slurries of ground root showed a total 
ginsenoside level comparable to dried roct samples, but teas for infusion yielded only 
low concentrations, and tablets did not contain detectable ginseno sides. (De Smet PAGM, 
Hansel Reta l , 1997) 
Beside this, restrictive using and import of poisoning herbal medicine is important. 
Such kind of procedure can decrease the morbidity caused by toxic herbs. In China, 
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Taiwan and Hong Kong already setup laws and some toxic herbal name list for regulates 
the manufacture, sale and use of Chinese herbal medicines. In Hong Kong, the 
regulatory measures for Chinese herbal medicines include a licensing system for 
Chinese medicines traders and a registration system for proprietary Chinese medicines. 
For the former, retailers and wholesale dealers of Chinese herbal medicines and 
wholesale dealers and manufacturers of proprietary Chinese medicines are required to 
obtain the appropriate licenses from the Chinese Medicines Board of the Chinese 
Medicine Council for their businesses. 
5.7 Conclusion 
In the long term, the government should provide screening services to the public for 
traditional medicine. This monitoring program provides a mechanism to identify 
adulterated traditional medicines. As for the countries that have not established adequate 
regulations covering the distribution of traditional Chinese medicines, the appropriate 
health authorities should be made aware of the potential hazards in such illegal 
adulterations to the health of their public. Public education on health hazards of such 
adulteration should be advocated. In addition, legislative requirements on adequate 
labeling of dispensed medicines, showing particularly the name of the product or its 
ingredients, is essential in enforcing prohibition of such hazardous practices. 
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Chapter 6 - Chinese proprietary medicines- General 
Aspects 
6.1 Chinese proprietary medicines 
6.1.1 Introduction 
In recent years, as more extensive studies have been carried out on herbal 
medicines, the knowledge of the chemistry and pharmacology of their active principals 
has increased remarkably.(Ko RJ, 1999) With freeze-drying technology and advances in 
extraction methods, many traditional Chinese medicinal prescriptions are now being 
formulated into tablets, pills, and liquids. These new formulations are known as Chinese 
proprietary medicines (CPM). 
Owing to the extensive modifications of drug formulations and chemical extraction 
from an expanding range of natural products, more cases of adverse reactions have been 
reported in recent years.(Li X and Yu QH, 2000) Misuse, mislabeled and inappropriate 
preparations may lead to serious health consequences. 
CPMs have gained wide acceptance by the Asian community in the past 20 years 
and have increased in popularity among non-Asian consumers who seek alternative 
therapy. They are sold as over-the-counter medicines labeled with indications and 
instructions, and patients no longer rely on the technical knowledge of a traditional 
Chinese medical doctor. More than this, the main or unapproved active ingredients that 
may or may not be declared on the label.(Li X and Yu QH, 2000) The true incidence of 
side effects to herbal products is not known because the systems for reporting adverse 
reactions are limited. 
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CPM-related adverse reactions can be caused by natural toxins, heavy metal 
poisoning, drug interaction, and drug overdoses.(Horowitz S, 2000) In traditional 
Chinese theories, CPMs often contain cinnabar (mercuric sulfide), realgar (arsenic 
sulfide), or litharge (lead oxide) as part of the traditional formula. Other common toxic 
herbal ingredients found in the imported patent medicines include bomeol (similar to 
camphor), aconite, Bufo secreta (toad secretion), mylabris, scorpion, borax, acorus, and 
Strychnos nux vomica (strychnine). Since certain herbs are highly potent, both Taiwan 
and China have required control of their sales. In Hong Kong, nearly 3,300 kinds of 
Chinese proprietary medicines were available on the market with about 500 being 
locally manufectured.(Medicine WPOC，1991) 
Although western medicine has already become the mainstream of Chinese modem 
medicine, it would stride forward significantly as the renovation of modem science and 
technology as well as the Anther development of life science, but it still is confined by 
the unconquerable limitation of ideological mechanical materialism.(Zhou JH, 1999) 
Chinese proprietary medicines are quite popular now in worldwide because of its 
convenient and therapeutic effect. There is a widespread belief in the therapeutic values 
of Chinese proprietary medicines, even among highly educated elite groups. A 
proportionate stratified random sample of 109 full-time faculty members of Chinese 
origin in The Chinese University of Hong Kong revealed that, in terms of over-the-
counter proprietary medicines kept at home for self-medication, 13% reported that they 
had more Chinese than Western medicines, 52% kept as many Chinese as Western 
medicines, and 35% had more Western than Chinese medicines.(Lee RP, 1980) 
The Pharmacy and Poisons Ordinance (Cap. 135), which specifies the regulations 
for pharmacists, pharmacies and pharmaceuticals, simply waived such requirements for 
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Chinese medicines. The last paragraph in that Ordinance states that "Nothing in this 
Ordinance shall apply to the sale, manufacturing, dispensing or compounding of 
traditional Chinese medicines as listed in the Chinese Herbal Materia Medica (本草綱 
目），or which are made from herbs customarily used by the Chinese people". In this 
context, the Government did very little on Chinese medicines except occasionally taking 
random samples to check if they contain Western pharmaceutical and excessive heavy 
metals. This laisser-faire practice has sometimes left rooms for discrepancies or even 
abuse. 
Because physician's dispensing of western and traditional Chinese medicines has 
been in existence for nearly half a century, policy makers in the Department of Health 
have been quite passive in pursuing the release of prescriptions from medical 
practitioners to community pharmacies. The missing requirement of adequate labeling 
on packages of dispensed medicine is an intentional omission: It represents a denial of 
the public's right to safe and effective medications. Without an affirmed policy on the 
right to adequate product information and labeling, all governmental efforts in 
monitoring and persecuting such misconduct as adulteration of medicines by 
practitioners of traditional Chinese medicine will meet with only limited success.(Huang 
WF, Wen K C e t a l 1997) 
6.1.2 Herbal Injection and Infusion 
In western pharmaceutical medicine, drugs are given in a >iire' form with a single 
active ingredient and have different kind of administrations. In China, herbal medicine 
is well developed and is marketed as pills, capsules, or tinctures and injection form also 
and was a kind of popular treating method in the hospital The transformation of herbal 
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medicine from crude material to a modem injection form illustrates principles of modem 
pharmacology that have helped make herbal medicine safer and more effective. 
However the percentage of herbal adverse reaction from the injection form were still 
greater than form of medicines. In China, a retrospective analysis was reported in 2000 
stated that nearly 42 % of herbal adverse reaction in 1096 cases was caused by 
injection.(Di SL, 2000) (Table 6a) It may relate to the following reason, 
6.1.2.1 Variety & Processing 
Controlled, high quality, manufacturing conditions, including authentication of 
ingredients, are essential to the production of safe, high quality herbal medicines. 
Improper processing and manufacturing can influence the pharmaceutical effects. 
Nonspecific labeling statements such as these both confuse consumers and promote 
skepticism among healthcare professionals. Basically, manufacturers can allude to a 
therapeutic use of an herb, whether it is effective or not. Theoretically, manufacturers 
should be able to substantiate their "structure and function" claims，but they are not 
required to share this information with the government's pharmecutical laboratory or 
make it publicly available. Poor quality-control personnel or lack of standard 
procedures to evaluate their products for its purity and reliability. Therefore, batch-to-
batch variability is a serious problem with herbal preparations.(Gazella JG. Pinto JT et al, 
1987) Factors predisposing to pharmacological adverse reactions may related to the 
impurities and unknown chemical substance. It was because herbal preparations are 
usually not evaluated for purity and consistency of active components, they often 
contain accidental contaminants. 
6.1.2.2 Stabilization 
Clearly, plants have ingredients with therapeutic activity, but their preparations 
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must be standardized to yield consistent products, which therefore can be given in doses 
that are maximally safe and effective. The uncertain composition of many herbal 
materials raises questions about their safety and stability. More than this, with the 
limitation of technical support, it was difficult to maintain the pH value and the stability 
for the mixed herbal solution, especially when mixing with glucose or normal saline 
solution for dilution. In addition, some unvisible or unknown chemical reaction may 
occur and caused adverse reaction after mixing the injection material for clinical usuage. 
6.1.2.3 The Molecular Size 
The molecular size of the herbal material was large and insoluble in in water, 
especially when mixed with other chemical molecule or distubed by acid-base 
inequilibrium. Insoluble molecule was form with different solubility and the molecule 
will obstructed the capillaries. In addition, the molecule may irritate the autoimmune 
system to start defence mechanism and cause anaphylactic reaction. 
Table 6a. Adverse Reactions Caused by Herbal Injection in Tientsin, China during 
1997-2000.(Di SL, 2000) 
Name of Herbai Injection No. of cases % 一 
Xie Sai Tong ZhusheYe (血塞通注射液） 7 18.92 
Sheng Mai ZhusheYe (生脈注射液） 6 16.22 
Fufang Danshen ZhusheYe (複方丹參注射液） 5 13.51 
^ u a n g Huanglian ZhusheYe (雙黃連注射液、粉針） 5 13.51 
i i n g Kai Ling ZhusheYe (淸開靈注射液） 4 10.81 
Huang Ji ZhusheYe (黃耆注射液） ^ 8.1 
Deng Zhan Hua ZhusheYe (燈—花注射液） 3 SA 
Can Mai ZhusheYe (參脈注纖） 2 5.40 
石e Gen Su ZhusheYe (葛根素注射液） 2 5.40 
Total 37 cases 100 
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The allergic reaction always happened in venous injection and the patient may have 
fever，allergic rash and even shock after injection. The duration of episode between 
several minutes to several days and not related to the dosage. In order to decrease the 
episode of adverse reaction, some standard protocol and instructions w e recommended 
to all hospitals in China to assess herbal injection.(Di SL, 2000) For instance, the period 
of using herbal injection therapy was suggested within the period of treatment and 
should under the guideline to practice. More than this, pharmaceutical manufacturer 
should keep quality control in the major position and the production should under GMP 
standard to decrease the possibilities of accidental contamination. In China, all 
proprietary Chinese medicines will be assessed and registered by State Administration of 
Traditional Chinese Medicine (SATCM). 
6.1.3 Adverse Reactions Caused by Chinese Proprietary medicines 
6.1.3.1 Aconitine poisoning 
In China, poisoning may occur after taking CPM containing aconite roots.(Chan 
TY and Critchiey JA, 1996) So far, there have not been any reports of CPM^induced 
aconitine poisoning from outside China but it is conceivable that Western-trained 
physicians would miss such aetiology. 
6,13.2 'Nan Lien Chui Fong Toukuwan^ 
The great majority of reports of poisoning by CPM in Western countries were due 
to T^an Lien Chui Fong Toukuwan', which was sold as tablets/capsules for the treatment 
of various muscu loske l e t a l d i s o r d e r s . (Anonymous, 1975; Ries CA and Sahud MA, 1975; 
Brooks PM and Lowenthal 賦 1977; Forster PJG, Calverley M e t a l 1979; Offerhaus 
L, Dukes MN et al, 1979; Yuen S and Lau-Cam CA, 1985) 
It has now been withdrawn in most countries. Depending on the manufacturer and 
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the country of export, adulterants of this preparation included aminopyrine, phenacetin, 
phenylbutazone, indomethacin, mefenamic acid, diazepam, hydrochlorthiazide, 
dexamethasone, mercuric sulphide and heavy metals such as lead and cadmium. 
Consequently, there have been cases of agranulocytosis following ingestion of some of 
these preparations.(Chm J and Fleming DS, 1974) 
6.1.3.3 ‘Jin Bu Huan, 
'Jin Eu Huan' is manufactured in China and is used as a sedative and analgesic. 
There were two reports in 1993 of severe toxicity following the use of this CPM in the 
U.S.A.(Horowitz RS, 1993; Woolf WGM, 1993) Life-threate誰g bradycardia of rapid 
onset and central nervous system and respiratory depression were seen in three children 
while in three adults, liver damage developed. (For detail please sees Chapter 11.— 
Review of Herbal Hepatotoxicity) 
6.1.3.4 'Baoyingdan' 
Two babies developed extrapyramidal symptoms including retrocollis, stiffening 
of the body, weak cry and marked tremor, a few hours after taking a bottle of 
Baoymgdan (Po Ymg Pills).(But PPH and Kan WK, 1995) One of the babies had also 
been prescribed maxolon 0.25 mg by a general practitioner 12 hours earlier.(Chan TY, 
Chan JC et al, 1993) There is a possibility that the extrapyramidal symptoms were 
caused by herbal ingredients in the Baoymgdan, The presence of western drugs that 
could cause such symptoms was not excluded. 
6.1.4 Heavy metals in CPM 
Details please see Chapter 1 5 , Adverse Effects of Heavy Metal contamination. 
6.1.5 The Necessarily to Develop Randomize Herbal Clinical Trial 
The effectiveness of a modem drug is ultimately judged by the results of clinical 
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trials. Ordinarily, such trials are designed to test the assumption that a drug's^ 
pharmacologic activity will favorably affect a disease process, which in turn is viewed in 
terms of a physiologic model Clinical trials yield convincing results, however, only if 
they are conducted in accordance with principles that, for example, ensure elimination of 
bias and reduce the possibility that results occurred merely by chance. Trials must also 
use drug preparations with consistent pharmacologic properties. These principles apply 
to all drugs, whether they originate as traditional remedies or in precepts of molecular 
biology. Randomized clinical trials have become the gold standard for evaluating the 
efficacy of a drug and have assumed a similar status for evaluating an herbal remedy. 
Although the methodology of herbal trials is improving, some studies cited in 
herbal compendia have shor t comings . One problem is that results of herbal trials often 
do not reach statistical significance because they enroll fewer participants than trials of a 
conventional drug, and the role of chance may be overlooked in interpreting such trials. 
Yet, when the active principle of an herb is not known and there is no accepted 
m e t h o d of s t andard iza t ion , a clinical trial offers an attractive approach t o evaluating the 
activity of an herbal preparation. In other words, instead of standardizing a medicinal 
herb before it is tested in a clinical trial, the results of a clinical trial might be used to 
identify an effective herbal formulation. This strategy，however, requires both a 
consistent formulation and a large study sample, 
6.1.6 Recommendation 
Understandable warnings in the package insert can certainly help to reduce the risk 
of inappropriate uses and adverse reactions.(De Smet PAGM, Hansel R et al, 1997) 
Besides improved their products quality, h e r b a l pharmaceutical company should actively 
by banning unsafe remedies and by discouraging unsafe practices. Unfortunately, the 
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introduction of herbal medicine-like products into the market is not adequately � 
monitored in various countries. This unsatisfactory situation could be greatly improved 
by the creation of a special licensing system for herbal medicines. Such a system would 
not only help to keep out preparations from herbs with known unsafely but it would also 
provide a valuable tool to improve herbal product quality.(De Smet PAGM, 1995) 
Moreover, limited the indication of herbal medicine is useful and the governmental 
health department was not necessary to take risks by always require a M l ban of some 
specific herbal ingredients. 
In order to improve the quality of herbal medicine, develop analytical technique to 
rapidly screen for undeclared toxic and therapeutic substances in CPM is necessary� 
Such as using high performance liquid chromatography-diode-array detection method 
was developed and used to screen for undeclared therapeutic substances in CPM. In 
addition, solute identification by comparing the analytical data (UV spectra, retention 
time and relative retention time) and Gas chromatography-mass spectrometry was 
always used as a confirmation method.(Liu SY, Woo SO et al, 2001) In recent years， 
researchers have shown that supercritical fluid extraction is an alternative for many of 
these matrices and analytes also. 
Herbal companies should be legally bound to report suspected adverse reactions to 
their products to the competent authorities, just as is now required from synthetic drug 
manufacturers.(De Smet PAGM, 1995) 
6.1.7 Conclusion 
Systematic efforts to collect, evaluate and disseminate scientific data about the 
safety or unsafely of herbal medicines should be continued and expanded. In addition to 
collecting data about real herbal medicines, it would also be useful to produce and 
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circulate exhaustive lists of those herbal products, which have been shown to contain 
dangerous amounts of heavy metals or pharmaceuticals. Update herbal OTC drugs data 
collections must also include non-Westem herbs，not only because Western doctors are 
increasingly confronted with non»Western patients who seek refoge in traditional 
remedies of their homeland but even more so because herbal therapy plays a vital role in 
the health care of developing countries. 
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Chapter 6.2 - Adulteration by synthetic therapeutic substances 
Throughout the world, Chinese proprietary medicines (CPM) are widely used in 
Chinese communities for the treatment of many common conditions such as colds and 
musculoskeletal pain. Partly because of this wide availability, CPM is commonly used 
for self-poisoning in many Chinese commimities.(Chan JC, Chan TY et al, 1994) There 
is reason to believe that such medicines with adulterations of synthetic therapeutic 
substances also exist in many other countries.(Huang WF，Wen KC et al, 1997) 
Numerous case reports originating from countries such as Australia, Belgium, China, 
The Netherlands, New Zealand, UK and USA demonstrate the adulteration of TCMs 
with synthetic drugs and associate the use of adultered remedies with health problems of 
the user.(Emst E, 2002) It is generally known that traditional Chinese medicines have 
been distributed without being adequately regulated in many countries. 
The term "adulteration" refers to traditional Chinese medicines that are tested and 
found to contain chemical substances not prescribed or labeled as part of the intended 
use.(Huang WF，Wen KC et al, 1997) Depending on the manufacturer, adulterants of 
this preparation included variable amounts of aminopyrine, phenacetin, phenylbutazone, 
indomethacin, mefenamic acid, diazepam, hydrochlorothiazide, dexamethasone, 
mercuric sulphide, and even heavy metals such as lead and cadmiuiiL (see Table 6 b & 6 
e ) The resulting clinical consequences are often serious and sometimes life threatening: 
agranulocytosis, Cushing's syndrome, coma, the excessive increase of the international 
normalized ratio (INR) has all been reported. Some of the medicines have been 
identified as coming from Oriental commercial sources while some were not identifiable 
because of unknown supplying sources. Although several reports stated that the 
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^ possibilities of certain adverse effect were high, people still reassured that Chinese 
medicines are natural and can cause no harm. 
The adulteration of traditional Chinese medicines with unlabeled synthetic 
therapeutic substances is hazardous to the public health at least in two respects. (Huang 
WF，Wen KC et al, 1997) First, it is not in the interest of the public for any medicine to 
be inadequately labeled. Many believers in traditional Chinese medicines tend to trust 
the "moderate nature" of herbal preparations; they are generally more reluctant to be 
treated by western medicines, which are misconceived as producing more adverse 
reactions than traditional Chinese medicines. Such adulterated preparations mislead 
consumers to expect effective treatment from traditional medicines. Second, adulterated 
traditional Chinese medicines sometimes contain certain poisonous synthetic therapeutic 
substances, for example, corticosteroids or phenylbutazone, that even medical doctors 
take cautions in prescribing. The adulterant is usually added without carefully assaying 
of its dose quantity; thus severe adverse effects are very likely to develop within a short 
period of treatment, 
people worry more about the safety of traditional medicines they procured. 
Consumers are far from cooperative m providing information to the health authorities on 
identities of distributors or in revealing the source(s) of supply. Adulterated samples are 
very rarely found in commercial packages of traditional Chinese medicines，because 
they require premarketing regulatory approvals and complete labeling of the contents; 
but such samples are often found in traditional Chinese medicines dispensed by 
practitioners, peddlers, or quacks. Because physicians' dispensing of western and 
traditional Chinese medicines has been in existence for nearly half a century, policy 
makers in the Department of Health have been quite passive in pursuing the release of 
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prescriptions from medical practitioners to community pharmacies. The missing 
requirement of adequate labeling on packages of dispensed medicine is an intentional 
omission. It represents a denial of the public's right to safe and effective medications. 
Without an affirmed policy on the right to adequate product information and labeling, all 
governmental efforts in monitoring and persecuting such misconduct as adulteration of 
medicines by practitioners of traditional Chinese medicine will meet with only limited 
success, 
6.2.1 The Experiences in China 
In China, the population widely accepts herbal products such as Chinese 
proprietary medicines (CPM) was an effective treatment for diseases and would like to 
purchase by themselves without any medical consultation. Chinese proprietary 
medicines are considered OTC drugs and 誰 s t comply with the product standard and 
formulations specified in the People's Republic of China Pharmacopoeia. However, 
there are inconsistent quality controls at the manufacturing level and the central 
government has l imi ted authority and resources to regulate the industry.(Koo J and 
Arain S, 1999) After several cases of intoxication caused by CPM, people worry more 
about the safety of CPM they procured. Consumers are far from cooperative in 
providing information to the health authorities on identities of distributors or in 
revealing the source(s) of supply. 
In China, the licensing and official regulation of traditional Chinese medicine and 
the Chinese proprietary medicine was by State Administration of Traditional Chinese 
Medicine (SATCM). The licensing of drugs and official regulation of their sale is 
equally stringent for Western and Chinese medicines. New drugs have to be examined 
and approved according to the Drug Administration Law. After approval, a New Drug 
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certificate is granted an approval number. The factory is then permitted to put the product 
on the market. Adulterated samples could find in commercial packages of traditional 
Chinese medicines, because they require premarketing regulatory approvals and 
complete labeling of the comments. 
Randomised controlled trials (RCTs) have already been conducted in TCM. There 
are, however, a few methodological issues that need to be resolved so that the quality of 
trials can be tether improved. The first RCTs in TCM in China were conducted in the 
early 1980s; the number of trials has doubled every 2 to 3 years over the past 15 
years.(Tang JL and Wong TW, 1998) A preliminary systematic review of the evidence 
for the effectiveness of TCM has identified some 2800 RCTs that were published in 
medical journals in China. Further work is needed to identify and to register all clinical 
trials ever published in the medical literature. The misunderstandingand scepticism 
about TCM therapies will likely continue until their clinical effectiveness is 
demonstrated by RCTs. Demonstration of the clinical effectiveness of TCM is thus an 
immediate and urgent task for researchers of TCM. 
Most of the Chinese proprietary medicines (CPM) that sold in Southeast Asia were 
produced in China, however, usually receive no premarket approval by the State 
Administration of Traditional Chinese Medicine (SATCM)�Some of the Chinese 
proprietary medicines that sold in the pharmacy were come from the black market and 
its commercial distribution was not legal More than this, even batches of CPM from the 
same manufacturer may contain variable amounts of active or potential toxic 
ingredients.(Li AM, Chan MHM et al, 2000) 
The unadulterated and adulterated samples of traditional Chinese medicines are 
further classified according to their supplying sources: traditional Chinese medicine 
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hospitals, clinics, and drugstores; chiropractors; herbalists; peddlers; quacks; and other 
sources. Herbalists are crude herbal retailers; peddlers are unauthorized retailers of 
various commodities along roadsides or in marketplaces; quacks are medical 
practitioners without professional licenses; and "others" are such sources as friends, 
relatives, mail order, etc. 
On the other hand, combination of western medicine and traditional Chinese 
medicine into proprietary form is the characteristic form in China. TCM and WM each 
have its own ideologic and philosophic basis. To pursue the "two combine into one" 
blindly is undesirable to the development of TCM and the people's health care. The 
practice over scores of years has proved that the combination way is correct，which bears 
the characteristics of Chinese culture and medicine. The controversies regarding the 
combination of synthetic therapeutic substances and traditional Chinese medicines 
without adequate labeling should be resolved through regulatory actions for better safety 
of drug use.(Huang WF, Wen KC et al, 1997) 
6.2.2 The Experiences in Hong Kong 
Because of their easy availability, CPM is commonly used for self-poisoning in 
Hong Kong. In Hong Kong, CPM is readily available without prescription as 'over-the-
counter' drugs. CHM are also freely available from most drug stores. The choice of a 
particular combination of herbs and other ingredients imy be based on that individual's 
own experience or beliefs. More often, particularly for minor complaints, the employees 
at the drug store may decide what combination of ingredients is best for a specific 
patient. Alternatively, a patient may request to be seen by one of the herbalists 
associated with the drug store and be given an individualized prescription. (Chan TY and 
Critchley JA, 1996) 
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As increasingly frequent warnings of Chinese health products containing 
prescription drugs highlight the dangers of using unregulated herbal products and should 
alert patients and their doctors to the risks associated with mixing Chinese and western 
medicines. For example, the Hong Kong Department of Health (DH) has recently issued 
a public warning regarding two Chinese health products that have been adulterated with 
a potentially harmful drug ingredient. Two oral tonics that imported from the mainland 
were found to have contained sildenafil, which is used to treat erectile dysfunction. 
Sildenafil is currently available in Hong Kong on a prescription only basis. It can cause 
headache, flushing, dyspepsia and visual disturbances, and in some cases was associated 
with severe cardiovascular adverse effects. In Hong Kong, products containing western 
medicine are considered as pharmaceuticals and therefore must be registered with the 
Pharmacy and Poisons Board, The two TCM products have not been registered and 
importers have been instructed to recall them immediately from the market. The 
possession and sale of unregistered pharmaceuticals is a legal offence liable to heavy 
penalties�However, some importers and distributors are willing to take the risk while 
others may be unaware that the herbal preparations contain western prescription drugs. 
The same situation could be seen in Macau where the Macau health department banned 
one oral tonic that contained sildenafil, which was imported from mainland China. 
Chan TY et al performed a retrospectively studied from a general medical wards at 
the Prince of Wales Hospital between January 1988 and December 1993 and suggested 
that topical medicaments (72%), which may contain methylsalicylates as wintergreen oil, 
and CPM tablets/capsules (24%), which may contain paracetamol, were the most 
important CPM used for self- poisoning in Hong Kong.(Chan TY, Lee KK et al, 1995) 
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Since there was a predominance of Vietnamese subjects in this study, the proportion of 
patients using topical medicaments might have been exaggerated. 
6.2.3 The Experience in Taiwan 
The adulteration by synthetic therapeutic substances of traditional Chinese 
medicines has been reported on various occasions and has been a public health concern 
in Taiwan over the past several years. Over the years, traditional Chinese medicines 
referred to the National Laboratories of Foods and Drugs from various sources have 
contained adulterants. It is obvious that the "unlabeled" addition of synthetic therapeutic 
substances to traditional Chinese medicines has been a quite alarming phenomenon, 
regardless of the illegal nature of such a practice. Whether western medicines could be 
combined with traditional Chinese medicines has been long debated in Taiwan and 
deserves more serious consideration by the regulatory authorities. However, 
fundamental differences in the disciplines underlying these two alternative approaches to 
disease treatments remain to be explored. 
Recent statistics indicate that consistently high percentages of 27.7%, 25.3%, and 
22.3% of adulterated medicines were detected among samples referred to local health 
authorities through consumers' complaints during 1991，1992, and 1993 respectively. 
The large-scale survey was performed in 1992 and totally screened 2,609 samples which 
were collected by eight major general hospitals in Taiwan.(Huang WF, Wen KC et al, 
1997) After analyzed, nearly 23.7% (n = 618) of the samples collected from the eight 
hospitals were adulterated unlabeled, synthetic therapeutic substances. The result 
showed that the traditional Chinese medicine samples that have premarketing approvals 
contained less adulterants may be related to the government attitude and regulatory 
enforcement. Pharmaceutical products, both in western and in traditional Chinese 
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medicine dose forms are required to have premarketing approvals by the Department of 
Health in accordance with Taiwan's Pharmaceutical Affairs Law. Law strictly prohibits 
addition of unlabeled therapeutic substances other than approved formula.(Huang WF, 
Wen KC et al, 1997) Not only because Taiwan's pharmaceutical regulations do not 
permit the combination of western pharmaceuticals with traditional Chinese medicine 
preparations, with violating manufacturers subject to severe penalty, but also because 
health authorities at various levels regularly perform inspections of manufacturing 
facilities and take inspection samples from the market for laboratory analysis.(Huang 
WF, Wen KC et al, 1997) Such kinds of commercial packages were produced in China 
and indicate that the prohibition of registering traditional medicines from China is not an 
effective mechanism for controlling such product distribution to Taiwan. 
6.2.4 Discussion 
The undeclared occurrence of thyroid hormones induced by botanical remedy was 
recently discovered when several United States residents developed thyrotoxicosis 
following the use of purportedly herbal slimming capsule adulterated with thyroid, 
diethylpropion, and hydrochlorothiazide. The product had been imported into the United 
States from Peru. Herbal products are claimed to cure numerous disorders ranging from 
diabetes to obesity, but these claims are often not supported by well-controlled clinical 
trials. In addition, herbal products are rarely packaged in childproof 
containers.(Anderson LA, 1996) 
In England, a 44 years old woman was admitted to the hospital because of taking 
some herbal remedies for weight lost and got new onset hypertension, palpitation, 
anxiety, with a body mass index of 19 kg/ml (Metcalfe K, Corns C et al, 2002) Initially, 
researchers suspected Ephedra or Ma Huang, herbs that widely used in the United States 
102 
and elsewhere in the world for weight loss but also linked to adverse side effects. 
However, after chemical analysis revealed there was a high concentration of 
fenfluramine in two of the products (sold as ‘Qian Er, and 'Ma zin dol,) and also in the 
patients' urine. The Food and Drug Administration (FDA) pulled Fenfluramine and 
dexfenfluramine from the market in 1997 after numerous reports the off-label cocktail 
combo increased the risk of heart valve damage in the United States and in the United 
Kingdom. This finding was published as a letter in the March 15 issue of British 
Medical Journal 
Another preparations that found to contain western drugs include “Tong Shap Yee's 
Shuenchih Wan" (pill for easy breathing) (theophylline) and "Leung Pui Kee cough 
pills” (bromhexine).(Tay SAB and Johnston MA, 1989) This old brand name of Chinese 
proprietary medicine was sold in Hong Kong and South East Asia for more than 30 
years. This drug has anti-asthmatic effects and contains powdered licorice 50 mg, 
aminophylline 20 mg, ephedrine HCl 1.3 mg, and starch 68.7 mg. The label instructs 
the user to take 10 pills 3 times a day when “short of breath” or five pills 3 times a day 
when asymptomatic.(Wong HCG, 2001) Nowaday it is readily available in Chinese 
herbal shops across Canada and probably elsewhere as well. The prescription drug 
aminophylline is clearly identified as one of the ingredients in the preparation, and not as 
an contaminant. The dosage of ephedrine used during the symptomatic period exceeds 
the maximal daily dose (24 mg) recommended by the US Food and Drug 
Administration's 1997 proposal, which was raised because of its adverse 
reactions.(Wong HCG, 2001) 
In addition, awareness of herbal medicine has also been facilitated by the 
proliferation of home computers and the explosive growth of the Internet，which have 
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provided ready access to information about herbs. Ordering supplies of botanical 
products from around the world is usually an easy process but such kind of botanical 
products are without any quality assurance. Health authorities have enforced inspections, 
and screening services have been made available through different channels to the 
general public with minimal cost. Although the health authorities usually have a list of 
CPM containing western drugs, such information may not be readily available. CPM 
may be adulterated with undeclared and, often more toxic, drugs.(Chan TY, Lee KK et 
al, 1995) 
Table 6b. Adulteration of Asian herbal medicines with synthetic drug substances: 
chemical and clinical reports. (From Adverse Effects of Herbal Drugs. Volume 
1. Heidelberg，Germany: Springer-Verlag; 1992: 48-50) 
preparation(s) I Chemical and clinical Details ‘ Ref 
1 ‘ Chuifong Toukuwan Nan Lien (巧^ CA 
2. Long Life Brand Ginseng Hui Sheng Tsaitsaowan ^ ^ 
3. Sanlungpai Ginseng Hui Sheng Tsaitsaowan MA^ 1 9 / � 
4. Fonsuning Tongwan 
5. Lilongpai Fonsuning 
6. Hippo Brand secret 
(Formula Chui Fung Eng (Nan Lien Pharm. Co.，Taiwan and Hong Kong) 
* All 6 brands contained amino phenazone and phenylbutazone. 
* Three of the brands (with 23-43 mg and 17-34 mg, respectively) produced life-
threatening agranulocytosis in 4 patients, when taken in doses of 8-12 pills/day. One 
patient died.  
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Breparatioa(s) . Chemical and c l i n i c a l D卿 s . | 
_ Chuifong Toukuwan - One patient developed agranulocytosis after (Brooks 
(Hong Kong) starting treat. PM and 
-Analysis of different batches showed varying Lowentha 
amounts of amino phenazone, 1 RM, 
phenylbutazone, and phenacetin.^ 1977) 
_ Chuifong-Toukuwan - One patient developed Cushing's syndrome (Uitdehaa 
(Hong Kong) from 12 pills/day. g CMJ’ 
- T h e pills contained dexamethasone (0.112 mg), Hekster 
indomethacin (7.5 mg), Hydrochlorthiazide, YA et al, 
and diazepam (see next entry). 1979) 
L Chuifong Toukuwan - Dexamethasone 0.112 mg (Anoniem 
(Nan Lien Phann.Co.. - Indomethacin 7.3-8.3 mg ,1979) 
Hong Kong) - Hydrochlorthiazide 4.1 mg 
-Diazepam 0.45 mg 
(Dose: 12 pills/day)  
L Chuei-Fong-Tou-Geu-- One patient developed a low plasma Cortisol (Forster 
wan concentration and a cushingoid look. PJG, 
Calverley 
M et al, 
1979) 
-Chuifong Toukuwan - Prednisolone 0.4 mg (Anoniem 
(Nan Lien Pharm. - Hydrochlorthiazide 4.0 mg ,1979) 
Co.,Singapore) - Chlordiazepoxide 0.5 mg 
— Chlorpheniramine 1.3 mg 
- Thiaminedisuiphide 5.0 mg 
(Dose: 12 pills/day)  
L Chuifong Toukuwan - Aminophenazone 8 mg (Anoniem 
(Shou Sing Pharm. Co. - Phenylbutazone 0.6-6.0 mg , 1979) 
Taiwan) - Thiamine (Dose: 12 pills/day)  
一 Dumeap capsules - Prednisolone 4mg (Morice 
(Duzcap Pharmacy,- Betamethasone A., 1986) 
Pakistan) - (Dose: 3 capsules/day)  
L Chihshiton (Yi Chung - Paracetamol 8,1 mg 
Tai Med�Manuf . Co., - Ethaverine 0.26 mg 
Taiwan) - Chlorzoxazone 2.0 mg 
- D i a z e p a m 0.55 mg 
- C a f f e i n e 1.9 mg 
- Thiamine (Dose: 18 pills/day)  
L Deecap capsules - Prednisolone (Monce 
(Shaham Romeo A, 1987) 
1 Pharmacy, Pakistan)  
-Ambonim special-F|- Dexamethasone 0.02-0.2 mg/ml ‘ (Stemigen 
syrupe M, 1987) 
I - (Sri Lai, United States)  
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W ^ P r e ^ r a t o ^ and clmical^etalb • 
- Cow's Head Brand - One patient developed a low plasma Cortisol (De Smet 
i
Timg Shueh concentration. Each pill contained 0.09 mg PAGM, 
(Ta Ang Pharm. Co., dexamethasone (dose: 12 pills/day). Elferink F 
—T—) ^ 
Chuifong Toukuwan- Dexamethasone (P^ Smet 
(Nan Lien) - Indomethacin PAGM 
- M e f e n a m i c acid 肌d 
-Hydrochlor thiazide & Diazepam ‘ Elferink  
F, 1988) 
Unmarked green- Phenylbutazone “ 思 ^ 
capsules (Chinese - One patient gained weight and became RW, 
herbalist, Kuala moonfaced Fulhnfaw 
Lumpur) - Powder #3 contained prednisolone (0.5 mg/g) RO et al, 
#3 Colds and Flu and paracetamol (63 mg/g). 1987) 
#6 Arthritis - Powder #6 contained similar amounts of both (Medical practitioner, Sri drugs as well as phenylbutazone (42 mg/g). D r ^ i g Shap Yee's - Theophyllin  12 mg per pill Bromhexine 0.7 (Tay SAB asthma ills mg er p U ” Johnston M A , 1989) Nan Lien Chui Fong Diaz pam 0.6 ，y Toukuwa  - Theophylline 12 mg =Dr. Tong Shap ec's B m ex 0.7 mg J st  asth a i ls ‘. L e u n g Pui Kee Cough ^仍） (Hong Kong) tt  a S F O N tural H rbs - t ethasone 0.1- 5 /ml (如Tea^ (Sri Lai, Sri ous 1988) La ) — j r  _ Chu fong Tokuwanh  D xamethasone (Na  Lie P rm. Co., _ Ind methacin ly防） on ong) M f n  acid Hydr c orthiazid  D iaze a ^- T h Ye Ob t China P ed is„ . b � “ 1 V � s, ) (Li Y k Kong) — c .Un pecif d hine e - h n zo , propy henaz ne, and ( Y u e n � . erb l reparat ons m t te tosteron have a so been identifie and Lau-s adul ts of Chinese rbal products. C m CA,1985) 
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Table 6 c. Undeclared pharmaceuticals that have been found in traditional Chinese 
remedies. 
1 Acetaminophen (paracetamol) 11. Fluocinolone acetonide 
2. Aminopyrine 12. Glibenclamide 
3 Caffeine 13. Hydrochlorthiazide 
4] Carbamazepine 14. Hydrocortisone 
5. Chlorzoxazone 15. Indomethacin 
6 Clobetasol propionate 16. Mefenamic acid 
7 Dexamethasone 17. Methylsalicylate 
8 Diazepam 18. Phenacetm 
9 Diclofenac 19. Phenylbutazone 
10 Ethoxybenzamide 20. Phenytom 
21. Valproate 
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Chapter 6.3 - Oil of Wintergreen (methyl salicylate) 
6.3.1 Overview 
In Hong Kong, there are at present more than 160 adult and pediatric preparations 
containing salicylates registered with the Government. This figure does not include the 
wide range of medicated oils containing methyl salicylate (wintergreen oil) that are 
commonly used in the self-treatment of conditions such as musculoskeletal pains and 
common cold. In Hong Kong, medicated oils containing methyl salicylate account for 
48% of acute salicylate poisoning cases treated in the general medical ward of the Prince 
of Wales Hospital.(Chan TY and Critchley JA, 1996) 
Oil of Wintergreen (methyl salicylate) is a common ingredient for liniments, 
ointments and essential oils used in self-treatment of musculoskeletal pain. Its pleasant 
smell also encourages its use to flavor confectionery.(Botma M，Colquhoun-Flannery W 
et al, 2001) The toxic potential of this preparation is not always fully appreciated by the 
general public and physicians. To appreciate the danger of this oil it can be compared to 
aspirin tablets (325 mg dose): one teaspoon (5 ml) of Oil of Wintergreen is equivalent to 
approximately 7000 mg of salicylate or 2L7 adult aspirin tablets. Ingestion of as little as 
4 ml in a child can be fatal. 
Methyl salicylate in topical analgesic preparations may cause irritant or allergic 
contact dermatitis.(Chan TY and Critchley JA, 1996) Excessive usage of these 
preparations in patients receiving war&in may result in adverse interaction and bleeding 
complications.(Joss JD and LeBlond RF，2000) A 22-year-old white woman presented 
with an INR of 12.2 after applying a topical pain-relieving gel to her knees daily for 
eight days. The potentiation of the warfarin anticoagulation was attributed to the low-
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dose methyl salicylate contained in the product. Methyl salicylate may increase warfarin 
action by affecting vitamin K metabolism or by displacing warfarin from protein-
binding sites. 
In view of the toxic potential of medicated oils containing methyl salicylate, Chan 
performed studies to the existing packaging of 7 commonly used preparations from 
Hong Kong and Singapore.(Chan TY, Lee KK et al, 1995; Chan TY, 1996) (See Table 6 
d) The medicated oils were all packed in translucent bottles without child-resistant 
closures. The result showed that the methyl salicylate content ranged from 15 to 67%. 
Many preparations also contained other potentially toxic ingredients in significant 
amounts, such as turpentine oil and camphor. Koong Yick Hung Far Oil had the highest 
methyl salicylate content (67%) and was available only in 60-ml bottles. If the entire 
bottle of this product were ingested, the equivalent of 184 adult 300-mg aspirin tablets 
would have been swallowed. Accidental ingestions of as little as 6 ml of Koong Yick 
Hung Far Oil by a child can be fatal. The other six products contained 15-40% methyl 
salicylate and their biggest bottle sizes were range from 28-57 ml.(Chan TY, 1996) 
Furthermore, the contents of the larger bottles could generally be emptied more easily 
because of the greater size of their openings. The product with the highest methyl 
salicylate content also had the biggest opening of all 
"Koong Yick Hung FA Oil” (KYHFO) (67% wintergreen oil {>70% methyl 
salicylate}, 22% turpentine oil, 5% ciimamic aldehyde, 4% ciimamon leaf oil，2% 
citroneUa oil), made in Singapore, is readily available in any Asian grocery 
store.(Maryann H, Jose ED et al, 1998) "KYHFO" claims to be useful in the self-
treatment of respiratory obstruction, cardiac pain, hemiplegia, paresthesia, sciatica, 
rheumatism, beriberi, abdominal pain, headaches, fatigue, bums, scalds, and bruises. As 
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per its product label, it is primarily indicated for external use, but can be taken orally for 
enhanced efficacy. 
Maryann H, et al reported that a 70-year-old Asian woman with a history of 
hypertension and arthritis ingested 60 mL of topical “KYHFO,，（〜1.2 g/kg salicylate 
equivalents) for relieve chronic knee pam.(Maryann H, Jose ED et al, 1998) One hour 
after ingestion abdominal pain, restlessness, and diaphoresis developed. On arrival in 
the emergency department, she was afebrile, euglycemic, and the ECG monitor showed 
a narrow complex tachycardia. Abdomen was soft, nondistended, and without active 
bowel sounds. However, A voluminous brown liquid bowel movement was noted. The 
neurologic exam revealed a confused and agitated patient with impaired attention and 
limited awareness to the surroundings. After analysis, the "KYHFO" bottle (60 mL) 
contains 56.2 g saUcylic acid and equivalent to 186 regular-strength adult aspirin tablets� 
Ingestions of as little as 4 to 6 mL of wintergreen oil can result in fetalities; a lethal adult 
dose is usually estimated as 30 mL. 
A significant central nervous system (CNS) deterioration (without seizures) 
developed after three hours of ingestion and required orotracheal intubation; marked 
metabolic acidosis with some respiratory compensation and a salicylate (SA) level of 
108.6 mg/dL also were noted. After treating with lavage and activated charcoal, the 
patient received three times of hemodialysis. Rhabdomyolysis (creatine phosphokinase 
19,570 U/L {20-149 U/L}), hepatitis (aspartate aminotransferase 4,190 U/L; alanine 
aminotransferase 2,808 U/L), coagulopathy (prothrombin time 17.1; partial 
thromboplastin time 89), and nephrotoxicity (blood urea nitrogen 29 mg/dL; creatine 2.7 
mg/dL) were found after 48 hours. The hemoglobin level steadily decreased (14.8 to 7.9 
g/dL) requiring transfusion. No site of active bleeding was identified. By the sixth 
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hospital day, all laboratory values had returned to normal. Unluckily, she was died on 
the 13th hospital day because of anoxic encephelopathy. (Maryaim H, Jose ED et al, 
1998) 
6.3.2 Prevention 
It was much more difficult to collect toxicity information on CPM than on 
therapeutic drugs，for several reasons.(Chan TY, Lee KK et al, 1995) Many patients 
knew the nature but not the brand name of the product they had taken. Even if patients 
knew the group name of the CPM, for example, Medicated Oil, there is a multitude of 
products collectively known as Medicated Oil which are locally manufactured or 
imported. Different manufacturers may use almost identical brand names for their 
products, which differ in their contents, and few patients or physicians will be able to 
note the subtle differences in the nomenclature. Futhermore, for the older people who 
lived in Chinese population, they always have a misunderstanding for the usuage of such 
kind of old-brand-named proprietary medicine and take it by mouth habitually when 
they felt “sickness”. In Hong Kong, a fatal case was reported several years ago that an 
old lady was die after taken the medicated oil. 
According to the fact that oil of wintergreen was available in an inappropriately 
labeled container may bear fatal consequences, so several points can probably 'reduced' 
the accidental ingestion of medicated oils, (i) Child-resistant containers should be 
implemented as required by the Poison Prevention Packing Act (1972) for all liquid 
products containing more than 5% methyl salicylate by weight; (ii) restricting the size of 
both the openings and the bottles; and (iii) reducing the methyl salicylate content (Lee K, 
Chan TY et al, 1997) ； (iv) public education. 
Prevention of accidental ingestion of methyl salicylate containing products can be 
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achieved by keeping the products out of reach of children, using child resistant bottles, 
restricting the size of the openings of the bottles, appropriate labeling on products and 
reducing the salicylate content.(Botma M, Colquhoun-Flannery W et al, 2001) 
Treatment is aimed at gastric decontamination with multiple doses of activated charcoal, 
replacement of fluid and electrolytes, and correction of acid-base abnormalities and 
hypoglycemia.(Maryaiiii H, Jose ED et al, 1998) Alkalinization of urine is effective in 
increasing salicylate clearance. Early hemodialysis is indicated for acute SA levels in 
excess of 100 mg/dL, severe acid-base disturbance, hepatic or renal failure, pulmonary 
edema, deteriorating vital signs, or persistent CNS toxicity. Hemoperfusion has a higher 
rate of drug clearance than hemodialysis; however, it is not effective in correcting pH, 
fluid, and electrolyte abnormalities. (Flomenbaum BE and Goldfrank LR, 1994) 
Table 6 d. Ingredients of some commonly used Chinese proprietary medicines 
in Hong Kong. (Chan TY, Lee KK et al, 1995) 
Brand name I Ingredients 一 
Topical medicaments  
1 P a k F ^ O i l ( W h i t e ! • M e n t h o l crystal 30%, wintergreen oil 40%, 
Flower Oil) eucalyptus Oil 18%, camphor 6%, lavender oil 6% 
2 Hung Far Oil 參 Cinnamon leaf oil 4%, cinnamic aldehyde 5%, 
(Red Flower Oil) citronella oil 2%, turpentine oil 22%, wintergreen 
oil 67% 
•3. Jaminton H e a l i ^ Oil or • Camphor 3%, spirit turpentine 9%, eucalyptus oil 
Lion Medicated Oil 0.5%, liquid paraffin 87.5%) 
4 T i g e r Balm • Menthol 10%, camphor 25%, clove oil 5%，cassia 
• oil 5%, peppermint oil 6%, cajuput oil 7%，NH3 
solution 0.10/0, wax and petrolatum 41.9% 
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Chapter 7 - Adverse reactions to Ginseng 
7.1 Overview 
Ginseng is a highly valued herb in the Far East and has gained popularity in the 
West during the last decade (Attele AS, Wu JA et al, 1999). The ginseng root has been 
used for over 2000 years, in the belief that it is a panacea and promotes longevity. 
Ginseng is regarded as the king of herbs and throughout the world it is treasured as a 
supreme health-tonic for its purported anti-stress, anti-fatigue and anti-aging 
properties.(But PPH, Lee TYS et al, 1995) In the US, ginseng is considered a 
nutraceutical The root is sold directly as a herbal remedy, or it may be extracted or 
powdered for use in dietary supplements. In Europe, ginseng is more closely regulated. 
Currently, the German government's Commission E allows Panax ginseng products 
containing at least 1.5 percent ginsenosides, calculated as ginsenoside Rg丨，to be labeled 
for use as a tonic for invigoration and fortification during times of fatigue and debility. 
In traditional Chinese medicine, the pharmacological effects of ginseng have been 
demonstrated in the CNS and in cardiovascular, endocrine, and immune systems. 
However, ginseng has been variously incriminated in herbal poisoning. A review of the 
reported cases suggests that adverse reactions to ginseng may occur because of the 
following problems, 
7.2 Botany 
There is extensive literature on the beneficial effects of ginseng and its constituents. 
Seven major species of ginseng are distributed in East Asia, Central Asia, and North 
America. Most studies of ginseng, including those cited in this commentary，have 
utilized constituents from three common species: Panax ginseng (Asian ginseng), Panax 
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quinquefolius (American ginseng), and Panax japonicus (Japanese ginseng).(Attele AS, 
Wu JA et al, 1999) The major active components of ginseng are ginsenosides, 
polysaccharides, peptides, polyacetylenic alcohol, and fatty acids.(Chang H and But P, 
1987) There is a wide variation (2-20%) in the ginsenoside content of different species 
of ginseng. However, many mechanisms of ginsenoside activity still remain unknown. 
Since ginsenosides and other constituents of ginseng produce effects that are different 
from one another, and a single ginsenoside initiates multiple actions in the same tissue, 
the overall pharmacology of ginseng is complex. 
7.3 Pharmacological Effects 
The efficacy of ginseng was known in the West by the 18th century, and the study 
of ginseng has a long history.(Huang KC, 1999) Recently there has been a renewed 
interest in investigating ginseng pharmacology using biochemical and molecular 
biological techniques. Pharmacological effects of ginseng have been demonstrated in 
the CNS and in cardiovascular, endocrine, and immune systems. In addition, ginseng 
and its constituents have been ascribed antineoplastic, anti-stress, and antioxidant 
activity. Most pharmacological actions of ginseng are attributed to ginsenosides.(Huang 
KC’ 1999) More than twenty ginsenosides have been isolated, and novel structures 
continue to be reported, particularly from Panax quinquefolius and Panax 
义(Yoshikawa M, Murakami T et al, 1998) The chemical composition of 
ginseng products may vary with the plant extract derivative, the age of the root, the 
location where grown, the season when harvested, and the method of drying.(Klepser 
TB and Klepser ME, 1999) Cultivating the plant during autumn and allowing at least 
five to six years of growth yields more ginsenosides. The drying technique influences 
114 
the concentration of various ginsenosides in the final product; air-drying produces white 
ginseng, and steam produces red giiiseng.(Bahrke MS and Morgan WP, 1994) 
Early studies revealed its modulatory effects on the higher center of the central 
nervous system (CNS)，facilitating both the physical and mental activities. Since 
ginsenosides and other constituents of ginseng produce effects that are different from 
one another, and a single ginsenoside initiates multiple actions in the same tissue, the 
overall pharmacology of ginseng is complex. The ability of ginsenosides to 
independently target multi-receptor systems at the plasma membrane, as well as to 
activate intracellular steroid receptors, may explain some pharmacological 
effects.(Attele AS, Wu JA et al, 1999) Scientific investigations have shown that these 
agents can release histamine; block calcium mobilization in smooth muscle, producing 
hypotension; stimulate a^adrenergic receptors; stimulate erythropoiesis; increase 
adrenocorticotropic hormone, antidiuretic hormone, and Cortisol secretion; raise sperm 
count; increase glucose utilization; increase levels of circulating immunoglobulins; and 
inhibit the cells of tumor cells cultivated in vitro.(Huang KC，1999) 
7.4 Adverse reaction of Ginseng 
7.4.1 Overdosage: 
A report of the much-publicized Ginseng Abuse Syndrome (GAS) concluded that 
patients developed hypertension, nervousness, sleeplessness, skin eruptions, edema and 
morning diarrhoea after long-term intake of ginseng products.(Siegel RK, 1979) 
Depression was also reported in those cases with ginseng doses higher than 15 g. The 
effects are similar to organic brain syndromes associated with corticosteroids and 
corticotrophin and may be related to ginseng's interference with cortisone and 
corticotrophin levels.(Kiin C, Kim CC et al，1970) Furthermore, elevation of mood was 
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also very common in GAS. The study, which was undertaken at the University of 
California, followed 133 ginseng users for a period of two years and suggested that GAS 
was a result of long-term abuse with ginseng. Such effects might be due to ginseng 
dammarenetriol glycosides, which have strong central nervous system excitatory actions. 
Treatment of patients with GAS should include withdrawal from ginseng and other 
stimulants. Larger doses of ginseng (15 g daily) have resulted in feelings of 
depersonalization, which can mimic psychosis. These adverse effects are thought to 
result from the central nervous system accumulation of ginseng alkaloids. Treatment is 
to discontinue use of the herb. Other potential adverse effects of ginseng include 
premature uterine contractions in pregnant women and possible interaction with 
monoamine oxidase inhibitor antidepressants， producing headache and 
tremouloiisness.(Michael S, 1999) 
Another report from China described two cases of visual defect, which appeared to 
be related to ginseng poisoning.(Lou BY, Li CF et a l 1989) After taking ginseng, the 
patients developed bilateral mydriasis and disturbance in accommodation, with systemic 
symptoms which included dizziness and impaired consciousness, which might be 
associated with hyper-excitability of the sympathetic nervous system due to overdose of 
ginseng. 
7.4.2 Substitution with cheaper and more toxic herbs 
In the United States, where roughly 60% of the population take herbal supplements, 
some manufacturers label the level of active compound voluntarily, but they are not 
legally required to do so or to guarantee a certain level Nor do the products need 
government approval for safety and efficacy.(Harkey MR, Henderson GL et al, 2001) 
Some ginseng preparations available in the USA were found to be adulterated with 
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Mandragora officinarum, Rauwolfia serpentina and Cola species.(Siegel RK, 1977) A 
few fatal/serious cases were reported in the Chinese literature, but the herb used was 
actually Physochlaina infundibularis, which contains atropine and related alkaloids. Also 
Siberian ginseng {Eleutherococcus senticosus) has been confused with ginseng (Panax 
g/似e;7g),(Awang DV, 1991) and the former has been found adulterated with Periploca 
sepium, which contains cardiotonic glycosides. 
Anticholinergic poisoning was reported after consumption of ginseng products. 
Analysis of the incriminated samples led to the conclusion that they were actually 
derived from or contaminated with other herbs (e.g. ephedrine). 
Additionally, some reports have incriminated ginseng to be the causative agent for 
various adverse reactions, but the actual identity of the products could not be properly 
established. This lack of substantiated information made it difficult to truly assess the 
problems, since it is quite common to find adulteration, contamination and poor quality 
control in ginseng products. For example, a 44 year-old lady had post-menopausal 
bleeding after using a ginseng face cream.(Hopkins MP, Androff L et al, 1988) After 
examined the level of follicle-stimulating hormone, they found that the hormone level 
was affected after using this ginseng face cream but the ingredients of this face cream 
were not known. The symptoms of this patient were disappeared after stopped using this 
cosmetic� 
Another 70 year-old lady developed swollen and tender breasts after taking 
ginseng powder regularly for three weeks.(Palmer BV, Montgomery AC et al, 1978) 
Her breast symptoms was settled after cessation of the ginseng powder. The patient had 
two further trials with this preparation and on each occasion the same symptoms 
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reappeared again. However, the serum prolactin levels were normal even the patient had 
taken ginseng or not. 
A 39-year-old Czech man was found to have hypertension (Blood pressure 
154/106 mm Hg) after taken about 3 years of different ginseng preparations 
orally.(Hammond TG and Whitworth JA, 1981) On examination his retinal arteries 
showed definite hypertensive changes. The patient was normotensive (140/85 mm Hg) 
5 days later without anti-hypertensive medication. He remained normotensive without 
treatment after three months and his symptoms resolves. 
A 33 year-old Chinese man with past good health suddenly convulsed and vomited 
of gastric content after taken 200cc of Red ginseng extract after several hours.(Zheng JY, 
1984) He had high grade fever (38.8�C) and high blood pressure (140/100 mmHg) 
accompany with incontinence. After resuscitation, the patient finally died with acute left 
heart failure and upper gastrointestinal bleeding. Based on this patient clinical 
manifestation, the author stated that this patient may died of misusing of the ginseng 
medication because ginseng has pharmaceutical effect of vessel dilation and not suitable 
for the patient with congenital cerebral vessel malformation. However, the author hasn't 
provided the follow up information about the case. 
All these cases have no further information about the ginseng product, so the 
relation cannot be substantiated. Another report from Australia (Hammond TG and 
Whitworth JA, 1981) also stated that a 39 year-old man had hypertension, dizziness and 
inability to concentrate after having taken a variety of different imknown ginseng 
preparations for about 3 years and the symptoms settled after discontinuing further 
intake of ginseng preparations. Ryu (Ryu SJ and Chien YY，1995) also report a 28 year-
old woman who had a severe headache after taking a large quantity of ethanol-extracted 
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ginseng to overcome physical fatigue. She ingested a bowel of extract (approximately 
200 ml) from 60 slices of ginseng root (approximately 25 grams dry weight) that was 
stewed with 400 ml rice wine (22% alcohol). The patient developed an explosive 
headache, nausea and vomiting with chest tightness after eight hours later. This was the 
first episode and the headache was severe and was temporarily relieved by 
acetaminophen. She was referred to the hospital 6 days later. There was no special 
finding after general and laboratory examination. Cerebral angiograms showed 
"beading" appearance in the anterior and posterior cerebral and superior cerebellar 
arteries, consistent with cerebral arteritis. The hospital course was uneventful, and her 
headache gradually disappeared over the next 10 days. Base on the result of the 
angiography of this patient, the appearance of cerebral arteritis may be associated with 
use of sympathomimetics or cocaine, various CNS inflammatory processes, or 
aneurysmal subarachnoid hemorrhage. However, detailed medical history excluded use 
of cocaine or any sympathomimetic drugs, and there was no CNS infection or aneurysm. 
The close temporal association between the intake of ginseng and cerebral arteritis may 
indicate a possible causal relationship but the nature and mechanism of this is uncertaiiL 
Some reports state that 200 ml of the ginseng tincture or large doses of ginseng 
powder could result in intoxication giving rise to rose spots, pruritus, headache, vertigo, 
hyperpyrexia and bleeding, the last symptom was the characteristic manifestation of 
acute intoxication induced by ginseng.(Chang H and But PPH, 1987) Overdasage of 
ginseng may also result in breathlessness, chest discomfort and abdominal distension. 
Radish has been used as a folk remedy for ginseng intoxication but the mechanism was 
not clear. 
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Misuse and abuse of ginseng could lead to adverse reactions. Herbal remedies are 
often touted in magazines and other popular media as being natural and safe, and many 
people take herbal preparations in addition to conventional medications prescribed or 
recommended by medical practitioners. Patients taking herbal medicines do not always 
volunteer this information to their physician.(McRae S, 1996) Many mislabeled and 
contaminated ginseng products further aggravate the problem. Thus, consumers should 
exercise appropriate caution in using ginseng products and proper controls should be 
levied on manufacturers of these preparations. Given widespread mislabeling, 
ingredients not listed in ginseng products may be responsible for therapeutic or adverse 
effects. Individuals with hypertension, diabetes, psychologic disorders, or insomnia 
should avoid or cautiously use ginseng. 
A 28-year-old woman was admitted because of severe headache.(Ryu SJ and 
Chien YY, 1995) Six days before admission, she had a sore throat and took some 
western medication by herself. Two hours later, to overcome physical fatigue, she 
ingested a bowl of extract (approximately 200 ml) from 60 slices of ginseng root 
(approximately 25 grams dry weight) that was stewed with 400 ml rice wine (22% 
alcohol). Eight hours after drinking the ginseng extract, she developed an explosive 
headache, nausea and vomiting, and chest tightness. The headache was severe and was 
temporarily relieved by acetaminophen. The patient has no history of hypertension or 
use of drugs such as oral contraceptives or anorexiants. Laboratory tests that included 
complete blood count, sedimentation rate, and biochemistry were also normaL CT of the 
brain showed slightly increased density over the falx, and subarachnoid hemorrhage was 
suspected. Cerebral angiograms demonstrated multiple areas of alternating focal 
constriction and dilatation ("beading" appearance) in the anterior and posterior cerebral 
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a r t e r i e s a n d t h e s u p e r i o r c e r e b e l l a r a r t e r y , w h i c h i s c o n s i s t e n t w i t h a r t e r i t i s . T h e h o s p i t a l 
course was uneventful, and her headache gradually disappeared over the next 10 days. 
The temporal association between the ingestion of ethanolic ginseng extract and the 
onset of severe headache in this case strongly suggests a causal relationship. The 
angiographic appearance of cerebral arteritis may be associated with use of 
sympathomimetics or cocaine, various CNS inflammatory processes, or aneurysmal 
subarachnoid hemorrhage. However, detailed medical history excluded use of cocaine 
or any sympathomimetic drugs, and there was no CNS infection or aneurysm. The 
syndrome seen in our patient was most likely related to ingestion of a large amount of 
ginseng extract. Although the acute oral toxicity (LD50) for ethanolic extract of ginseng 
has been determined in mice, its toxic dose in humans is not known. 
Patients who take ginseng risk paying a high price without proven benefit. In Asian 
cultures, ginseng is commonly consumed by pregnant women and is given to newborns 
in hopes of bolstering energy.(OUara M，Kiefer D et al, 1998) A case-control study of 
88 pairs of women (matched only for age and parity) found a significantly lower rate of 
pregnancy-induced hypertension, but a 3-fold higher incidence of gestational diabetes 
among ginseng consumers.(Chin RK, 1991) Ginseng was not recommending for 
pregnant or lactating women or for children until safety and efficacy are proven in 
randomized controlled trials. 
7.5 Drug - herb Interaction 
Both Asian and American ginseng have been shown to reduce blood glucose levels 
and hemoglobin Ale levels in people with type 2 Diabetes mellitus.(Sotaniemi E, 
Haapakoski E et al, 1995; Vuksan V，Sievenpiper JL et al, 2000; Vuksan V，Sievenpiper 
JL et al, 2001] Given concurrently with insulin or oral antidiabetic agents, ginseng may, 
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without careful blood glucose monitoring, result in hypoglycemia. There has been one 
case report of ginseng decreasing the effect of warfarin in a previously stable patient 
with a mechanical heart valve. Within two weeks of adding ginseng, the INR dropped to 
1.5 from the targeted 3.0-4.0 and returned to 3.3 after ginseng was 
discontinued.(Janetzky K and Morreale AP, 1997) However, some current animal 
experimental showed no significant impact of ginseng on the pharmacokinetics / 
pharmacodynamics of warfcin when they are concomitantly administered.(Zhu M, 
ChanKWet al, 1999) 
A 74-year-old asymptomatic man taking a constant dose of digoxin for many 
years to control atrial fibrillation and was found to have an elevated serum digoxin level. 
(McRae S, 1996) No signs of digoxin poisoning such as mental disturbance, nausea, 
vomiting or abnormal vision. The patient then revealed that he was taking Siberian 
ginseng, a popular herbal remedy. After stopping ginseng intake, the serum digoxin 
level soon returned to an acceptable level However, the patient resumed taking ginseng 
several months later and the serum digoxin level again rose. After regional forensic 
laboratory analyzed the samples of the Siberian ginseng capsules; no digoxin or 
digitoxin contamination was found. 
Siberian ginseng contains eleutherosides, which are chemically related to cardiac 
glycosides such as digoxin. In this patient, some component of the Siberian ginseng 
capsules may have been converted in vivo to digoxin. The case reported here should 
remind physicians to ask patients about nonprescribed medications, ”natural" or 
otherwise, and to consider those remedies as possible factors when unexpected 




Based on the accumulation of experience over many thousands of years, some 
principles have been developed to guide the use of Chinese medicines. According to the 
lack of standardization of ginseng products and the common practice of adulteration 
with cheaper substitutes, it is often difficult to be certain of the extent to which true 
ginseng was involved in some previous reports of its alleged adverse effects.(D'Arcy PF, 
1991) Both medical professionals and the general public should be alerted to the 
potential toxicity of herbal remedies. Furthermore, in order to gain better understanding 
of the toxicity of ginseng and its individual allergic reactions, research should be 
encouraged. 
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Chapter 8 - Herbal Medicines With Cardiovascular 
Adverse Reactions 
8.1 Overview 
The use of alternative therapies, herbs, and supplements occurs at a very high rate 
among patients attending a variety of health care settings. Such therapy may cause 
significant interactions or effects on hypertension and other cardiovascular disorders and 
needs to be considered by clinicians. Plants that contain cardiac glycosides are used 
throughout the world for the treatment of heart failure and some arrhythmias. Current 
conventional pharmacological treatment includes at least five classes of drugs: 
Antiadrenergic, vasodilators, Calcium channel blockers, diuretics, and ACE inhibitors. 
It is rare to use single drug therapy. Non-drug conventional therapy limits itself to diet 
counseling, exercises, and the cessation of smoking and drinking. Herbals including ma 
huang, S t John's wort, yohimbine, garlic，and licorice all may cause important 
consequences in the hypertensive patient. Added care is needed in monitoring the use 
and effects of herbal and alternative therapies in the hypertensive population. 
8.2 Hypertension 
Hypertension is very prevalent with some 50 million Americans diagnosed with 
hypertension and the majority taking antihypertensive drugs. Based on the fact that 
tighter goal for the treatment of hypertension, hyperlipidemia, and hyperglycemia has 
been recommended, multidrug therapy is routine for these disorders. 
8.3 Atherosclerosis 
Atherosclerosis is a multifactorial disease, and other factors besides lipid 
peroxidation can accelerate atherogenesis independently or in association with lipid 
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peroxidation. Increased retention and aggregation of LDL in the arterial wall and LDL 
oxidation are key events in the acceleration of atherogenesis. Because LDL and 
macrophages are retained in the atherosclerotic lesion on the arterial wall and 
macrophages release proteoglycans to their surroundings under atherogenic conditions, 
the macrophage-mediated aggregation of LDL may play a physiologic role in LDL 
modification in vivo. 
8.4 Arrhythmias 
There is increasing awareness of the problem of drug-induced cardiac 
arrhythmias.(Lean MF and Lee A, 1999) A cardiac arrhythmia is defined as any 
abnormal cardiac rhythm, whether the abnormality is one of rate, regularity or origin of 
the impulse initiating each heart beat. Drug-induced arrhythmias may be an adverse 
effect of a non-cardiac drug, a pro-arrhythmic complication of an anti-arrhythmic drug， 
or may arise from a drug overdose. Predisposing factors include underlying rhythm 
disturbances (especially ventricular tachycardia or fibrillation), impaired left ventricular 
function, pre-existing heart disease, high plasma levels of antiarrhythmic drugs and 
electrolyte abnormalities, especially hypokalemia and hypomagnesaemia. Effects on the 
QT interval The QT interval on the electrocardiogram (ECG) are an indirect measure of 
the duration of the ventricular action potential and ventricular repolarisation. 
Prolongation of ventricular repolarisation can cause arrhythmias, the most characteristic 
of which is torsades de pointes (twisting of the points), a specific form of ventricular 
tachycardia, which causes dizziness or syncope, it may lead to ventricular fibrillation 
and sudden death. Causes include bradycardia, certain inherited disorders, biochemical 
disturbances such as hypokalaemia, and acquired heart disease. Some patients with 
125 
torsade de pointes may be asymptomatic while others experience dizziness, light-
headedness, syncope, collapse, irregular heartbeat and palpitations. 
8.5 Cardie Failure 
A number of herbs contain potent cardioactive glycosides, which have positive 
inotropic actions on the heart.(Nick HM, George IL et al, 1998) The drugs digitoxin, 
derived from either D purpurea (foxglove) or Digitalis lanata, and digoxin, derived 
from D. lanata alone, have been used in the treatment of congestive heart failure for 
many decades. The only way to control dosage is to use standardized powdered digitalis, 
digitoxin, or digoxin. As is evident, treating congestive heart feilure with 
nonstandardized herbal drugs would be dangerous and foolhardy. 
8.6 Angina Pectoris 
Crataegus of hawthorn is an important tonic for the cardiovascular system that is 
particularly useful for angina in TCM. Crataegus leaves, flowers, and fruits contain a 
number of biologically active substances, such as oligomeric procyanins, flavonoids, and 
catechins. Crataegus extract antagonizes the increases in cholesterol, triglyceride, and 
phospholipid levels in low-density lipoprotein (LDL) and very low-density lipoprotein 
in rats fed a hyperlipidemic diet; thus, it may inhibit the progression of 
atherosclerosis.(Shanthi S, Parasakthy K et al, 1994) Crataegus also prevents 
cholesterol accumulation in the liver by enhancing cholesterol degradation to bile acids, 
as well as suppressing cholesterol bio synthesis. (Rajendran S, Deepalakshmi PD et al, 
1996) 
8.7 Thromboembolic Disorders 
Thromboembolic disorders result from the sudden occlusion of a blood vessel by a 
blood clot (thrombus) in the arterial or venous circulation.(Lean MF and Lee A, 1999) 
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Venous thromboembolism is common and is associated with a mortality of 1-2 per cent. 
Deep vein thrombosis (DVT) usually arises in the veins of the lower limbs or pelvis. 
Clinical features include pain involving the calf or thigh associated with swelling, 
redness and warmth. Management involves restoring normal circulation and 
anticoagulation. If part of a venous thrombus breaks off it can lodge in the pulmonary 
circulation, causing pulmonary embolism (PE). This can present with breathlessness, 
chest pain and collapse. In the arterial circulation, a thrombus may result in peripheral 
arterial occlusion, either in the lower limbs or in the cerebral circulation, where it may 
result in stroke. 
8.8 Discussion 
Several herbs offer potential for treating cardiovascular conditions including 
venous insufficiency, intermittent claudication, hyperlipidemia, hypertension and 
congestive heart failure (CHF).(Vam G and Giardina EGV, 2002) (See Table 8 a & b) 
Varied mechanisms, including antioxidant, antiplatelet, fibrinolytic, antiatherosclerotic, 
antihyperlipidemic, antiarrhythmic and vasodilatory actions, are ascribed to h e r b s � I n 
addition, the growing demand for soft drinks and foods with herbal additives greatly 
expands public exposure. More than this, Chinese herbs were also reported to have the 
possibilities to cause heart disease in Belgium. (Vanherweghem JL， 1997) 
Vanherweghem J.L. stated that nearly 30% patients with drug induced renal failure (they 
were taken as appetite suppressants: fenfluramine, dexfenfluramine, or phentermine, 
alone or in combination) were found to have aortic insufficiency. The valvular heart 
disease in Chinese-herb nephropathy seen in Belgium seems most likely to be due to the 
combined use of (dex)fenfluramine and Chinese herbs. It is also obvious that the 
nephropathy recorded both in Belgium and in Japan is not caused by (dex)fenfluramine, 
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and that tubulointerstitial disorders are induced by the prolonged use of Chinese herbs 
that contain aristolochic acid. 
The adverse effects, efficacy and interactions for herbal therapies that impact on the 
cardiovascular system are as follow. 
Table 8 a. Herbs With Adverse Cardiovascular Effects. (Valli G. and Giardina 
EGV, 2002) 
一 Herb Adverse Effect Comments — 
Belladonna Tachycardia Herbal source of atropine (Blumenthal M, Busse WR 
et al, 1998) 
Danshen Platelet dysfunction In vitro evidence of platelet antagonism (Wang Z， 
Roberts JMetal , 1982) 
Dong quai Increased bleeding Presence of natural coumarins and in vitro evidence 
� tendency of platelet antagonism (Zhu DP, 1987; Page RL, 2nd 
and Lawrence JD, 1999) 
Feverfew Platelet dysfunction In vitro evidence of platelet antagonism (Heptinstall 
S, White Aet al, 1985) not supported in clinical trials 
(Groenewegen WA, Knight DW et al, 1992; Vogler 
BK and Ernst E，1999) 
Garlic Increased bleeding Case reports of hemorrhage.(Rose KD, Croissant PD 
tendency et al, 1990; Bumham BE, 1995) 
In vitro evidence of platelet dysfunction (Ali M, 
1995; Bordia T, Mohammed N et al, 1996; Ali M, 
Thomson M et al, 2000) but conflicting platelet and 
fibrinolytic evidence from clinical trials (Harenberg 
J, Giese C et al, 1988; Kieswetter H, Jung F et al, 
1991; Bordia A, Verma SK et al, 1998) 
Ginger Platelet dysfunction Conflicting results in studies of platelet antagonism 
in human trials (Lumb AB, 1994; Janssen P, 
Meyboom S et al, 1996; Bordia A, Verma SK et al, 
19971 
Hypertension Animal studies of specific purified ginger 
compounds demonstrate pressor effects (Suekawa M, 




Herb Adverse Effect~ Comments  
Ginkgo Increased bleeding Case reports of central nervous system hemorrhage. 
tendency, platelet Pharmacologic evidence of platelet antagonism; 
dysfunction however, active compounds not present in sufficient 
amounts in most extracts (Braquet P, 1993; Skogh M, 
1998) : 
Ginseng Hypertension An abuse syndrome involving hypertension is 
described in chronic iisers.(Siegel RK, 1979 
However, evidence from clinical trials also supports 
hypotensive effects (Han KH, Choe SC et al, 1998) 
Hellebore Hypotension, Accidental ingestion occurs when plant is mistaken 
bradycardia for another, especially gentian (Jaffe AM, Gephardt 
D et al, 1990; Quatrehomme G, Bertrand F et al, 
1993) 
Kava Platelet dysfunction Limited in vitro evidence (Gleitz J, Beile A. et al, 
1997) 
Licorice Hypertension, Occur as a result of decreased inactivation of Cortisol 
pulmonary edema, causing symptoms of mineralocorticoid excess 
cardiomyopathy (Walker B and Edwards CRW, 1994) 
(rarely)  
Mahuang Stroke, myocardial Numerous case reports of serious adverse events in 
infarction, healthy young people. (Haller CA and Benowitz NL, 
arrhythmia, 2000) 
hypertension Myocarditis Rare case report (Zaacks SM, Klein L et 
al，1999) 
Oleander Arrhythmia Cardiac glycosides cause symptoms similar to 
digoxin toxicity. Responds to digoxin antibody 
treatment.(Safadi R, Levy I et al, 1995) 
Yohimbine Hypertension, Increases norepinephrine levels and central 
arrhythmia sympathetic outflow via a2 antagonism (Grossman 
E, Rosenthal T et al, 1993; Hof&nan BB, Lefikowitz  
| r J et al，1996) 
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Table 8 b . Important Cardiovascular Drug Interactions. 
Drug Herb Evidence for Interaction  
Warfarin Dong quai Case reports of elevation of PT and INR in patient 
stable on warfarin.(Page RL，2nd and Lawrence JD, 
1999) 
Demonstration of pharmacological interaction in 
rabbits.(Lo ACT, Chan K et al, 1995) 
Danshen Decreases warferin clearance and increases 
bioavailability. Case reports of hemorrhage in 
subjects on warfarin. (Yu CM, Chan JCN et al, 1997; 
Chan TY, 1998) 
Garlic Rare reports of elevation in INR in subjects 
previously stable on warfarin.(Sunter W, 1991) 
Ginkgo Case report of CNS hemorrhage in patient previously 
stable ofwarfarin.(Matthews MK, Jr, 1998) 
Ginseng Case report of decreased INR in patient stable on 
warfarin. (Janetzky K and Morreale AP, 1997) 
Antiplatelet Dong quai In vitro evidence of platelet antagonism. (Page RL, 
drugs 2nd and Lawrence JD, 1999) 
(NSAIDs, Feverfew Potential antiplatelet effects.(Heptinstall S, White A 
ticlopidine, et al, 1985) No case reports of hemorrhage.  
others) Garlic Case reports of platelet dysfunction with increased 
bleeding time (Rose KD, Croissant PD et al, 1990; 
Bumham BE, 1995) 
Conflicting evidence from clinical trials of 
antiplatelet effects. (Harenberg J, Giese C et al, 1988; 
Kieswetter H, Jung F et al, 1991; Legnani C, Frascaro 
M et al, 1993; Bordia A, Verma SK et al, 1998) 
Antiplatelet Ginger In vitro evidence of antiplatelet activity, but no effects 
(inigs seen in clinical trials and no case reports of adverse 
(NSAIDs, events.  
ticlopidine, Ginkgo Case reports of hemorrhage.(Rowin J and Lewis SL, 
others) 1996; Rosenblatt M and Mindel J, 1997; Vale S, 
1998) In vitro evidence of antiplatelet activity but no 
confirmatory evidence in human trials.(Jung F, 
Mrowietz C et al, 1990; Braquet P, Esanu A et al, 
1991; Braquet P, 1993; SkoghM, 1998) 
Kava In vitro evidence of platelet antagonism. (Gleitz J, 
Beile Aeta l , 1997) 
Clonidine Yohimbine Competitive a2-aiitagonist.(Hoffinan BB，Lefkowitz  
| r J et al, 1996) 
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Drug Herb Evidence for Interaction  
Digitalis Hawthorn Claims of interaction but no case reports and no 
pharmacologic data.(Miller LG and Murray WJ, 
1998) 
Herbal laxatives Herbal laxatives such as buckthorn, cascara sagrada 
and senna can cause loss of potassium leading to 
digitalis toxicity.(Tyler VE, 1994) 
Oleander Contains active cardiac glycosides. (Eddleston M, 
Rajapakse S et al, 2000) 
Digitalis St. John's wort Reduces serum digoxin levels. (Johne A, Brockmoller 
J et al, 1999) 
Siberian ginseng May interfere with assay, does not cause elevated 
digoxin levels (Awang DVC, 1996; McRae S，1996) 
Tricyclic Yohimbine Antidepressants potentiate pressor effects.(De Smet P. 
antidepressants and Smeets 0，1994) 
Methysergide, Feverfew Antagonizes serotonin release, may potentiate the 
pizotifen, other effect of other serotonin antagonists. (Wong HCG, 
serotonin 1999) 
antagonists J  
CNS — central nervous system NSAID _ nonsteroidal anti-inflammatory drug 
INR _ international normalized ratio PT — prothrombin time. 
8.8.1 Herbal Medicine Used in Cardiovascular System 
8.8 丄 1 Ginseng 
Ginseng is regarded as the king of herbs and throughout the world it is treasured as 
a supreme health-tonic for its purported anti-stress, anti-fatigue and anti-aging 
properties.(Chong SK and Oberholzer VG, 1988) In China it is utilized for angina 
pectoris, MI and CHF. It has been evaluated for many other indications, most notably for 
use as an antihyperglycemic. The active compounds are heterogeneous triterpene 
saponin glycosides, collectively termed ginsenosides. The exact ginsenosides vary by 
Panax species,(Attele AS, Wu JA et al, 1999) root age (Gillis CN, 1997) and preparation 
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method (i.e., red or white). The Commission E monograph recommends a dosage of 1 
to 2 g of root daily.(Blumenthal M，Busse WR et al, 1998) 
Clinical trials in China and Korea have investigated ginseng for cardiac function, 
although there is no known mechanism and little data from placebo-controlled or 
blinded studies. An open trial evaluating CHF contrasted, 1) red ginseng, 2) digoxin, and 
3) digoxin plus red ginseng, and found that hemodynamic improvement was most 
marked with combined therapy.(Dmg DZ, Shen TK et al, 1995) In a double blind, 
placebo-controlled trial of coronary heart disease, a mixture of Chinese herbs，including 
ginseng, found that stroke volume index and cardiac index improved.(Fang J, Jian J et al, 
1987) 
Ginseng has been shown to have both hypertensive and hypotensive effects in 
animal studies trials.(Gillis CN, 1997) Hypotensive effects are attributed to enhanced 
synthesis of nitric oxide. An open trial of 4.5 g red ginseng daily found systolic blood 
pressure decreased after eight weeks.(Han KH, Choe SC et al, 1998) In contrast, a 
ginseng-abuse syndrome has been described wherein hypertension, behavioral changes 
and diarrhea occur.(Siegel RK, 1979; Siegel RK, 1980) In an observational study of 133 
chronic ginseng users, 22 developed elevated blood pressure.(Siegel RK, 1979) Such 
effects might be due to ginseng dammarenetriol glycosides, which have strong central 
nervous system excitatory actions. 
Animal studies suggest that ginseng scavenges free radicals.(Gillis CN, 1997) In a 
placebo-controlled trial of 30 patients undergoing mitral valve surgery, ginseng and 
ginsenoside Rb were evaluated for protective effects in ischemia and reperfiision 
injiiry.(Zhan Y, Xu XH et al, 1994) Both improved postoperative cardiac function; 
however, ginseng provided greater benefit than the isolate ginsenoside Rb. An 
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interaction of ginseng with warfarin, in which the INR was reduced to subtherapeutic 
levels, has been reported.(Janetzky K and Morreale AP, 1997) However, no mechanistic 
evidence for the interaction has been provided. (Vaes LP and Chyka PA, 2000) 
Interaction with digoxin, or with the digoxin assay and Siberian ginseng, has been 
observed’ though this may have been due to a contaminant.(Awang DVC, 1996) Of note, 
many products that claim ginseng content have no ginsenosides.(Liberti LE and Der 
Marderosian A, 1978; Cui J, Garle M e t a l , 1994) Some ginseng preparations have been 
contaminated with germanium, which has led to an account of ginseng related diuretic 
resistance and renal failure.(Becker BN, Greene J et al, 1996) 
8.8.1.2 Ma huang {Ephedra sinica) 
Ma huang is a natural source of ephedrine and has potent sympathomimetic activity. 
Herbal remedies and soft drinks used for energy or weight loss often contain ma huang. 
Its pharmacokinetics and bioavailability are similar to standard doses of 
ephedrine,(White LM, Gardner SF et al, 1997) but the effects are delayed in onse t�This 
is one of the most commonly taken supplements and is called by a variety of names 
including ma huang, ephedra extract, ephedra sinica, ephedra equisetina, ephedra 
intermedia, ephedra geradiana, ephedra herb powder, epitonin, or ephedrine.(Mansoor 
GA，2001) Between 1997 and 1999, a total of 140 reports of adverse events were 
related to ma huang; (Hailer CA and Benowitz NL, 2000) 13 caused permanent 
impairment and 10 resulted in death. Ephedrine and related alkaloids have been 
associated with adverse cardiovascular events, including acute myocardial infarction, 
severe hypertension, myocarditis, and lethal cardiac arrhythmias.(To LB, Sangster JF et 
al, 1980; Wiener I，Tilkian AG et al, 1990) Constriction of coronary arteries and, in 
some cases, vasospasm is believed to be the mechanisms of myocarditis and myocardial 
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infarction. The adrenergic effects of ephedrine shorten cardiac refractory periods, 
permitting the development of reentrant cardiac arrhythmias. Ephedrine can predispose 
patients to both hemorrhagic and ischemic stroke.(Bruno A, Nolte KB et al, 1993) Many 
reports concern healthy young people without known cardiac disease. The majority had 
new-onset hypertension, and other findings included cerebrovascular accidents, 
arrhythmias and ML Several reports link the adverse response of ma huang to 
concurrent use of caffeine, guarana (a source of caffeine and theophylline)(Carlson M. 
and Thompson RD, 1998) or exercise. In a 2-year period in Texas, some 5000 reports of 
adverse effects of dietary supplements containing ephedra were reported.(CDC, 1996) It 
makes good sense to specifically instruct patients with hypertension, diabetes mellitus, 
thyroid disease, cardiac rhythm disorders, and seizures not to take herbals with ephedra. 
Subarachnoid hemorrhage is thought to be a result of the hypertensive action of 
ephedrine, which can be short lived, or of cerebral vasculitis, which has been described 
in association with a variety of sympathomimetic drugs.(Wooten MR, Khangure MS et 1, 
1983; Fallis RJ and Fisher M, 1985) Thrombotic stroke is presumably related to 
vasoconstrictionof large cerebral arteries，which leads to local thrombosis as a result of 
stasis and sympathomimetic-induced platelet activation. 
An additional cause of concern for clinicians treating hypertension is the reported 
association of kidney stones with ephedra mgestion.(Powell T，Hsu FF et al, 1998) 
Chemical analysis has revealed these concretions to contain ephedrine and its 
metabolites. Renal calculi containing ephedrine have also been found in patients 
consuming large amounts of guaifenesin and ephedrine in over-the-counter 
preparations. (Assimos DG, Leinbach RF et al, 1999) It should be noted that ephedra has 
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also been linked to cases of psychoses, (Jacobs KM and Hirsch KA, 2000) mood 
disorders, and myocarditis. (Zaacks SM, Klein L et al, 1999) 
Many of the cases we reviewed involved side effects such as anxiety, tremulousness, 
insomnia, palpitations, and personality changes that are well known to occur with the use 
of stimulant drugs. When ephedrine is used for medical purposes, these types of reactions 
are considered side effects and must be included in the assessment of risks and 
benefits.(Haller CA and Benowitz NL, 2000) In fact, ephedrine is rarely prescribed 
today for medical purposes, because newer drugs have more specific actions and fewer 
side effects. The risks of taking ephedra alkaloids as a dietary supplement, however, are 
difficult to justify because the alkaloids have no demonstrated benefit. 
Caffeine is present in many products that contain ephedra alkaloids, and those who 
take these products might also be consuming considerable quantities of caffeine in coffee, 
tea, and soft drinks. Caffeine is likely to enhance the cardiovascular and central nervous 
system effects of ephedrine. Caffeine acts by competitively antagonizing the receptors 
for adenosine, a hormone released by endothelial cells that dilates blood 
vessels.(Benowitz NL, 1990) By inhibiting adenosine-mediated dilatation of blood 
vessels, caffeine constricts blood vessels and may increase blood pressure in persons 
prone to hypertension. Caffeine also augments the release of catecholamines, an effect 
that, when combined with that of ephedrine, could lead to increased stimulation of the 
central nervous system and cardiovascular system. (Robertson D, Frolich JC et al, 1978) 
Phenylpropanolamine, another ephedrine alkaloid, was marketed with caffeine in 
various weight-reducing aids until 1983, when the combination was banned by the FDA 
after numerous reports of adverse effects. Several studies have shown that caffeine and 
phenylpropanolamine have an additive effect on blood pressure.(Brown NJ, Ryder D et 
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al, 1991) These interactions between phenylpropanolamine and caffeine support the idea 
that the combination of ephedrine and caffeine in a dietary supplement could increase the 
risk of adverse effects. 
8.8.1.3 Yellow oleander (Thevetia neriifolia) 
Yellow oleander {Thevetia neriifolia) is a commonly grown tree found widely in 
Eastern India.(Bose TK, Basu RK et al, 1999) The seeds of yellow oleander are highly 
poisonous and contain three glycosides—thevetin, thevetoxin and peruvoside. Yellow 
oleander seed ingestion is usually with suicidal intent in Eastern India. 
In the case of oleander, all plant tissues, including the seeds, roots, stems, leaves, 
berries, and blossoms, are considered extremely toxic.(Safadi R, Levy I, et al, 1995) In 
fact, death in humans has been reported following ingestion of as little as 1 oleander 
leaf.(Szabumewicz M, McGrady JD et al, 1971) The clinical manifestations of oleander 
intoxication, as well as other natural glycosides, are virtually identical to digoxin 
overdose. Morbidity and mortality are mainly related to cardiotoxic adverse effects that 
usually include life-threatening ventricular tachyarrhythmias, bradycardia, and heart 
block. The diagnosis should rely on the clinical presentation of unexplained 
hyperkalemia, and cardiac, neurologic, and gastrointestinal symptoms.(Safadi R, Levy I 
et al, 1995) 
Poisoning symptoms indicated serious cardiac, neuromotor and mental 
malfunctioning, and manifested as tachycardia, arrhythmia, paralysis, ataxia and 
disorientation.(Oji O and Okafor QE, 2000) Serious yellow oleander induced 
arrhythmias were associated with higher serum cardiac glycoside concentrations and 
hypokalemia but not with disturbances of magnesium.(Eddleston M，Ariaratnam CA et 
al, 2000) Anti-digoxin Fab fragments are a safe and effective treatment for serious 
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cardiac arrhythmias induced by yellow oleander. The diagnosis can be further supported 
by the detection of the substance digoxin in a radioimmunoassay for digoxin. 
8.8.1.4 Stephania tetrandra 
Stephania tetrandra is an herb sometimes used in traditional Chinese medicine to 
treat hypertension. Tetrandrine, an alkaloid extract oiS. tetrandra, has been shown to be 
a calcium ion channel antagonist, paralleling the effects of verapamil. Tetrandrine 
blocks T and L calcium channels, interferes with the binding of diltiazem and 
methoxyverapamil at calcium-channel binding sites, and suppresses aldosterone 
production.(Rossier MF, Python CP et al, 1993; Sutter MC and Wang YX, 1993) A 
parenteral dose (15 mg/kg) of tetrandrine in conscious rats decreases mean, systolic, and 
diastolic blood pressures for more than 30 minutes; however, an intravenous 40-mg/kg 
dose killed the rats by myocardial depression. In stroke-prone hypertensive rats, an oral 
dose of 25 or 50 mg/kg produced a gradual and sustained hypotensive effect after 48 
hours without affecting plasma renin activity.(Kawashima K, Hayakawa T et al, 1990) 
In addition to its cardiovascular actions, tetrandrine has reported antineoplastic, 
immunosuppressive, and mutagenic effects.(Sutter MC and Wang YX, 1993) 
Tetrandrine is 90% protein-bound with an elimination half-life of 88 minutes, 
according to dog studies; however, rat studies have shown a sustained hypotensive effect 
for more than 48 hours after a 25- or 50-mg oral dose. Tetrandrine causes liver necrosis 
in dogs orally administered 40 mg/kg of tetrandrine 3 times weekly for 2 months, 
reversible swelling of liver cells with a 20-mg/kg dose, and no observable changes with 
a 10-mg/kg dose.(Sutter MC and Wang YX, 1993) Given the evidence of hepatotoxicity, 
many more studies are necessary to establish a safe dosage of tetrandrine in humans. 
More recently, tetrandrine has been implicated in an outbreak of rapidly progressive 
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renal failure, termed Chinese herb nephropathy. Numerous individuals developed the 
condition after using a combination of several Chinese herbs as part of a dieting regimen. 
It has been hypothesized that the cause may be attributed to misidentification of S 
tetrandra; nonetheless, questions still remain as to the role of tetrandra in the 
development of this serious toxic effect. (Vanherweghem JL, 1994; Schmeiser HH, 
Bieler CA et al, 1996; Violin C’ 1997) 
8.8.1.5 Danshen (Salvia miltiorrhiza) 
Salvia miltiorrhiza (Danshen), a relative of the Western sage Salvia officinalis, is 
native to China.(Mashour NH, Lin GI et al，1998) Danshen is used in TCM to promote 
blood flow and treat cardiovascular diseases. Besides function of circulatory stimulant, 
sedative, and cooling are also available. It is sold in over-the-counter herbal 
preparations, prescribed by TCM doctors and administered in Chinese hospitals for 
angina pectoris, acute myocardial infarction (MI) and ischemic and thrombotic disorders. 
Salvia miltiorrhiza may be useful as an antianginal drug because it has been shown 
to dilate coronary arteries in all concentrations, similar to P. notoginseng, Futhermore, S. 
miltiorrhiza also shown to have protecting function of myocardial mitochondrial 
membranes from ischemia-reperfusion injury and lipid peroxidation because of its free 
radical-scavenging effects.(Zhao BL, Jiang W et al, 1996) In vitro and animal studies 
suggest it may be vasoactive, scavenge free radicals and inhibit platelet 
aggregatiorL(Wang Z, Roberts JM et al, 1982) The active compounds in danshen are 
tanshinones and phenolic compounds. (Lei XL and Chiou G.C, 1986) 
8.8.1.6 Ginkgo biloba 
Ginkgo biloba, is derived from the leaves of the maidenhair tree.(Valli G and 
Giardina EGV, 2002) Although the root and kernels of G. biloba have long been used in 
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traditional Chinese medicine, the tree gained attention in the West during the 20th 
century for its medicinal value after a concentrated extract of G. biloba leaves was 
developed in the 1960s.(Mashour NH, Lin GI et al, 1998) It is used for cognition and 
memory as well as cerebrovascular disease, peripheral vascular disease, sexual 
dysfunction, affective disorders, multiple sclerosis, retinal disorders and hearing loss. 
The mechanisms by which ginkgo and its constituent compounds improve vascular 
health include free radical scavenging, antiplatelet actions, anti-inflammatory actions, 
vasodilation and decreased blood viscosity. Gamma-amino butyric acid receptor agonism 
and inhibition of monoamine oxidase-B have also been investigated. Active isolates of 
ginkgo fall into two classes: flavonoids and terpenoids. 
At least two groups of substances within G biloba extract (GBE) demonstrate 
beneficial pharmacological actions. The flavonoids reduce capillary permeability as 
well as fragility and serve as free radical scavengers. The terpenes (ie，ginkgolides) 
inhibit platelet-activating factor, decrease vascular resistance, and improve circulatory 
flow without appreciably affecting blood pressure. Continuing research appears to 
support the primary use of GBE for treating cerebral insufficiency and its secondary 
effects on vertigo, tinnitus, memory, and mood; also, GBE appears to be useful for 
treating peripheral vascular disease, including diabetic retinopathy and intermittent 
claudication. Ginkgo may improve intermittent claudication via vasoregulation, platelet 
antagonism and protection against postischemic oxidative damage.(Kleijnin J and 
Knipschild P, 1992; Matthews MK, Jr, 1998) 
Ginkgo may inhibit platelets and platelet-induced postischemic inflammatory 
response by antagonism of platelet activating factor (PAF), which has been implicated in 
reperfiision injury and cardiac dysfunction in shock.(Montrucchio G, Alloatti G. et al, 
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2000) Ginkgolide B is a potent inhibitor of PAF in humans.(Chung KF, Dent G et al, 
1987; Braquet P, 1993) Other components of ginkgo extract have been identified as 
inhibitors of phospholipase A2, and thus the production of PAF as well as eicosanoids. 
Although approved as a drug in Europe, Ginkgo is not approved in the United States 
and is instead marketed as a food supplement, usually supplied as 40-mg tablets of 
extract. The recommended dosage in Europe is one 40-mg tablet taken 3 times daily 
with meals (120 mg/d).(Z'Brun A, 1995) Commission E recommends 120 to 240 mg 
extract two to three times daily for cerebral insufficiency.(Blumenthal M, Busse WR et 
al, 1998) 
Two cases of CNS hemorrhage occurred with ginkgo, 120 to 160 mg/day.(Rowm J 
and Lewis SL, 1996; Vale S, 1998) Common side effects are nausea, dyspepsia, 
headache and allergic skin reactions.(Kleijnm J and Knipschild P, 1992; Pittler MH and 
Ernst E，2000) More serious adverse effects, including spontaneous subdural 
hematomas,(Rowin J and Lewis SL, 1996) intracerebral hemorrhage (Vale S, 1998) and 
hyphema,(Rosenblatt M and Mindel J, 1997) as well as warfarin and trazodone 
interactions, have been described. 
8.8.1.7 Dong Quai {Angelicae Sinensis) 
Dong quai is a popular Chinese herbal medicine.(Page RL, 2nd and Lawrence JD, 
1999) In China, it is prepared as a soup, with half-dollar-sized pieces of thinly cut, dried 
root of Angelica sinensis added to chicken stock. In the United States, dong quai is sold 
as a powder contained in capsules. It is among the 20 top selling herbal medicines. 
In humans, dong quai has been evaluated for estrogenic effects.(Hirata JD, Swiersz 
LM et al, 1997) It is taken by women as palliation for dysmenorrhea, irregular 
menstruation, anemia, postpartum weakness, and uterine hypotonia. Quinidine-like 
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effects have been reported in animals,(Zhu DP, 1987) but not evaluated in clinical trials. 
Antithrombotic effects are attributed to coumarin derivatives and ferulic acid contained 
in the oil of the root. (Zhu DP, 1987; Page RL, 2nd and Lawrence JD, 1999) Ferulic 
acid may cause platelet dysfunction by inhibiting production of thromboxane A2.(Page 
RL, 2nd and Lawrence JD, 1999) Case reports of warfarin potentiation have been 
reported, and an interaction is supported by animal studies, which demonstrate alteration 
of warfarin pharmacodynamics after dong quai. 
More than this, dong quai was reported to have relation to cause 
hypertension.(Nambiar S，Schwartz RH et al, 1999) A previously health 32 year old 
woman of Chinese-Malaysian origin. Three weeks postpartum, was admitted to an 
emergency ward due to an acute onset of headaches, weakness, lightheadedness, and 
vomiting. The patient stated that she had ingested a special ethnic soup prepared by her 
mother, who had recently arrived from Malaysia to help with postpartum chores. The 
soup had been made with pieces of the Dong quai root {Angelica sinensis) parshased in 
Malaysia. She improved rapidly and was normotensive within 12 hours�However, her 
3-week old son was taken to the pediatrician for evaluation and was confirmed to have 
hypertension on the next day. The baby was not treated with antihypertensive 
medication, and luckily his pressure normalized within 48 hours. 
8.8.1.8 Licorice {Glycyrrhiza Glabra) 
Licorice, an extract of the root of Glycyrrhiza glabra, is used as a sweetening and 
flavoring agent in Western countries. But in China, it has it's pharmecutical function 
and used in pharyngolaryngitis, cough, palpitation, stomachache due to asthenia, peptic 
ulcer, pyogenic infection and ulceration of the skin.(Walker B and Edwards CRW’ 1994; 
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Heikens J, Fliers E et al, 1995; Hasegawa J, Suyama Y et al, 1998; Olukoga A and 
Donaldson D, 2000) 
The active constituent of licorice is glycyrrhizic acid. A metabolite, glycyrrhetinic 
acid, inhibits renal 11 p-hydroxysteroid dehydrogenase and causes a state of 
mineralocorticoid excess by impeding the inactivation of Cortisol. The extract, powder, 
glycyrrhizin, and glycyrrhetinic acid of the herb exhibited deoxycorticosterone-Iike 
action, reducing the urinary volume and sodium excretion and increasing potassium 
excretion in various animal species.(Chang H and But P, 1987) However, the herb could 
not maintain the electrolyte balance in bilaterally adrenalectomized rats, nor could it 
prolong their lives. A so-called pseudo-aldosteronism with manifestations of edema and 
hypertension could develop in association with its clinical use. When used in high 
dosages for long periods，licorice may cause pseudoaldosteronism, which can be 
manifested as headache, lethargy, sodium and water retention, hypokalemia^ 
hypertension, heart feilure, and cardiac arrest. To minimize the risk of adverse effects, 
German Commission E recommends that licorice be used for no longer than four to six 
weeks. 
Case reports link licorice to hypertension, hypertensive encephelopathy, pulmonary 
edema, edema, hypokalemia, arrhythmias, CHF, muscle weakness and acute renal 
failure. Dilated cardiomyopathy resulting from excessive use of licorice and glycyrrhizin 
for gastritis has been reported. Moreover, a patient with hypokalemia and severe 
ventricular tachycardia of torsades de pointes type, which turned out to be caused by an 
apparent mineralocorticoid excess syndrome, associated with liquorices consumption. 
Base on the information stated that 50 to 100 g of confectionary licorice, or 50 to 300 
mg glycyrrhetinic acid, over weeks may cause adverse effects.(Heikens J, Fliers E et al, 
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1995) Adverse effects may take weeks to reverse because of suppression of the 
reninangiotensin - aldosterone axis and because glycyrrhetinic acid has a large volume 
of distribution. The use of licorice is contraindicated in patients with liver cirrhosis, 
cholestatic liver disorders, hypertonia, kidney diseases, hypokalemia, pregnancy, and 
cardiovascular diseases. (Walker B and Edwards CRW, 1994) 
8.8.1.9 Berberine 
Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb 
Huaiiglian.(Lau BH, 2001) It is widely used in traditional Chinese medicine as an 
antimicrobial in the treatment of dysentery and infectious diarrhea. Berberine has 
positive inotropic, negative chronotropic, antiarrhythmic, and vasodilator properties. 
Both derivatives of berberine have antiarrhythmic activity. Some cardiovascular effects 
of berberine and its derivatives are attributed to the blockade of K+ channels (delayed 
rectifier and K(ATP)) and stimulation of Na^-Ca^^ exchanger. Berberine has been shown 
to prolong the duration of ventricular action potential. 
8.8.2 Potential Problem Caused by Chinese Proprietary Medicine* 
Base on the fact that many products that contain ephedra also contain multiple 
stimulants such as caffeine and are marketed for weight loss, energy and performance 
enhancement, body building, and as substitutes for street drugs. Such kind of 'cocktails' 
containing multiple pharmacological compounds appears to have produced an 
undesirable and potentially dangerous interaction. Furthermore, the amount of the active 
substance stated may not be acciirate.(Gurley BJ, Gardner SF et al, 2000; Mansoor GA, 
2001) In addition, these kinds of products may contain multiple ephedra alkaloids that 
may cause summation adverse effects by acting through similar mechanisms of action. 
The Food and Drug administration has not approved any product with multiple ephedra-
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like alkaloids because of fear of synergistic side effects. Consumers should consider 
buying from manufacturers that have obtained Pharmacopoeia standards for product 
purity and content reliability, thus at least ensuring some standards are used in 
manufacture. 
8.9 Other Herbal Adverse Effects and Drug Interactions 
Interactions of herbals and supplements with the cardiovascular medications will 
affect the pharmacokinetic or pharmacodynamic properties of antihypertensive drugs. In 
the case of hypertension, the achievement of goal blood pressure (BP) especially in 
high-risk patients with diabetes or renal disease routinely requires multiple drugs. 
Therefore, not only is it likely that drug-drug interactions will occur as the number of 
drugs increases in an individual patient but also the likelihood that drug-supplement or 
drug—herb interactions will occur. Any herb with cardioactive, hypertensive or 
hypotensive action may interfere with nitrate drugs (e.g. isosorbide dinitrate) which are 
potent coronary dilators or with calcium channel blocking drugs (e.g. nifedipidine) used 
to treat angina, hypertension and arrhythmias. A number of herbs, including adonis, 
black Indian hemp (apocynum), black hellebore, lily-of-the valley (convallaria), squill 
and strophanthus, contain cardiac glycosides that can potentiate digoxin.(Tyler VE, 1994) 
St. John's wort {Hypericum perforatum) decreases serum levels of digoxin through 
induction of a p-glycoprotein drug transporter.(Johne A, Brockmoller J et al, 1999) In a 
single-blind, placebo-controlled study, after 10 days of St. John's wort, digoxin levels 
were reduced more than 25%.(Johne A, Brockmoller J et al, 1999) Several herbs used 
for a laxative effect, such as senna, cascara sagrada and buckthorn, (Tyler VE, 1994) 
may augment potassium loss and lead to toxicity in digoxin users. Belladonna, an herb 
used for gastrointestinal symptoms, is a source of atropine and may cause 
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tachycardia.(Blumenthal M, Busse WR et al, 1998) A number of herbs contain 
sympathomimetic amines，e.g. parsley, and there is the risk of developing hypertension 
when used with pharmaceutical medicines which also have sympathomimetic action (e.g. 
isoprenaline, ephedrine). Gypsum Fibrosum, Concha Ostreae, Os Draconis and Os 
sepiae are contain calcium ion and are not suitable in using with digoxin. 
8.10 Conclusion 
Continuing research is necessary to elucidate the pharmacological activities of the 
many cardiopotent herbal medicines and to stimulate future pharmaceutical development 
of therapeutically beneficial herbal drugs. Legal surveillance of herbal medicine use 
with low safety margins should be instituted for the sake of public health; this is 
especially imperative for those herbs with adverse cardiovascular reactions and drug 
interactions. Adverse effect data is almost exclusively available as case reports and, as a 
result, may be vastly underreported.(Valii G and Giardina EGV, 2002) Lack of 
regulation of quality control and of product standardization makes it difficult to establish 
safe doses of herbal products�Considering that the growing appeal of herbal remedies is 
likely to continue, physicians, particularly cardiologists, must become familiar with the 
available cardiovascular information on herbs. As more information becomes available 
regarding the safety and efficacy of herbal medicines through new clinical trials, 
research-supported claims may one day become available to consumers and physicians 
in a manner similar to the allopathic medicines. 
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Chapter 9 - Review of the Adverse Reactions to Herbal 
Treatments of Obesity 
9.1 Overview 
Overweight and obesity are the most common nutritional disorders in modem 
society. Successful weight loss and healthy weight management depend on long-term 
lifestyle changes such as reducing calorie consumption and increasing physical activity. 
However, because patients find these changes difficult, easily obtained nonprescription 
weight loss products and prescription diet pills are an appealing alternative to the 
increasingly overweight worldwide population. In 1999, $321 million was spent in the 
United States on prescription medications to treat obesity.(Wilhelm C, 2000) Between 
1996 and 1998，2.5 % of the adults in the United States — or about 4.6 million 
persons — reported having used such medications.(Khan LK, Serdula MK et al, 2001) 
Approximately 10 % of women and 3 % of men with a body-mass index of 30 or higher 
have reported using weight-loss medications for obesity. Health care professionals 
should be concerned about overweight and obesity because of the well-established 
relations between excess body weight and such medical conditions as type 2 diabetes, 
hypertension, and osteoarthritis.(Anonymous, 2000) Medications for the treatment of 
obesity are currently approved for use in adults who have a body-mass index of 27 or 
higher plus obesity-related medical conditions or a body-mass index of 30 or higher in 
the absence of such conditions.(Montvale NJ, 2001) 
9.2 Combination With Unknown Medication 
The adulteration of Chinese patent medicines with synthetic therapeutic substances 
has been reported in several industrialized countries over the past two decades. The 
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Department of Health in Hong Kong advised members of the public not to buy and use 
the "slimming health food — Slim Smile" which contained a western drug ingredient -
mazindol last year. This patent medicine "Slim Smile" was sold in the form of capsules 
and is imported from the United States and the adverse effects of mazindol include 
nervousness, fatigue, irregular heart beat, insomriia, dizziness, headache and abdominal 
cramps. As a result, a surveillance programme hold by government to regularly sample 
and analyze "health food" and proprietary Chinese medicine was necessary to detect the 
presence of western medicine ingredients. Even batches of the herbal medicme from the 
same manufacturer may contain variable amounts of active or potential toxic ingredients. 
9.3 Dietary Supplements and Herbal Preparations 
According to the fact that many patients do not inform their physicians about their 
use of these products. Dietary supplements and alternative therapies are a particular 
challenge for physicians. In the past few years, the FDA has investigated more than 800 
reports of adverse reactions associated with more than 100 different products that 
contained or were thought to contain Ephedra alkaloids. Many herbal supplements used 
to treat obesity also have caffeine and ephedrine-containing herbs in them. 
Commercially available products are not well standardized, varying greatly in content of 
active ingredients. 
Allison and colleagues critically reviewed the published literature on herbal and 
dietary supplements for which claims have been made about the promotion of weight 
loss: chitosan, chromium picolinate, conjugated linoleic acid, ephedra alkaloids (ma 
huang), and garcinia cambogia.(Allison DB, Fontaine KR et al, 2001) They found that 
most such reports were based on poorly designed trials that lacked randomization, 
blinding, or control groups. Although some dietary supplements have mechanisms of 
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action that could plausibly lead to weight loss or have shown promising results in small-
scale studies in humans or animals. Allison et al. found that there were insufficient data 
to provide evidence of either the safety or the efficacy of any of these compounds as 
agents promoting weight loss. Herbal compounds containing ephedra alkaloids and 
caffeine are the only types for which there are data from randomized, double blind, 
placebo-controlled trials indicating efficacy in promoting weight loss. (Boozer CN, 
Nasser JA et al, 2001) 
Ephedrine is an adrenergic agent with thermogenic and appetite-suppressant 
properties. Ephedra contains alkaloids, including ephedrine, pseudoephedrine, 
norephedrine, methylephedrine, and norpseudoephedrine. (Gurley BJ, Gardner SF et al, 
1998) Ephedra causes dose-dependent increases in blood pressure and heart rate. 
Dietary supplements that contain ephedra alkaloids are widely promoted and used in the 
United States as a means of losing weight and increasing energy.(Haller CA and 
Benowitz NL, 2000) Ephedrine in combination with caffeine, aspirin, or both, has been 
found in controlled trials to produce greater weight losses than placebo for periods of up 
to one year, although most studies have been short-term.(Astrup A, Breum L, Toubro S, 
Hein P, Quaade F, 1992; Breum L, Pedersen JK, Ahlstrom F, Frimodt-Moller J, 1994) 
Ephedra (ma huang) is commonly found in herbal weight-loss products referred to 
as "herbal fen-phen." Marketed uses of ephedrine-containing products such as "herbal 
ecstasy" include induction of a euphoric state and heightening of awareness and sexual 
sensations. Dietary supplements containing ephedra alkaloids frequently contain a 
dosage that differs substantially from that indicated on the product label. Case reports 
concerning ephedra alkaloids (often in combination with caffeine) have noted serious 
cardiovascular and central nervous system events, including hypertension, cardiac 
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arrhythmia, stroke，seizure, myocardial infarction, and sudden death. Concomitant use of 
ephedra and monoamine oxidase inhibitors can result in life-threatening hyperpyrexia, 
hypertension, and coma. Finally, heavy use of ephedra has been documented as a very 
rare cause of radiolucent kidney stones.(Powell T, Hsu FF et al, 1998) Subarachnoid 
hemorrhage is thought to be a result of the hypertensive action of ephedrine, which can 
be short lived, or of cerebral vasculitis, which has been described in association with a 
variety of sympathomimetic drugs.(Wooten MR, Khangure MS et al, 1983; Fallis RJ and 
Fisher M, 1985) Because of potential adverse health effects among persons with diabetes, 
hypertension, heart disease, and other conditions, the FDA has recommended a labeling 
statement that instructs ephedra users to seek the advice of a health care provider before 
use. 
Since obesity is a chronic disease， it is possible that individuals may use 
nonprescription products to maintain weight loss; however, use of these products by 
normal-weight individuals could expose them to risks for which there are no 
counterbalancing benefits. 
9.4 Conclusion 
Losing weight is difficult for most obese persons, yet long-term maintenance of a 
reduced weight is even more challenging. Even several kinds of prescription were 
currently approved for control body weight, and can help carefully selected obese 
patients lose weight and can reduce the rate of regain, behavioral interventions to 
improve diet and increase physical activity are considered the primary means to promote 
and maintain weight loss. Weight-loss medications should be considered as an adjunct 
only for patients who are at substantial medical risk because of their obesity and in 
whom nonpharmacologic treatments have not resulted in sufficient weight loss to 
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improve health or to prevent regain. Providing appropriate science-based advice will be 
a challenge for health care professionals because of the increasing variety of 
nonprescription products on the market and the lack of methodologically sound efficacy 
studies. With such understanding, we can hope not only to develop safe and effective 
ways to help obese persons to achieve and maintain a healthy weight but also to 
understand how to prevent the development of obesity in those who are at risk. 
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Chapter 10 - Adverse effects of CHM used for Diabetes. 
10.1 Introduction 
Type 2 diabetes is a global health problem of enormous magnitude, especially in 
newly industrialized nations.(Paul Z，1999) Projections recently published by the World 
Health Organization (WHO) suggest that there will be well over 150 million people with 
diabetes in the year 2000 and expect the number to reach 300 million by the year 2025. 
(Gojka R et al, 1999) The majority of the new cases will be those with Type 2 diabetes 
and the majority of these will be in China, the Indian subcontinent and Africa. Although 
insulin is a life-saving drug it is not a “cure-all，’. A growing public interest in herbal 
medications for this metabolic disorder has developed around the world. Insulin-
resistance and the poor response of neuropathic complications in diabetic patients 
receiving insulin treatment have encouraged the development of alternative 
medication. (Cheng JTYRS, 1983) The known use of plant treatments for diabetes dates 
from the Ebers papyrus of about 1550 BC.(John C et al, 1998) Many traditional plant 
treatments for diabetes are used throughout the world. 
10.2 Traditional Chinese medicine used in Diabetes 
Traditional Chinese herbs are used for protecting from and treating diseases under 
the guidance of therapy of TCM and they have properties of natural herb, but it has the 
special connotation and unique theory system and application method. Many herbs used 
in Chinese traditional medicine and natural products have been attributed with 
hypoglycemic effects, (see Table 10 a) 
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Table 10 a. Herbs used in Chinese traditional medicine that may be attributed with 
hypoglycemic effects. 
Chinese Herb Botanical Name , Active . Main Chemical Constituents 
Name-� � . [Part • ； ； 
Baizhu Atractylodes Rhizome Volatile oils - mainly atractylol 
macrocephala and atractyione  
Cangrzi Xanthium sibiricum Fruit Glycosides etc  
Cangzhu Atractylodes lancea Rhizome Volatile oils mainly p-eudesmol 
and hinesol  
Changchunhua Catharanthus roseus Plant Alkaloids including vinblastine 
and vincristine  
Danshen Salvia miltiorrhiza Root Tanshinones and derivatives 
Digupi Lycium chinense Root bark Betaine, p-sitosterol etc  
Dihiiang Rehmannia glutinosa Rhizome p-sitosterol, mannitol etc  
Gouqizi Lycium barharum Fruit Betaine etc  
Huang)ing Polygonatum spp. Rhizome Mucilage etc  
Jiegeng Platycodon grandiflorum Root Platycodin etc  
Maiya Hordeum vulgare L Sprouts a-amylase, P-amylase, maltose 
germinating ^  
Sangye Morus alba L Leaf Ecdysterone etc  
Xianhecao Agrimonia pilosa Plant Agrimonin etc  
Xuanshen Scrophularia Root Scrophularin etc 
ningpoensis  
Yinyanghuo Epimedium spp. Plant Icariin, flavones etc  
Yumixu Zea mays Style and Potassium nitrate, vitamin K etc 
stigma  
Yuzhu Polygonatum odoratum Rhizome Convallamarin and various 
glycosides  
Zexie Alisma orientalis Tuber Triterpenes etc  
Zhimu Anemarrhena Rhizome Saponins etc 
asphodeloides  
10.3 Adverse Reactions to Alternative Diabetic Treatments 
Many natural products are promoted to improve the health status of patients with 
diabetes by people making a profit on these products.(Gori M and Campbell RK, 1998) 
Few of these claims have any scientific basis. Certain natural products are potentially 
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damaging to patients with chronic diseases, especially if the products are used instead of 
proven scientific treatment regimens. 
Diabetic patients who are treated with insulin and/or hypoglycemic drugs are at a 
greater risk of suffering hypoglycemic episodes than diabetic patients treated by diet 
only, a fact that has been supported by the widespread systemic monitoring of blood 
glucose during the last decade.(Unger RH, 1982; Bolli G, De Feo P et al, 1983) Several 
mechanisms for the development of hypoglycemia during renal insufficiency have been 
found, including reduced renal gluconeogenesis and decreased energy intake. 45% of 
new glucose supply from renal gluconeogenesis in normal patients could be found 
during prolonged starvation.(Rutsky E，McDaniel HG et al, 1978) Therefore, elderly 
diabetic patient with impaired renal function should be aware from episode of drug-
induced hypoglycemia, (see Table 10 b) 
An investigative survey in 1997 showed that nearly thirty percent of Americans 
aged 65 and older using alternative medicine.(Foster DF, Phillips RS et al, 2000) 
Almost three million people aged 65 and older took herbal therapies, with two million 
taking both herbal therapies and prescription medications. Those who use both 
prescription medications and herbal therapies are at potential risk for unintended adverse 
interactions. Especially for some Chinese proprietary medicines contain western drugs 
either legitimately, with a declaration on the package or package insert, or as a hidden 
adulterant which may increase the short-term efficacy of the preparation. Hypoglycemia 
due to the consumption of “Xiao Kee Wan" has been described in the Chinese literature. 
Hue reported a case of a 67 year old diabetic male who died from severe hypoglycemia 
after taking “Xiao Kee Wan,, 8 pills tad for 1 month.(Hui X, Li J et al, 1992) Due also 
reported 2 cases of hypoglycemia with the use of “Xiao Ke WarC'.Qiut D and Xue LX, 
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1992) Both patients were female diabetics, aged 73 and 67 years, with normal renal 
function and they had taken 5 pills bid for 5 days and 4 pills bid for 14 days respectively� 
Both recovered after intravenous glucose. Tomlinson B. reported another case of severe 
hypoglycemia caused by “Xiao Ke Wan,, and “Liu Wei Di Huang Wan'\(Iowi\mson B, 
But PPH et al) A 5 3-year-old Chinese male was brought to Emergency department due 
to lost of conscious. He was found to be hypoglycemic with plasma glucose of 2.0 
mmol/L. Physical examination revealed a mild left hemiparesis, bilateral symmetrical 
glove-and-stock sensory neuropathy, bilateral retinopathy with previous laser scars and 
bilateral ankle edema. Investigations revealed that the patient had severe renal 
impairment with plasma urea 24.9 mmol/L, creatinine 549 fimol/L and 24-hour urine 
protein 4.8 g/d. There was a normochromic normocytic anaemia and phosphate 
retention as well as metabolic acidosis. The patient was suffered 4 years of diabetes 
mellitus with bilateral proliferative retinopathy. He had a cerebrovascular accident 
whilst in China three months later and he was treated with Chinese herbal medicines. 
When he come back to Hong Kong, he started to treat his diabetes by himself with three 
over-the-counter Chinese patent medicines “Xiao Ke WarC\ “Xin Nao Shu Tong” and 
“Liu Wei Di Huang Wan,, which were purchased from a pharmacy in China. The patient 
adjusted the dosage by himself without any consultation with herbal practitioner. Two 
weeks before this admission, he had increased the dosage of "Xiao Ke Wari" from 5 pills 
to 10 pills daily because of bilateral ankle swelling, polyuria and nocturia over the 
previous montL After analyzed, the dosage that the patient took was approximately 
1.25 mg glibenclamide daily that may have produced adequate diabetic control, but after 
doubling the dose to increase the diuretic effect he developed toxicity. The action of 
glibenclamide may be enhanced by various other drugs such as “Liu Wei Di Huang 
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JVan” in this case which may act by displacing it from protein binding, interfering with 
its metabolism or by having hypoglycemic effects through other mechanisms. Patients 
often consider such treatments as purely herbal and may not volunteer that they are 
taking them so physicians should take a careful history about this type of medication. 
These preparations are readily available in China and could be brought into Hong Kong 
and many other countries although they would come under the same licensing 
regulations as standard drugs and would not usually be marketed. 
FDA also gave warning to the public, especially diabetics, on February last year not 
to use five brands of Chinese herbal products. It was because the herbs were found 
illegally contain prescription drugs that could cause dangerous drops in blood sugar. 
The products claim to contain only natural Chinese herbal ingredients. However, an 
investigation by the California Department of Health Services' Food and Drug Branch 
determined they contain the prescription drugs glyburide and phenformin, which can be 
used to treat diabetes. (The product brand name were Diabetes Hypoglucose Capsules, 
Pearl Hypoglycemic Capsules, Tongyitang Diabetes Angel Pearl Hypoglycemic 
Capsules, Tongyitang Diabetes Angel Hypoglycemic Capsules and Zhen Qi Capsules) 
Both of them were available from mail order and can be purchased by telephone or via 
the Internet. The investigation was launched after a diabetic patient in Northern 
California suffered from several episodes of low blood sugar after consuming one of the 
products. Diabetes Hypoglucose Capsules. The FDA has stopped imports of the 
products and is investigating how the drugs were added to the herbs and whether any 
other herbal products are contaminated. 
Patient suffered from chronic disease such as diabetes should pay attention during 
using traditional Chinese medicine or other dietary supplement. Vautier report a case of 
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fulminant hepatic failure happened after taken a locally dispensed Chinese herbal 
remedy called ” eternal life" as treatment for simple lipomas for 4 weeks. (Vautier G and 
Spiller RC, 1995) One week later he was deeply jaundiced and became encephelopathic. 
Despite urgent liver transplantation he died and no viral, immunological, or metabolic 
cause for his liver failure was identified. Analysis of the herbal remedy that this man 
had taken confirmed the presence of Dictamnus dasycarpus; this herb was found to have 
hepatotoxicity. Another similar adverse reaction was a 27-year-old insulin-dependent 
diabetic man presented with a two-week history of progressive jaundice after consuming 
"eternal life." (Sanders D, Kennedy N et al, 1995) After analyzed, there was a high 
possibility of relation between the herbal tea and this patient's hepatitis. Liver biopsy 
showed inflammation around the portal tract and piecemeal necrosis. The patient's 
clinical condition improved over the next four weeks. 
A 72-year-old Portuguese woman experienced sudden onset of nausea, vomiting, 
and diaphoresis after she drank a glass of extract made from lupine beans. (Tsiodras S， 
Shin RK et al, 1998) She also complained of blurred vision and generalized weakness. 
She took the preparation with the belief it represented a cure for her recently diagnosed 
diabetes. Analysis of the patient's lupine bean extract identified a significant amount of 
the preponderant compound as oxo-sparteine by gas chromatography / mass 
spectrometry. Lupine beans are commonly eaten as an appetizer in Southern Europe and 
the Middle East. People in Portugal and Southern Europe believe that the extract from 
boiled lupines has hypoglycemic effects even no scientific supports such a belief that 
lupine extract could lower blood sugar levels. It should be noted that nearly 100 
different species are found in the United States but not all species are poisonous. 
Toxicity actually depends on the amount of toxic alkaloids contained. Sparteine like 
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other quinolizidine alkaloids (such as anagyrine and lupanine, as well as piperidine) 
have been implicated in producing dyspnea, restlessness, spasms, coma, and even death 
as a result of respiratory paralysis in cases of acute intoxication in animals, as well as 
classic anticholinergic effects. Lupine beans in a natural state are very bitter and toxic 
and need debittering process continues for several days. In this case, the patient drank a 
glassful of the bitter water in which the beans had been initially boiled in the belief that 
it could lower her blood sugar level. The patient was discharged home less than 24 hours 
after her initial admission. 
Another herb need to pay caution was ephedra (Ma Huang). It is an herbal 
stimulant that acts similarly to amphetamine. Approved by the U.S. Food and Drug 
Administration (FDA) in some asthma medications, but it was also widely used in 
combination with caffeine in unregulated supplements for losing weight, building 
muscle, or giving energy. These alkaloids were implicated in over 800 reports of 
adverse effects including nervousness, insomnia, irritability, psychosis, headache, 
dizziness, seizures, stroke, premature ventricular contraction, hypertension, myocardial 
infarction, and death.(Boullata J and Nace AM, 2000) As a result the FDA proposed 
limits on the use of ephedrine-containing products: a maximum of 8 mg/dose and 24 
mg/day for no more than a week, and combined with no products that contain caffeine� 
Studies show the actual doses of ephedra found in supplements vary dramatically from 
much less to much more than the stated content on the label For people with diabetes, 
the risks are even greater because ephedra can raise blood sugars dramatically and make 
control extremely difficult. 
Gill GV (Gill G, Redmond S et al, 1994) reported that four patients with insulin-
dependent diabetes reduced or stopped their insulin in favor of therapeutic approaches 
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including prayer, faith healing, unusual diets, and supplements of vitamins and trace 
elements. This resulted in ketoacidosis in three, in one case life threatening; and weight 
loss and hyperglycemia in the other. One patient developed serious retinopathy. 
A case of acute hepatic and renal toxicity associated with drinking sheep bile for 
diabetic treatment was report in Saudi Arabia.(Anonymous, 1996) A traditional healer in 
Al-Wadein village had advised patients with diabetes to drink raw sheep bile as a 
treatment for their diabetes. After drinking sheep bile，the patient was found to have 
gastrointestinal, hepatic, and renal toxicity. 
Table 10 b. Herbs Affecting Blood Glucose and Associated Adverse Effects. 
Herbs Associated Adverse Effects  
Aconitum carmichaelie Subject to poison control in some Australian states  
Arctium lappa Commission E state the root is not permitted for therapeutic 
(burdock root) use; usefulness not documented adequately; no risks was 
known  
Artemisia ahbysinica Essential oil should not be used; listed as unsafe in FDA 
(1975) 
Catharanthus roseus Subject to poison control in some Australian states  
Echinacea spp. Contraindicated in progressive systemic diseases (eg. 
(coneflower) Tuberculosis, MS) according to Commission E; associated 
with metabolic worsening in some diabetic patients; should 
not be used more than three weeks.  
Eleutherococcus Should not be given to patients whose blood pressure exceed 
senticosus 180/90 mmHg; palpitations, pressure headaches, and 
arrhythmias have been reported in the Russian literature.  
Lupinus tennis Lupinus extracts cause “ crooked calf disease “，a congential 
abnormality in bovine stock  
Momordica charantia Hepatic necrosis has been associated with excessive intake; 
(karela, bitter melon) testicular lesions have occurred in dogs.  
Taraxacum officinalis Contraindicated in biliary obstruction empyema of gallbladder 
(dandelion root) and ileus; can produce poisoning especially in children 
(nausea, vomiting, diarrhea and arrhythmias)  
Vaccinium myrtillus Doses> Ig may result in nausea, vomiting, diarrhea, 
(huckleberry) fibrillation, dyspnea, cyanosis, delirium and collapse; 
hemolytic anemia, cachexia, hepatic steatosis, and hair 
depigmentation have been reported; fetal doses range from 2 
|to 12 g.  
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10.4 Conclusion 
Diabetes is a chronic incurable disease, for which modem treatments remain 
somewhat unsatisfactory. It is therefore perhaps not surprising that some patients seek 
alternative treatments with more attractive claims. However, the lack of such trials has 
been characterized as a major deficiency in the assessment of alternative therapies. It is 
important to remember that these adverse events are extremely unusual. Chinese herbal 
medicine is generally both safe and effective, and there are many patients who have 
experienced dramatic benefits to their health from treatment. All medicines are assessed 
in terms of their risk-benefit ratio and it should not be surprising that Chinese herbal 
medicines may also have occasion rare but significant adverse events. Patients should 
be taught the importance of using proven effective treatment regimens. Diabetes health 
professionals need to be aware of the potential dangers associated with some of these 
treatments. Patients should not stop using drug treatments abruptly as there is a risk of 
hyperglycemia or diabetic ketoacidosis. Any patient who decides to use a natural 
product should be foilowed closely to make sure that no toxic effects occur and that 
treatment objectives are achieved. According to the risk that concurrent use of drugs 
and herbal treatment may have synergistic effects on lowering the blood glucose levels. 
During the transition period when the patients take both drugs and herbs, they should 
under the instruction of family doctor and their blood glucose levels should be 
monitored at least twice daily to assess the effectiveness of the treatment and to avoid 
hypoglycemia. Dosage must be adjusted as needed to keep blood glucose within the 
normal range. Herbal treatment may reduce the dosage and frequency of insulin 
injections needed; however, it can never replace insulin, especially in insulin dependent 
diabetes mellitus (IDDM) patients. 
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Chapter 11 - Herbal Hepatotoxicity 
11,1 Introduction 
Treatment options for common liver diseases such as cirrhosis, fatty liver, and 
chronic hepatitis are problematic.(Luper S, 1998) The effectiveness of treatments such 
as interferon, colchicine, penicillamine, and corticosteroids are inconsistent at best and 
the incidence of side effects profound. All too often the treatment is worse than the 
disease. Conservative physicians often counsel watchful waiting for many of their 
patients, waiting in fact for the time when the disease has progressed to the point that 
warrants the use of heroic measures. Physicians and patients are in need of effective 
therapeutic agents with a low incidence of side effects. 
Herbs have been used traditionally by herbalists and indigenous healers worldwide 
for the prevention and treatment of liver disease. Clinical research in the past had 
already confirmed the efficacy of the herbal medicine in the treatment of liver disease. 
Basic scientific research has uncovered the mechanisms by which some plants afford 
their therapeutic effects. The effectiveness of treatments such as interferon, colchicine, 
penicillamine, and corticosteroids are inconsistent at best and the incidence of side 
effects profound. In most cases, research has confirmed traditional experience and 
wisdom by discovering the mechanisms and modes of action of these plants as well as 
reaffirming the therapeutic effectiveness of certain plants or plant extracts in clinical 
studies. 
Hepatotoxicity of Chinese herbs has been recognized, e.g. during treatment of 
patients with atopic eczema. However, the mechanism of herbal-induced liver injury is 
unknown, and the pathologic findings are nonspecific, with steatosis，acute and chronic 
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hepatitis, hepatic fibrosis, zonal or difilxse hepatic necrosis, bile duct injury, veno-
occlusive disease, acute liver failure requiring liver transplantation and carcinogenesis. 
Recently, reports have mounted about hepatotoxicity of herbal remedies，which 
ranges from mild liver enzyme alterations to chronic liver disease and liver failure. 
Unfortunately, there are no formal data on the incidence even of acute severe side effects， 
such as liver failure after certain herbal medications, and knowledge of longer-term 
sequelae such as mutagenicity and carcinogenicity is even more scanty. 
11.2 Drug-induced hepatic injury 
Drugs and other chemical toxins account for less than 5% of cases of jaundice or 
acute hepatitis and fewer cases of chronic liver disease, but they are an important cause 
of more severe types of hepatic injury.(Farrell GC, 1997) Drug reactions produce an 
array of hepatic lesions that mimic all known hepatobiliary diseases; this poses a 
diagnostic challenge for physicians and pathologists. Diagnosis of drug-induced hepatic 
injury is circumstantial, with positive rechallenge being the only fector that 
unequivocally implicates a particular agent. Nonetheless, other aspects of the temporal 
relationship between drug ingestion and adverse reaction, exclusion of other diseases, 
the presence of extrahepatic features of drug hypersensitivity and some findings on liver 
biopsy can lend support to the diagnosis. 
In western medicine, factors that predispose to dose-dependent hepatic injury will be 
considered in relation to acetaminophen, an example of acute hepatotoxicity, and 
methotrexate, an agent that can produce hepatic fibrosis. Flucloxacillin will be discussed 
as an example of drug-induced cholestatic hepatitis often associated with prolonged 
cholestasis and the vanishing bile duct syndrome. Minocycline and diclofenac will be 
mentioned as two drugs for which drug hepatitis is an exceedingly rare complication. 
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Many drugs and chemicals are idiosyncratic hepatotoxins: isoniazid, amiodarone, 
tetracycline, methyldopa, bromobenzene, valproic acid, and halothane.(Haller CA, Dyer 
JE et al, 2002) Hepatotoxins may have intrinsic, idiosyncratic, or immune-mediated 
mechanisms of liver injury. Intrinsic hepatotoxins, such as acetaminophen, amanitin 
(found in Amanita phalloides mushrooms), or carbon tetrachloride, produce liver 
damage in a predictable, dose-dependent manner. Toxic hepatitis may also occur 
sporadically due to differences in individual susceptibility related to factors such as age, 
sex, underlying disease, concomitant medications, and genetic iiifluences.(Haller CA, 
Dyer JE et al, 2002) Hypersensitivity or immune-mediated hepatitis may develop after 
repeated exposure to a causative agent. Immune-mediated hepatitis may manifest with 
systemic findings such as fever, rash, eosinophilia, or atypical lymphocytosis and recur 
with reexposure. Liver injury due to drugs such as sulfonamides, chlorpromazine, 
erythromycin, and phenytoin is thought to be immune-mediated. 
Treatment includes removing exposure to the toxic agent and supportive patient 
care.(Haller CA, Dyer JE et al, 2002) Often, herbal-related acute hepatitis will resolve 
spontaneously once ingestion of the offending product is discontinued. Rarely, acute 
liver injury progresses to fulminant failure, necessitating transfer to a tertiary care 
facility with a liver transplantation service. Clinical deterioration may develop rapidly in 
toxin-induced hepatic failure, so the decision to transfer the patient should be made 
quickly. Some hepatotoxic herbs cause chronic pathologic liver changes. Herbs such as 
coltsfoot (Roulet M, Laurini R et al, 1988), comfrey (Ridker PM and McDermott WV, 
1989), bush tea, and senecio contain pyrrolizidine alkaloids,(Smith LW and Culvenor 
CCJ, 1981) direct hepatotoxins that can cause centrilobular necrosis, veno-occlusive 
disease, portal hypertension, and an increased risk of hepatocellular carcmoma.(Stillman 
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AS, Huxtable R et al，1977; Fox DW, Hart MC et al, 1978) 
11.3 TVpes of Liver In j u ry 
In the cases of herbal hepatotoxicity, several kinds of pathological changes could 
see in the liver during liver biopsy. These include zonal necrosis, necrotic lesions with 
steatosis or bile duct injury and vascular injury, especially veno-occlusive disease, which 
is commonly caused by pyrrolizidine alkaloids.(Chittiiri S and Farrell GC, 2000) 
Some herbs are thought to be intrinsic hepatotoxins and show dose-related liver 
toxicity, either through direct hepatocellular damage, such as with Atractylis gummifera, 
or through the generation of a reactive metabolite, as is the case with pennyroyal oil 
{Mentha pulegium).{Andtrson IB, Mullen WH et al, 1996) Recently, greater celandine, 
which is widely used for biliary disorders and dyspepsia, was identified as a cause of 
cholestatic hepatitis. Hepatotoxic reactions have also been observed after the ingestion 
of Atractylis gummifera, Callilepsis laureola, Senna, Kavapyrone and Pulegium. 
11.4 Hepatotoxicity Herbs 
In Chinese literature, the following herbs are taken orally and have been associated 
with incidents of hepatitis: Dioscorea bulhifera (bulbil), Livistona chinensis (fruit), 
Lycoris radiata (blub), Melia toosendan (fruit), Pine I Ha ternata (tuber), Ricinus 
communis (seed), Taxillus chinensis (leafy twig), Tripterygium wilfordii (root), Typha 
species (pollen), Viscum coloratum (leafy twig)，and Xanthium sibihcum (fruit).(But 
PPH, Tomlinson B et al, 1996) (see Table 11 d) 
11.4.1 Tripterygium wilfordii 
Tripterygium wilfordii Hook f . (TWH) is a plant of the genus Tripterygium of the 
family celastraceae.(Ming J, 1996) Many preparations，mainly from its root, have been 
used in the clinic, among which the polyglycoside (TP) has shown better effects with 
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relatively mild side effects. Its pharmacological effect is mainly inhibitory on all stages 
of cell cycle TP and acts much like cytotoxic drugs. Traditionally it is used as an 
antirheumatic and to clear out channels and collaterals for the treatment of rheumatic 
arthritis. Although much of the clinical experience with this herb comes from 
uncontrolled studies and anecdotal reports, recent clinical trials have confirmed the 
efficacy of TWH in the treatment of rheumatoid arthritis and other autoimmune diseases. 
In patient with lupus nephritis unresponsive to prednisone and other immunosuppressive 
drugs, combined administration of prednisone and TP resulted in reduction or even 
complete disappearance of protein in urine in 40% to 50% of cases. 
Many side effects, however, have been reported. About 45% of patients who 
received poly glycoside complained of such adverse effects as skin rashes, skin 
pigmentation, stomatis and softening of finger nails. Intoxication of Tripterygium 
wilfordii showed gastrointestinal symptoms such as nausea and vomiting, abdominal 
pain with diarrhea, hepatomegaly with tenderness, etc. Fatty infiltration and necrosis of 
the liver with appearance of liver direct intoxication. Intrahepatic cholestasis with 
inflammation was seen in pathologic appearance. Besides this, leukopenia and irregular 
menstruation in women also. In male patients, the number and motility of sperms were 
reduced and the sperms disappeared completely after one month of this herb intake. In 
general, the longer the duration of administration and the older the patients, the smaller 
the probability of their menses or sperms returning to normal. 
11.4.2 Rhizonta Discoreae Bulbiferae 
This drug consists of the dried rhizome of Discoreae bulbiferae /..(family 
Discoreaceae). It is used as hemostatic and to eliminate evil heat from blood and as a 
detoxicant for the treatment of various kinds of bleeding, boils and carbuncles, but 
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nowadays mainly used for the treatment of tumors and goiters. The main toxic 
ingredient was Dioscorein and Dioscoretoxin. Fatty infiltration and lobar necrosis could 
see in animal models. In China, several cases of intoxication of rhizoma Discoreae 
bulbiferae were reported and patient had jaundice, lethargy, poor appetite and 
hepatomegaly with mal liver ftinction. 
11.5 Consumption of Insect Herbs 
A 67-year-old man was admitted to hospital because of jaundice and general 
weakness after taking herbal medicine for few days. This patient consulted a traditional 
Chinese practitioner because of lumbago for one month and the practitioner prescribed 
several dosage of anticonvulsive medication which include fresh centipede {Scolopendra 
subspinipes mutilans L. Koch) 12 g and fresh scorpion {Buthus martensii Karsch) 15g. 
The patient felt weakness and jaundice could see in the sclera and whole body after 
taken the medication for few days. No itching sensation but has tea colour urine. 
Laboratory examination and liver echography confirmed diagnosis of acute hepatitis, 
which was caused by consumption of toxic herbs (insect). After symptomatic treatment, 
the jaundice disappear and the liver function return to normal.(Yeung PH, 2000) 
Toxic insects were always used in subduing the hyperactivity of the liver and the 
endogenous wind. It used for anti-convulsion as for the treatment of various kinds of tic, 
convulsions and tetanus. Only a minor dosage was recommend because of its renal and 
liver toxicity. If prolong usage or mixed with other toxic herbs, accumulation with 
toxicity will result. So, regular checking for the liver function is necessary. 
11.6 Hepatotoxicity Cause by Chinese Proprietary Medicine 
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Hepatic impairment resulting from the use of conventional drugs is widely 
acknowledged, but there is less awareness of the potential hepatotoxicity of herbal 
preparations and Chinese proprietary medicine, many of which are believed to be 
harmless and are commonly used for self-medication without supervision. Injections 
prepared from Crotalaria sessiliflora (whole plant), Trichosanthes kirilowii (root), and 
several combinations of herbs have also led to hepatotoxicity.(Zhou OH，1988; Zhao JY, 
1991; But PPH, Tomlinson B et al. 1996) 
11.6.1 Jin Bu Huan 
“Jin Bu Huan Anodyne Tablets" {Lycopodium serratum), a traditional Chinese 
h e r b a l r e m e d y , h a s b e e n u s e d f o r m o r e t h a n 1 0 0 0 y e a r s a s a s e d a t i v e a n d a n a l g e s i c b u t 
has only been available in the United States for 10 years.(Dharmananda S, 1993) The 
name "Jin Bu Huan" literally means 'not to exchange (even) for gold’，implying that the 
herb is invaluable in certain treatments. In the Encyclopedia of Chinese Materia 
Medica^(Anonymous，1977) the name "Jin Bu Huan" applies to eleven herbs: 
Aneciochilus taizwanensis (Orchidaceae), Aristolochia yunnanensis (Aristolochiaceae), 
Asystasiella neesiana (Acanthaceae), Lycopodium serratum (Lycopodiaceae), Panax 
pseudoginseng var. notoginseng (Araliaceae), Polygalo chinensis (Polygalaceae), Rumex 
madaio (Polygonaceae), R. patientia (Polygonaceae), Selaginella involvens 
(Selaginellaceae), Stephania delavayi (Menispermaceae) and S. sinica 
(Menispermaceae). Many of these herbs are used as an analgesic. The alkaloid levo-
tetrahydropalmatine is responsible for the morphine-like properties of "Jin Bu Huan" but 
the hepatotoxic mechanism was unknown. 
A recent study described three children who had taken unintentional overdoses of 
Jin Bu Huan tablets and who developed central nervous system and respiratory 
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depression with bradycardia.(Horowitz RS, 1993) Seven cases of hepatitis have been 
reported in adults who used Jin Bu Huan and had no history of hepatic disease, obesity, 
diabetes mellitus, or atopy.(Woolf WGM, 1993) All denied a history of excessive 
alcohol or hepatotoxic drug intake. Liver disease occurred after a mean duration of use 
of 20 weeks (range, 7-52 weeks). Six of the 7 patients showed complete resolution of 
symptoms within 8 weeks. Two patients had a recrudescence of symptoms with re-
exposure to the herb. The duration of use before manifestations of clinical hepatitis was 
the same for "Jin Bu Huan，，as for another hepatotoxic herb, germander. 
The package insert for "Jin Bu Huan" recommended a dosage of 2 to 4 tablets 1 to 
3 times a day for pain relief or 1 to 3 tablets at night for insomnia. Thus, all patients 
were taking appropriate doses. The insert also indicated that tablets contained 70% 
starch and 30% levo-alkaloid from the plant Polygala chinensis. Although the insert of 
"Jin Bu Huan Anodyne Tablets” indicates in the English description that the ingredient 
is ,Polygala Chinensis L Alkaloid', results of the analysis show that the alkaloid is L-
THP which is not found in P. chinensis. (Jiimiucao GSL, 1988) Among the other ten 
herbs also known as "Jin Bu Huan”，only those derived from species of the genus 
Stephania are known to contain L-THF. Therefore, the description on the insert that the 
ingredient is Tolygala Chinensis L Alkaloid' is definitely an error and a 
mislabeling.(But PPH, 1994) Although L-THP can be obtained from plant sources, it is 
used as a fine pharmaceutical in mainland China and is registered as such under 
Rotundinum (rotundine) in Part 2 of the Pharmacopeia of the People's Republic of China; 
the recommended single and daily oral doses of rotundine are 60 to 120 and 60 to 480 
mg respectively.(Phannacopoeia C, 1990) 
"Jin Bu Huan Anodyne Tablets" presents an excellent case example for review on 
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what actually constitutes a herbal preparation. For pure and potent components 
presented in sufficient quantities, even though derived from natural sources, 
reclassification would deem necessary to ensure proper supervision by health authorities 
for the protection of consumers in the territory. 
11.6.2 Chi R Yun (Breynia officinalis) 
Breynia officinalis has the Chinese proprietary name, “Chi R Yun", which means 
dizziness or vertigo for 7 d.(Lin TJ, Tsai MS et al, 2002) In daily practice, it has been 
used to treat venereal diseases, contusion, heart failure, growth retardation and 
conjunctivitis in combination with other traditional Chinese medicines. Two hospital-
based cases of Breynia officinalis poisoning have been reported to the Poison Control 
Center. The first case was a 43-y-old female who consumed a mixture of 1,500 g lower 
stem and root of Ji Mu Ju in boiled water in a suicide attempt. Her AST reached 264 
and ALT reached 2443. Another case was a 51-y-old female who consumed 20 pieces 
of lower stem and root of Ji Mu Ju stewed with meat and 100 ml of wine to treat chronic 
contact dermatitis. Her AST reached 3815 and ALT reached 6625�In both cases Breynia 
officinalis was identified as the cause of poisoning. Poisoning in humans involves the 
neurologic, gastrointestinal, hepatic, urinary and respiratory systems. Hepatotoxic 
effects have been reported for some Chinese herbal medicines, but not Breynia 
officinalis: Breynia officinalis poisoning causes hepatocellular liver injury rather than 
cholestatic liver injury. 
11.6.3 Sho-saiko-to 
Another famous example of herbal hepatotoxic, which has been repeatedly 
happened in Japan, was a Kampo medicine, which called "Sho-saiko-to". This 
traditional herbal corrplex consisting of Bupleuri radix, Ginseng radix, Glycyrrhizae 
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radix, Pinelliae tuber, Scutellariae radix, Zingiberis rhizoma’ and Zizyphi fructus. This 
formula has been used in treating hepatitis in China since the Han Dynasty (i.e. about 
100 AD), and it was generally considered to be devoid of serious side effects. There is 
now a respectable series of case reports from Japan, however, which associate its use 
with allergic pneumonitis and/or hepatitis.(Kubo K, Watanabe F et al, 1986; Tsukiyama 
K, Tasaka Y et al, 1989; Daibo A, Yoshida Y et al, 1992; Imokawa S, Sato A et al，1992; 
Takada N, Arai S et al, 1993; Kawasaki A, Mizushima Y et al., 1994; Itoh S, Marutani K 
et al, 1995) '^ho-saiko-to" is by no means the only Oriental herbal medicine which is 
associated with rare but serious cases of hepatitis, (Perharic L, Shaw D et al, 1995) 
Itoh reported four patients treated with the herbal medicine “Shosaiko-to” exhibited 
acute drug-induced liver injury.(Itoh S, Marutani K et al, 1995) All of the patients 
showed a rise in amino-transferases after re-administration or challenge test. The liver 
histology revealed centrilobular confluent necrosis, acute hepatitis with centrilobular 
necrosis or spotty necrosis, microvesicuiar fatty change, acidophilic degeneration, and a 
granuloma. 
11.6.4 Shou-Wu-Pian 
Hepatitis developed in a 31-y-old pregnant Chinese woman after consumption of 
"Shou-Wu-Pian", a proprietary Chinese medicine prepared from Polygonum 
multiflorum.(B\Jt PPH, Tomlinson B et al, 1996) Laboratory examination showed mal-
function of the liver. On detailed questioning the patient admitted that for several weeks 
prior to this illness she had been taking tablets of the proprietary Chinese herbal 
medicine, "^hou-Wu-Pian", at the recommended dosage to treat hair loss. She used to 
have a previous episode of acute hepatitis about 2 y ago after taking a liquid extract, 
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"Shou-Wu-Zhi", prepared from the same herb. Her liver function tests returned to 
normal after stopping that preparation. 
The proprietary Chinese medicine incriminated was "Shou-Wu-Pian", 
manufactured in Shanghai, China.(But PPH, Tomlinson B et al, 1996) The package was 
a bottle of 100-coated tablets. The ingredient, according to the label description on the 
product was 100% Radix Polygoni Multiflori (root tuber of Polygonum multiflorum or 
the Chinese corobind). The recommended dosage was 5 tablets 3 times/day. It is often 
taken to prevent graying of hair. Thin-layer chromatographic analysis of the tablets 
confirmed the presence of 2 anthraquinones, emodin and physcin. 
After analysis of "Shou-Wu-Pian^, anthraquinones were found to be present and it 
is known that anthranoid derivatives can form highly reactive anthrones in the colon, 
which are then able to induce liver damage after absorption and transportation to the 
liver. A case of toxic hepatitis in a young female patient was reported after the 
excessive use of senna which contains similar kinds of anthraquinones.(Beuers U, 
Spengler U et al, 1991; Kestendorf JI, 1993) Another case of hepatotoxicity was 
associated with excessive use of the laxative DOXIDAN, which contains the 
anthraquinone danthron (1,8-hydroxyanthraquinone) and dioctyl calcium 
sulfosuccinate.(ToIman KG, Hammar S et al, 1976) Anthraquinones present in "Shou-
Wu-Pian" was highly suspected for either an idiosyncratic response or a toxic effect 
from prolonged or excessive usage. 
Polygonum multiflorum is a member of Polygonaceae and is used either raw or 
processed. The raw herb is a laxative，but is rarely used because excessive dosage or 
prolonged use of the raw herb causes diarrhea, abdominal pain, nausea, vomiting, tonic 
spasm, convulsion, restlessness and even respiratory paralysis. The processed herb is 
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the common form and is prepared by cooidng the raw herb with Chinese yellow wine 
and the juice of the black soybean. It is used as a tonic for dizziness with tinnitus, 
premature graying of hair, lumbago, spermatorrhea and leucorrhoea. 
Several cases of adverse reactions caused by Polygonum multiflorum were reported. 
Erythema appeared in one case after taking "Shou-Wu-Pian" for 5 d [Zhang Q.R” 1987]; 
and the other was taken the decoctions made by several kind of herbs which including 
the vine or the root tuber of P multiflorum. (Du XZ, 1984; Zhang QR, 1987; Li SH, 1992; 
Zhu T and Jiang PC, 1992) Besides this, rashes and pruritus appeared after taking “Yi-
Ning-Jing", (Liu F，1990) and “Sham-Hai-Dan,,.(Zhao CR, 1994) and both of them 
contained several herbs which included the root tuber of P multiflorum. Dyspnea^ 
palpitation, upper abdominal pain, restlessness, tachypnea, itching rashes, dizziness, and 
blurred vision would appeared after taking a decoction containing the root tuber of P 
multiflorumiU Y and Cheng Y, 1998) 
11.7 Importance of Drug-Herb and Herb-Herb Interactions 
Possible drug-herb interactions are of concern to primary care physicians, but 
published clinical studies are scarce.(Adriane F and Ernst E, 2001] (see Table 11c) 
Recent studies show that Saint-John's-wort has pharmacokinetic interactions with drugs 
that are substrates for cytochrome P-450 enzymes and P-glycoprotein transport 
mechanisms, such as cyclosporine, ethinyl estradiol, and digoxin.(Barone GW, Gurley 
BJ et al, 2000) Herbs that induce hepatic cytochrome P-450 enzymes could potentiate 
the toxicity of intrinsic hepatotoxins such as acetaminophen. Other herbs may have 
clinically relevant drug interactions or synergistic actions with other botanicals. For 
example, herbs with anticoagulant effects such as ginkgo biloba, ginseng, and garlic 
could increase the risk of bleeding in patients taking warfarin or platelet inhibitors. 
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There are few published data in the English-language literature to support the practice of 
combining numerous active herbal ingredients in a single product, and yet, such 
products are widely available in nutrition and health food stores, retail pharmacies, and 
supermarkets, potentially increasing the risk of serious herb-herb interactions. For 
instance, there is growing concern about combination products that contain several 
cardiovascular stimulant herbs such as ephedra, guarana, and Citrus aurantium that could 
increase the risk of adverse effects, including hypertension, cardiac arrhythmia, and 
stroke.(Gurley BJ, Gardner SF et al, 1998; Haller CA and Benowitz NL, 2000) 
11.8 Diagnosis of Herbal Hepatotoxicity 
Toxic hepatitis shows no specific pattern of symptoms and is difficult to diagnose. 
When considering herbs as a cause for toxic hepatitis, physicians will frequently rely on 
the elimination of other causes and a temporal relationship between ingestion of herbs 
and onset of hepatitis and between withdrawal of herbs and recovery.(Ko RJ, 1999) 
The important considerations for establishing an accurate diagnosis of herbal 
hepatotoxicity include a thorough history, pattern recognition, awareness of the spectrum 
of herbal liver injury and botanic identification where at all possible.(Chitturi S and 
Farrell GC, 2000) Unlike the pharmaceutical industry, makers of herbal remedies are 
not required to provide premarketing evidence of efficacy and safety, as herbs are 
considered dietary supplements. Manufacturers also do not need to guarantee herbal 
ingredients, and the ingredients of identically named supplements from different 
companies vary. Furthermore, patients do not always mention herbal medicines when 
questioned about the use of medications. For instance, at least one-third of patients 
attending an academic liver clinic failed to disclose concurrent herb use. This 
underscores the importance of encouraging patients to check the ingredient of the herbal 
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medicine intake and provide information about all concurrent drug intakes, including 
natural products. Because no specific diagnostic tests exist, it is particularly important 
to consider the temporal relationships between drug ingestion, the onset of illness, the 
response to drug omission (dechallenge) and any history of deliberate or inadvertent 
drug rechallenge. 
11.9 Recommendation 
Establishing a diagnosis of herbal-related toxic hepatitis is difficult because the 
effects of herbs are often chronic and nonspecific and may not become clinically 
apparent for some time.(Haller CA, Dyer JE et al, 2002) Proper documentation of 
adverse effects of herbal medicines is hindered by several factors. Physicians may not 
ask patients about their use of herbal medicines, or patients may be reluctant to discuss 
their use of alternative remedies. More than this the manufacturers of herbal 
supplements are not required to guarantee the ingredients of their products. As a result, 
many cases of herbal-related toxic hepatitis may go unrecognized and unreported. 
Inadequate product labeling, multiple-ingredient herbal products, batch-to-batch 
variation, and adulterants or contaminants may complicate attempts to accurately 
identify the toxic component. Because the English-language literature consists mostly of 
case reports of herbal toxicity rather than scientific studies, there is often little sound 
evidence to support a clinical diagnosis of herbal-related hepatitis. 
A retrospective study for suspected cases of herb-induce hepatotoxicity was 
reported in China 2 years ago.(Peng XL, Li CS et al, 1999) (see Table 11 a) This study 
collected those cases within recent 13 years (from I 9 8 6 �1 9 9 8 ) and showed that nearly 
80 0/0 intoxication were under the instruction from the practitioner! ！ Misusing or wrong 
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prescription became the major problem for herbal intoxication. This means even the 
herbal practitioner didn't have enough experience or knowledge about herbal 
hepatotoxicity. Therefore, a registration of medical practitioners is necessary on their 
achievement of qualifications considered to indicate competence to practice. Ensuring 
that practitioners maintain annually certified levels of competence is left up other 
mechanisms such as the activities of the professional colleges. Maintaining theoretical 
and practical standards are thus the task of continuing medical education, peer review 
and quality assurance activities. 
Table 11 a. The Relation Between the Medicine Intake Behavior and Liver 
Damage.(Peng XL, Li CS et al, 1999) 
Behavior P C a s e Percentage ^ ^ I 
I Under instruction j 54 1^-26 
j Presume taking IL 13 1 � 8 4 
I Mistaking li 2 H i 2.89 
i " T o t a l I I 6 9 _ _ I L 1 0 0 
When a physician suspects a toxic reaction from an herbal medicine, the patient 
should be urged to provide the product in its original packaging, along with the date and 
place of purchase. Because herbal products are sometimes poorly labeled or contain 
misinformation, a definitive diagnosis can be established only with laboratory 
confirmation of hepatotoxins. Unfortunately, access and availability of such assays are 
limited. State and county health departments may provide such analytic testing free of 
charge. Specimens of the patient's urine and blood should also be obtained and frozen 
for possible future testing to confirm the presence of the hepatotoxins. 
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11.10 Conclusion 
TCM is of a long history and has accumulated a rich store of clinical experience. 
The dominant Western medical culture has largely ignored this knowledge until recently. 
Research into plants traditionally used in the treatment of liver disease has significantly 
advanced in the recent years, and much of what has been discovered supports traditional 
knowledge. However, people still need to pay attention to the usage of TCM due to 
herbs can be hazardous in many ways. They may be directly toxic or toxic when taken 
in combination with other preparations. In order to aware the toxic effect from herbal 
medicine, there is necessary to undergone long-term, large-scale, randomized, double-
blinded trials to get more information about TCM in the future. Furthermore, herbalists 
prescribing and dispensing herbal preparations, and medical practitioners whose patients 
may be reluctant to admit that they are taking them, should be aware of their potential 
for occasional serious hepatotoxicity. 
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Table 11 b. Adverse effects of herbal remedies on the liver. (Langmead L and 
Rampton DS，2001) 
|Herb name [Botanical name [Main use ~ Liver in jury Ref  
H e r b a l t e a Senecio and iomc veno- (McDermott 
Crotolaria occlusive WV and Ridker 
disease PM, 1990) 
Mistletoe Viscum album tension hepatitis (Harvey J and 
Colin-Jones DG, 
I M )  
Pennyroyal Hedeoma puleioides abortifacient hepatitis (Sullivan J, Jr, 
: Rumack BH et 
a l 1979) 
— 一 — ” e , D Vial  
chamaedrys hepatitis T et al, 1992)__ 
Chelidnium majus diuretic hepatitis (Bennmger J, 
, J . Schneider HT et 
c — a l 1999) 
" " " " ^ ^ cholestatic g^eikh 二， 
inflammatory hepatitis Philen RM et al, 
1997) 
fe^ \piper methysticumanxiety fiilmmant (Escher M and 
hepatic failure Dsemeules J, 
2001) 
et al, 1989) 
Vallerian" ^ hepatitis (MacGregor FB 
Abemethy Vb 
et al, 1989) 
fe^ ^ ^ ^ i ， e r PM and 
occlusive McDermott 
disease WV, 1989) 
S ^ ^ ^ ^ a l b i d u m ' ^ c ^ ^ ^ ^ ^ “ ( S e g e l m a n ^ 
Segelman FP et 
al, 1976) 
Kane J A, Kane  
J IsP et al, 1995) 
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Table 11 c. Interactions between herbal remedies and conventional drugs of 
relevance to gastroenterology. 
Herb jConventional drug |Conseqiience   
Interactions causing gastrointestinal side-effects  
Feverfew， garlic, I warfarin jPotentiation leading to GI bleeding 
ginseng’  
Gingko, ginger, iron Reduced absorption 
devils claw — 
St. John's wort cyclosporin Reduced blood levels  




Tamarind aspirin Potentiation leading to GI bleeding—— 
Inkcap lalcohol iDisulfram effect — 
Interactions with herbs used in gastrointestinal disorders  
Chilli/capsaicin lACE inhibitors |Cough — 
Psyllium lithium Reduced blood levels__ _ 
Shosaiko^ F e S i i ^ ^ Reduced bioavailability and 
effectiveness  
Liquorice spironolactone p^tagonism of effect 
prednisolone increased salt/water retention, 
hypokalaemia  
Table 11 d. Traditional Chinese Medicine with Hepatotoxicity. (Huang KC, 1999) 
Herbs 一 ""”~ iToxic ingredient~1Pathoiogical Appearance  
Lycorine & DifiUse fatty infiltration of the liver and 
p^^iatae Sekisenine increase the liver transaminase enzymes 
Radiatae 肌d bilirubin. Intrahepatic cholestasis 
with inflammation.  
rmjli, A kehiae 木通 H e d e r a g e n i n Damage of liver cells.  
Chloranthus S ^ ^ s “ S ^ Diffuse fatty infiltration of the liver with 
及己 necrosis.  
Cortex MMzziae 合歡皮 X I ^ Necrosis of the liver ceU could see in 
I animal study.  
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H ^ s [Toxic ingredient [Pathological Appearance 
Cortex Meliae 苦棟皮T o o s e n d o n i n Degenerative swelling of the hepatocyte. 
. Toosendonin can increase the caprillary 
permeability and affect coagulation, so 
cause internal massive bleeding of the 
organ.  
Croton Tiglium 巴 豆 ^ ^ & Toxic hepatitis appearance with 
Crotonoside hepatocyte necrosis.  
Eucalyptus Globulus Oleum Eucalypti In vivo study showed damage of liver 
桉葉 ^  
Folium Uicis Purpureae Protocatechuic acid Toxic hepatitis 
夂青葉 
Fructus Bruceae 腾膽 f^Bracamarine , Bracamarine are s e v e r e cytotoxin and 
Yatanine& could cause the animal organs have 
Brucealin diffuse hemorrhage and congestion, 
J ^ ^ s ^ R ^ C a m p t o t h e c i n e T h e appearance of liver intoxication 
Campto-thecae could see in the liver, focal necrosis of 
Acuminatae hepatocytes and necrotic cholecystitis. 
Fructus Xanthii 蒼 耳 f X a n t h o s t n m a r i n F a t t y infiltration of the animal liver with 
口 hemorrhage and necrosis.  
F ^ Qing Dai W a n l ^ ^ J ^ C m increase the liver transaminase 
(CPJv^ Naturalis. enzymes and bilirubin level with 
jaundice.  
Herba Chenopodii Ascaridole Toxin can accumlate in the intesti^ and 
丄描尤 caused hepatomegaly, jaundice and renal 
土刑介 J 
damage.  
J ^ a S^^^^^d^s Senecio Alkaloids The main toxicity can cause liver 
Orvzetori damage and necrosis m acute phase. In 
^ ^ 頂宦 Chronic phase, the toxin can make 
入 bd调早 degeneration of liver, cirrhosis and 
ascites and even coma.  
Hydno-carpusAM Chaulmoogric acid Fatty infiltration of the liver could see in 
j^lyitica & Hydrocarpic animal studies. 
大風子 acid  
HyrislicafragransH^t Myristicin Fatty infiltration of the liver and kidney. 
肉豆寇 ： 7 — 7 y TT 
Indigo Naturalis 青驚 Indigo, Indircan, & Focal necrosis of J e hver cell. 
^ Indirubin Indirubin can decrease the RNA of liver 
cell and decrease protein synthesis and 
cause atrophy of liver cell  
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Herbs 丨Toxic ingredient [Pathological Appearance  
Milabris Phanalerata""" Cantharidin, Degeneration of the liver cell and 
斑蜜 (C10H12O4) necrosis of the liver cell may happened. 
Mistletoe 懈寄生 Several p o t e n t i a l N e c r o s i s of hepatocytres could see and 
toxins (p- later change into Misletoe Hepatitis, 




Punica Granatam Iso-pelletienine & Fatty infiltration and necrosis of the liver 
石溜根皮 Methionine with appearance of liver intoxication. 
Radix Aconiti 烏頭 & Hypaconitine, Pathological appearance of liver 
Radix Aconiti Lar .m// . Aconitine, intoxication could see in animal studies. 
Preparata 附子 Mesaconitme - _ -
Radix et Rhizoma Rhei Rhein, Degeneration of the liver cell with 
大黃 Chrysophanol & venous congestion could see in animal 
Emodin studies.  
J ^ x Stephaniae M a g n o f l o r k；^N e c r o s i s of the liver cell could see in 
Tetrandrae 防己 Allantoin & animal studies. 
Aristochic acid B,C   
Radix Tripterygii Wilforine, [Congestion of the liver and swelling of 
Wilfordii Wilforgine, the liver cells could see m animal 
雷公藤 Wilfozine & studies. 
Wolfortine - _ 
Ricinice&Ricm Toxin can change the liver cell mto 
萝疏子 turbid form and have nercosis. Result ot 
毘麻卞 necrosis of liver cell could see in animal 
liver.  
Dioscorein & Dilatation and congestion of the central 
hnlhifprae 萤藥子 Dioscoretoxin venous system & portal sinus. Vacuole 
頁榮卞 like degeneration of liver cell with focal 
nercosis.   
Jj^ma et Radix Fem/r/Jervine, Germerine Diffuse hemorrhage and congestion 
藜蘆 & Rubijervine could see in liver and spleen tissue. 
RJ^oma Pinelliae Homogentisie acid The non-processing form of the herb can 
半夏 &Photo-chatechuicmake the liver transfemice enzyme 
aldehyde increase.  
Rhizoma Polygoni Polygonin & Necrosis of hepatocytes could see in 
Cuspidan 虎仗 |Polydatin |animal studies.  
1 7 9 
•v 
Herbs [Toxic ingredient iPathoIogical Appearance  
Senecio Scandens Isatidine, Fatty infiltration of the liver could see in 





Terminalia Chebula Chebulibn Appearance of liver intoxication and 
呵子 necrosis of liver cell.  
Trichosanthes Kirilowii Trichosanthin Mild degeneration could see in animal 
天花粉 liver and renal cell  
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Chapter 12 - Herbal Nephropathy 
12.1. Introduction 
Members of the genus of Aristolochia have been used as medicines in the Orient 
and the West. However, the nephrotoxic response to several Aristolochia species has 
surfaced in recent decades. Two renal diseases, Balkan endemic nephropathy (BEN) and 
Chinese herbs nephropathy (CHN), have been traced to Aristolochia species. BEN is 
widespread in the Balkan region where poor peasants consumed wheat contaminated 
with the seeds of Aristolochia clematitis. CHN, on the other hand, was reported in 
Belgium where more than 100 cases suffered interstitial fibrosis in the kidney after 
taking a slimming regimen containing the herb, Aristolochia fangchi. 
12.2 Aristolochia acids (AA) 
Recently, rapidly progressive renal failure resulting in end-stage renal disease has 
been reported to occur in women who have taken weight-reducing pills containing the 
Chinese herbs Stephania tetrandra and Magnolia officinalis which containing 
nephrotoxic and carcinogenic aristolochic acids (AA). Aristolochic acid, the component 
implicated in the present case，has been used in Germany for more than 25 years as an 
immunomodulatory drug.(De Broe ME, 1999) Vanherweghem J.L.&st described the 
new entity of CHN.(Vanherweghem JL, Depierreux M et al, 1993) He reported 2 
patients with rapidly progressive renal failure with similar renal biopsy specimens 
showing extensive interstitial fibrosis and severe tubular loss most prominent in the 
outer cortex. These patients were the index cases in a cluster of cases of rapidly 
progressive renal failure occurring in young women in 1992 to 1993. All the women 
received a slimming regimen containing Chinese herbs prescribed by the same physician. 
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Besides this, a nonexclusive list of agents that have been firmly implicated in causing 
allergic interstitial nephritis include the penicillins, cephalosporins, sulfonamides, 
rifampin, ciprofloxacin, NSAIDs, thiazide diuretics, furosemide, cimetidine, phenytoin, 
and allopurinoL 
It is estimated that 1,741 patients in Belgium took the slimming medication, more 
than 100 cases have been described in Belgium related to the ingestion of a potentially 
nephrotoxic ingredient that had been mistakenly substituted for a nontoxic 
substance.(Vanherweghem U , 1998) Vanherweghem's investigation revealed that in 
1990, Stephenia tetrandra and Magnolia officinalis had replaced pancreas powder, 
laminaria powder, and focus extract in the traditional slimming regimen. Initially the 
medication, in use for 15 years contains the herb Han Fang Ji {Radix Stephania 
tetrandra) and had no reported side effects. Subsequently it was discovered that there 
was mistaken identity of the herb. After the outbreak, thin-layer chromatography was 
performed on the preparation, and Aristolochia manshuriensis rich in aristoiochic acid 
(^Radix Aristolochiae fangchi, Guang fangji) was found instead of Stephenia tetrandra 
^Radix Stephaniae tetrandrae, Fangji). Aristoiochic acid was identified independently by 
groups from Hong Kong and Belgium from a sample of “pure” Stephenia powder 
distributed in Belgiui iL(Vanhaelen M, Vanhaelen-Fastre R et al, 1994) In the cases 
reported by Vanherweghem and colleagues, the herbs were not used according to 
established principles and cannot be accepted as Chinese medicine. As pointed out by 
Professor Atherton and colleagues, the cases reported in Belgium raise the additional 
issue of the risk of adverse interactions between herbs and modem medicine. In China, 
there is much research into the possibility of integration of traditional Chinese and 
modem medicine involving careful experimental and clinical design, and systematic 
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observation and monitoring of efficacies, interactions, and side-effects. The Belgian 
cocktail is not an integration of traditional and modem medicine, but a confusion of the 
two.(Tai YT, But PPH et al, 1993) 
12.2.1 Intoxication of Aristolochic acids in Worldwide 
Cases of severe interstitial nephritis associated with rapidly progressive renal 
failure have been reported in other countries other than Belgium. In 1996, Spanish 
investigators reported a case of rapidly progressive renal failure in a man who self-
treated right upper quadrant pain for 4 years with a homemade infusion containing mint 
and Aristolochia pistolochia (used to treat jaundice in farm animals).(Pena JM, Borras 
M e t a l , 1996) Renal toxicity due to Aristolochia was already reported in China in 1964， 
(Zhu YP and Woerdenbag HJ, 1995) i.e. almost thirty years before the Belgian outbreak 
of renal Aristolochia toxicity was described. In 1998 in United Kingdom, two illnesses 
were reported following years of ingestion of herbs. Upon examination, it was found 
that there was a dispensing error. Graham Lord and colleagues report these two cases of 
nephropathy from ingesting Chinese herbal remedies that were traceable to a derivative 
of the herb MuTong. 
In Japan, Tanaka reported 2 cases ofCHN from a slimming regimen that contained 
aristolochic acid but differed from the Belgian formula in that appetite suppressants 
(fenfluramine, dexfenfluramine, phentermine, and diethylpropion) were not 
p r e s e n t . ( T a n a k a A, Nishida R et al, 1997) Moreover, ten more similar cases of 
nephropathy were reported in Japan in 1995, of which five could be attributed to a 
herbal medicine imported from China by a company in Osaka.(Tanaka A, Nishida R et 
al, 1997) After a warning was published, the suspected product was recaUed.(Hashimoto 
K^ Higuchi M et al, 1999) Toxicity occurred in this case because Aristolochia 
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manshuriensis had been substituted in the Chinese product for Akebia quinata Decdism, 
a herb with diuretic properties that is included in the Japanese Pharmacopoeia. The 
presence of aristolochic acid was confirmed in Aristolochia manshuriensis and other 
plants of the genus Aristolochia (Aristolochiaceae), and Asarum (Aristolochiaceae), but 
not in authentic samples of Akebia quinata Decaism. Aristolochia manshuriensis and 
other plants of the genus Aristolochia are not contained in the Japanese Pharmacopoeia 
and the Japanese Herbal Medicine Codex, the basic compendia used by the 
manufacturers of traditional Japanese herbal medicines (Kampo) in Japan. 
The interaction between the components in <Cuangfangji> and western synthetic 
drugs deserves further investigation, especially when unscrupulously mixed together 
with such synthetic pharmaceuticals as acetazolamide and prescribed for prolonged 
consumption as a weight control regimen.(Cosyns JP, Jadoul M et al, 1994; Cosyns JP, 
Jadoul M et al, 1994) 
12.2.2 Morphological findings 
Depierreux et ai described the pathological findings from the renal biopsies of 33 
cases of CHN.(Depierreux M, Van Damme B et al, 1994) There was a gradient of 
intensity from most severe in the outer cortex to less involvement in the inner cortex and 
medulla. The extent of interstitial fibrosis, tubular atrophy, and complete tubular 
disappearance was striking. The interstitium was remarkably hypocellular. There were 
few lymphocytes infiltrating between tubular epithelial cells. Granulocytes were absent. 
Xhere was thickening of the walls of interlobular and afferent arterioles. Morphological 
changes consisted of intimal thickening with fibroblast proliferation and peripheral 
sclerotic thickening. Glomeruli were relatively spared compared with the severity of 
tubulointerstitial fibrosis. Immunofluorescent staining was essentially negative.(Cosyns 
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JP, Jadoul M e t a l , 1994; Depierreux M, Van Damme B et al, 1994) Mild low-molecular-
weight proteinuria, hypertension, severe anemia, and development of uroepithelial 
atypia are characteristic ofCHN. CHN developed as early as 2 months after exposure to 
the slimming regimen and as late as 3 years after discontinuation of the drug.(Reginster 
F, Jadoul M et al, 1997) Generally, the course to end-stage renal disease was subacute 
and faster than in other tubulointerstitial nephropathies. Rate of progression was 
inversely related to the duration of treatment with the Chinese herbs and seemed to be 
dose related. Those patients who ingested a low dose over many years experienced 
delayed onset of renal failure. 
12.2.3 Carcinogenicity 
Base on the fact that Aristolochic acids is a mixture of nitrophenanthrene 
derivatives known for their potent carcinogenic action in rats (Mengs U, Lang W et al, 
1982) and their mutagenic properties in bacterial (Schmeiser HH, Pool BL et al, 1986) 
and mammalian models.(Pezzuto JM, Swanson SM et al, 1988) Register postulated that 
there were both a direct cytotoxicity and a more chronic change involving modification 
of DNA.(Regmster F, Jadoul M et al, 1997) The presence of aristolochic acid DNA 
adducts in renal tissue and the association with late development of uroepithelial tumors 
in patients with CHN support this view. Moreover, Schmeiser et al. were able to detect 
DNA adducts formed by metabolites of aristolochic acid (aristolactams) in samples of 
kidneys removed from five patients with Chinese-herb nephropathy. [Schmeiser H.H., 
Bieler C.A. et al., 1996] These adducts are specific markers of exposure to aristolochic 
acids and are directly involved in tumorigenesis.(Bieler CA, Stiborova M et al, 1997) 
For these reasons, patients with Chinese-herb nephropathy, or aristolochia nephropathy, 
appear to be at risk for the development of cancer. Unfortunately, two of three patients 
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that got Chinese-herb nephropathy were found to have urothelial carcinoma.(Cosyns JP, 
Jadoul M et al, 1994) A follow up survey was performed for 43 other patients with 
Chinese-herb nephropathy and found that 39 of them confirm to have high prevalence of 
urothelial carcinoma. 
The role of Chinese herbs (specifically, aristolochia species) as a cause of renal 
failure and urothelial carcinoma is still a matter of debate, for several reasons. First， 
promoters of Chinese herbs have claimed that the renal disease originated from the 
injection of a ”hidden substance" (serotonin) at the time of mesotherapy; this claim has 
not been confirmed.(Malak J, 1998; Mclntyre M, 1998) Second, analgesic nephropathy 
is a frequent type of renal disease in Belgium (De Broe ME and Elseviers MM, 1998) 
and could thus be misdiagnosed as Chinese-herb nephropathy, since urothelial cancer 
develops in up to 10 percent of patients with analgesic nephropathy.(Kliem V., Thon W� 
et al.，1996) Third, similarities between Chinese-herb nephropathy and Balkan endemic 
nephropathy have been described, including the association of both with urothelial 
carcinoma. Some evidence suggests that Balkan endemic nephropathy is an 
environmentally induced disease, perhaps related to exposure to fungal or plant 
nephrotoxins such as ochratoxin A and aristolochic acids.(Stefanovie V and Polenakovic 
MH, 1991) Both compounds are nephrotoxic and carcinogenic. Studies performed by 
Nortier JL indicated that regular intake of powdered Chinese herbs of the aristolochia 
species dramatically increases the risk of urothelial carcinoma.(Nortier JL, Martinez M , 
CM et al, 2000) 
Furthermore Vanherweghem JL also suggested that there may be a high possibilities 
that Chinese-herb nephropathy may corelated to the vascular disease because he 
discovered that a symptomless diastolic murmur could detected by routine examination 
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in about a third of patients with Chinese-herb nephropathy.(Vanherweghem JL, 1997) 
45 cases of the original Belgian group was received ultrasound studies and 14 patients 
were found aortic insufficiency even all patients with nephropathy had been given 
appetite suppressants: fenfluramine, dexfenfluramine, or phentermine, alone or in 
combination. 
12.3 MuTong {Aristolochia manshuriensis) 
MuTong is the name of the Chinese plant derived either from Aristolochia 
manshuriensis or various species of akebia or clematis.(Goshi T, 1992) Mutong is the 
stem of Akebia quinata (Thunb.) Decne (Lardizabalaceae).(Chang H. and But PPH, 
1987) There is, however, much confusion regarding the products which are used as the 
Chinese herb Mutong. This lack of verification can result in the inadvertent use of 
Aristolochia manshuriensis and subsequent adverse health effects. Pharmacognostic 
study, however, revealed that most of the so-called "Mutong products” being sold in the 
market are actually <Guanmutong> derived from the dried vines of Aristolochia 
manshuriensis Kom�(Aristolochiaceae), which have a bitter taste and "cold" property� 
The herb is credited with latent-heat-clearing antipyretic, sthenic "heaf'-purgative, 
diuretic and lactagogue actions. 
The acute toxicity of excessive doses of MuTong has been previously reported in 
Chinese publications. One woman wanting to promote milk production ate soup 
containing 70 g MuTong and red beans; she and her father-in-law who also ate the beans 
developed acute renal failure.(Wu SH, 1964) Another woman who took a decoction 
made with 175 g of MuTong also had acute renal failure and none of them died. Less 
fortunate were the other two men and two women who took decoctions prepared with 50 
g, 70 g, 60 g, and 120 g MuTong respectively and they died of renal failiire.(Wu SH, 
187 
'V 
1964; Lord GM, Tagore R et al, 1999) There is no report on the long-term adverse 
effects of MuTong, except a case of renal-function impairment in a man who took ten 
doses of a decoction containing 25 g of MuTong.(Liu JY and Ceng HJ, 1994) All these 
cases were probably caused by GuanMuTong, which is derived from Aristolochia 
manshuriensis. 
12.4 Ma-dou-ling {Fructus Aristolochiae) 
Members of the genus of Aristolochia have been used as medicines in the Orient 
and the West. A Chinese herb, Ma-dou-ling {Fructus Aristolochiae), is derived from the 
fruits of contorta Bunge. or A. debilis Sieb. et Zucc. In traditional Chinese medicine， 
the pharmaceutical function of Ma-dou-ling is to remove heat from the lung and relieve 
cough and asthma, and to remove heat from the large intestine (rectum) for the treatment 
of hemorrhoid. Short-term prescription of Ma-dou-ling was used for treatment of cough 
and asthma at doses ranging from 3-9 g without any side effects. However，two cases of 
adverse reaction were reported due to overdose. In one case, a woman vomited severely 
after having taking a decoction prepared with 15 g of Ma-dou-ling�(Xiao P, 1989) 
Another case showed symptoms of nausea, dizziness and severe vomiting resulted from 
the intake of a decoction prepared with 30 g of Ma-dou-ling�Overdose and long-term 
usage of Ma-dou-ling should be avoided.(Yin R, 1983) 
12.5 Tripterygium wilfordii 
Tripterygium wilfordii Hook f . (TWH) is a plant of the genus Tripterygium of the 
family celastraceae.(Ming J, 1996) In China Tripterygium wilfordii was used to treated 
renal disease because the polyglycoside (TP) have pharmacological effect in 
autoimmune system. However, a case of herb-induce renal failure was reported in 
China.(Chai SR and Qu J, 1987) A patient suffer with Psoriasis consulted a practitioner 
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and was prescribed 8 g of Tripterygium wilfordii for one time daily and boiled with 
water for a month. However, the patient presumes using 12 g of Tripterygium wilfordii 
for the first time and only boiled for 20 minutes. Nausea and vomiting happened 2 hours 
later but he didn't seek medical help. He took 8 g of Tripterygium wilfordii on the nest 
day and started to have frequent vomiting and only have 100 ml of urine for that day. 
He was taken to hospital and found electrolyte imbalance with acidosis and symptoms of 
acute renal failure. The cause of ARF may relate to overdosage of Tripterygium 
wilfordii and the patient recover 2 months later. The mechanism of the intoxication may 
be related to the damage caused by direct toxin and ischaemia.(Bi KB, 2000) This was 
because the circulation of the renal system will decrease due to hypovolumic condition 
caused by diarrhea and vomiting after intoxication. Damage of the renal tubular cell 
from toxin directly may happen and changed into degenerating necrosis. 2 cases of 
biopsies confirmed the main cause of ARF from Tripterygium wilfordii intoxication was 
came from the toxin by the herb directly.(Bi KB, 2000) 
12.6 Gastrodia Elata 
The drug consisted of the dried tuber of Gastrodia elata BL In traditional Chinese 
theory, it used as antihypertensive and anticonvulsive agent for the treatment of 
headache, vertigo and numbness of limbs, induced by hypertension and the premonitory 
symptoms of apoplexy. An anaphylaxic reaction for Gastrodia elata was reported in 
China that a 50 years old lady was found vertigo, nausea and vomiting after taken 10 g 
of for 6 hours.(Liu ZB, 1991) Purpura and skin itching was found for the whole body. 
Persistent abdominal pain and oliguria happened on the 2-day and she was diagnosed to 
have herb-induced ARF. She was recovering after one week of symptomatic treatment 
but the mechanism of the anaphylaxic reaction was still unknown. 
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12.7 Licorice (Glycyrrhiza glabra) 
An early report documented acute renal failure due to rhabdomyo lysis, which was a 
consequence of chronic licorice mgestion and, possibly, due to the administration of 
furosemide for the two days prior to presenting. Withdrawal of the licorice and renal 
dialysis brought about complete recovery.(Mourad G, Gallay P et al, 1979) 
In a subsequent case, myoglobinemia led to glomerulopathy and tubulopathy, but 
there was no clinical evidence of acute renal failure (ARF).(Heidemann HT and 
Kreuzfelder B, 1983) It was proposed that the mineralocorticoid-like actions of 
glycyrrhizin cause sodium retention and volume expansion, and thereby prevent the 
decrease in the glomerular filtration rate and the development of ARF, in spite of 
evidence of tubular dysfunction. (Mourad G, Gallay P et al, 1979; Heidemann HT and 
Kreuzfelder B, 1983) Moreover, another case reported the development of reversible 
tubulopathy. (Delcroix C, Poncin E et al, 1985) 
Besides this, a 72-year-old man that developed acute renal failure following severe 
hypokalemic rhabdomyo lysis, subsequent to chronic use of a glycyrrhizin-containing 
antacid.(Chubachi A, Wakui H et al, 1992) This patient presented with several 
predisposing factors, complicating the implication of glycyrrhizin, but was stabilized via 
plasma exchange, hemodialysis, potassium supplementation, and modest use of a 
glycyrrhizin-containing preparation. These authors conclude that the mineralocorticoid-
like actions explained above may be inadequate to protect all persons, especially elderly 
people with decreased renal function and severely dehydrated patients. (Chubachi A, 
Wakui H et al，1992) 
More than this licorice root containing glycyrrhizin has been reported in association 
with Fanconi syndrome.(Izumotani T, Ishimura E et al, 1993) The authors hypothesized 
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that glycyrrhizin inhibits the Na K-ATP ase activity of proximal tubular cells, possibly 
leading to irreversible Fanconi syndrome. 
12.8 Hippocampus (Sea Horse) 
Hippocampus is the dried body of Hippocampus kellogi Jordan et Snyder. It is used 
to replenish the vital function of the kidney especially that of sexual organs for the 
treatment of impotence, swelling in the abdomen and is also used externally for the 
treatment of carbuncles and furuncles. In traditional Chinese theory, Hippocampus were 
given to the newborn babies for strengthen the body within 3 days after delivery. 6 cases 
of newborn babies were found to have oliguria, fever, cyanosis, alert and abdominal 
distention after taken 1-2 pieces of Hippocampus and one of the babies was dead.(Yuan 
HN, 1992) Another cases of renal intoxication was reported that a patient who took a 
herbal decoction including Hippocampus due to mal-renal function. 
12.9 Milabris Phanalerata 
The dried body of Milabris Phanalerata Pall or Milabris cichorii L is used 
externally as a rubefacient, irritant and caustic to promote local blood circulation, 
remove dead tissue and accelerate the healing of wounds for the treatment of psoriasis, 
neurodermatitis, chronic ulcers and scrofula. If used internally, it was used for treating 
of the swelling of the lymph nodes and rabies. Cantharidin included was a severe toxin 
and caused adverse reaction in China occasionally. 2 cases of a 10 years old girl and a 
46 years old man was taken herbal decoction that included 0.15g and 0.25 g of Milabris 
Phanalerata respectively due to prevention of rabies.(Liao LJ, 1987) Both of them 
started to have symptoms of ARF (oliguria, purpura and BUN increased rapidly) 3nd 
y^ere treated in the hospital According to the severe toxin from Milabris Phanalerata, it 
betters to have caution for this when using in the elderly and children. 
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The clinical manifestations of intoxication are: Skin: Dehydration and vesicle 
formation, erosion of the buccal cavity with patchy hemorrhage. Gastrointestinal: 
nausea and vomiting, abdominal tenderness with diarrhea. In severe case, hemoptysis 
and melena will occur; Urologic: lumbar pain, frequent urination, dysuria, proteinuria, 
hematuria, anuria or oliguria; Neurologic: blurred vision, headache and dizziness with 
paralysis of extremities; Circulation: increase blood pressure first and change to 
hypovolumic with circulation failure with arrhythmia. 
No special antidote and symptomatica! and supportive treatment are suitable. 
12.10 Chinese Proprietary Medicine 
A case of reversible acute renal failure associated with the ingestion of a Chinese 
herbal medicine adulterated with a nonsteroidal anti-inflammatory agent and diazepam 
was reported.(Arthur AB, John OY et al，1995) Such kind of adulteration with synthetic 
therapeutic substances is a main problem of herbal adverse reaction. A 51-year-old 
woman prepare to receive cholecystectomy in the hospital but needed to delay because 
she was found creatinine level around 300 micro mo 1/L and rapidly progressive 
glomerulonephritis was rendered. The patient had taken eight herbal pills daily for 4 
weeks and her medications included estrogen, a herbal tea, and a Chinese herbal 
medicine (Tung Shueh pills). Chemical analysis of the Tung Shueh pills confirmed the 
presence of mefenamic acid (not quantitated) and diazepam (0.43 mg per pill) 
accompanied with the herbal tea contained caffeine. 
Excessive dosage or contamination of heavy metal in some Chinese proprietary 
medicine is sometimes present. Cinnabar (mercuric sulfide), realgar (arsenic sulfide), or 
litharge (lead oxide) may be present as part of the traditional formula and used in China 
for thousand of years. Other common renal-toxic herbal ingredients found in these 
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imported patent medicines include bomeol (similar to camphor), aconite, bufo secreta 
(toad secretion or bufotoxin), mylabris, scorpion, borax, and Strychnos nux vomica 
(strychnine). 
In the case of aristolochic poisoning, But PPH (But PPH and Ma SC, 1999) 
suggested that in the People's Republic of China Pharmacopoeia, there are seven kinds 
of Chinese proprietary medicines that contain GuanMuTong. For example, are 
registered, ‘‘Anyang Jingzhi plaster”, “Dahuang Qingwei Pills”, “Daochi pills”, 
“Fenqing Wulin pills,,, “Fuke Fenqing pills,,, "Longdan Xiegan pills”, and “Xiao'er 
Jindan tablets”. According to the toxicity of aristolochic acid, priority should be given 
to review of the long-term safety of these products, and GuanMuTong should be 
excluded from ftirther use. Other sources of MuTong, for example ChuanMuTong from 
Clematis armata and C. montana, which do not contain aristolochic acids, could be used 
instead. 
12.11 Conclusion 
Many cases of CHN developed because of failure to verify the identity of the 
prescribed herbs. Some of the confusion arose from name similarity (Fangchi vs Fangji) 
and from lack of precision about the type of MuTong Chinese plant used. MuTong can 
be derived either from Aristolochia manshuriensis or from various species of Akebia or 
Clematis. Some patented Chinese medicines contain GuanMuTong, which is derived 
from Aristolochia manshuriensis. Others contain ChuanMuTong from Clematis armata 
and Clematis montana and do not contain aristolochic acids. Patients and practitioners 
should try to avoid using Mu-Tong containing aristolochic acid and pay attention to 
monitoring the renal function if the medication has to be given. Incidents of this kind 
highlight the importance of developing and enforcing appropriate quality assurance 
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procedures for herbal medicines. 
Table 12 a. The Renal-toxicity of Traditional Chinese Medicine & Chinese 
Proprietary Medicine. 
Ti^ditional Chinese Medicine (TCM) [Chinese Proprietary Medicine (CPM) 
1. 蘆薈） 1. AngongNiuhuang Wan (安宮牛黃九） 
2. Caulis Aristolochiae Manshuriensis (關 2. NiuHuang Jiedu Wan/Pian (牛黃解毒 
木通） 片） 一 
3. (朱砂） 3. SanXiandan (三仙丹） 
4. Cortex MagnoUae Officinalis (厚朴） 4 . Suxiao Sangfeng Jiaonang (速效傷風 
5. Flos Rhododendri Mollis (鬧羊花） 膠囊） 
6. Folium Sennae�番鶴葉� 5. TianWang Buxin Dan (天王補心丹） 
7. Fructus Aristolochiae (馬究鈐） 6. Yunnan Baiyao (雲南白藥） 
8. Fructus Bruceae (腾膽子） 7. Zhusha Anshen Wan (朱砂安神九） 
9. Fructus Crotonis ( E S ) 
10. Fructus Quisqualis 
11. Fructus Xanthii (蒼耳子） 
12. Gastrodia Elata ( ^ i f i ) 
13. Herba Leomiri〔益母萆) 
14. Hippocampus (海馬） 
15. Me/(蜂蜜） 
16. Afy/“Z7r/>y (斑蜜） 
17. Radix Trichosanthis (天花粉） 
18. Radix Tripterygii JVUfordii (M公藤) 
19.Realgar (雄黃） 
20. Radix Angelicae Pubescentis (獨活) 
21. Rhizoma Alismatis (澤蕩) 
22.Ricinus Communis (MfS"?) 
23. Semen Arecae (^f ffiP) 
24.Semen Strychni (MWF) 
25. Scolopendra 
26. 全螺） 
27. Trichosanthes Kirilowii (天花粉） 




Chapter 13 • Adverse Reaction of Herbal Medicine in 
Dermatology. 
13.1 Overview 
Herbal therapy is becoming increasingly popular among patients and physicians. 
Many herbal preparations are marketed to the public for various ailments including those 
of the skin. It emphasizes the importance of using many herbs that are combined in 
different formulations for each individual patient. Among some segments of the patient 
population it has become increasingly popular as a mode for treating dermatologic 
diseases. As a result, it is now worthwhile for dermatologists throughout the West to 
gain some femiliarity with this method. Yet, dermatologists are largely unfamiliar with 
TCM and may possess some misconceptions. 
Herbal treatments are increasingly popular. A recent survey implied that, between 
1990 and 1997, the general population usage of unconventional treatments had risen 
from 33% to 42%. It also suggested that 8.6% of people who use unconventional drugs 
did so to treat dermatological problems, and showed that the usage of herbal remedies 
has increased by 380% in this time span. This level of popularity clearly begs the 
question as to how safe herbal treatments are� 
Thus dermatologists should know about their potential to cause adverse events. 
Some agents, particularly Chinese herbal creams, have been shown repeatedly to be 
adulterated with corticosteroids. Virtually all herbal remedies can cause allergic 
reactions and several can be responsible for photosensitization. Some herbal medicines, 
in particular Ayurvedic remedies, contain arsenic or mercury that can produce typical 
skin lesions. Other popular remedies that can cause dermatological side effects include 
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St Johns Wort, kava, aloe vera, eucalyptus, camphor, henna and yohimbine. Finally, 
there are some herbal treatments used specifically for dermatological conditions, e.g. 
Chinese oral herbal remedies for atopic eczema, which have the potential to cause 
systemic adverse effects. 
13.2 Chinese Herbal Medicine Used in Psoriasis 
According to TCM，psoriasis is subtyped into 3 main categories: "blood-heat" type, 
"blood deficiency-dryness" type, and "blood stasis" type.(Koo J and Arain S, 1999) 
According to the subtype of psoriasis the patient has, a different mixture of herbs is 
suggested. For example, when inflicted with blood stasis psoriasis the lesions are 
indurated and have little tendency to resolve spontaneously. There is also a purplish or 
dark red coloring of the tongue with occasional petechia. The pulse is often small and 
loose. 
The principle of treatment of this type of psoriasis is to activate the blood and 
eliminate the stasis. The most often used prescriptions include Herba Hedyotis diffusae, 
Flos carthami, Semen persicae, Ramulus euonymi, Rhizoma sparganii, Rhizoma 
curoumae’ Pericarpium Citri reticulatae, and Caul is spatholob. (Koo J and Arain S, 
1999) These are only the core ingredients that are recommended. They are ingested as 
decoctions. According to the needs of each patient, this list would be altered. 
To treat blood deficiency-dryness a different set of herbs is considered more suitable. 
Among the physical manifestations of this type is the appearance of the tongue 
characterized by pinkish color with a thin coating.(Koo J and Arain S, 1999) Western 
dermatologists do not routinely inspect the tongues or pulses of their patients with 
psoriasis. Thus, it is difficult to make a comparison between this two treatment. 
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13.2.1 Tripterygium wilfordii 
Tripterygium wilfordii Hook and Triptergium hypoglaucum Hutch are 2 popular 
TCMs.(Koo J and Arain S, 1999) Tripterygium wilfordii Hook has yielded positive 
therapeutic effects when used to treat various types of psoriasis. Although Tripterygium 
wilfordii Hook's possible mechanism of action has been investigated to be both anti-
inflammatory and immunosuppressive, there have been several negative consequences. 
The clinical efficacy is similar for Triptergium hypoglaucum Hutch and Tripterygium 
wilfordii Hook. Chinese medical literature concludes that with the current results 
Tripterygium wilfordii Hook and Triptergium hypoglaucum Hutch have shown modest 
efficacy with an acceptable adverse effects profile.(Long YI, Zhou GP et al, 1983; 
Zheng FZ, 1984; Gao JC, 1990) Some toxic effects have been observed in both animals 
and human subjects. Among these are gastrointestinal reaction, cutaneous/mucotaneous 
reactions, and abnormal menstruation. Some abnormalities in the hematopoietic system 
were also noted. In addition, exacerbation of latent chronic hepatitis and abnormal liver 
function was observed in several cases, 
13.2.2 Radix Angelicae pubescentis and Radix Angelicae dahuricae 
Although TCM has been used to treat a variety of skin diseases, of particular 
interest to us is psoriasis» Both topical and systemic use of herbs has been administered 
to treat psoriasis, as well as a combination of herbal medications with UV-A. This 
method is similar to psoralen-UV-A phototherapy. Radix Angelicae pubescentis and 
Radix Angelicae dahuricae were the Chinese herbal medicine that were administered in 
combination with UV-A irradiation. Radix Angelicae dahuricae UV-A therapy was 
reported to have an obvious result with 46.8% in 204 psoriasis patients and inducing 
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marked improvement in 121 patients (42.6%) in whom psoriasis was not completely 
cleared.(Koo J and Arain S, 1999) 
13.2.3 Radix macrotomiae sen Lithospermi Injection 
Although TCMs are commonly found in topical, oral, and photochemotherapeutic 
modalities, some of them are also injectable.(Koo J and Arain S, 1999) Sometimes the 
injectable agent yields better results than when used in the other forms. For instance. 
Radix macrotomiae sen Lithospermi when injected resulted in a more significant 
therapeutic effect in treating psoriasis than in an oral formulation. 
13.3 Chinese Herbal Decoction For Atopic Dermatitis 
Traditional Chinese medicine (TCM) for the treatment of atopic dermatitis and 
psoriasis has recently received much attention. In traditional Chinese theory, the body is 
treated as a whole and the aim of therapy is to restore harmony to the functions of the 
body.(Atherton DJ, Sheehan MP et al, 1992) This requires a mixture of various herbs 
individually formulated for the patient, making randomized controlled trials difficult to 
undertake.(Sheehan MP, Rustin MH et al, 1992) Recently, 2 randomized placebo-
controlled crossover trials were performed in England to study the effects of orally 
administered CHM in the treatment of atopic dermatitis in which traditional Western 
therapy had failed.(Sheehan MP and Atherton DJ, 1992; Sheehan MP，Rustin MH et al, 
1992; Armstrong N and Ernst E, 1999) The investigators were aided by a Chinese 
physician who was able to create a standardized mixture of 10 herbs useful in treating 
atopic dermatitis characterized by erythema, lichenification, and plaques of dermatitis in 
the absence of active exudation or clinical infection. The standard TCM practice 
emphasizes the importance of using many herbs combined in different compositions for 
each individual patient. The formulation is based on the diagnosis and individual 
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condition of the patient. Whereas Western medicme emphasizes monotherapy, standard 
TCM promotes herbal mixtures sometimes involving more than 10 different herbs and 
other agents. The 10 herbs used were Potentilla chinensis, Tribulus terrestris, 
Rehmannia glutinosa, Lophatherum gracile, Clematis armandii, Ledehouriella 
saseloides, Dictamnus dasycarpus’ Paeonia lactiflora, Schizonepeta tenuifolia, and G 
glabra. (Sheehan MP and Atherton DJ, 1992) These herbs were placed in sachets and 
boiled to make a decoction that was orally administered daily as a tea. The placebo arm 
consisted of a decoction made from several herbs with similar smells and tastes that 
have no known efficacy in the treatment of atopic dermatitis. The first study focused on 
37 children and showed a median decrease in erythema score of 51.0% in the treatment 
group compared with only a 6.1% improvement in the placebo group. The percentage 
siirfece involvement also decreased by 63.1% and 6.2% for the treatment and placebo 
groups, respectively. In this initial study, no serious adverse effects were found. These 
37 children were offered continued treatment with the CHM and then followed up for 1 
year.(Sheehan MP, Rustin MH et al, 1992) Eighteen children completed the year of 
treatment and showed 90% reduction in eczema activity scores’ The children who 
withdrew from the study did so because of lack of further response to treatment, 
unpalatability of the tea, or difficulty in preparation of the treatment. By the end of 1 
year, 7 patients were able to discontinue therapy without relapse. Asymptomatic 
elevation of aspartate aminotransferase level was noted in 2 patients, which returned to 
normal with discontinuing treatment. No other serious sequelae were observed. In the 
other study, the design was similar; however, the investigators studied 31 adult patients 
with atopic dermatitis.(Sheehan MP, Rustin MH et al, 1992) Again, the decrease in 
erythema and surface damage was statistically superior in the treatment group compared 
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with the placebo group. There was also subjective improvement in itching and sleep. 
These patients were also followed up for a year, with continued improvement and no 
serious adverse effects, whereas the patients who discontinued treatment noted a decline 
in their condition. (Sheehan MP, Rust in MH et al, 1992) Although the sample sizes were 
limited during the course of the study, initial results were promising for patients in 
whom standard therapy failed. The main limitation appeared to be the taste and the 
preparation of the decoction. It should be emphasized, however, that, although no 
serious adverse effects were noted in this study, careful monitoring of complete blood 
cell count and liver function is recommended, as reports of liver failure and even death 
have been reported when baseline laboratory values were not followed up.(Brown G, 
1992; Kara M, Pauwels A et al, 1992; Koo J and Arain S, 1998) 
13.3.1 Tea Extracts 
Ultraviolet solar radiation may induce a variety of adverse effects in humans, 
including melanoma,(Koh H, Kligler B et al, 1990) photoaging of the skin (Wenk J, 
Brenneisen P et al, 2001); (Krutmann J, 2000), sunburn (Biesalski H and Obermueller-
Jevic U, 2001), and immunosuppression.(Gil E and Kim T, 2000; Hart P, Grimbaldeston 
M et al, 2001] Protection against UV-induced skin damage includes avoidance of sun 
exposure, application of sunscreens, low-fat diets，(Black H, 1998; Hakim I, Harris R et 
al, 2000) and pharmacologic intervention with retinoids.(DiGiovanna J, 2001) More 
recently, green tea extracts have been reported to be beneficial in treating UV-induced 
p h o t o d a m a g e . (Levin CBA and Maibach HMD, 2002) The (-)-epigallocatechin-3-gallate 
and (-)-epicatechin-3-gallate polphenolic fractions were most effective in a dose-
dependent reduction of UV-induced erythema as measured by chromatometry and visual 
evaluation. Histological examination showed a decrease in sunburn cells in green tea 
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polyphenolic (GTP)-treated skin. Epidermal Langerhans cells, the antigen-presenting 
cells involved in the skin immune response, were significantly protected against UV 
damage. Furthermore, oral and topical standardized black tea extracts also decreased 
photochemical damage to the skin. 
13.4 Potential Adverse Effect with Herbal Medicine 
Many patients have the misconception that，because herbs are "natural," there are 
no adverse effects. Physicians often do not question patients about herbal supplements, 
and patients are often reluctant to divulge the use of these agents for fear of criticism 
from their physician. It is important that dermatologists become aware of the most 
common, as well as the more serious, effects.(see Table 13 a & 13 b) This will aid in 
better education of patients, as well as better diagnosis of possible fatal sequelae. 
13.4.1 Allergic skin reactions 
Many cutaneous reactions to herbal preparations have been reported. The most 
common cutaneous adverse effect of herbal preparations is allergic contact dermatitis. 
However, more serious cutaneous reactions have been reported. Allergies are a potential 
adverse effect with virtually any herbal (or indeed synthetic) medication. (Mantyranta T 
and Haahtela T，1993) The risk obviously increases with topical administration and 
long-term usage. A notable case describes an aromatherapist with allergic eczema and 
positive patch tests to 18 different essential oils.(Selvaag E, Holm J et al, 1995) 
The number of cases related to allergic reactions to herbal remedies reported in the 
medical literature is too large to be comprehensively reviewed here. Table 13 a provides 
examples only. Emphasis is put on more recent case reports with clinical relevance. 
Two patients developed erythroderma after using topical herbal treatments for psoriasis 
and atopic dermatitis, and 1 patient developed Stevens-Johnson syndrome after taking 
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"Golden Health Blood Purifying Tablets," which contained multiple herbs, including red 
clover, burdock, queen's delight, poke root，prickly ash, sassafras bark, and 
Passiflora.(Monk B, 1986) There have been reports of bullous and nodular lichen planus 
induced by ingestion of native African medicines.(Soyinka F, 1973) A young woman 
has also been described with leukemia-related Sweet syndrome elicited by pathergy to 
topical arnica creairL(Delmonte S，Bmsati C et al, 1998) 
13.4.2 Stevens-Johnson syndrome 
Following the consumption of a health drink containing ophiopogonis tuber, a 66-
year-old woman noted erythema and swelling of her face, neck and chest (Table 13 
a).(Mochitomi Y, Inoue A et al, 1998) Subsequently, she developed bullous and eroded 
lesions on the skin of her entire body as well as of the mucous membranes of her mouth, 
conjunctiva and cornea. She also had a fever and liver dysfunction. Difilise necrosis of 
the epidermis was confirmed by biopsy. She tested positive in drug lymphocyte 
stimulation and patch tests as well as on a rechallenge with 1/1000 of the original dose. 
The patient made a full recovery on steroid therapy. 
13.4.3 Photosensitization 
Essential oils used topically for aromatherapy and herbal creams have repeatedly 
been implicated as the cause for photosensitization. A particularly dramatic case was 
reported recently; a 3 3-year-old woman was admitted to a U.K. bums unit with 70% 
superficial partial thickness biirns.(Cocks H and Wilson D, 1998) She had self-
administered an aromatherapy bath 3 days previously using six drops of bergamot and 
six drops of geranium oil After the bath she had spent about half an hour on a sunbed. 
During the ensuing 48 h she noted increasing erythema and blistering on the exposed 
areas. The authors conclude that bergamot oil (which contains 5-methoxypsoralen and is 
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a known photo sensitizer) was the cause of this event. Numerous other herbal remedies 
contain psoralens (Rutaceae, Umbelliferae, Moraceae, Leguminosae) and can therefore 
cV 
cause photosensitivity. (Koo J and Arain S, 1999) 
Based on animal data, photosensitivity has always been considered a possible 
adverse effect of St Johns Wort, a best-selling herbal antidepressant.(Stevinson C and 
Ernst E, 1999) German dermatologists reported a case of a 61-year-old patient who 
presented with an itching erythema of the light-exposed areas. She was on St Johns 
Wort extract for depression. Using a systemic oral photoprovocation test, these authors 
were able to demonstrate a decreased minimal erythema dose for ultraviolet radiation B 
that was reversible after withdrawal of the herbal remedy.(GoIsch S, Vocks E et al, 1997) 
Recently a further case report of photosensitivity after oral administration of St Johns 
Wort was published.(Bove GM, 1998) A 35-year-old women took 500 mg/day of 
ground whole St Johns Wort leaf for about 1 month when she began to feel a stinging 
pain on the skin of her face and dorsum of her hand. The pain was exacerbated through 
exposure to the sun. The problem spread to all areas of the skin exposed to the sun. 
When she discontinued self-medicating with St Johns Wort the pain ceased promptly. 
A forther case of acute photosensitivity following treatment with an herbal remedy 
relates to Psorolea corylifolia (Babchi). The patient had taken the herbal treatment in the 
form of a cream that he had used to treat his long-standing vitiligo and subsequently 
experienced erythema in exposed areas,(Maurice PDL and Cream JJ, 1989) By 
excluding other causes, a diagnosis of photosensitivity due to P. corylifolia was made� 
This diagnosis was subsequently confirmed through inadvertent rechallenge. The herb, 
which is frequently used for vitiligo in Indian populations, contains psoralen, isopsoralen 
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and psoralidin. Its extracts have been demonstrated to have potent sensitizing activity 
on guinea-pig skin.(Pathak MA, Daniels F et al, 1962) 
CV 
13.4.4 Pellagra 
A 25-year-old woman presented with a 6-week history of photosensitive dermatitis 
with painful erythema of the feet and progressive involvement of sun-exposed 
areas. (Wood B and Wishart J, 1997) Dermato logical examination revealed erythematous 
plaques with well-demarcated, peeling hyperpigmented borders, which were distributed 
symmetrically over the dorsal aspect of the limbs. She also showed the classic Casals 
necklace. A clinical diagnosis of pellagra was made and she recovered quickly on oral 
nicotinamide. Even though no satisfactory mechanism of action could be identified, the 
authors considered the patients self-medication with Kombucha tea the most likely cause 
for the pellagra. 
13.4.5 Hepatotoxic Effects 
Serious systemic adverse effects have been reported with the use of TCM for the 
treatment of dermato logic disorders. (Monica BK and Philip SD, 2002) The most 
common are hepatotoxic effects. Although most patients recover without serious 
consequences as long as the medication is stopped, there have been reports of patients 
with acute liver failure and death. 
In Great Britain, a 29-year-old woman was prescribed Chinese herbal treatment for 
eczema.(Walton P and Murray V, 1992) She consequently developed 2 episodes of 
hepatitis that led to hospitalization. She had acute liver failure after the second 
hospitalization. This later led to her death, despite an emergency liver transplantation. 
The British governmental agency has recorded 11 cases of liver damage following the 
use of TCM for skin conditions from January 1991 to December 1993. In many of the 
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cases, recovery occurred after discontinuation of the herbal medicines. Later when 
rechallenged with the same herbal medicine, there was a recurrence of hepatitis. 
Although it is difficult to establish absolute etiologic association for all 11 cases, there is 
an obvious circumstantial link between TCM and the consequent liver damage. 
13.4.6 Others Adverse Reaction 
There are also reports of renal failure and agranulocytosis. (Brown G, 1992; Kara M, 
Pauwels A et al, 1992; Koo J and Arain S, 1998) One patient has been described with 
adult respiratory distress syndrome after administration of a CHM, Kamisyoyo-san, for 
seborrheic dermatitis.(Shota Y, Wilson JG et al, 1961) Another patient was described 
with reversible dilated cardiomyopathy after treatment for her atopic dermatitis with a 
Chinese herbal tea.(Ferguson JE, Chalmers RJG et al, 1997) 
13.4.7 Potential Adverse Reaction Caused by Interactions 
There are many possible drug interactions with herbs and prescription medications. 
The most important in the dermatologic setting are discussed.(Ferguson JE, Chalmers 
RJG et al, 1997) The immune-modulating effects of Echinacea, Astragalus, licorice, 
alfalfa sprouts, vitamin E, and zinc may decrease the efficacy of corticosteroids and 
immunosuppressants.(Miller LG, 1998) There are herbs that have been shown to cause 
hepatitis and therefore should not be used in combination with such medications as 
methotrexate. These include many of the ingredients in the CHM preparations, as well as 
Echinacea, chaparral, germander，ragwort, and life root.(Ferguson JE, Chalmers RJG et 
al, 1997; Borins M, 1998) Herbs containing gamolenic acid, such as evening primrose 
oil which has been used for dermatitis, psoriasis, and xerosis, lower the seizure 
t h r e s h o l d , a n d t h e r e f o r e d o s a g e s o f a n t i c o n v u l s a n t s m a y n e e d t o b e i n c r e a s e d . 
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13.5 Adverse Reaction Caused by Contaminats of Chinese Herbal Product 
Various authors have previously published analyses of Chinese herbal 
cy 
medications.(Koo J and Arain S, 1999) These findings have revealed many types of 
contaminants. Methyltestosterone, dexamethasone, indomethacin, chlordiazepoxide, 
prednisolone, betamethasone, lead, diazepam, mefenamic acid, prednisone, or 
hydrocortisone is some of many substances that have been found in these medications. 
Other possible contaminants of Chinese herbal medications include Hydrochlorthiazide, 
chlorpheniramine, phenylbutazone, aminopyrine, paracetamol, thiamin, caffeine, and 
ethaverine. 
13.5.1 Herbal creams adulterated with corticosteroids 
The most important and perhaps most prevalent adulterants in herbal creams are 
corticosteroids. This seems to be a particular problem with Chinese herbal creams. A 
53-year-old woman with psoriasis saw a Chinese herbalist and purchased a herbal cream 
from a Chinese health center.(Wood B and Wishart J, 1997) She experienced excellent 
improvement of her skin condition but discontinued the medication because she could 
not afford it any longer. Subsequently, liquid chromatographic analysis showed that the 
cream contained significant amounts of clobetasol propionate. Similar cases have been 
reported repeatedly.(Shaw D, Leon C et al, 1997) In a large-scale investigation from 
Taiwan, 2,609 samples of traditional Chinese remedies were analyzed. Thin-layer 
chromatography demonstrated that 24% of them were adulterated.(Huang WF, Wen KC 
et al, 1997) More recently a team of dermatologists from London asked 10 patients to 
bring in their Chinese herbal creams for analysis and submitted these to 
chromatographic analysis.(Keane FM, Mimn SE et al, 1999) Eight of 11 samples 
contained dexamethasone at a mean concentration of 456 mg/g (range 64-1500 mg/g). It 
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is obvious that the risk of adverse effects of such potent topically applied steroids is 
considerable and is increased through inappropriate use. 
c*. 
13.5.2 Arsenic dermatoses 
Traditional Indian (Ayurvedic) and Chinese medicines wonyingly often contain 
arsenic. (Ernst E and De Smet PAGM, 1996) This can lead to serious intoxication, and 
several cases with dermatological side effects have been reported. A 3 5-year-old Indian 
man had consulted his hakim for his atopic eczema and was given an Ayurvedic herbal 
remedy. Six weeks later he was seen by a dermatologist who noted hyperkeratosis of the 
soles of the feet and impaired cutaneous sensation following a glove and stocking 
distribution. In addition, there were signs of symmetrical muscle wasting on the limbs. 
The patient's urinary concentration of inorganic arsenic was more than 30 times the 
normal value.(Kew J, Morris C et al, 1993) The remedy was analyzed and the patient's 
daily dose was shown to be equivalent to 210 mg of inorganic arsenic trioxide. In spite 
of adequate treatment, the patient was unable to work 2 years after these events. 
The National Skin Center of Singapore reviewed all records of patients with 
cutaneous lesions related to chronic intake of arsenic seen between 1990 and 
1996.(Wong SS, Tan KC et al, 1998) The sample consisted of 17 Chinese patients, 14 of 
who had taken Chinese herbal remedies contaminated with inorganic arsenic. The most 
frequent dermatological manifestations were Bo wen, s disease, arsenical keratosis and 
squamous cell carcinoma. Such complications have been repeatedly related to the 
administration of Asian herbal remedies. Between 1972 and 1973 no less than 74 cases 
were reported in Singapore.(Tay CH, 1974) 
13.5.3 Mercury poisoning 
Asian (e.g. Ayurvedic and traditional Chinese) herbal preparations are often 
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contaminated with mercury.(Kew J, Morris C et al, 1993) This can lead to 
dermatological signs like tylotic eczema, dryness of the skin, skin ulceration and 
erythroderma.(De Groot AC, 1996) 
Table 13 a. Allergic skin reactions to herbal remedies and aromatherapy oils. 
(Ernst E, 2000) 
� [ 丨 Type of adverse I j 
Herbs \ Indications Application i • effect J Ref 
I , , .... I ,.. , I I-, - • ..,.,, . 广 — - - • •»_••__• — •’-»•«— I I • - .-•—.•»—•• — — " ‘ • • • . • - • • > - _ - 、 . • » • _ _ 丨 一 — • 一 
Aloe vera I various | topical | severe and | (Hunter D and 
I i effects j j prolonged allergic jFrumkin A, 1991) | 
！ 丨 dermatitis 丨 i 
, ^  „ _ _ - J • .1 , I I ——•一一 — — — _ — - - � - • - — • ' - • —.»—»•. —-- - — • — — 
Aristochol jcholagogue ！ oral | allergic contact j (Bayerl C and I 
I ! dermatitis jJung EG, 1996) 
Balsam of Peru cosmetic topical allergic contact | (Hausen BM, I 
I wound i dermatitis Simatupang T et I 
I healing | | jal, 1995) | 
Black cumin o i l f a c n e , eczema topical | allergic contact [(Steinmann A, | 
I and others 1 dermatitis Schatzle M et al, i 
I 1 9 9 7 ) 
! Camomile anti- topical 丨 allergic contact (Van Ketel W, 
I i n f l a m m a t o r y j j d e r m a t i t i s 1 9 8 7 ) | 
Camphor 1 various | topical erythematous, ^ a r g u e r y MC, | 
I I papulous I Rakotondrazafy J | 
j ！ oedematous, et al, 1995) j 
I I pruriginous | 
I I——— eruptions ] ！ 
Cedarwood oil aromatherapy j topical I allergic contact | (Franz H, Frank Rj 
I j dermatitis jetal, 1998) 丨 
j C h i n e s ^ e r b ^ [ V a r i o u s | topical | allergic contact ~^(Leow YH, 1997) | 
! mixture unknown dermatitis | 
I herbal j { 
Citrus hystrix I insect bite topical I delayed erythema (Koh D and Ong I 
I I |C.N. 1999) I 
I — 一 一 ~ — — —^^— "I — — ； — - - - ‘ ) 
Curcumin various i topical allergic contact | (Hata M, Sasaki EI 
^ dermatitis jetal, 1997) | 
j Echinacea | immune oral | generalized (Koh D and Ong | 
i I stimulant | urticaria CN, 1999; |  
I I i anaphylaxis j Mullins RJ, 1998)； 
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J —i"一— i 
i j 丨 Type of adverse [ 
Herbs Indications I Application effect Ref 1 i—— + .1 
！French marigold | aromatherapy . | topical allergic (Bilsland D & i  
i I— 1 dermatitis — — Strong A, 1990) I 
- J t ， J …-'’ j ‘ j 
Garlic | lip id-lowering ! oral | urticaria, \ (Asero R, Mistrello | 
] , l ^ g i o ^ d e ^ jOetal , 1998 � 
Jasmine I aromatherapy topical 1 contact allergy | ( ^ s s R & | 
I oil I (oedematous, |Lehmann P, 1996) I 
I i {exudative, | | 
I 丨 erosive I 
1 ！ ！ i 
I i I i erythema) ！  
jKava I anxiolytic | oral | contact-type (SchallerM& i 
I I dermatitis 丨 Korting HC, 1995) I 
Lavender I aromatherapy topical allergic contact (Isaksson M & �\ 
丨 oil i dermatitis | Bmze M, 1999) ！ 
I I (oedematoiis, I | 
exudative, ： 
erosive i i i 
I i erythema) [— ！ 
— — — I ‘ “ ‘ ~ ‘ ‘ 1 
Mai-Meu-Dong- i Chinese health j oral Stevens-Johnson | (Mochitomi Y, | 
Tang I drink ^ syndrome | Inoue A et al, 1998) | 
Olive oil used as a topical allergic contact (Pazzaglia M, | 
I massage oil dermatitis Venturo N et al, i 
I 1 9 9 5 ) 1 
； '__ 1 j j ^ 1 
！ Paprikaycapsaicin Imusculoskelet I topical dermatitis (Foti C, Carino M ； 
a l p a i n ！ a n a p h y l a x i s e t a l , 1 9 9 7 ; i 
丨I I I Williams SR，Clark 
— J [ � RF et al, 1 9 9 4 ) — 
Peppermint oil aromatherapy topical | allergic contact | (Weiss RR and | 
I I dermatitis James WD, 1997) 
j I j (erythematous | 
! J I i eruption) | 
\ j-— ‘ I J i ' j 
I Rosewood j aromatherapy j topical i contact allergy | (SussR& | 
I joil I I (oedematous, Lehmann P, 1996) j 
I i I exudative, 
I erosive 
j j erythema) I 
Tea tree oil 1 aromatherapy, I topical i allergic contact | (Weiss RR & James | 
i — idermatkis 1997) ! 
I cosmetics ！ i 
L —— i — L-, 5 
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I I Type of adverse I | 
Herbs Indications j Application effect j — Ref __ I 
Various aromatherapy cJ topical or allergic contact 1 (Sjiight TE & "1 
I aromatherapy ; airborne | dermatitis iHausen BM, 1994; | 
) I I 1 ! 
oil mixtures \ I Selvaag E, Holm J | 
I I let al，1995; Suss R I 
I i 丨 &LehmannP, j 
) ！ j t ^ t 
丄 L i 11996) i 
！ ) * I j * i 
Ylang-ylang i aromatherapy ! topical i allergic contact I (Weiss RR & James ！ 
I d e r m a t i t i s I W D , 1 9 9 7 ) I 
i i I 
I (erythematous | I  
i [ eruption) | j 
Table 13 b. Herbal Medicine that could cause Skin Allergy Reaction. 
By Oral administration 
1. Bombyx Batryticatus (僵蠶) 
2. Borneolum Syntheticum (冰片，梅片) 
3. Bulbus Fritillariae Cirrhosae (川貝母） 
4，Cinnabaris (朱砂） 
5. Cornu Saigae Tataricae (鈴羊角） 
6. Cortex Phellodendri (黃柏） 
7. Folium Mori (桑葉） 
8. Fructus Amomi (砂仁) 
9.F r u c t u s Evodiae (吳茱英） 
1 0 . Herba Andrographitis [穿心Wd 
11. Herba Desmodii Styracifolii (廣金錢草） 
12. Herba Houttuyniae (魚腥草) 
13. Herba Taraxaci (蒲公英） 
14.Pericarpium Trichosanthis (瓜萎皮) 
15. 柴胡） 
16. Radix et Rhizoma Rhei (大黃） 
1 7 . i ^ a J / x Z s 如 根 ） 
18. Radix Notoginseng (三七） 
1 9 . Radix Rehmanniae Preparata ( ^ i ： ^ ^ ) 
20. Radix Scutellariae (黃萼） 
2 1 . Rhizoma Gastrodiae fli) 
22. Rhizoma Pinelliae (生半夏) 
2 3 . 义 ( 蜈 松 ） 
24. 全赐） 
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2 5 . r e ” g m / m B z / o m ； ? ( 蟾 酥 ) 
By External Used � 
1. Calomelas 
2 . Eupolyphaga Seu Steleophaga (ih罾虫) 
3 . Fructus Bruceae (鴉膽子） 
4 . Fructus Xanthii (蒼耳子） 
5 . Radix Aconiti Lateralis Preparata (附‘子） 
6. Radix Clematidis (威靈仙） 
7 . Radix Rehmanniae Preparata (熟地黃) 
8. Radix Trichosanthis (天花粉) 
9 . Radix Tripterygii Wilfordii (雷公藤） 
1 0 . Rhizoma Alismatis (释搞� 
1 1 . Rhizoma Zingiberis Recens (生姜) 
12. i^idm•(菌麻子) 
13.6 Dermatological Adverse Reaction Caused by Herbs 
13.7 Contact Dermatitis Caused by CPM 
Topical application of Chinese medicines is a popular treatment in Chinese 
medicines, particularly for rheumatic pain, traumatic injury, and skin diseases. It is not 
uncommon to find allergic or irritant responses to such topical treatments. 
13.7.1 'Liushenwan' 
“LimhenwarT (Lushenwan) is a common over-the-counter proprietary Chinese 
medicine, manufactured with six items: toad venom <Chansu>, ox gall-stone 
<Niuhuang>, musk <Shexiang>, bomeol <Bingpian>, pearl <Zhenzhu>, and realgar 
<Xionghuang>. It is often used for the treatment of upper respiratory infections, 
especially tonsillitis and other causes of sore throat; by oral ingestion. It is sometimes 
also applied topically to treat boils, carbuncles, cellulitis and other skin infections. A 
woman applied “Lushenwan” to her neck to relieve neck pain. Within two days, she 
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developed an itchy erythematous rash on her neck. The erythematous patches bear well-
defined margins, lichenification and excoriation. A few micro vesicles were present in 
r* 
some lesions. Another woman applied ‘‘LiushenwarT to her eyelids to treat itchiness 
there. By the next morning, her eyelids had become red, swollen and very itchy. On 
examination, both eyelids were red, swollen and edematous. The borders of the lesions 
were well-defined and excoriations were seen. Patch tests confirmed that “LiushenwarT 
caused an irritant rather than an allergic type of reactions. Patch tests of each of the six 
herbs in “Liushenwcm,, revealed that only toad venom Chansu was the cause of the 
irritant reaction.(Lee TY & Lam TH, 1988) 
13.7.2 'Heiguiyou' 
"Heiguiyou" or “Black Man Oil" is an over-the-counter medicament retailed in 
Hong Kong. Its Malay name is "Minyak Orang Hitam Obat Gosok’，. Its ingredients 
include thymol crystal, citronella oil, wintergreen oil and turpentine oil. A male patient 
applied the oil for itchiness on his neck but developed erythematous patches with well-
defined margins, edema, vesicles and excoriation, over the anterior neck. Another male 
patient applied the oil to his genitals for itchiness of the scrotum. But on the next day, 
there was marked redness, swelling and exudation of the scrotum. Patch tests confirmed 
that the oil was the cause of the irritant reactions. Turpentine oil was regarded as the 
most likely putative irritant.(Lee TY & Lam TH, 1989) 
13.7.3 '101 Hair Regrowth Liniment' 
“101 Hair Regrowth Liniment" is manufactured with 19 herbs for restoring hair on 
the head. A woman applied the liniment for two weeks and developed redness and 
itching over the scalp. She stopped applying it and the symptoms subsided in a week. 
She applied it again and the symptoms reappeared two days later. Another patient used 
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the liniment for gradual difilise alopecias. A week later, his scalp showed multiple 
erythematous lichenified patches with welldefmed margins and mild excoriation. Patch 
tests on these two patients confirmed the allergic reactions were due to the liniment. 
However, a control study of another 20 eczematous control patients, with no history of 
using the liniment, showed no allergic response at 48 and 96 hours after application of 
the liniment.(Lee TY & Lam TH, 1989) 
13.7.4 'Zhenggushui' 
“Zhenggushur is a Chinese herbal orthopedic tincture. According to the product 
description, it is prepared with Croton tiglium <Wuma qincheng〉，Cinnamomum 
cainphora <Jig uxiang>, Angelica dahurica <Baizhi>, Moghania macrophylla 
<Qianjinba>, Inula cappa <Daliwang>, Panax notoginseng <Tianqi>, menthol 
<Bohenao> and camphor <Zhangnao>. Four patients developed blisters, redness, 
swelling, edema, excoriation and lichenification over the areas topically applied the 
tincture. A control study on 20 patients showed that four patients developed erythema 
and another four developed erythema with overlying microvescicles but no 
infiltration.(Lee TY & Lam TH，1991) 
13.7.5 'Tiedayaoiing' 
<Tiedayaojing> or Tieh Ta Yao Gin is another Chinese herbal orthopedic tincture� 
Its ingredients are: mastic <Ruxiang>, myrrh <Moyao>, flower of Carthamus tinctorius 
<Honghua>, extract of twig of Acacia catechu <Ercha>, root of Panax notoginseng 
<Tianqi>, gel of Aloe vera <Luhui>, root of Angelica sinensis <Danggui>, and resin 
from Daemonorops draco <Xuejie>. After topical application of the tincture, three 
patients developed rashes with edema and microvesicles. Patch tests confirmed that the 
allergic contact dermatitis was due to the tincture. The putative allergens were identified 
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as mastic and myrrh in the tincture.(Lee TY & Lam TH, 1992) 
Table 13 c. Dermatological signs caused by adverse effects of herbal remedies. 
(Ernst E, 2000) 
； 1 ! 
Dermatological signs jResponsible herbal remedy | j 
i (location) i(mode of application) — j Type of reaction I 
i Anaphylaxis | paprika (topical) j a t o g y j 
i ^ g i o ^ e m a I C^l ic (oral) lall^gy J 
Bo wen's disease Contamination of (Asian) herbal j arsenic poisoning | 
— [prep^ation (oral) I | 
jBuming skin (exposed a re^ — A^oe vera (topica]}^ 丨not^ovm  
Bums, partial thickness {Bergamot aromatherapy oil I photosensitivity | 
I (exposed areas) | (topical) j j 
Contact dermatitis i Numerous herbal remedies i allergy I 
1 ； I 
(usually exposed area) | (usually topical) i j 
Dry skin with scaly yellow Kava (oral) \ chronic abuse I 
pigmentation (palms, soles, j (mechanism | 
I forearms, back, shins) 丨 unknown) j 
Dryness of skin Contamination of (Asian) herbal j mercury poisoning ！ 
preparation (oral) | 
E c z e m a ( e x p o s e d ^ e a s ) ~ ~ ~ j K r a ^ r i a t r i a n d r a ( o r a l ) — [ a l l e r g y j 
Erythema (exposed areas) 丨Psorolea corylifolia (oral) |photosensitivity ！ 
Erythematous plaques Kombucha tea (oral) ！ pellagra j 
(symmetrical over dorsum of j I 
limbs) — _ J j 
Erythroderma | Contamination of (Asian) herbal | mercury poisoning ； 
j preparation (oral) ！ | 
Exudative erythema (exposed | Jasmine (oral) i allergy | 
areas) | I I 
L j T -| 
Exudative erythema j Rosewood (topical) I allergy j 
Generalized urticaria (exposed {Echinacea (oral) I allergy \ 
1 1 I i 
i a r e a s I s 
1 ——•—— [ j ； ； ； 
j Hyperkeratosis (soles of feet) ； Contamination of (Asian) herbal j arsenic poisoning | 
I preparation (oral) j | 
Itching erythema (light-exposed j St John's Wort (oral) |photosensitivity | 
a r ^ J — i I 
Itchmg skin (exposed area) | Aloe vera (topical) j not known | 
Lupus-like syndrome | Yohimbine (oral) not known —丨 
Necrotic skin lesions (face and I Amica (topical) TSweet's syndrome I 
M ) I J I 
214 
Dermatological signs Responsible herbal remedy T 
(location) (mode of application) Type of reaction 
Painful skin (light-exposed St John Wort (oral) • photosensitivity ] 
areas) j— [_ | 
Papulous itching eruptions 丨 Camphor (topical) i allergy | 
(exposed areas) | |  
Skin ulceration | Contamination of (Asian) herbal i mercury poisoning 
I preparation (oral) | j 
Squamous cell carcinoma | Contamination of (Asian) herbal | arsenic poisoning | 
\ ！ i } 
—i preparation (oral) ! 
j Stevens-Johnson syndrome Ophiopogonis tuber (oral) i a l l ^ y I 
Stevens-Johnson syndrome Mai-Men-Dong-Tang (Chinese I allergy | 
—— I herbal remedy) (oral) I j 
Tylotic eczema | Contamination of (Asian) herbal | mercury poisoning | 
I preparation (oral) j j 
13.8 Non-dermatological adverse effects of systemic herbal treatments used for 
dermatological conditions. 
A Chinese mixture of numerous herbs has been promoted as a symptomatic 
treatment of atopic eczema.(Armstrong N & Ernst E，1999) Since it has been in popular 
use in the U.K. numerous cases have been reported of liver damage and one case of 
cardiomyopathy associated with this mixture.(Davies EG, Pollock I et al, 1990; 
Ferguson JE, Chalmers RJG et al, 1997) One poison unit in London recorded 21 cases 
of hepatotoxicity following the use of Chinese herbal treatments for dermatological 
conditions; 47 in 14 of these there was sufficient evidence to suggest a causal 
relationship. Two cases of eczema patients treated with Chinese herbal mixtures have 
been recently reported. Both developed end-stage renal failure that required renal 
transplants. The herbal mixtures were demonstrated to contain aristolochic acid, possibly 
due to the inadvertent use of Aristolochia manshuriensis as one plant in the mixture. 
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The topic of traditional Chinese medicine for dermatological conditions has recently 
been reviewed elsewhere in some detail.(Koo J & Arain S, 1999) 
13.9 Conclusion 
Many practicing dermatologists in the industrial cities are only familiar with 
orthodox Western procedures for the treatment of skin disorders. However, an increasing 
number of patients have begun to seek TCM as an alternative mode of therapy. It has 
been demonstrated in published studies that there is a real possibility that TCM has a 
substantial efficacy beyond a simple placebo effect. However, TCM has also been 
associated with notable adverse effects, some fatal It is concluded that adverse effects 
of herbal medicines are an important albeit neglected subject in dermatology, which 
deserves further systematic investigation. The current clinical studies in the Chinese 
medical literature are not a complete source of information about TCM. 
Many of the studies have been conducted without a placebo arm and it is difficult to 
interpret the results in comparison studies. This is so because the standard Western 
medications used for comparison in China are often not those agents currently used in 
Western medicine. Further research should target this complex area more systematically 
with a view to establishing reliable incidence figures and increasing patient's safety. 
The above data suggest that adverse effects of herbal treatments are an important issue 
in dermatology. Dermatologists should be aware that these remedies can cause adverse 
effects which, at times, may be serious. It thus seems important for clinicians to ask 
patients about their use of such therapies, particularly as a large proportion would not 
normally volunteer such information. 
In the hopes of determining any future adverse effects，we recommend that Chinese 
herbal medications be subjected to drug licensing, monitoring, and surveillance 
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procedures. This should be done in a manner similar to what any new drug is subjected 
to for approval in the United States or United Kingdom. The individualized 
polypharmacy approach of TCM is intuitively sensible. This is especially in countering a 
complex, chronic, and often recalcitrant inflammatory process such as psoriasis or 
eczema in which it would be most beneficial to attack the process through many facets 
simultaneously. However, this approach would lead to extremely difficult scientific 
analysis of these medications. A more rigorous, systematic analysis and testing of 
therapeutic agents used in TCM may eventually lead to the development of a standard 




Chapter 14 - Chinese Herbal Medicine in Pregnancy, 
Infants & Children. 
14.1 Overview 
Despite widespread popularity, the use of many Chinese herbal medicine and dietary 
supplements during pregnancy remains poorly documented and inadequately studied in 
controlled clinical trials.(Beatrice T, Cathi DE et al, 2001) Certain traditional Chinese 
medicine (TCM) is commonly consumed by Chinese women during pregnancy with the 
belief that these herbs will have beneficial effects on the mother and/or the baby. Herbal 
medicines are often used by the general public in the self-treatment of many common 
diseases. A survey of 1,004 Chinese pregnant women living in Hong Kong in 1983-84 
revealed that 54% used TCM. There is very important to take serious consideration for 
the pregnant woman and its baby because in pregnancy, there are two parties involved, 
the mother, who willingly incurs any benefits or risks associated with the product, and 
the fetus，who is an unwilling participant.(Beatrice T, Cathi DE et al，2001) It is clear 
that pregnant women who choose to use dietary supplements need to be adequately 
informed about which products have undergone sufficient clinical study to warrant a 
recommendation for use during pregnancy (eg，folic acid) and which rely more on 
historical precedence for their efficacy and safety data. 
When a herb has oxytocic properties (the capacity to cause contraction of the 
uterus), the risks of its unrestricted use during pregnancy will be readily discovered. 
However, when a sick baby is bom, who will attribute the disease to maternal 
consumption of a herbal preparation many months before the baby's delivery? Herbal 
drugs containing pyrrolizidine alkaloids may have been used since prehistoric 
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times,(Lietava J, 1992) but the first case report about neonatal hepatotoxicity following 
the use of such a remedy during pregnancy did not appear until a few years ago.(Roulet 
M, Laurini R et al, 1988; Spang R, 1989) There is a great need for more and better 
information about the embryotoxic and fetotoxic risks of herbal drugs, not in the least 
because herbal drug use during pregnancy is sometimes encouraged by uncritical 
publications.(Bunce KL, 1987) This need for better information is illustrated by an 
Australian study, in which calls to a drug information center about drug use in pregnancy 
and lactation were analyzed. 
14.2 Asian Cultures for Pregnancy 
The traditional practice of selecting food to maintain the body in balance between 
'Yin' and 'Yang' in the Chinese usually means the avoidance of a large number of items 
which are highly mitritive.(Please see Table 14 a & b) Certain foods are also believed to 
provoke undesirable body reactions, making the choice of foods for the growing child 
feirly limited. This is particularly significant during weaning, which most Asians regard 
as the period of'cessation of milk-feeds'.(Yeung CY, 1988) 
TABLE 14 a. Traditional Chinese belief of foods provoking undesirable body 
reactions. ( From C.Y. YEUNG. Traditional Asian Practices and their Influences on 
Child Health. 1988 ) 
Hot Cool Toxic 
All fried foods Fruits - banana, peach, melon etc. Shell fish - crab, 
especially deep fried Vegetables - cabbage, mustard green shoots 
Game meats Roots - ginger Carp 
Roastings Beans - green bean Bamboo 
Milk powder Ice cream Eggs 




In Asian cultures, ginseng is commonly consumed by pregnant women and is given 
to newborns in hopes of bolstering energy. A case-control study of 88 pairs of women 
(matched only for age and parity) found a significantly lower rate of pregnancy-induced 
hypertension, but a 3-fold higher incidence of gestational diabetes among ginseng 
consiimers.(Chin RK, 1991)Ginseng was not recommended for pregnant or lactating 
women or for children until safety and efficacy are proven in randomized controlled 
trials. 
TABLE 14 b. Chinese Herbal Medicine Not Suitable For Pregnancy. 
Herbs for invigorating blood circulation Herbs for diuretic  
Semen Persicae 移匕仁 Talcum 滑石 
Flos Carthami 紅花 Semen Ahutili 冬葵子 
Rhizoma Sparganii 三梭 Radix Euphorbiae Kansui 甘遂 
Rhizoma Zedoariae 栽 j | t Radix Euphorbiae Pekinensis 大戟 
Herba Lycopi 澤蘭 Flos Genkwa 完花 
Tabanus 虫亡蟲 Croton tiglium 巴豆 
Olibanum 乳香 Semen Pharbitidis 牽牛子 
Myrrha 沒藥 Caulis Aristolochiae Manshuriensis 關木通 
Toxic Herbs Herbs with Fragrant Odour 
Radix Aconiti Lateralis Preparata 附子 Moschus 麝香 
Radix Aconiti 川烏 Fructus Tsaoko 草果 
Radix Aconiti Kusnezoffti 草烏 Flos Caryophylli 丁香 
Lignum Dalbergiae Odoriferae 降香 
Chinese mothers living in Hong Kong are used to giving their babies special 
medicinal food to strengthen the infant's internal defences and to restore the body's 
harmonious state.(Sung RY, Lui S et al, 1988) However since the majority of registered 
doctors are trained in the Western pharmacological tradition it is difficult for them to 
comprehend the concepts and idioms of this practice. Their common use and the 
continued availability of toxic preparations may explain the frequent occurrence of 
serious and even fatal poisonings.(Chan TYK & Critchley J A, 1996) The main causes 
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of death in patients were taken aconites and have cardiovascular collapse and ventricular 
arrhythmias. Moreover，children may also be accidentally poisoned by herbal medicines 
given by their parents for the treatment of minor ailments in childhood. 
Infants and children may be even more susceptible to some of the adverse effects 
and toxicity of these products because of differences in physiology, inadequate hepatic 
drug biotransformation and detoxification enzymes systems, and dose per body weight. 
As neonatal jaundice is a highly prevalent pediatric condition in the South East Asians, 
especially in Chinese, it is not surprising that herbal therapy may have a role for 
managing this problem. Even in a modern and westernized city like Hong Kong, nearly 
42% of the pregnant mothers among the Chinese community in 1982 were still taking 
herbs themselves and another 40% had given their children in the neonatal period herbal 
tea for various reasons.(Yeung CY, 1994) 
Yeimg and colleagues reported in 1990 nearly 28-51% of Chinese infants in Hong 
Kong were given “Chuen-lin” by their mothers to "clear the toxin of pregnancy".(Yeung 
C’ Lee FT et al, 1990) However, several herbs (Chuen-lin, Ngau-Huang and Yin-Chen) 
which are popularly consumed in the neonatal period are found to be highly effective in 
displacing bilirubin from its protein-binding and generate an increased amount of 
unbound bilirubin. "Yin-Chen", which is normally given as a herbal tea, has been 
processed and prepared as an intravenous extract in China. In recent years, based on 
anecdotal stories of success, the intravenous preparation of the herbal extract ‘Ym-
Chen,, {Artemisia scoparid) was used by many hospital pediatric units in China to treat 
neonatal jaundice. However, its displacing bilirubin function could generate increase the 
amount of unbound or 'free' bilirubin, which could potentially damage various tissues, 
especially the brain. 
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Although kemicterus or bilirubin-induced brain damage has become much less 
prevalent in Hong Kong, its continued occurrence is seen in many other South East 
Asian countries. Clinical statistics of a hospital in Hong Kong showed that herbal 
consumption was an outstanding factor in jaundiced infants with kemicterus.(see Table 
14 c) Increased frequency of herb-taking was associated with increasing severity of the 
aimdice in the group of jaundiced infants admitted for treatment. (Yeimg C, Lee FT et al, 
1990) Laboratory studies showed that berberine could displace bilirubin from its serum 
binding proteins, which can result in a rise in the free bilirubin concentration. Since 
there is a high prevalence of glucose-6-phosphate dehydrogenase deficiency and 
neonatal hyperbilirubinaemia among southern Chinese, kemicterus is common in 
Chinese infants. It was suggested that feeding the jaundiced infants with “Huanglian” 
might increase the risk of brain damage, by further increasing the concentrations of free 
bilirubin. Ox gallstone 'TsFiuhuang" and "Yin-Chen" are also shown to be bilirubin-
displacement agents. It is not clear which source herb of "Yin-Chen" was incriminated. 
As neonatal hyperbilirubinemia is highly prevalent among Southern Chinese, the use of 
"Chuen-lin" and “Yin-Chen” in the perinatal period should be strongly discouraged. 
Table 14 c. Herb exposure and neonatal jaundice. (Yeung CY, 1988) 
(From CY. YEUNG. Traditional Asian Practices and their Influences on Child Health. 
1988 ) 
Infants [Moderate jaundice ^ Severe jaundice With brain damage 
Total number 1811 ^  
No. of given herbs 211 90 
R ^ ^ ^ h herbs 20.1% 36.3% 57.7o/o 
a bilirubin > 10 mg/dl. b bilirubin > 20 mg/dl 
c All infants were referred for admission for jaundice. 
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Besides generating increased amount of free bilirubin in the jaundiced serum 
predisposing the infants to brain damage, many herbs are also known to precipitate acute 
！ 
haemolytic crisis in G6PD deficient children..(Wong HI, 1980; Hotham NJ，1990) 
Sudden severe haemolytic jaundice occurred repeatedly following casual administion of 
herbal tea. Although the child or the newborn may appear healthy and asymptomatic, a 
significant morbidity occurs with acute haemolytic anaemia, jaundice, haemoglobinuria 
and renal failure. 
Babies and children are particularly at risk because both traditional Chinese 
medicme (TCM) and Chinese proprietary medicine (CPM) are used for the treatment of 
minor ailments in childhood. Moreover, babies and children may be given higher doses 
of these preparations / kg body weight than adults would normally consume. They may 
lack the hepatic enzymes responsible for drug biotransformation and detoxication. It 
should also be remembered that TCM and CPM taken during pregnancy and just prior to 
delivery might affect the fetus and baby, respectively. 
Sung et al studied 166 Chinese mothers and their babies in 1984 with regards the se 
of Chinese herbs during the first 30 mo after birth.(Sung RY, Lui S et al, 1988) About 
890/0 of the babies in that study were given CHM or medicinal foods at some stage, with 
the frequency of their administration varying from weekly to once or twice monthly. The 
most popular compound herb preparations and their indications (in brackets) were: "milk 
preparation solution" (49%) (to make up milk formula in place of water); "flower teas" 
(310/0) (to eliminate endogenous heat); and various "cool teas" (17%) (to eliminate 
endogenous heat). In this study, these herb preparations did not appear to have a harmful 
effect on the baby. 
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Table 14 d. Herbs or Herbal Combinations Commonly Taken by Pregnant Women 
in Hong Kong. (Chan TYK，Chan JCN et ai, 1998) 
Herb/herb combination Reasons 
5-flower tea Urinary frequency indigestion, constipation  
”Lianzi” {Nelumho nucifera) To facilitate delivery  
"Danggui' {Angelica sinesis) To improve the general wellbeing and vitality  
“Zicao” {Lithospernum Soothing effect, for the treatment of urinary 
otficinale) frequency and constipation  
"Renshen" (Panax Ginseng) To improve the general wellbeing and vitality, to 
provide the extra energy required for labour  
13B herbs To ensure firm implantation of the foetus in the 
uterus and for the treatment of threatened abortion 
“Xiakucao” {Prunella vulgaris) For the treatment of indigestion and flu  
12B herbs Same as for 13B herbs  
"Jinyinhua" (Lonicera iaponica) |Same as for 5-flower tea  
14.3 Teratogenic Herbs 
Teratogenic herbs are known to have the tendency or likelihood of causing danger 
or harm to the fetus during pregnancy and thus leading to birth-defects or spontaneous 
abortion.(Chen J, 1998) Teratogenic herbs are classified into two categories: prohibited 
and use with cautioiL 
Prohibited herbs are very potent and very toxic. The use of these herbs during 
pregnancy is prohibited to avoid possible harm to the fetus. Prohibited herbs include 
Semen Crotonis (Ba Dou), Semen Pharbitidis (Qian Niu Zi)，Radix Euphorbiae (Da Ji), 
Mylabris (Ban Mao), Radix Phytolaccae (Shang Lu), Moschus (She Xiang), Rhizoma 
Sparganii (San Leng), Rhizoma Zedoariae (E Zhu), Hirudo seu Whitmania (Shui Zhi) 
and Tabanus (Meng Chong). 
Herbs that should be used with caution are herbs that are pungent and warm in 
nature and have the functions to activate Qi, activate Blood circulation, and remove 
blood stasis. They are also very potent in nature and should be avoided during pregnancy 
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whenever possible. The use of these herbs should be limited only to later stages of 
pregnancy and only when the benefits of using the herbs outweigh the risks. Herbs that 
should be used with caution include Semen Persicae (Tao Ren), Flos Carthami (Hong 
Hua), Radix et Rhizoma Rhei (Da Huang), Fructus Aurantii (Zi Shi), Radix Aconiti (Fu 
Zhi), Rhizoma Zingiberis (Gan Jiang), and Cortex Cinnamomi (Ron Gui), 
14.4 Chinese proprietary medicines 
Apart from herbal extracts, CPM may contain western drugs, including paracetamol, 
aspirin and antihistamines, which may or may not be listed in the manufacturer's 
information leaflet.(Chan TY & Critdiley JA, 1994) A survey performed in 1993 by the 
National Poison Center in Taiwan reported that 103 cases of poisoning were found in 
relation to the use of herbal medicine. Surprisingly, 33% of the cases recorded were in 
children below 15 years old. This implies that many of the pediatric poisonings are 
actually directly related to the inappropriate safety concepts and attitudes preexisting in 
the parents. Through the data collection system of National Poison Center, nine cases of 
poisoning in children were related to the use of “Pa-Bow Fen", "Chi-Yin Wan" and 
"Gin-Fong-Fen". According to the severity of the poisoning, the cases can be classified 
as mild (22%): nausea, vomiting, abdominal fullness, diarrhea; moderate (33%): organ 
dysfunction such as liver, kidney, and metabolic acidosis; severe (29%): 
unconsciousness, cardiopulmonary distress, death. (Deng JP，1994) 
14.4.1 ”Tse Koo Choy” 
Kang-Yum and Oransky recently described a case of mercury poisoning in a 4-y-old 
Chinese boy living in the US.(Chan H，Billmeier GJ et al, 1977) He had been given 
"Tse Koo Choy", which 
contains calomel (mercurous chloride), by his mother for his 
respiratory symptoms. Moreover, Yu and Yeung described in 1987 the second of lead 
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babies were brought back for follow-up the next day. 
14.4.4 "Jin Bu Huan" Toxicity in Children 
Consumption of traditional ethnic remedies can have adverse health effects, 
especially among children. Life-threatening bradycardia with rapid onset and central 
nervous system (CNS) and respiratory depression developed in three unrelated children 
in Colorado during 1993 following ingestion of "Jin Bu Huan,, tablets, a Chinese herbal 
medicine used for relieving pain.(Horowitz RS, 1993; Woolf WGM, 1993) After 
analyzed the tablets retrieved from the patient's parents. It included 36% concentrated 
weight-by-weight levo-tetrahydropalmatine (L-THP), a substance present in the plant 
genus Stephania but not in the genus Polygala - - the plant of origin indicated on the 
product package insert. However, the investigation has not detected any evidence of 
pharmaceutical contamination of this product. The potential toxicity may result from a 
combination of factors, including the extreme potency ofL-THP, the misidentification of 
the plant from which the product was derived, the false and potentially misleading 
medical claims, the availability of the product, and lack of childproof packaging. 
14.5 Topical Preparations 
As in adults, babies and children may develop contact dermatitis due to topical 
application of "Yunnan Paiyao" and "Lu Shen Wan". Some of the Chinese topical 
herbal medicaments have been shown by patch testing to cause mild to moderate 
irritation in patients with a history of endogenous eczema or contact dermatitis due to 
other substance.(Lee TY & Lam TH，1990) These include "Red Flower Oil" or "Hung 
Far Oil", "White Flower Medicine Oil”，"Jaminton Healing Oil" or ”Lion Medicated Oil" 
and "Tiger Balm". (Ingredient of the medicated oil in pages 119) Excessive topical 
application of these and other preparations may result in significant absorption of the 
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active ingredients and systemic toxicity.(Lee TY & Lam TH, 1988) 
Many brands of ointments are frequently used to rub over various sites for the 
treatment of a number of ulments and disease. The use of an oil such as “Pak Fa Oil” 
rubbed onto the abdomen of the crying infant to treat colic is very common 
practice.(Yeung CY, 1988) Ointments are also applied to bruised areas and sore points. 
Oils of nany kinds are frequently smeared around the temporal region for dizziness， 
vomiting or motion sickess. Those nauseating smells in the cabins of airraft full of 
Oriental passengers on long distance fights are only too familiar to frequent travellers. 
Besides being socially unacceptable, many of these ointments or liniments frequently 
produce local reactions such as skin rashes and exfoliation and accidental ingestion with 
poisoning in young children has also been observed. 
14.6 Dietary supplement 
A survey performed between November 1999 and March 2000 in University of 
California showed that nearly 13% of 150 was using dietary supplements during 
pregnancy.(Beatrice T’ Cathi DE et al, 2001) The most common products were 
echinacea (4/45, 8.9%), pregnancy tea (4/45, 8.9%), and ginger (3/45, 6.7%). The most 
common reasons for beginning or discontinuing use of dietary supplements were to 
relieve nausea and vomiting (25%) and to avoid potential harm to the fetus (25%). Even 
most of the side effects were mild and included gastrointestinal discomfort, late-onset 
thrombocytopenia was reported in a mother who used St John's wort for depression 
during pregnancy.(Gmsh LR, Nierenberg A et al, 1998) In another case, hypoxia, renal 
failure, and seizures occurred in an infant whose mother had used a combination of 
black and blue cohosh during pregnancy.(Gunn TR & Wright IMR, 1996) Physicians 
and pharmacists should be more diligent in asking questions about the use of dietary 
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supplements, particularly in those patients who are ofchi记bearing age. 
14.7 Conclusion 
It is anticipated that the use of herbal medicine will also increase in children, as 
parents incorporate alternative therapies into their family health care. Pregnant patients 
and babies may use these products instead of prescription medications. However the 
effects of such kind of supplements on a developing fetus are largely unknown; the 
teratogenicity of dietary supplements in humans and their mutagenicity are often 
speculated on the basis of in vitro and animal data. Therefore mothers should keep in 
mind and discouraged Irom treating their children with herbal or proprietary medicines. 
In order to prevent cases of unintentional poisoning associated with herbal and 
other botanical products, such products should be sold in childproof packaging and kept 
in childproof containers, and parents should be informed about the potential toxicity of 
herbal products. Health care providers can play an important role in educating patients 
and their parents about the potential risks of herbal therapies and the need to closely 
monitor any use in children. 
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Chapter 15 - Heavy metals poisoning in traditional 
Chinese medicines. 
15.1 Introduction 
Traditional Chinese medicine (TCM) is gaining popularity as a form of 
complementary and alternative medicine.(Koh HL & Woo S, 2000) Despite the belief 
that TCM and herbal remedies are of natural origin, unlike Western medicine, and are 
hence safe and without many adverse effects, there have been numerous reports of 
adverse effects associated with herbal remedies. Numerous case reports and case series 
of heavy metal poisoning associated with the use of TCM have been published.(Ernst E, 
2002) Mercury, lead and arsenic are the three heavy elemental toxins pathology 
laboratories are most often requested to measure. Lead has relatively often been 
implicated as the cause of such poisoning but mercury, cadmium, arsenic, copper, and 
thallium have also been found in TCM. In many cases, TCM intake had been prolonged 
until a diamiosis of intoxication was made. Intoxications are not confined to Southeast 
Asia but have also been documented in the West. 
Several possibilities exist to explain the presence of heavy metals in TCM. (Peter 
AGMDS. 1992) The first reason was the usage of heavy metal as a part of the herbal 
formulation and those prescriptions are still widely accepted by ordinary people, 
especially in China. Some senior herbal practitioner still prefer using complex mineral 
drugs as did their ancestors thousands of years ago. Second, the presence of heavy 
metals may be the result of accidental contamination during manufacture, for instance, 
from grinding weights or lead-releasing containers or other manufacturing utensils. 
Third, medicinal herbs may contain heavy metals when grown in seriously polluted soil. 
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Contamination oi'the general environment with toxic metals has increased. The sources 
of the environirental pollution are quite varied, ranging from industrial and traffic 
emissions to the use of purification mud and agricultural expedients, such as cadmium-
containing dung, organic mercury fungicides, and the insecticide lead arsenate. Beside 
environirental pollution, contamination may also occur in those “homemade” herbal 
medicines such as the case of ‘‘Boa Ning Dan". 
Californian officials have screened for undeclared pharmaceuticals and heavy metals 
in imported Chinese remedies on sale in Californian herbal retail stores.(Ko RJ, 1998) 
Seven percent of the 251 products tested contained undeclared pharmaceuticals (e.g. 
ephedrine, chlorpheniramine, methyl-testosterone and phenacetin). Twenty-iour 
products contained at least 10 ppm lead, 36 contained an average of 14.6 ppm arsenic, 
35 contained an average of 1046 ppm mercury, and 23 had more than one contaminant 
and/or adulterant. Koh and Woo reported the detection of toxic heavy metals that 
exceeded Singapore's legal limits in 42 Chinese proprietary medicines.(Koh HL & Woo 
S. 2000) They collected 2080 samples of such medicines in Singapore and tested them 
for heavy metal content. Forty-two different medicines were found to contain metals in 
amounts exceeding the legal limits. Mercury was found in 28 products, lead in eight, 
arsenic in six and copper in one. One product contained both mercury and lead and 
another product contained both mercury and arsenic. 
Beside traditional Chinese medicine, Indian medical systems also have the same 
problem. Indian medical systems (e.g. Ayurveda and Unani) have a long and rich 
history of herbal medicine, and heavy metals have been a regular and deliberate 
constituent of traditional Indian remedies. A London-based toxicology unit published a 
case series of adverse events associated with traditional medicines thai were reported to 
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them between 1991 and 1995.(Shaw D, Leon C ct al, 1997) Of 12 eases of poisoning 
with lead, arsenic or mercury, nine cases were associated with herbal remedies from 
India and the remainder was due to traditional Indian cosmetics (e.g. “Surma”). 
15.2 LEAD 
15.2.1 Overview 
While lead is a very old poison whose toxicity was known to the ancient Greeks, 
new infonnatioii about mechanisms and effects of lead toxicity is continually being 
discovered. The sources of iead intoxication in adults without occupational exposure are 
often insidious and the diagnosis can be missed in the absence of a typical history. 
Exposure to lead-based paint is the leading cause of high-dose lead exposure among 
children. However, previous reports have documented childhood lead poisoning related 
to the use of traditional ethnic remedies.(Colgrove ML, Zinion M et al, 1984; Flattery J, 
Gambatese R et a l 1993) In recent years, mistaken herbal medicine that contaminated 
with heavy metal was found in Asian population occasionally and maked people pay 
attention to those herbal medicines. Several well-documented cases of lead intoxication 
associated with Chinese patent medicine which indicate that the use may significantly 
contribute to the overall incidence of iead toxicity in the Asian population. However’ 
the relative risk in this ethnic problem has not been clearly established.(Bayly GR, 
Braithwaite RA et a l 1995) 
Exposure to traditional remedies and cosmetics containing lead has also been 
identified as a potential cause of childhood toxicity in the Asian community in the 
United Kingdom.(Ali AR, Smales ORG et al, 1978) Several of these products obtained 
in the Indian subcontinent and in Britain were found to contain high concentrations of 
heavy metals. Surma samples have been found to contain up to 86% lead. 
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15.2.2 Poisoning Cases of “Boa Ning Dan” 
Totally 19 citizens in Hong Kong was found suffering from lead poisoning alter 
taking pills prepared by a TCM practitioner a year ago. Based on the published 
information state thai a 23-year-old lady was first found to have non-specific 
musculoskeletal pain by herself and she seek medical help thereafter.(Auyeung TW, 
Chang KK el a l 2002) Physical examination was unremarkable but the laboratory 
studies of the parameters of heme biosynthesis revealed an enzymatic inhibition. The 
diagnosis of lead poisoning was confirmed by detection of an elevated blood lead 
level.{The first blood lead level was 3.03|am()l/L (<1.5pnol/L)}. The patient look some 
herbal pills rescently form a traditional Chinese practitioner and the drug was called 
"Boa Ning Dan". This herbal pills was made by this practitioner and she have to take 
four to six pills daily. She totally took this herbal pill for two months in order to treat 
acne. Chelating therapy was not given because of the deranged liver function. Her liver 
function normalised in 3 weeks after stopped taking the herbal pills. 
Another victum was a 35-year-old housewife, who had been suffering from anxiety 
neurosis for eight years, was receiving follow up treatment in Psychiatry Clinic regularly. 
She consulted the same TCM practitioner as in the first patient and was taking "Boa 
Nina Dan" in the belief that it could “'help excrete the toxin of the psychiatric 
medication from the body and stop the left groin pain’，. She had been taking four pills 
daily for 6 months. She received screening for blood lead level after learning that "Boa 
jSjins Dan,, contained excess lead and her first blood lead level was 5.6 ^imol/L (< 1.5 
umol/L). Furthermore, a 48-year-old housewife who had suffered from common cold 
symptoms consulted the same TCM practitioner. She took four "Boa Nm Dan” pills 
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daily (or three days. Her blood lead level was 6.7 叫nol/L (< 1.5 ^mol/L). She was 
referred to received further management. The highest blood lead level in the third patient 
could be caused by acute lead intake and the lead needs time to distribute to the body 
tissues. At this stage, the body tissues could still be free from lead deposition. This 
explains why she had no dinical features of poisoning despite having the highest blood 
lead level. 
The second and third patient, although relatively asymptomatic, were treated with 
chelating therapy. In douhtful clinical situations, a Calcium Disodium EDTA 
mobilization test can be done to decide whether chelating therapy should be given. 
The Department of Health has already banned the distribution of the pills and 
confiscated the patient list from this practitioner for further investigation. The 
department appealed to people who have taken the pills to come forward for free lead 
screening and appropriate treatment. Nearly eighty people have to take blood lead 
screening test by the Department of Health after learning that the pills contained excess 
lead. 
The herbal pili was analyzed chemically by the laboratory of the Department of 
Health and showed that each pills contained 200 times more lead than the daily 
allowable intake. Based on the practitioner statement showed that no heavy metal was 
used in this formula and the presence of heavy metals might be the result of 
contamination during manufacture. 
According to the fact that in China there was no formal regulation for traditional 
medical practice and qualified medical pactitioners in the past. Some TCM practitioners 
are trained specifically as Chinese herbal medicine practitioners and have little or no 
knowledge of medicine. They only get training from the senior practitioner and lack of 
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western medical concept also. Some of them even made the herbal drug by themselves 
at home and the constituents of the herbal pills cannot be standardized or regulated. 
15.2.3 L e a d P o i s o n i n g W o r l d w i d e 
Beside “Bao Ning Dan”，several cases of lead poisoning reported in recent years. 
Lead poisoning cases may happen in diffisrent countries.(Fisher A & Couteur D, 2000) 
A 4-month-old boy presented at a Hong Kong hospital with a history of fever, cough, 
anorexia, vomiting, and a grand mal seizure.(Chan TY, 1997) On physical examination 
he was comatose with repealed tonic-c丨onic convulsions. His whole blood lead level was 
137 {_ig/100g and the 24-h urinary lead excretion was 52 ^g. Since birth the boy had been 
treated with several Chinese herbal medicines (16 unit dose packages of “Po Ying Tan”， 
5 packages of ' 'Chun Chu MiT. and one package each of "Po Lung Yuen" and ‘‘Siu Fun 
San”). 
In Chinese communities, these medicines are used very frequently, without 
prescription, Ibr many minor ailments. All these medicines were found to contain lead. 
The analyses of 11 brands of Chinese herbal medicines by flameless atomic absorption 
spectrophotometry revealed that one of the medicines, “Po Ying Tan,, had a mean lead 
content of 7.5 mg per unit dose; the other 10 brands had lower but still significant lead 
contents. Samples of six other “Po Ying Tan" brands showed lead levels from 0.012 to 
0.07 mg/dose.(Chan TY, 1997) A survey done by the Hong Kong Medical and Health 
Department showed that 2 of 44 patent herbal medications contained > 30 fag/pill of lead 
and would provide > 3 mg/week when taken in recommended doses (i.e. more than the 
provisional weekly tolerable intake for lead established by FAO/WHO).(Yu ECL & 
Yeung CY，1987) 
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A semiconscious 2-nionth-()id boy was admitted with repeated convulsions to a 
Hong Kong hospital.(Yu ECL & Yeung CY, 1987) Subsequent investigations showed a 
blood lead level of 195 |.ig/dl and a 24-h urinary lead excretion of 20.7 mg. Sincc the 
4th day olhis life he had been treated with a herbal powder mixture with a tota] and 
leachable lead content of 23.3% and 15.6%, respectively. At least 0.2 g of this powder 
had been painted onto his buccal mucosa twice a week, resulting in a lead intake of 62.4 
mg/week. 
Heavv metal intoxication of newborn infants fed with “Ba-Pao-Neu-Hwang-San" 
has been reported every year by many hospitals in Taiwan. Nearly ten years ago, the 
National Laboratories of Foods and Drugs of the Department of Health, Executive Yuan, 
have a case report for a five-month-old female infant who died as a result of long term 
feeding with "Ba-Pao-Neu-Hwang-San". The drug was found to have contained lead 
44,000 ppm.(Chi YW. Chen SL et a l 1993) 
A 59.year-old woman in the United Stales developed anemia, diffuse pain, 
insomnia, imtability. and paranoia as well as dirnculty using her hands.(Lightfoote J, 
Blair liJ el a l 1977) Her 24-h urinary lead excrction was 1044 [xg. Four months before, 
she had been instructed by a herbalist.acupuncturist to take 30 Chinese herbal pills per 
day. Since the pills showed a lead content of 0.5 mg per bill, this advice amounted to a 
lead intake of 15 mg/day.(Lightfoote J, Blair HJ et al, 1977) 
“Chuifong tokuwan pills” (Nan Ling Pharmaceutical Company. Hong Kong) 
illegally sold in Texas contained not only synthetic Western drugs (diazepam, 
indomethacin. Hydrochlorothiazide, mefenamic acid, dexamethasone) but also lead and 
cadmium.(Anonymous, 1989) When 93 persons who had ingested these pills were 
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tested for exposure to these hca\'y mclals. none showed elevated levels of lead, hut 22 
(24%) had abnormally high urinary cadmium levels over 2.5 f.ig/1 ml. and 39 (42%) 
showed elevated urine values for retinolbinding protein, a low molecular weight protein 
indicative of renal tubular dysfunction.(Anonymous. 1989) 
A s m e s of five cases of lead poisoning due to traditional remedies in the West 
Midlands.(Bayly GR. Braithwaite RA et a l 1995) All developed typical clinical features. 
Blood lead and zinc protoporphyrin (ZPP) concentrations were elevated 2-10 times the 
upper limit of normal. The remedies contained up to 60% lead t)� 11 ] 
of the medicines as the cause of the poisoning was made in one patient by measurement 
of lead isotopic ratios, (see Table 15 a) Moreover two cases of lead poisoning from the 
Chinese herbal medicine Cordyceps were reported by the Department of Health in a 
laboratory-based blood lead surveillance program in Taiwan.(Wii TN. Yang KC et aL 
1996) This was caused by. These two patients took Cordyceps herbal medicine for 
treatment of underlying diseases. Loss of appetite and anemic signs of lead poisoning 
were manifested in one patient with a blood lead level of 130 microg/dl. while the other 
patient was asymptomatic with a blood lead level of 46 microg/di. After cessation of 
intake in the asymptomatic patient, and cessation of intake and treatment with chelating 
agents in the symptomatic patient, the blood lead levels returned to normal range. 
A 33-year-old Korean woman was diagnosed to have combination of chronic lead 
and arsenic poisoning following consumption of a Korean herbal medicine prescribed 
for haeiTiorrhoids.(Heggs M‘ Conway M et aL 1990) The patient had malaise, severe 
difficulty walking, arthralgia, oedema and abdominal pain w 
showed anaemia with basophilic stippling, fragmentation and a raised reticulocyte count. 
Laboratory examination showed that the blood and urine lead levels and urine arsenic 
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levels were aiscd. Analysis of the herbal medicine revealed a high lead and arsenic 
content. Ti-eatment with the newer chelating agent 2,3-dimercaplosuccinic acid was 
successful, with no detectable side-effects. Another South Korean case report describes 
lead poisoning (abdominal pain, anemia, and a urinary lead level of 739.4 )Lig/l) due to a 
herbal medicine containing a high concentration of lead.(Chung JG, Yoon YB et al, 
1980) 
In western European, a patient was suffered from severe anaemia after ingestion of 
several kinds of ayurvedic drugs during travel to India.(Spriewald BM, Rascu A et aL 
1999) This 37 year old man was admitted to the hospital because of weakness, dizziness, 
nausea, and diffuse muscle pain that had developed over the past few weeks. The patient 
stated that two months before he had travelled to India and took some herbal medicine 
when he make visited a traditional ayurvedic medical centre. He took nearly all the 
medication before admission. The metallic appearance of the paste and the detection of 
basophilic stippling in the red blood cells raised the suspicion of heavy metal poisoning. 
The diagnosis of lead intoxication was confirmed by high blood lead concentrations’ an 
increased urinary lead concentration, and an increased urinary excretion of delta-
aminolaevulinic acid. Also, slightly increased urinary concentrations of arsenic and 
silver were found. After chelation treatment with D-penicillamine threatment. the 
patient recovered. 
15.3 M E R C U R Y 
15.3.1 Overv iew 
Mercury has been used in medicine and industry for over 2000 years, e.g.; by 
medieval alchemists in gold extraction.(Campbell BG, 1999) A large variety of 
inorganic and organic compounds containing mercury have been used as cathartics. 
238 
antiseptics, vermicides and diuretics. Mercury is a ubiquitous substance in our 
environmenl. Mercury vapor in the atmosphere makes its way into fresh and salt water 
by falling in precipitation. Methyl mercury compounds are created by bacterial 
conversion of inorganic mercury in water and soil’ which subsequently concentrates in 
seafood and fish. Beside this, mecury is also used as medicinal purpose and spiritual 
practice in some other countries such as Caribbean islands.(Luis ZH & Philip 0 0 , 1996) 
15.3.2 C i n n a b a r 
Mercury compounds were also used in traditional Chinese medicine (TCM) for 
thousand years. Cinnabar, a crude form of mercury sulphide (HgS), has been widely 
used in the traditional Chinese mcdicines.(Tseng HH) It consisted of a mineral 
composed of red mercuric sulphide. It is used as sedative and transquilizer for the 
treatment of palpitation, insomnia, infantile convlusion due to fever, epilepsy. In 
traditional Chinese medicine, mercury is part of some preparations under the 
terminology of "cinnabaris" (mercury sulfide), "calomer'(mercury chloride) or 
"hydrarsyri oxvdiim rubrum: (mercury oxide). Such products are used for a variety of 
indications including, for example, as a tranquilliser, an anti-epileptic, for ulcers or to 
treat insomnia.(Koh HL & Woo S, 2000) In traditional Chinese theory, the usuage may 
depend on its pharmaceutical function and the dosage of the heavy metal used may 
laraer than the safety level. However, in western attitude, this kind of heavy metal 
contamination was unacceptable and dangereous. The approximate minimum lethal 
dosa(Te for a 150-lb man is 500 mg (mercuric chloride); other inorganic and organic 
mercury compounds vary widely in toxicity. 
Cinnabar is insoluble in water but the free partical of mercury compounds and some 
compounds are soluble in water. Different kind of processing may affect the percentage 
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of the soluble and free mercury compounds. Base on the result from the research of the 
soluble mercury and free mercury compounds showed that only traditional griding 
method can not remove those impurities. Adding water into it to elutriate could allow 
the turbid fluid to settle in tanks and then collecting the deposit. After elutriate, the 
percentage of soluble part of mercury and the free particle of mercury compounds will 
decrease and have low toxicities. In the animal experiment of Cinnabar showed that 
there was a clear dose-response effects could see in the clinincal and pathological 
slituation with the appearance of nodulation and edema of liver, kidney and spleen with 
serious gastrienteriiies and necrosis.(Tseng HH) 
15.3.3 P r e s e n t a t i o n 
The manifestations of mercury toxicity vary, depending on the chemical form of the 
mercury compound and patient sensitivity.(Li AM, Chan MHM et ai, 2000) In the acute 
phase, symptoms are produced within minutes of exposure. These include a burning 
sensation in the mouth and throat, abdominal pain, vomiting, eschars on the lips, loss of 
fluids and electrol>4es, tachycardia followed by shock and peripheral vascular collapse. 
Delayed actions are evident after about 12 hr to several days. These include ulcerative 
colitis, excessive salivation, foul breath and metallic taste. Initially the urine volume 
increases, later there is oliguria, anuria, uremia, acidosis and renal tubular necrosis. 
Exposure may be by all portals of entry. 
In chronic exposure to mercury compounds, the kidney is a major target organ. In 
chronic intoxication, inflammation of the mouth, swollen salivary glands, soft spongy 
gums, loose teeth, blue-black gum line, excessive salivation, metallic taste, foul breath， 
muscular tremors and behavioral changes are symptoms which should be confirmed by 
mercury determinations in the urine. In organic mercury intoxication, gastrointestina] 
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symptoms are rare, mental and nervous symptoms, such as ataxia, visual disturbances, 
paresis and delerium, predominate. 
15.3.4 P o i s o n i n g Cases 
‘ A 5 year old Chinese boy presented with recurrent ora] ulceration followed by 
motor and vocal tics.(Li AM, Chan MHM et a l 2000) The oral ulceration, which mainly 
affected the left lateral aspect of his tongue, appeared approximately five weeks prior to 
the onset of tics. Herpetic ulceration was diagnosed and confirmed by the isolation of 
herpes simplex virus (HSV) type 1 from his tongue swab. Symptom was improved after 
medication but relapse several days later. His lamiiy then consulted a local pharmacist 
and then started to used a Chinese patent medicine named “Watermelon Frost” It is an 
oral spray for healing mucosal ulcer. After using this medication for several weeks, the 
symptom improved. However, the patient family found that the patient developed a 
sudden onset of motor tics that consisted of eye blinking, head turning, and shoulder 
shrugging. There was no preceding history of flu like symptoms, head injury, or 
consumption of other drugs or herbs. There was no family history of any psychiatric or 
neuroioeical problems. He was taken to hospital to received follow up investigation and 
no abnormalities were revealed after examination. The patient admitted that he had been 
using the this herbal oral spray up to 20 times a day for the preceding four weeks, when 
the recommended dose was only one spray twice a day. As the use of herbal medication 
always arouses the suspicion of heavy metal exposure in the locality, screening for 
heavy metals was performed. After analyzed, the mercury content of the spray was 878 
ppm (2% methylmercury and 98% inorganic mercury) and the patient's blood mercury 
level was 83 nmol/1 (normal for adults <50 nmol/1). His tics completely resolved at 
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follow up four weeks later and the blood mercury level also returned to normal after 
stopped taking the herbal spray. 
"Watermelon Frost” is an old famous patent medicine in Southeast China. This 
patent medicine was widely used and easily obtainable over the counter in China and 
Asian population also because of its low price and pharmecutical value. The medicine 
that the patient look was contained 878 ppm of mercury and mainly in the inorganic 
form. Although methylmercury constituted only 2% of total mercury in this preparation, 
the content was 18 times the action level of mercury in food as proposed by the Food 
and Drug Administration.(FDA, 1998) This high mercury intake, together with the 
temporal association between symptom onset and increased blood mercury level and the 
subsequent resolution of symptoms with normalisation of mercury concentration, make 
chronic mercury poisoning the most likely culprit. 
Recently, a lawsuit in New York City netted two million dollars for a child who 
suffered from permanent neurological symptoms related to the use of the product ‘Tse 
Koo Choy"., which contains calomel (mercurous chloride).(Elaine KY, 1994) A Chinese 
store and two hospitals were cited in the case for the sale of the product and the failure 
to diagnose the symptoms of toxicity. 
15.4 A R S E N I C 
15.4.1 Overv iew 
Arsenic intoxication is known for centuries as a result of suicidal and homicidal 
intentions. Arsenic has been in use as a therapeutic agent and as a poison for more than 
2,400 years. Its use as a general remedy and tonic was common in Europe last century 
(eg; in Fowler, s solution which contained 1% potassium arsenite) In the early 1970s, it 
was introduced to treat acute promyelocytic leukemia (APL) and chronic myeloid 
242 
leukemia (CML) in China and showed surprising clinical efficacy.(Ni JH, Chen GQ et a l 
1998) 
15.4.2 A r s e n i c Toxic i ty 
The clinical picture of acute arsenic poisoning due to ingestion starts with abdominal 
pain, vomiting and diarrhoea followed by hypovolemic and hemodynamic alterations, 
renal failure secondary to acute tubular necrosis from ischemia or direct cortical necrosis, 
(see Table 15 c) Gastrointestinal absorption of inorganic arsenic depends on the 
solubility of the arsenical compound. For most trivalent and pentavalent arsenical 
compounds dissolved in water, the gastrointestinal absorptive rale exceeds 90% in 
human and animal studies with greatest absorption occurring predominantly in the small 
intestine, follow by the colon. Nervous symptoms (peripheral neuritis, encephalopathy) 
could found in advanced poisoning. Amenic crosses the placental barrier, and acute 
maternal arsenic poisoning has been incriminated in neonatal death. Arsenic also 
produces hepatic cytolysis, myocarditis (with AV block, prolonged QT’ flat or inverted 
丁 waves and ventricular tachycardia) and encephalopathy (coma and convulsions). With 
a massive intoxication, death supervenes with cardiogenic and hypovolemic shock, 
profound metabolic acidosis and DlC. 
Inorganic arsenic compounds are established carcinogens in man. Occupational and 
medicinal exposures to arsenical products have been associated with lung cancer (due to 
chronic inhalation), skin cancer and visceral cancers. 
Seafood may contain large amounts of arsenic in a non-toxic form and this is very 
important in interpretation of urinary arsenic measurements. However, the arsenic in 
most seafood is predominantly in the form of organoarsenicals’ mainly arsenobetaine 
and arsenocholine, and these compounds are non-toxic.(Bruce G, 1999) When they 
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absorbed, I hey do not metabolised and then excreted unchanged. The majority of this 
“seafood,, arsenic is excreted within three days. 
15.4.3 T h e Toxicologic M c c h a n i s m s of I n o r g a n i c A r s e n i c 
The acute toxicity of arsenic has been shown to vary according to the chemical 
species involved. The 50% lethal doses for oral administration to mice are as follows: 3 
mg/kg for arsine; 14 mg/kg for arsenite [ As 20 mg/kg for arsenate [As 700-1800 
mg/kg for monomethylai-sonic acid (MMA); 700-2600 mg/kg for dimethylarsinic acid 
(DMA); and >10 000 mg/kg for arsenobetaine and arsenocholine. Therefore, the 
inorganic spccies of As" ‘ and As' ' are more toxic than their methylated forms MM A and 
DMA. Arsenobetaine and arsenocholine are nontoxic and are eliminated rapidly in the 
urine after absorption. The lethal dose of inorganic arsenic is 100-200 mg of arsenic 
trioxide for an adult individual, although people have survived larger doses.(Hindmarsh 
JT and McCurdy RR 1986) After acute intoxication, the inorganic arsenic was partly 
methylated into MMA (monomethylarsonic acid) and DMA (dimethylarsinic acid), 
which are excreted largely in the urine, (see Table 15 d) 
A Chinese study of excretion of arsenic sulphide in 4 
realgar was first absorbed in the bod}' and excreted by the renal system.(Chung Q W & al 
e. 1991) The period of excretion was regularly and last for 7-10 days. The peak of 
excretion of arsenic in urine was in the second day after ingestion. However the total 
volume of arsenic excretion prominently less than the intake volume (One patient had 
already taken 132930.0昭’ the total volume of excretion after 11 days was 1387.6路，so 
the ratio was 96:1). This means large amount of arsenic may excreted by another route 
or accumulated inside the body. 
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Tasteless and odorless, arsenic is well-absorbed via the gastrointestinal, respiratory. 
and parental routes.(Savory J, el a l 1977) The principal biochemical lesion in acute 
arsenic intoxication is the reversible combination of arsenite with susceptible 
suiphydryl-containing enzymes. The resultant blockade of cellular oxidative processes 
results in capillary and relative tissue injury and relative tissue hypoxia leading to 
vasodilatation and transudation of fluid.(Schoolmeester WL & White DR, 1980) The 
toxicity of arsenite (As:” ) is primarily due to its high reactivity with sulfliydryl groups of 
dihydrolipoamide, preventing regeneration of iipoamide, which is a necessary cofactor 
in the conversion of pyruvate to acetyl coenzyme A (acetyl CoA). Diminished acetyl 
CoA levels’ in turn, reducecitric acid cycle activity with resulting decreased production 
of adenosine triphosphate (ATP). Arsenate toxicity may result from its substitution for 
phosphate in enzyme-catalyzed reactions.(Vahter M, 1983) Arsenic also interferes with 
glucose production and uptake. The drop in acetyl CoA levels, also inhibits the activity 
of pyruvate carboxylase, which catalyzes the conversion of pyruvate to oxaioacetate. the 
initial step in gluconeogenesis. Animal study showed that impaired gluconeogenesis 
combined with carbohydrate depletion due to the stress of poisoning can result in 
hypoglycaemia�Arsenic also affects other sulthydryl-containing enzymes，including 
membrane transport enzymes involved with insulin-independent cellular glucose uptake. 
Thus cellular lack of glucose may be a consequential problem in As'" poisoning 
although it remains unproven in human. Trivalent arsenic also inhibits glutathione 
synthetase, glucose-6-phosphate dehydrogenase, and glutathione reductase. This result 
in decreased levels of reduced glutathione, which facilitates arsenic metabolism, protects 
red blood cells (RBCs) from oxidate damage, and maintains hemoglobin in the ferrous 
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fonn 1 I n human, the highest concentration of arsenic arc found in tissue rich in 
sullhydryl groups such as the skin, hair, and nails. 
15.4.4 Po i son ing Cases 
A 13-year-old patient who had previously been well was admitted to Macau 
Government Hospital because of mild fever 4 days.(Cunha J, Pereira L el al, 1998) She 
had few productive cough with some sputum, and severe dyspnea with frequency 
vomiting. The patient's mother remembered that the patient had a complain of gingivitis 
ten days before admitlion, so her mother told her to take two patent medicines “ Niu 
Huang Chieh Tu Pien" 1.,|:贸解/1^片-]and ’' Yin Chiao Jiedu P i a n "[銀•解 f l j片 ] b y 
herself. Based on the information given hy the patient's mother stated that her daughter's 
fever seems better but her dyspnea and vomiting were deteriorated. She could not lay 
flatly in bed in recent two days associated with oliguria and thirst. However the urine 
colour remained the same as usual. According to the patient's condition was getting 
worse, she was taken to the hospital and was transferred to the Intensive Care Unit for 
rescurition. After examination, the patient was diagnosed as cerebral edema, 
multisystem organ failure, acute renal and liver failure, metabolic acidosis, pulmonary 
edema, and pericarditis and died after ten days. Based on the clinical course and post-
mortem examination the authors proposed that arsenic in the traditional Chinese 
medicines was the cause of her death, causing acute arsenic intoxication. After this case 
happened, Macau government had led to a complete ban on all brands of "Niu Huang 
Chieh Tu Pieif' from October 1996 for one year. Currently all imported “Niu Huang 
Chieh Tu Pien’，products are subject to analytical test of Arsenic contents of which must 
be within the acceptable range of Arsenic level. 
246 
15.4.5 Discussion 
Dr. Espinoza EO et al have reported that after they examined samples of some 
Chinese patent medicines, they found that most the patent medicine preparations had 
a potentially serious health risk to consumers because of arsenic contamination. As in 
the case mention above, an interesting question was pointed out 一 why Arsenic trioxide 
{As.03^ could be found in those patent medicine contain realgar? Base on the 
information from P.R.C. Pharmacopoeia (1995 Edition) showed that the main 
component of realgar is As.S,, (nearly 90%) and the rest of the component were other 
mixed metal (including the impurity arsenic trioxide As.O^). Those impurities are the 
main cause of its toxicity and needed to be clear by curing before used. 
In China，the high quality of realgar is so expensive because the processing 
procedure was complicated. If the procedure is not enough, impurities such as arsenic 
trioxide AS2O3 would be retained. Futhermore, improper heating process could lead to 
the conversion of arsenic disulphide to arsenic trioxide also and was toxic.(Yuan ST, 
1987) Therefore, a qualified processing procedure is very important in the making of 
realgar. However, many unauthorized manufiicturors prefer using the unqualified realgar 
compound in stead of it in order to decrease the production price. That's the reason why 
the level of As.O, in the sample of the suspected medicine was very high. A similar 
research also showed similar result.(Koi KI & et al, 1998) The result stated that the 
ranges of arsenic level from these testing sample were between 4 -12000 p.p.m. 
Another report of chronic arsenic sulfide poisoning from the consumption of 
traditional Asian medicinal agents in Singapore were also stated that the patients was 
ingested approximately 10 mg per day.(lay CH & Seah CS’ 1975) Arsenic poisoning 
was observed in 74 patients who had been using Chinese herbal medicines providing a 
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high inorganic arsenic intake. Among the various symptoms noted were sensorimotor 
polyneuropathy, psychosis, acute toxic hepatits, anemia, transient albuminuria, skin 
cancers, and internal malignancies. Three patients died from spreading arsenic-induced 
carcinomas and one from ventricular arrhythmia. Of those remaining alive, 12% were 
moderately disabled. 
Forty-seven patients (64%) had taken an antiasthmatic herbal pill called "Sin Lak,,, 
which contained 12 mg/g arsenic sulfide. This pill provided an arsenic intake of about 
10.3 nWdav when used as recommended. Another 28 brands of Chinese herbal 
preparations with high concentrations (ranging from 45 ^g/g to 107 mg/) of arscnic 
sulfide or trioxide were identified. These preparations resulted in daily exposures to 0.5-
3.3 mg arsenic.(Tay CH & Soih CS, 1975) 
15.5 Conclusion 
Unexpected or accidental intoxication by medication containing heavy metal in any 
formula, should call attention for quality control on manufacture, trading and medical 
prescription. In the long term, the governmental department should setup a standard 
regulation system for herbal medicine that operate under the basis of Chinese 
Pharmacopoeia, in reference of international regulations, to work out the standard of 
microbe, residual pesticide and heavy metal content in Chinese herbal medicine. The 
government should lay down rules regarding production, importation, wholesaling, 
retailing, testing and licensing also. Only if the government does so will citizens regain 
confidence in TCM. Though still relatively rare, heavy metal poisoning with herbal 
medicine should always be suspected if a previously healthy child develops unusual 
symptoms, especially those involving the central nervous system. 
248 
T a b i c IS a . S y m p t o m s of Lead Po ison ing in Di f fe ren t Blood Lead C o n c e n t r a t i o n s 
r^S^M^dlT]—25-50 ^g/dL ] >80 Mg/dL 
Symptoms None None Mild, nonspecific Colic, irritability, 
complaints drowsiness, nausea 
and vomiting,  
seizures, coma  
P a t h o p h y s i o l o g y  
Metabolic Unknown Urinary ALA Increase in Same as 50-80 
may increase urinary ALA and )j,g/dL 
coproporphyrins, 
increased EP  







Renal Unknown No acute Minimal acute Fanconi-Hke 
effects; dysfunction; syndrome 
possible chronic (reversible) 
chronic irreversible 
nephritis nephritis  
” C N S Ui^nown Unknown Cognitive Minimal to severe 
deficits brain damage 
(permanent)  
“P^erTpher^ Unknown Possible Decreased nerve Child: weakness or 
nervous decreased conduction paralysis; 
system nerve neuropathy rare 
conduction  
Efidocrin- Unknown Impaired Unstudied Unstudied 
ologic spermatogene Same as 25-50 Same as 25-50 
sis and )ag/dL )ag/dL 
oogenesis  





Table 15 b . Characteristics of Acute and Chronic Lead intoxication. 
Chronic Acute  
Symptoms Nonspecific; vague aches Anorexia, constipation, abdominal pain, 
and signs and pains. nephritis. behavioral changes, vomiting, lethargy: 
peripheral neuropathy fatigue, hyperactivity, clumsiness, ataxia, 
convulsions, coma  
Presumptiv Lab: anemia (Hb <10 g/dL). Lab: same as in chronic increased urinary 
e evidence basophilic stippling, coproporphyrins, hemolysis 
increased urinary ALA. Radiographic: same as in chronic 
Radiographic : opacities on 
abdominal radiographs; Hisolry： same as in chronic 
lead lines (children). 
History: environmental lead 
source, family history  
Diagnostic Blood lead concentration Blood lead concentration >60 jag/dL and 
evidence 30-60 \ig/dL and EP less EP > 190 i^g/dL, or 7-10 times normal 
than 7 times normal  
Table 15 c . Characteristics of mcrcury poisoning. 
Characteristic Elemental Inorganic Organomercurial 
Route of Inhalation i Oral Oral food chain 
j i 
exposure I j  
Tareet organ | CNS. kidney j Kidney CNS. liver  
Clinical manifestat ions  
-Lunas Bronchial Nil Nil 
irritation 
i Pneumonitis  




salivation |  
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C h a r a c t e r i s t i c E l e m e n t a i I n o r g a n i c O r g a no m e r c u r i a l 
Kidney Tubular necrosis Tubiilar necrosis  
CNS Erethism Nil Ataxia, chorea, athetosis. 
tremor  
Tremors Nil Convulsions, 
paresthesia, erethism 
Toxic level 
“Blood �5 0 " n m o l / L 50nmol/L 5 Q ^ o l / L — 
T h r n e 50 nm()l/24H 5^0 nmol/24H 50 nmol/24H 
Treatment CaNa.-EDTA IML ‘ D K ^ 
Penicillamine  
B i o l o g i c T c T - T s ^ d a y s 70-90 days 
life  
T a b i c 15 d . P r e s e n t i n g s y m p t o m s in A c u t e a n d C h r o n i c Arsen ic Po ison ing . 
Acu tc C h r o n i c 
Derniatoiogic Hair: delayed loss. Nail: Mees, lines (2-3 weeks' 
Skin eruptions poslingestion) 
Melanosis - mottled brown spots 
Hyperkeratosis - palmer and plantar 
surfaces 
Neurologic Hypoxic convulsions, Peripheral neuritis, tremors 
coma  
Abdominal pain, severe 
Gastrointestinal nausea, profound Ulceration of gastrointestinal tract 
diarrhoea, rice-water 
stools, projectile vomiting  
Hepatic Fatty infiltration Chronic hepatitis, liver cirrhosis  
Renal Oliguria uremia Proteinuria, haematuria  
Haematologic Bone marrow suppression, 
pancytopenia, anemia, impaired folate 
absorption  
Cardiac ST segment and T-wave 
abnormality, cardiac  
arrhythinia  
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Chapter 16 - Review of Herb - drug Interaction 
16.1 Overview 
Herbal medicines are ubiquitous: the dearth of reports of adverse events and 
interactions probably reflects a combination of under-reporting and the benign nature of 
most herbs used. Many herbs and pharmaceutical drugs are therapeutic at one dose and 
toxic at another. This means herbs can potentiate or modify the action of a drug or 
another herb, leading to a situation where interactions between herbs and drugs may 
increase or decrease the pharmacological or toxicological effects of either one.(Berman 
AF, 2000) Clinicaliy important interactions appear to involve cfleets on drug 
metabolism via cytochrome P-450 isoenzymes, impairment of hepatic or renal function, 
and other possible mechanisms.(Scott GN, 2002) 
Experimental data in the field of herb-drug interactions are limited, case reports 
scarce, and case series rare. This lack of data is also true of drug-drug interactions: 
published clinical studies are mainly case reports (controlled trials are scarce, since the 
random assignment of patients to trials that examine unintended effects is not ethical). 
The true prevalence of drug interactions is substantial but unknown.(Berman AR 
2000)(See Table 16 b) 
Concurrent use of herbs may mimic, magnify, or oppose the effect of drugs. Many 
reports of herb-induced interactions lack crucial documentation on temporal relations 
and concomitant drug use. Perhaps the most serious problem encountered in analysing 
such reports is the consistent absence of any effort (beyond that of reading the label) to 
establish a positive identification of the herb involved, and to exclude the effect of 
contaminants or adulterants.(Berman AF, 2000) Therefore, practitioners should inquire 
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uhoLit all the herbal supplements, prescriptions, and over-the-counter (OTC) medicines 
that patients are taking (as well as asking about diet and other life style factors), and 
patients should be counseled about potential crossreactions. As a general rule, 
concomitant use of herbs and drugs thai produce like effects is best avoided to avert 
“synergistic overload."(Horowitz S, 2000) Approximately 25-30 percent of all 
conventional drugs are derived from plants, and cautions that such double-dosing 
becomes more likely. It was because herbs, as they move incrementally further from 
their plant origins in becoming more standardized, arc transformed into herbal drugs thai 
are capable of producing similar side effects to potent bioinedicine. 
Natural products that have been reported to interact with drugs in humans include 
coenzyme QIO, dong quai, ephedra, Ginko biloba’ ginseng, glucosamine sulfate, 
ipriflavone. melatonin, and St. John's wort.(Scott GN, 2002) In many cases, more 
research is needed to confirm these interactions and to determine whether other natural 
products may also interact with drugs. To effectively counsel patients about interactions 
involving natural products, pharmacists should be familiar with the most commonly 
used products and have access to information on more obscure products. Interactions 
between natural products and drugs are based on the same pharmacokinetic and 
pharmacodynamic principles as drug-drug interactions. Natural products may affect the 
absorption of drugs and other natural products. 
Two studies reported in the February 12, 2000，issue of The Lancet journal 
implicated the use of St. John's wort {Hypericum perforatum), one of the most popular 
herbals used primarily to treat depression, as potentially detrimental in two very specific 
medical circumstances. St. John's wort was found to compromise the efficacy of both 
the HIV protease inhibitor indinavir,(Piscitelli SC. Burstein AH et a l 2000) and the anti-
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rejcclion transplant drug cyclosporin (Chitzka RF & el al, 2000) that is used to suppress 
the immune system of heart transplant patients. While such situations may represent 
atypical cases, given that phytochemicals tend to be in less potent form than 
pharmaceuticals and thai most have been used safely throughout history, these cases do 
focus attention on the fact that botanicals are medicines that deserve as much respect and 
professional supervision as synthetically produced allopathic prescription drugs. 
Another example is using laxative or bulk-forming agents. Both agents will speed 
intestinal transit, and thus may interfere with the absorption of almost any intestinally 
absorbed drug. The most popular stimulant laxative herbs are the anthranoid-containing 
senna {Cassia senna and C angustifolia) and cascara sagrada {Rhamnus purshiana). 
Dried exudate from the aloe vera {Aloe harhadensis) leaf (not gel) also contains 
anthranoids and is used as a laxative. Aloe vera ge l found within the leaves, is used 
topically for burns and cuts, and is sometimes recommended by herbalists for internal 
ingestion to treat ulcers and other disorders. The gel (or juice made from the gel) does 
not contain anthranoids, but some oral preparations are contaminated by the laxative leaf. 
Less commonly used anthranoid-containing plants are frangula {Rhammis frangula), 
yellow dock {Rumex crispus), and Chinese rhubarb {Rheum officinale). 
While many drug interactions can be serious, the consequences of some involving 
such as St. John's wort are potentially life-threatening.(Berman F & Ernst E, 2001) 
Significant decreases in antiretroviral drug concentrations can lead to treatment failure 
and viral rebound in HIV-seropositive patients; drops in cyclosporine levels have been 
shown to cause organ rejection in kidney and heart transplant patients. Pharmacists in 
these two areas of practice must be especially vigilant to protect their patients from such 
interactions. 
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16.2 E f f ec t s of Herb-dru<^ i n t e r ac t i ons 
16.2.1 G a s t r o - i n t e s t i n a l sys tem 
The majority of all absorption occurs in the intestines, where herbs or drugs must 
pass through the intestinal wall to enter the blood. Several mechanisms may interfere 
with the absorption of drugs through the intestines. The efficacy of antacids or antiulcer 
drugs used in therapy may be affected in individuals taking herbs such as horse chestnut 
which is irritant to the gastro-intestinal tract.(Newall CA & Phillipson D) Drugs such as 
Questran (cholestyramine), Co lest id (colestipol) and Carafate (sucralfate) may bind to 
certain herbs, forming an insoluble complex, and decrease absorption of both substances 
because the size of the insoluble complex is too big to pass through the intestinal wail. It 
is possible that the activity of a laxative may be potentiated or its side effects increased 
by concomitant use of a herbal laxative such as senna. 
The absorption of herbs may be adversely affected when the herbs are given 
together with some drugs that change the pH of the stomach. Drugs such as antacids, 
Tagamet (cimetidine). Pepcid (famotidine)，Axid (nizatidine). Zantac (ranitidine) and 
Prilosec (omeprazole) may neutralize, decrease or inhibit the secretion of the stomach 
acid. With the subsequent decrease of stomach acid, herbs may not be broken down 
properly, leading to poor absorption in the intestines. To minimize the risk of interaction, 
it is best if the drugs and the herbs are taken separately by approximately two hours. 
Lastly, drugs that affect the G.I. motility may affect the absorption of herbs. G.I. 
motility is the rate at which the intestines contract to push the content from the stomach 
to the rectum. Slower G.I. Motility means the herbs stay in the intestines for a longer 
period of time and there will be an increase in absorption. Conversely, faster G.I. 
Motility means the herbs stay in the intestines for a shorter period of time and there may 
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be an decrease in absorption. Drugs such as Reglan (metoclopramide) and Propulsid 
(cisapride) increase G.I. Motility and possibly decrease absorption of herbs; and drugs 
such as Haldol (haloperidol) decrease G.I. Motility and may increase absorption of herbs. 
Therefore, it may be necessary to decrease the dosage of herbs when the patient takes a 
drug that decreases the G.I. Motility and increases overall absorption; and increase the 
dosage of herbs when the patient takes a drug thai increases the G.I. Motility and 
decreases overall absorption. 
16.2.2 C a r d i o v a s c u l a r sys tem 
A number of pharmaceutical drugs with different modes of action may be 
prescribed for cardiovascular abnormalilies.(NewalI CA &Phillipson D) Diuretics are 
commonly prescribed for the management of hypertension and their activity may be 
potentiated by co-administration of herbal diuretics such as dandelion. Elderly patients, 
in particular, are susceptible to the side effects of diuretics. Herbs which either lower 
blood pressure (e.g. ginseng) or raise it (e.g. broom), or have mineralocorticoid activity 
(e.o. liquorice) or are diuretic (e.g. dandelion) may adversely affect the beneficial 
clinical effects of antihypertensive therapy. Blood lipid levels, already lowered by 
treatment with lipid-lowering drugs, may be further reduced by the use of 
hypolipidaemic herbs such as alfalfa. 
Herbs, such as angelica, which contain coumarins have anticoagulant activity 
whereas other herbs, such as agrimony, are reported to have coagulant activity. Aspirin 
increases the risk of bleeding in warfarin therapy and it is possible that herbs such as 
willow, which contains salicylates may have similar effects. Therapeutic doses of garlic 
should not be given to patients with slow blood clotting time and caution is 
recommended for those on anticoagulant therapy. 
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16.2.3 C e n t r a 1 n e r v o u s system 
Hypnotics and anxiolytics may react with sedative herbs, e.g. passiflora, valerian, 
or with slimulanl herbs, e.g. ginseng.(Newall CA &Phillipson D) Evening primrose oil 
may have the potential to manifest undiagnosed temporal lobe epilepsy and caution 
should be exercised in patients taking epileptogenic drugs such as phenolhiazines. 
Herbal sedatives, e.g. hypericum. may affect the activity of antidepressant drugs and it is 
possible that any sedative herb may interfere with the activity of analgesic and 
antiepileptic drugs. 
16.2.4 E n d o c r i n e system 
Drugs acting on the endocrine system including antidiabetics, corticosteroids and 
oral contraceptives may interact with herbal remedies.(NewaI] CA & Phillipson D) 
Alfalfa has hypoglycaemic activity whereas deviFs claw is reportedly hyperglycaemic 
and therefore it is possible that co-administration of these herbs with conventional 
diabetic therapy may result in adverse effects. 
16.3 Reasons c o n t r i b u t i n g to h e r b - d r u g interact ions . 
16.3.1 Lack of Knowledge Abou t H e r b s 
In USA, nearly 300,000 higher plant species and only approximately 10 percent 
have been carefully assessed for their medicinal and toxic properties. In China, nearly 
12,807 species of herbal medicine could use, 11,146 are plants species and 1,581 are 
animal species and 50 kinds of mineral herbs. Nearly 200 species are always used in 
medical treatment. Even an experienced herbalist might not be familiar with more than 
]000-2000 of these species. Doctors who rely on standard Western medicine are apt to 
be even less knowledgeable in this area. 
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16.3.2 Misiabel i inj^ o r A d u l t e r a t i o n 
Such mislabelling or adulteration may account for some of the problems noted with 
in the reactions with prescription medicines, thus complicating the scientific assessment 
of herbal-drug interact ions. (Horowitz S, 2000) 
1 6 3 . 3 L a c k of P a t i e n t C o m m u n i c a t i o n A b o u t Use of Botan ica l s 
Despite the steadily increasing popularity of medicinai herbs, surveys indicate that 
only a small percentage of patients disclose such usage to their mainstream physicians 
and pharmacists. Patients may neither report or be asked about their diets and use of 
nutritional supplements. Furthermore, such surveys reveal that a majority of patients do 
not inform their allopathic physicians of herbal use because of fear of the practitioners' 
disapproval of alternative medical treatments and the conventional top-down 
information flow from physician to patient. 
16.3.4 L a c k of P r a c t i t i o n e r K n o w l e d g e A b o u t Po ten t i a l I n t e r ac t ions 
While the trend toward more integrative or complementary medical practice and 
education continues, information regarding potential harmful interactions between 
herbal and pharmaceutical drugs is still largely lacking in mainstream medical school 
curricula and professional literature.(Horowitz S, 2000) 
16.4 Me tabo l i sm and H e r b - D r u g I n t e r a c t i o n s 
Many herbs and drugs are metabolized by the liver into inactive derivatives. The 
rate at which the liver metabolizes these herbs and drugs determines the length of time 
these herbs or drugs stay active in the body. If the liver were induced to speed up its 
metabolism, herbs and drugs would be inactivated at a faster pace and the overall 
effectiveness of ingested substances would be lower. On the other hand, if the liver 
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were induced to slow down its metabolism, herbs and drugs would be inactivated at a 
slower pace and the overall elTecliveness of the substances would be higher. 
In general, drugs thai induce liver metabolism do not exert an immediate effect. 
The rate of liver metabolism changes slowly over several weeks. Therefore, the effect of 
increased liver metabolism is not seen until weeks a f k r the initiation of drug therapy. 
Some examples include Dilantin (phenytoin). Tegretol (carbamazepine), phenobarbital 
and rifampin. These drugs speed up liver metabolism. Therefore, the herbs may be 
inactivated faster and their overall effectiveness may be lower. Under such 
circumstances, the patient may need a higher dose of herbs to achieve the desired 
effectiveness. 
On the other hand, drugs that inhibit liver metabolism have an immediate onset of 
action. The rate of liver metabolism may be greatly impaired within a few days. 
Therefore, there is a higher risk of herbs accumulating inside the body as the function of 
the liver to inactivate them is compromised. Examples of drugs that slow down or inhibit 
liver metabolism include, but are not limited to. Tagamet (cimetidine), erythromycin, 
ethanoL Diflucan (fluconazole). Sporonox (itraconazole) and Nizoral (ketoconazole). 
Therefore, the herbs may be inactivated more slowly and the overall effectiveness may 
be prolonged, in this case, one may need to lower the dosage of herbs to avoid 
unwanted side-effects‘ 
16.5 P h a r m a c o l o g i c In t e r ac t i ons 
It should be noted that there is more theorizing to date about herbal-drug 
interactions than experimental data; patients tend to underreport such crossreactions to 
allopathic physicians and pharmacists.(Horowitz S, 2000) In addition, much clinical 
experience of such metabolic interaction problems is typically based on a small number 
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of patients and a re specific product-related and dose-relalcd. 
In clinical practice, polypharmacy is common, and to the mixture physicians 
prescribe, patients add various over-the-counter medications, vitamins, herbs, and foods. 
All ingested substances have the potential to interact. (Berman AF, 2000) 
16.5.1 In t e r ac t i on with Ant ibiot ics 
Tetracycline hydrochloride and St. John's wort act synergistically to increase the 
photosensitivity side-effect of each medicine.(Horowitz S, 2000) Besides herbs: mineral 
supplements, such as calcium, iron, magnesium, and zinc, can prevent the absorption of 
tetracycline, ciprofloxacin (Cipro) and other antibiotics, if taken together with such 
pharmaceuticals. Even grapefruit juice was recently found to inactivate medications 
used to treat allergies, cancer, heart failure, and high blood pressure, as well as for 
immunosuppression in patients who receive organ transplants. The juice also was found 
to increase the potency of some antihistamines and calcium-channei blockers.(Herbst D, 
1999) 
16.5.2 i n t e r ac t i on with Nonsteroidal A n t i - i n f l a m m a t o r y Drugs 
The NSAIDS should not be used with herbal medicinals that are known to cause 
gastrointestinal damage.(Miller LGPB, 1999) Gossypol has been associated with tissue 
congestion, mucosal sloughing, mucosal necrosis, and ileus and intestinal wall 
.iiemorrhage.(Wailer OP, Zaveveld UD et ai’ 1985) Other gastric irritants include 
Arctostaphylos uva-ursi, Rula graveolens, Cetraria islandica, Sanguinaria canadensis, 
Chamaelirium lutewn，Schinus terebinthifolia, Cqffea arabica, Schimis molle, Cola 
acuminata, Symplocarpusfoetidus, Cola nilida, Trillium erectum, and Quill aj a 
saponcir丨a.(Smet PAAD, Hansel R et al, 1993; Smet PAAD, Hansel R et al. 1996) Hence, 
a patient complaining of unexpected gastrointestinal upset should be questioned 
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regarding herbal nicdicinal use and concomitant use with known gaslroinleslinal irritants, 
such as NSAIDs, should be avoided. 
16.5.3 I n t e r a c t i o n wi th Seda t ives 
In general, concomitant use of herbs and drugs that produce similar effects is best 
avoided.(Horowitz S. 2000) This rule applies to herbs utilized as anti-anxiety drugs and 
sleep aids such as kava and valerian (Valeriana officinalis), which are liable to enhance 
the sedating or tranquilizing cfleets of psychopharinacologic drugs such as Valium 
(diazepam),other benzodiazepines, and night time pain formulas containing 
diphenhydramine. 
Kava is used as a sedative to enhance sleep.(MiHer LGPB, 1999) Long-term use is 
not advised because tolerance has been shown to develop rapidly in animals.(Duffield 
PH & Jamieson D, 1991) Additionally, long-term use has led to kawaism, which is 
characterized by dry. flaking, discolored skin and reddened eyes.(Ruzo P, 1990; Norton 
SA & Ruze P. I 994) The toxicity o f kava is increased if taken with alcohoL 
a-Pyrone. the active component of kava, has been found to have weak effects on y-
aminobutyric acid and benzodiazepine receptors in vitro, although this has been 
disputed.(Davies LP. Drew CA et al, 1992; Davies LP, Drew CA et al, 1992; Jussofie A, 
Schmiz A et a l 1994) Synergism between a-pyrones and other active sedatives with y-
aminobutyric acid was verified in 1994 by a German study group.(Almeida JC & 
Grimsley EW‘ 1996) However, concomitant use with benzodiazepene is ill advised 
based on a case of coma following concomitant use. 
A 54-year-old man was hospitalized in a lethargic and disoriented state.(Stimpel M, 
Proksch A et a l 1984) His medications included alprazolam, cimetidine. and terazosin 
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hydrochloride; his alcohol levels were negative and his drug screen was positive for 
benzodiazepine. He became more alert alter several hours and staled tliat he had been 
taking kava for 3 days; he denied overdosing on kava or alprazolam.(Stimpel M, 
Proksch A et al, 1984) The kava-alprazolam drug interaction was identified as the cause. 
Mixing kava and valerian may also produce excess sedation or worse. Patients 
have been hospitalized for being disoriented and extremely lethargic after ingesting such 
combinations even on a short-term basis. 
16.5.4 Interaction with Anticoaguiants 
Several herbs are popular because of their clot-protective benefits, such as garlic 
{Allium saliviwi) and ginger {Zingiber o/Zzcm^/e).(Horowitz S, 2000) Herbs with 
anticoagulant effects include herbs that have blood-activating and blood-stasis-removing 
functions. In general concomitant use of herbs and drugs that produce similar effects is 
best avoided. Several case reports have documented increased bleeding problems with 
oinkuo (Ginkgo biloba), with or without concomitant anticoagulant drug therapy, and 
interactions between warfarin and Panax ginseng (ginseng) or Angelica sinensis (dong 
quai). Herbs that interfere with Coumadin (warfarin) include Sal viae Milliorrhizae (Dan 
Shen), Ligiislici Chuanxiong (Chuan Xiong), Persicae (Tao Ren)’ Carlhamus Twctorii 
(Hong Hua) and Hirudo seu Whitmania (Shui Zhi). The synergistic interaction between 
herbs and Coumadin (warfarin) may be advantageous for the patient as the dosage of 
both the herbs and the drugs can be reduced without compromising clinical effectiveness. 
The reduction in dosage will also decrease the frequency and severity of side effects of 
the drugs. Any anticoagulant drug, such as aspirin, may cross react with blood-thinning 
herbs such as ginkgo and feverfew {Tanacetum parlhenium), and may seriously reduce 
the platelet aggregation needed for postsurgery clotting.(Miller LGPB, 1999) Based on 
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the potential interaction of herbal medicines with ancslhclics. I he American Socicty of 
Anesthesiologists advises physicians to ask their patients about what herbal supplements 
arc being used and to tell patients to discontinue use of the se herbs 2 - 3 weeks prior to 
surgery.(see Table 16 c) 
16.5.5 I n t e r a c t i o n wi th A n t i h y p e r t e n s i v e s and Diure t ics 
Use of herbs to excess or in combination with thiazide-type diuretics that are used 
to treat high blood pressure and edema, however, can lead to hypokalemia, a serious 
condition resulting from potassium loss.(Horowitz S, 2000) Licorice (Glycyrrhiza 
glabra) taken with diuretics, or with stimulant laxative herbs such as cascara sagrada 
(Rhamniis purs hi ana or senna (Cassia senna), can also deplete potassium and even 
triooer a life threatening arrhythmia. Herbal and other medicines that are used lo treat 
the same condition should probably not be used together such as in the case of using 
aarlic with other hypertensives. Such "doubling dosing” may IOWLT blood pressure too 
drastically.(Milier LGPB, 1999) 
Goldenseal is an aquaretic. but is referred to by most herbalists as a diuretic. Other 
herbal diuretics include agrimony, artichoke, boldus, broom, buchu, burdock, celery 
seed, zea, coughgrass. dandelion, elder, guaiacum. juniper, pokeroot, shepherd's purse, 
squill uva-ursi, and yarrow.(NewaII CA. Anderson LA el al. 1997) The differentiation 
between a diuretic and an aquateric is of clinical significance because with diuretics, 
sodium is excreted with the water whereas with aquateric, sodium is not excreted. 
Therefore, aquateric are not well suited for the treatment of edema and hypertension and 
may in fact worsen it. If taken with a diuretic (eg, hydrochlorthiazide) or any allopathic 
antihypertensive drug, it is conceivable that the antihypertensive effects will be 
diminished or offset as sodium is retained.(Miller LGPB, 1999) 
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16.5.6 Interaction with Spironolactone 
Licorice may offset spironolactone's effects.(Miller LGPB, 1999) Licorice is 
advocated as an antispasmodic and anti-inflammatory herb for use in gastritis and peptic 
ulcer disease. The hemisuccinate derivative of glycyiThetainic acid, a component of 
licorice, is carbenoxoloiie, which is used ailopathically for duodenal and gastric 
ulcers.(Reynolds JEF. 1989) Licorice renders the patient unable to convert 11-
deoxycortisol or deoxycorticosterone into the active glucocorticoids, Cortisol and 
corticosterone. respectively.(Gomez-Sanchez CE & Yamakha N, 1995) This acquired 
]l-p-hydroxylase deficiency results in sodium retention, hypertension, and 
hypokalemia.(Gomez-Sanchez CE & Yamakita N, 1995) it l~i 11"! 1 d s ^ � s to 3 \ o 
the discontinuation of the licorice regimen, the blood pressure will return to 
baseline.(Biachley JD & Knochel JP, 1980; Piccoli BC, Salvade S et al, 1985) Given the 
underlying mechanism of licorice's effect on hypertension, spironolactone's 
antihypertensive effects may be diminished by licorice. Conversely, hypertension caused 
by licorice may be effectively treated with spironolactone. 
16.5.7 Interaction with Corticosteroids and Cyclosporine 
The theoretical concern underlying this drug-herb interaction is that 
immunostimulating herbs will offset or minimize the immunosuppressive effects of 
corticosteroids and cyclosporine. Echinacea is classified as an immunotonic agent 
because of its ability to augment basophils, mast cells, and white blood cell 
counts.(Stimpel M, Proksch A et a l 1984) Astragalus stimulates T-cell activity and 
ginseng is thought to nourish major immune system glands but in an unspecified 
manner.(Jin R, Wan LL et al, 1995) Licorice root supposedly stimulates interferon 
production and pau d'arco with its antioxidant and anti-infiammatory activity has been 
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recommended for use by herbalists lor immunodeficiencies. (Dinnen RI) & Ibibuzaki K, 
1997; IJlsunomiya 1\ Ko bay as hi M et ai, 1997) Alfalfa sprouts and some vitamin E 
products contain toxic amino acid L-canavanine that has been implicated in cases of 
systemic lupus erythematosus and other autoimmune diseases.(Herbert V & Kasdan TS, 
1994) 
16.5.8 In t e r ac t i on with Est rogen I l ep i acemen t T h e r a p y 
Theoretically, concomitant use of phytoestrogens with estrogen replacement may 
result in symptoms of estrogen excess such as nausea, bloating, hypotension, breast full-
ness or tenderness, migraine headache, and edema.(MiHer LGPB, 1999) Phytoestrogens 
are naturally occurring plant or food substances that are functionally similar to 
estradioL(Kincheloe L � M i l l e r LG et al, 1998) While more than 500 plant species 
contain phytoestrogens, the more common herbs include dong quai, red clover, alfalfa, 
licorice, black cohosh, and soybeans.(Costeiio C\ 1950: Holt S, 1997) To date, no 
incidents of estrogen excess have been reported following concomitant use, but 
prudence would dictate avoiding simultaneous use if al all possible. 
16.5.9 In te rac t ions between N a t u r a l P r o d u c t and D r e g s 
Evidence for natural product - drug interactions in which effects on drug 
metabolism occur is growing. Interactions between natural products and drugs are based 
on the same pharmacokinetic and pharmacodynamic principles as drug-drug interactions. 
Natural products, like drugs, can affect cytochrome P-450 (CYP) isozymes. The best-
investigated metabolic interactions are those involving St. John's wort. For example, 
herbs such as Zinc lozenges taken for the common cold can chelate fluoroquinolones 
and tetracyclines, re suiting in lower serum antimicrobial levels. St. John's wort 
(Hypericum perforatum) induces intestinal P-glycoprolein, which may decrease the 
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absorption of common P-glya)pK)tcnn substrates, such as digoxin. etc. (Dun- LX Sliegcr 
B et al, 2000) 
Of interactions involving natural products, those that occur because of changes in 
volume of distribution are probably the least clinically important. Theoretically, a drug 
with high plasma protein binding that has a small volume of distribution can be 
displaced by a natural product competing for the same binding sites. Because an increase 
in metabolism or excrction usually offsets higher serum drug levels, the clinical effccl 
may be transient or may be meaningful only when drugs are added or discontinued. 
Theoretically, acscin, a constituent of horse chestnut seed (Aesculus hippocaslcmum), 
might interfere with highly plasma proleinbound drugs, such as warfarin.(Rolhkopf M, 
Vo^el G et aL 1977) Natural product-drug interactions that involve distribution 
mechanisms have not been reported. 
16.6 Herb- to -Herb Interactions 
Cases of pharmacodynamic interactions have also been documented in Oriental 
Medicine.(Chen J, 1998) The additive 
accentLiaiion (Xiang Xu) or mutual enhancement (Xiang Shi), such as the combination 
of Gypsum (Shi Gao) and Rhizoma Anemarrhenae (Zhi Mu) to "clear heat and purge" 
fire. The antagonistic effect is generally referred to as mutual counteraction (Xiang Wei), 
mutual suppression (Xiang Sha) or mutual antagonism (Xiang Wu). such as the 
combination of Semen Raphani (Lai Fu Zi) and Radix Ginseng (Ren Shen): in which the 
effect of the latter herb is decreased. 
In addition, classic Chinese texts slate numbers herb-to-herb interactions, such as 
the E igh teen Incompa t ib l e s (Shi Ba Fan) and Nineteen C o u n t e r a c t i o n s (Shi Jiu Wei). 
Eighteen Incompatibles (Shi Ba Fan) is a classic list of eighteen herb-to-herb 
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interactions. Nineteen Counteractions (Shi Jiu Wei) is a classic list of nineteen herbal 
combinations in which the herbs counteract each other. Combinations of such herbs will 
likely lead to adverse side effects and/or toxic reactions. 
Tabic 16 a. T h e list of Eighteen I n c o m p a t i b l e s (Shi Ba F a n ) & Nine teen 
C o u n t e r a c t i o n s (Shi J iu Wei) . (Chen J , 1998) 
E igh teen i n c o m p a t i b l e s (Shi Ba Fan)  
Radix Glycyrrhizac (Gan Cao) incompatible 珍 Radix Euphorbiae Kan sin (Gan 
Sui), 
# Radix Euphorhiue sen Knoxiac 
(Da Ji). 
# Gcnkwa (Yuan I iua), 
# ticrha Sargassum (Mai Zao)  
Rhizoma Aconili (Wu Ton) Incompatible 罄 Bi^lhus FritilIariae Cirrhosac 
(Chuan Bei Mu)， 
像 Bill bus Frilillariae Tlmnhcrgii 
(Zhe Bci MuX 
# Fruclus Trichosanlhis (Gua Lou), 
# Rhizoma PineUiae (Ban Xia), 
像 Radix Ampelopsis (Bai Lian), 
Rhizoma Blelillae (Bai Ji)  
Rhizoma el Radix l,era!n- (U incompatible _ Radix Ginseng (Ren Shen). 
Lu) • Radix Glehniae (Bei Sha Shen), 
# Radix Adenophorae (Nan Sha 
Shen), 
e Radix Sophorae Flavescen/is (Ku 
Shen), 
# Radix Salviae MilHorrhizae (Dan 
Shen), 
# Radix Scrophulariae (Xuan Shen/, 
Radix Paeoniae Alba (Bai Shao), 
春 Radix Paeoniae Rubra (Chi Shao), 
# Herha Asari (Xi Xin).  
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N i n e t e e n C o u n t e r a c t i o n s (Shi J i u Wet )  
Sulfur (Liu Huang) & Mirahilitum (Viang Xiao)  
Mercury (Shui Yin) & Arsenal He (Pi S huang)  
Rhizoma Euphorhiac E. (Lang Du) & Lithargyrwn (Mi Tuo Seng)  
Semen Crotonis (Ba Dou) & Semen Pharhitidis (Qian Niu Zi)  
Flos Caryphyili (Ding Xiang) & Radix Curcumac (Yu Jin)  
NUrum (Ya Xiao) & Rhizoma Sparganii (Shan Ling)  
Cornu Rhinoceri (Xi Jiao) & Rz. Aconiti Kusnezoffii (Cao Wu)  
Conni Rhinoceri (Xi Jiao) & Rhizoma Aconiti (Chuan Wu)  
Radix Ginseng (Ren Shen) & Rhizoma Trogop(erorum (Wu Ling Zhi) 
Cor(ex Cinnamomi (Ron Gui) & llallosHum Rub rum (Chi Shi Zhi)  
16.7 C o n c l u s i o n 
Natural products can interact with drugs and with other natural products by the 
same pharmacokinetic and pharmacodynamic mcchanisms as drugs. Herb-drug 
interactions occur but are under-researched. In many cases there is no plausible 
mechanism to explain the observed phenomena and causality is uncertain. Many 
medicinal herbs and pharmaceutical drugs are therapeutic at one dose and toxic at 
another, however, little is known about the incidence and consequences of drug 
interactions. interactions between herbs and drugs may increase or decrease the 
pharmacological or toxicological effects of either component. Synergistic therapeutic 
effects may complicate the dosing of long-term medications. Pharmacists must also be 
aware that natural products may have variable potencies, unidentified components, 
unproven efficacy’ and unknown adverse effects and interactions. To reduce the risk, 
pharmacists should recommend only those products that are manufactured to high 
quality-control standards. Natural product information resources should provide 
objective’ complete, referenced information, including data on interactions and adverse 
effects, to help health care practitioners provide accurate information to consumers. A 
reference that is regularly updated will provide the most useful information. Some online 
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refcrcnccs olTcr more frequent updates than printed references, but these may not be 
easily accessible in all sellings. Pharmacists should consult reliable, independent sources 
of information on natural products rather than rely on literature provided by 
manufactured to high quality-control standards. 
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Chapter 17 - Recommendation 
17.1 O v e r v i e w 
Medicinal plants and herbal medicines have been used for thousands of years and in 
many cases there is already a strong body of knowledge on their use. Patients who use 
herbal remedies often self-diagnose and may delay seeking medical attention. 
17.2 T h e need to eva lua t e the clinical e f fec t iveness of t r a d i t i o n a l Ch inese med ic ine 
Some scientists believe that a regulation drive will bring necessary iegilimacy to 
the traditional remedies. But others fear that it could confer false legitimacy on 
compounds that have no proven medical value.(Cyranoski D, 2001) As herbs are 
increasingly packaged and advertised to compete with pharmaceutical drugs, consumers 
and healthcare providers expect botanical products to meet comparable quality standards. 
However, quality control and manufacturing standardization are not required of herbal 
medicines in many countries such as the United States. (Because botanical medicinals 
are classified as dietary supplements, they must comply only with the Good 
Manufacturing Practice (GMP) regulations for foods.)(Rotblatt MD, 1999) Even the 
FDA is considering more extensive GMP regulations for dietary supplements, but has 
not yet finalized those standards.(Rotb]att MD, 1999) Furthermore, herbal medicines 
products are not, in general, subject to patent protection. This reduces the motivation for 
drug companies to invest in trials.(Linde K, Gerben ter R et al, 2001) Many of the 
existing herbal medicine manufacturers are comparably small companies, often with 
limited research resources and expertise. May be partly for these reasons, the quality of 
many older herbal medicine trials is low. Moreover, negative trials which could threaten 
the company's survival might not become published. 
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Standardization o i� spec i f i c active constiluenls within herbal medicincs is also 
proving to be di01 cull and complex, unlike that of drug products with a single chemical 
entity. Standardization often implies that the preparation contains a designated 
percentage of a certain chemical component thought lo be therapeutically active. 
Traditional Chinese medicine and those botanicals may contain hundreds of bioaclive 
chemicals, however, and the compounds responsible for thcrapculic activity are usually 
not known. Moreover, additive or synergistic activit)' of�several constituents may be 
required for elTectiveness. In the case of herbals, there lore, standardization is not a 
reliable control lor pharmacologic activity; instead, it is best thought of as a control for 
accurate plant identification or for batch-to-batch rcplicability.(Rotblan MD, 1999) 
Although many ethical herbal medicine manufacturers are thought to be producing 
high-quality products with carcful identification procedures, batch-to-batch 
standardization- and assays for impurities, it is difficult to identify which brands and 
products meet even basic quality standards. In the abscnce of gencric equivalents and 
reizulatorx' standards of quality, health care professionals and patients considering to 
prescribe or lake a pailicluar herbal product should check carefully whether the 
respective product or extract has been tested in the trials included in a review. (Linde K. 
Gerben ter R et a l 2001) 
17.3 F o r the P h a r m a c e u t i c a l Indus t r i e s 
1. To facilitate control and minnnize poisoning incidents, various administrative 
measures have been levied to ensure the authenticity and quality of Chinese 
medicines and also the qualifications of practitioners and dispensers. The circulation 
• f many potent toxic herbs are restricted by laws. For example, in Mainland China 
and Taiwan, respectively. 27 and 31 potent herbs are controlled. Only qualified 
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practitioners and dispensers arc allowed to prcscribc or handle these potent herbs. 
(But PPI-L Tai YT et a I 1995) 
2. Pharmacists must stay informed and keep up with new developments of herbal 
medicine and have a responsibility to educate themselves about herbal therapies in 
order to help patients discern the facts from the fiction, avoid harm, and gain what 
benefits may be available.(Klepser TB & Kiepser ME. 1999) 
3. The products should be reviewed as any other drug, evaluating for drug-related 
problems such as allergies, drug-drug, drug-disease, or drug-food interactions, and 
possible therapeutic duplication. 
4. Government should increase effort in research and development for the 
standardization of the active ingredient in the herbs such as DNA fingerprinting 
analyzes herbs by using polymerase chain reaction to identify the active ingredients 
by their DNA characteristics.(Briggs K, 2000) 
5. Supplements with known harmful effects or questionable efficacy should not be 
recommended. 
6. Pharmacists should inform consumers about the lack of GMPs and thus the risks of 
contamination, adulteration, and inadequate or excessive concentration of the active 
ingredient. 
7. As more research with dietary supplements is conducted and better controls and 
regulations are implemented, there will likely be increasing use of complementary 
medicine, both as sole therapy and in conjunction with allopathic medicine. 
17.4 F o r the phys ic ians & pa t ien t 
1. It is important for physicians and other healthcare providers to establish open 
communication with their patients regarding the use of herbal medicine and dietary 
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supplements. Many patients are unwilling to inform their physicians, fearing 
disapproval and perceiving a lack of knowledge and understanding in their 
physicians. A British survey reported that more than 40% of patient would not 
consult their family doctor or seek medical advise even they got a serious adverse 
reaction from herbal medicine.(Tang JL & Leung PC, 2001) Inquiring about the use 
of herbs, vitamins, and other remedies should be part of normal history taking, 
along with other questions about social habits and background. Physicians often talk 
with patients about controversial subjects, so discussing the merits and drawbacks 
of herbs does not require new skills.(Cisenberg DM, 1997; Zink T & Chaffin J, 
1998) 
2. When communicating with the patient, the physician should pose questions that are 
direct, neutral, and nonjudgmentai. Patients often consider herbal remedies as 
natural products or food and not as medicine. They assume, therefore, that herbal 
remedies are free from side effects. 
3. Physicians need to emphasize that many pharmaceuticals were originally derived 
from plant products and that herbal remedies can be as potent as pharmaceuticals. 
4. Physicians need to ask specific questions regarding the the use of vitamins, minerals, 
herbs or other botanicals, amino acids, concentrates，metabolites, extracts, and any 
other dietary substances being used by their patients and they should also obtain 
information about directions for use. methods of preparation, and dosage 
formulations. It is especially important for physicians to inquire about method of 
preparation when raw botanicals are being used. 
5. Patients should be asked whether they have consulted with other healthcare 
providers, e.g.. acupuncturists, herbalists, naturopathic practitioners, or natural 
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healers. Asking this question directly will oil en reveal other complaints, other 
symptoms, or the choice of alternative treatments, including herbal medicine. 
6. Knowing the method by which an herbal remedy has been prepared is important, 
because many toxic herbs can become relatively safe for use if they have been 
processed properly. 
7. In suspected adverse reactions, the physician should secure the prescriptions, 
packaging, residue of the herbs used, samples of unused herbs still possessed by the 
patient, and samples of the herbs dispensed by the same herb shop using the 
prescription, and physicians should also obtain an estimate of the amount of herbs 
(or decoction) consumed.(Ko RJ, 1999) 
8. Patients should be advised to avoid using a wide variety of herbs concomitantly 
because herb-herb interactions are poorly understood. The starting dosage should be 
the lowest at which the desired effects occur. 
9. Long-term use of herbal products should be discouraged because long-term effects 
are unknown. 
17.5 Conclusion 
For the advancement of traditional medicine as well as conventional medicine, 
there should be a balance (or more appropriately an imbalance) between benefits and 
harm——useful treatments should be able to bring about more good than harm. The best 
way to demonstrate this balance is through a clinical trial though trials may not always 
be feasible or provide information within a desired time-frame, particularly when the 
harmful effect is with long-term use and rare. 
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Chapter 18 - Conclusion 
Chinese medicine has a documented history of over I wo thousand years. It is still 
serving as a major source ol'primary healthcare with satisfactory results in China and the 
Orient. Until recently, the safely of herbal preparations was considered in medical 
journals only when toxicity was detected from a contaminated herbal product, usually 
because of care less or unscrupulous manufacturing practices. Unlike other medications, 
the risk of unexpected effects may be influenced by a user's age, gender, genetics, 
nutrition status, and concurrent disease states and treatments. A toxic herb might replace 
the traditional one, a conventional drug might be added covcrtly, or a harmful 
contaminant might appear without the manufacturer's knowledge. As a result of limited 
oversight, consumers and clinicians alike should have concerns for safety, efficacy, 
contents, bioavailability, and dosing of the variety of products available on the market. 
True herbal toxicity, on the other hand, is almost certainly underreported. Users of 
herbal remedies are generally convinced of their safety and are therefore biased against 
reporting an adverse clinical event of possible herbal origin. Furthermore, physicians 
are often unaware of the herbs their patients are taking, either because they do not ask 
about them or the patient does not tell them. Indeed, half of the herbs taken by patients 
are not reported to their physicians. 
To heip maximize the benefits of Chinese medicine, the subject of safety of 
Chinese medicines deserves proper attention. Although excessive emphasis on adverse 
effects could stifle the development of TCM and lead to the rejection of efficacious 
therapies. In fact, as obvious in the cases mentioned above, many cases of adverse 
reactions were the result of human negligence or mistakes. 
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All medicinal agents have potentially unexpected ciTects including toxicity, and 
herbals are no different. If the raw herbs or herb powders are ingested without any 
processing or treatment, adverse reactions are likely caused by the naturally occurring 
medicinal compounds in the herbs or less often by heavy metal. However, toxicity from 
herb decoctions can be due to complicated chemical reactions of different herbs, heat 
stable medicinal compounds, and organic or inorganic contaminants in the containers 
used to boil the herbs. Due to the different methods of preparation, the physical and 
chemical characteristics of many medicinal compounds can aid in identification. On the 
other hand, herbal tea generally has a lower concentration of active ingredients and any 
adverse reactions are often from chronic consumption rather than acute poisoning. 
Base on the fact that our knowledge of the constituents of herbal medicines and their 
pharmacological and possible toxic effects is extremely limited. In this research thesis, I 
present a wide-ranging, though not exhaustive, review of reports in the English or 
Chinese language literature of adverse events involving Chinese herbs. 
Misidentification or substitution of the herbal components can result in outbreaks of 
severe poisoning. Plant misidentification may be due to similarities in appearance 
duriim bulk purchase or when harvested. In addition, confusing nomenclature or several 
terms with common, transliterated, Latin, and scientific names lead to misidentification. 
Inadvertent substitution of raw materials may cause adverse effects and contamination is 
a repeated problem due to lack of quality control. 
Besides renal and liver toxicity, many herbs (include heavy metal and insect) have 
their own pharmaceutical valve and unique side effects. This is to say that TCM has her 
own special evaluating standards, special disposal measures, as well as special 
observation index and cognitive methods, for instance’ seeking the cause form patterns 
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identified, etc. Such cxpcricncc should be developed with the help of modern scientiilc 
mode. 
For the Chinese proprietary medicines, it was much more difficult to collect 
toxicity information on this than on therapeutic drugs for several reasons. Many patients 
only knew the nature but not the brand name for the product they had taken. Different 
manufacturers may use almost identical brand names for their products, which differ in 
the contents. Unfortunately- only lew patients or physicians will be able to note the 
subtle differences in the nomenclature. Contamination of herbal products consumed by 
both adults and children with prescription and nonprescription drugs may lead to adverse 
clinical outcome and even death. Although the health authorities usually have a list of 
Chinese proprietary mcdicines containing western drugs, such information may not be 
readily available. This means a better quality control of imported Chinese proprietary 
medicines is very important. There should be regular monitoring of imported herbs for 
adulterants. Any outbreaks of poisonings should be fully investigated. Any use of fake 
herbs should always be prohibited. 
In Hong Kong or other cities, the exact incidence of poisonings by Chinese herbal 
medicines is difficult to assess. First of all the diagnosis can be easily missed if patients 
are not questioned with regard to the use these preparations. The second point is the 
existing knowledge of the pharmacological effects of Chinese herbal medicines is 
limited and each prescription typically consists of 10-15 herbs, which in turn contain 
many ingredients. Accompany with scratchy character mixed with secret signals always 
found in the prescription, especially for some old practitioner who worked within the 
herbal shop. The aim for this secret pothook was to compel the customers to buy the 
herbal material in their own shop every time. In addition, the herbalists are often 
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rcluclant to disc lose the contents o f their prescriptions. All this may increase the 
difficulties for investigation. As for western medicines, there was no government 
sclicme to monitor the safely of these compounds also. That is why patients may not 
report milder adverse effects. 
In TCM. however, the need to demonstrate clinical efficacy has not been widely 
recognized. For the past 50 years in China, resources have been focused on the search 
for the scientific basis of TCM, for the active substances used in therapies, and for the 
mechanisms of action. Experience shows that this mechanism-centered approach has 
been costly and largely unsuccessful. The advancement of TCM now requires thai the 
demonstration of clinical efficacy is placed high on 
tin ！ c^ sCiii C/li ci^ c^ I]dci，w itii ID S 
research taking place only alter efficacy has been clearly demonstrated in clinica! trials. 
More than this, attention was also called to those possible interactions between herbs 
and prescription drugs recently. 
At present only a small proportion of herbal remedies has been subjected to in-
depth pharmacological, analytical and clinical studies. The most basic requirement for 
quality assurance for herbal products is that the correct botanical ingredients should be 
used. This essential rule may be broken by adulteration, by erroneous substitution of 
herbal products. Toxicological data in animals do not necessarily reveal all human 
hazards. Clinical trials in human volunteers are often small. Moreover, the lack of 
stringent quality assurance for herbal medicines also necessitates monitoring the safety 
of these products. In fact, even lack of knowledge about the mechanisms and active 
substances involved does not have to prevent the use of clinically efficacious therapies. 
Many powerful medical interventions, such as penicillin and smallpox vaccinations, 
were accepted and widely used before their mechanisms were understood. 
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With the increasing complexity of medications available today, a comprehensive 
Herbal Adverse Reaction (HAR) surveillance program is necessary to detect, evaluate, 
and develop mechanisms to prevent HARs and their associated morbidity, mortality, and 
increased costs. For the long run, development of TCM may be best to conduct research 
ill the reverse order, commencing with demonstration of the clinical efficacy in humans 
using randomised controlled clinical trials. Clinical efficacy refers to the capacity of a 
drug to bring about more good than harm in treated patients and is what matters most for 
any medical intervention. In the efficacy-driven approach, investigation into the 
mechanisms and the search for active substanccs is also important, but should be 
undertaken after clinicai efTicacy is firmly demonstrated. 
In this era of regular review, it may also be appropriate to stress audits to ensure 
efficacy, safety and maximum cost-effectiveness. For clinical evaluation of herb-
induced poisoning, there should be a high index of suspicion and awareness of the 
problem. Close clinical-scientific collaboration should be available and mechanisms 
established for prompt notification of suspcctcd cases. This should lead to coordinated 
efforts to seek out possible offending agents and exclude alternative causes. Such 
assessments should include evaluation of the herbal prescription, pharmacognostic as 
well as chemical analysis of herb samples, herb residue and authentic herb decoctions. 
It 's worth to put more coordinated efforts to evaluate the potential hazards, to establish 
protocols for authentication and quaiity control, and to standardize the procedures in 
handling potent and strong herbs. At a scientific level, international, interinstitutional 
and multi-disciplinary collaboration should be facilitated. Critical scientific reappraisal 
of the use of Chinese medicines should be undertaken to provide scientific support of 
their anticipated efficacy. If an herbal therapy does not work clinically, then it should be 
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discarded and not subjected to further investigation. Demonstration of clinical efficacy 
first will thus save resources by avoiding unnecessary basic research into ineffective 
therapies. 
Finally, it should emphasis that Chinese herbs should only ever be prescribed by 
fully trained practitioners of Chinese herbal medicine, in accordance with a traditional 
individualized diagnosis. Chinese herbs should be prescribed in the traditional manner, 
according to an individualized diagnosis based on the theory and practice of Onental 
medicine. Moreover the herbs should be used according lo their traditional indications 
and in established combinations. 
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